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  Abstract 
ABSTRACT 
 
Of the many post-translational modifications organisms can undertake, glycosylation is the most prevalent 
and the most diverse. The research in this thesis focuses on the structural characterisation of glycosylation 
in two classes of glycopolymer (lipopolysaccharide (LPS) and glycoprotein) in two domains of life (bacteria 
and archaea). The common theme linking these subprojects is the development and application of high 
sensitivity analytical techniques, primarily mass spectrometry (MS), for studying prokaryotic glycosylation. 
Many prokaryotes produce glycan arrangements with extraordinary variety in composition and structure. A 
further challenge is posed by additional functionalities such as lipids whose characterisation is not always 
straightforward. Glycosylation in prokaryotes has a variety of different biological functions, including their 
important roles in the mediation of interactions between pathogens and hosts. Thus enhanced knowledge of 
bacterial glycosylation may be of therapeutic value, whilst a better understanding of archaeal protein 
glycosylation will provide further targets for industrial applications, as well as insight into this post-
translational modification across evolution and protein processing under extreme conditions. 
 
The first sub-project focused on the S-layer glycoprotein of the halophilic archeaon Haloferax volcanii, which 
has been reported to be modified by both glycans and lipids. Glycoproteomic and associated MS 
technologies were employed to characterise the N- and O-linked glycosylation and to explore putative lipid 
modifications. Approximately 90% of the S-layer was mapped and N-glycans were identified at all the 
mapped consensus sites, decorated with a pentasaccharide consisting of two hexoses, two hexuronic acids 
and a methylated hexuronic acid. The O-glycans are homogeneously identified as a disaccharide consisting 
of galactose and glucose. Unexpectedly it was found that membrane-derived lipids were present in the S-
layer samples despite extensive purification, calling into question the predicted presence of covalently linked 
lipid. The H. volcanii N-glycosylation is mediated by the products of the agl gene cluster and the functional 
characterisation of members of the agl gene cluster was investigated by MS analysis of agl-mutant strains of 
the S-layer. 
 
Burkholderia pseudomallei is the causative agent of melioidosis, a serious and often fatal disease in humans 
which is endemic in South-East Asia and other equatorial regions. Its LPS is vital for serum resistance and 
the O-antigen repeat structures are of interest as vaccine targets. B. pseudomallei is reported to produce 
several polysaccharides, amongst which the already characterised ‘typical’ O-antigen of K96243 represents 
97% of the strains. The serologically distinct ‘atypical’ strain 576 produces a different LPS, whose 
characterisation is the subject of this research project. MS strategies coupled with various hydrolytic and 
chemical derivatisation methodologies were employed to define the composition and potential sequences of 
the O-antigen repeat unit. These MS strategies were complemented by a novel NMR technique involving 
embedding of the LPS into micelles. Taken together the MS and NMR data have revealed a highly unusual 
O-antigen structure for atypical LPS which is remarkably different from the typical O-antigen.  
 
The development of structural analysis tools in MS and NMR applicable to the illustrated types of 
glycosylation in these prokaryotes will give a more consistent approach to sugar characterisation and their 
modifications thus providing more informative results for pathogenicity and immunological studies as well as 
pathway comparisons. 
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1 INTRODUCTION 
 
1.1 GLYCOSYLATION AND ITS SIGNIFICANCE ACROSS THE THREE 
DOMAINS OF LIFE 
 
1.1.1 Overview 
 
Glycosylation is the ubiquitous and covalent attachment of carbohydrates to proteins and lipids. All domains 
of life express an abundance of glycopolymers on their cell surfaces where they play important roles in cell-
cell interactions. Of the many post-translational modifications proteins can undergo, glycosylation is the most 
prevalent and the most diverse. Today, it is clear that both N-glycosylation and O-glycosylation, once 
believed to be restricted to eukaryotes also occur in bacteria and archaea (Eichler and Adams, 2005, 
Messner, 2004, Abu-Qarn et al., 2008a). In fact, prokaryotic glycoproteins and glycolipids rely on a wider 
variety of monosaccharide constituents than those of eukaryotes. In recent years, substantial progress in 
describing the enzymes involved in bacterial and archaeal glycosylation pathways has been made. It is 
becoming clear that enhanced knowledge of bacterial glycosylation enzymes may be of therapeutic value as 
this post-translational modification is seen with increasing frequency in pathogenic species (Szymanski and 
Wren, 2005), while the demonstrated ability to introduce bacterial glycosylation genes into Escherichia coli 
represents a major step forward in glycoengineering. 
 
The three-domain system as a biological classification was introduced by Carl Woese in 1977 (Woese and 
Fox, 1977). It divides cellular life forms into archaea, bacteria and eukaryote domains (Figure 1.1). In 
particular, it emphasises the separation of prokaryotes into two groups, originally called eubacteria (now 
bacteria) and archaebacteria (now archaea). Woese argued that since there was an increasing emphasis on 
molecular level comparisons of genes, initially on the basis of differences in their 16S rRNA genes as the 
primary factor in their classification, genetic similarity is more important than outward appearance and 
behaviour. Furthermore the eukaryotic genetic make-up at the molecular level related it more closely to the 
archaebacteria, rather than the eubacteria. 
 
 
Figure 1.1 – Phylogenetic tree of life. 
This image of a highly resolved tree of life, was first published by Ciccarelli and colleagues who generated the image based on 
completely sequenced genomes (Ciccarelli et al., 2006). Archaea are highlighted in green and eukaryotes are highlighted in 
red, whilst bacteria are highlighted in blue. 
 
17 
 
Chapter 1  Introduction 
With advances in molecular biology and improved analytical techniques a significant change of perception 
has taken place regarding prokaryotic glycoproteins. Glycosylation of proteins from prokaryotes is no longer 
considered an uncommon feature of a few organisms but has been demonstrated for many archaea and 
bacteria. So far, several differences in structure and biosynthesis have been observed in comparison to 
eukaryotic glycoproteins. Further, many prokaryotes produce polysaccharide arrangements (bacterial 
capsules, cell wall peptidoglycan or lipopolysaccharides) with extraordinary diversity in composition and 
structure. These glycopolymers are typically much more complex than those produced by plants and animals 
and are often partially composed of unusual monosaccharides rarely seen elsewhere in nature. Over 100 
different monosaccharides have been found in bacteria and their polysaccharides are often immunogenic to 
humans and are responsible for the specific immunological properties of a bacterial strain or type. 
 
Currently, heightened attention is focused on protein glycosylation in bacteria, primarily because of the 
increasing frequency with which this post-translational modification is seen in pathogenic species. 
Accordingly, research conducted in several laboratories over the past decade has served to decipher the N-
glycosylation pathway of the intestinal pathogen Campylobacter jejuni, making it the first bacterium for which 
such a complete pathway has been described (Szymanski et al., 2003, Szymanski et al., 1999). In addition, 
O-glycosylation has been shown to occur in several other bacterial pathogens, such as Neisseria 
gonorrhoea and Helicobacter pylori, with glycosylation-defective mutants displaying attenuated virulence-
associated properties (Szymanski and Wren, 2005). Such pathways of protein glycosylation in these 
pathogens, may offer novel therapeutic targets, and the achievement of expressing the C. jejuni pgl gene 
cluster in E. coli, raises the hope that protein N-glycosylation will be added to the menu of biological and 
biotechnological processes (Wacker et al., 2006, Wacker et al., 2002). Much less is known of the steps 
involved in this post-translational modification in archaea, despite the fact that the first non-eukaryotic N-
glycosylated protein was discovered over three decades ago in the haloarchaeon Halobacterium salinarum 
(Mescher and Strominger, 1976) and that N-linked glycoproteins are more prevalent in archaea than in 
bacteria (Eichler and Adams, 2005, Messner, 2004). These issues are addressed in more detail in the 
following sections (Sections 1.1.2.1, 1.1.2.2 and 1.1.2.3). First, though, key features of eukaryotic 
glycosylation are summarised so that similarities and differences in prokaryotic glycosylation can be more 
easily discussed. 
 
1.1.1.1 N-linked glycosylation in eukaryotes 
 
N-linked glycans in eukaryotic glycoproteins are attached to the amide nitrogens of asparagine side chains in 
the consensus sequon Asn-X-Ser/Thr, where X can be any amino acid except proline (Marshall, 1974). 
Nearly all N-glycans share a common core sugar sequence (Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-
4GlcNAcβ1-Asn-X-Ser/Thr. N-glycans of higher eukaryotes can be classified into oligomannose, in which 
only mannose residues are attached to the core, complex N-glycans, where antennae are attached to the 
core, and finally hybrid N-glycans in which only mannose residues are attached to the Manα1-6 arm of the 
core and one or two antennae are on the Manα1-3 arm (Varki et al., 2009). 
 
The general biosynthesis of eukaryotic N-glycans begins on the cytoplasmic face of the endoplasmic 
reticulum (ER) membrane with the transfer of GlcNAc-P from UDP-GlcNAc, catalysed by GlcNAc-1-
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phosphotransferase, to the lipid-like precursor dolichol-phosphate (Dol-P) to generate dolichol 
pyrophosphate N-acetylglucosamine (Dol-P-P-GlcNAc). Dolichol is a polyisoprenol lipid comprised of five-
carbon isoprene units linked linearly in a head-to-tail fashion. The number of isoprene units in dolichol varies 
within cells, cell types and organisms. The presence of 19 isoprene units means that the hydrophobic portion 
of this lipid is far longer than the fatty acid tails on membrane phospholipids, and this extended hydrophobic 
region is inserted into the lipid bilayer possibly in a helical or folded conformation. A second GlcNAc and five 
mannose residues are subsequently transferred in a stepwise manner from UDP-GlcNAc and GDP-Man, to 
generate Man5GlcNAc2-P-P-Dol on the cytoplasmic side of the ER. The Man5GlcNAc2-P-P-Dol precursor is 
transferred across the ER membrane bilayer so that the glycan becomes exposed to the lumen of the ER, by 
a “flippase” (Helenius et al., 2002). Man5GlcNAc2-P-P-Dol is then extended in the ER lumen by the addition 
of four mannose residues transferred from Dol-P-Man. Assembly of the Dol-P-P-glycan precursor is 
completed with the addition of three glucose residues donated by Dol-P-Glc. Dol-P-Man and Dol-P-Glc 
donors are formed on the cytoplasmic side of the ER from GDP-Man and UDP-Glc by transfer of the 
respective sugar to Dol-P and must therefore also be flipped across the ER bilayer for use by the 
mannosyltransferases and glucosylatransferases that catalyse the synthesis of the mature N-glycan 
precursor Glc3Man9GlcNAc2-P-P-Dol (Kornfeld and Kornfeld, 1985, Burda and Aebi, 1999). Once assembled 
the entire 14 sugar glycan is transferred en bloc from the lipid to a consensus sequon in a protein that is 
being synthesized and translocated through the ER membrane. A multisubunit protein complex in the ER 
membrane is responsible for catalysing this transfer. It is called the oligosaccharyltransferase (OST) and 
binds to the membrane-anchored Dol-P-P-oligosaccharide and transfers the glycan to the nascent protein by 
cleavage of the high-energy GlcNAc-P bond, releasing Dol-P-P in the process (Silberstein and Gilmore, 
1996). Yeast OST complexes have been purified and are comprised of nine different membrane-bound 
subunits, where Stt3p seems to be the catalytic subunit, which is accompanied by a total of seven additional 
proteins whose roles remain poorly understood (Lennarz, 2007, Kelleher and Gilmore, 2006, Alaimo et al., 
2006, Schulz and Aebi, 2009). This process is depicted in Figure 1.2a. 
 
The protein-bound N-glycan is subsequently remodelled in the ER and Golgi by a complex series of 
reactions catalysed by membrane-bound glycosidaseS and glycosyltransferases. The initial steps appear to 
be conserved among all eukaryotes and are now known to have key roles in regulating glycoprotein folding 
via interactions with ER chaperones that recognize specific features of the trimmed glycan. Processing or 
trimming of Glc3Man9GlcNAc2-Asn begins with the sequential removal of glucose residues by α-glucosidases 
I and II. Before exiting the ER many glycoproteins are acted on by an ER α-mannosidase I, which specifically 
removes a terminal α1-2Man to yield a Man8GlcNAc2 isomer. A further α-mannosidase I-like protein has an 
important role in the recognition of misfolded glycoproteins, targeting them for ER degradation. Glycans, 
containing between five and nine mannose residues are called high mannose oligosaccharides (Varki et al., 
2009). 
 
Biosynthesis of hybrid and complex N-glycans in multicellular eukaryotes is initiated in the medial-Golgi by 
the GlcNAcT-I catalysed addition of GlcNAc to the 2-position of the mannose α1-3 in the core of 
Man5GlcNAc2. The majority of N-glycans are then trimmed by α-mannosidase II, to form 
GlcNAcMan3GlcNAc2. Once the last two mannose residues outside the core are removed, a second GlcNAc 
is added to the 2-position of the mannose α1-6 in the core by the action of a GlcNAcT-II to yield the 
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precursor for all biantennary complex N-glycans. Tri- and tetra-antennary glycans result from the initiation of 
additional antennae by GlcNAcT-IV and V. Hybrid glycans are formed if the GlcNAcMan5GlcNAc2 glycan is 
not acted on by α-mannosidase II, leaving the peripheral residues intact and unmodified in the mature 
glycoprotein. Complex and hybrid N-glycans may carry a “bisecting” GlcNAc that is attached to the β-
mannose of the core by GlcNAcT-III. Further sugar additions, mostly occurring in the trans-Golgi, convert the 
limited repertoire of hybrid and branched N-glycans into an extensive array of mature, complex N-glycans. 
This includes sugar additions to the core, which in vertebrates is the addition of fucose as an α1-6 linkage to 
the GlcNAc adjacent to the Asn in the core. Invertebrates modify their cores more extensively with fucose, 
xylose and sometimes other sugars (Schiller et al., 2012). Elongation of the branching GlcNAc residues by 
sugar additions to produce the ubiquitous building block Galβ1-4GlcNAc is referred to as the “LacNAc” 
sequence. Capping or decoration of elongated branches involve the addition of sialic acid, fucose, GalNAc 
and sulphate to the branches (Varki et al., 2009). 
 
 
Figure 1.2 – General N-glycan biosynthesis pathways in the three domains of life. 
The above figure depicts the similarities and differences in N-glycosylation pathways in eukaryotes, bacteria and archaea. The 
figure collates prokaryotic N-glycosylation pathways from studies in H. marismortui (archaea) and C. jejuni (bacteria) and was 
adapted from a review by Dell and colleagues (Dell et al., 2010) 
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The N-linked glycans of an individual glycoprotein are usually heterogeneous and glycoprotein molecules 
with a common polypeptide chain but bearing different glycans are called glycoforms. The extent of this 
heterogeneity varies from protein to protein. High mannose structures are ubiquitous in all eukaryotes but 
are particularly abundant in lower eukaryotes. A large number of mammalian glycoproteins bear complex N-
linked glycans that exhibit heterogeneity in the degree of branching, the presence or absence of core fucose 
and bisecting GlcNAc residues, the presence or absence of polylactosamine extensions and a great diversity 
of terminal epitopes many of which are sialylated and/or fucosylated (Taylor and Drickamer, 2011). The 
complex type glycans of invertebrates are characterised by short antennae, highly modified cores, lack of 
sialylation and the presence of functionalities such as O-methyl and phosphorylcholine (Wilson, 2002, 
Haslam et al., 1997). In yeast and fungi, the high mannose glycans are extended rather than trimmed, and 
they serve a structural role, forming the outer wall of these single-celled eukaryotes. High mannose 
structures of N-glycans therefore represent an evolutionary precursor to the more complex glycans and a 
pre-existing pathway seems to have been adapted to generate glycans with more complex terminal 
elaborations needed for recognition purposes in multicellular organisms (Taylor and Drickamer, 2011). 
 
1.1.1.2 O-glycosylation in eukaryotes 
 
O-linked glycans are extremely diverse in both structure and function and the full extent of this diversity has 
not yet been established. In contrast to N-linked glycans, the groups of O-linked glycans are built on different 
protein-glycan linkages, in which sugars such as GalNAc, Fuc, GlcNAc, Man, Xyl, Gal and Glc can be 
attached to serine, threonine, tyrosine, hydroxyproline and hydroxylysine as is shown in Figure 1.3 (Spiro, 
2002, Elhammer et al., 1993). 
 
 
Figure 1.3 – O-linked glycosylation in eukaryotes. 
The schematic depicts the variety of protein-glycan linkages used by eukaryotes in O-linked glycosylation as adapted from 
Spiro and colleagues (Spiro, 2002). 
 
The best understood O-glycosylation in eukaryotes is mucin-type glycosylation in which O-glycans are 
covalently α-linked via a GalNAc moiety to serine or threonine. The first step of mucin-type O-glycosylation is 
the transfer of GalNAc from UDP-GalNAc to serine or threonine residues, which is catalysed by a 
polypeptide-N-acetylgalactosaminetransferase (ppGalNAcT), of which there are at least 21. Most of these 
enzymes are found in the Golgi and the subcellular localization of ppGalNAcTs and other 
glycosyltransferases involved in O-glycosylation has a critical role in determining the range of O-glycans 
synthesised by a cell. In contrast to N-glycosylation, no lipid-linked intermediates or glycosidases are 
involved in mucin biosynthesis and processing. The first sugar added to the protein in mucin biosynthesis 
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creates the Tn antigen (GalNAc-Ser/Thr). There are eight GalNAc-linked core structures (cores 1-8) in 
eukaryotes, most of which may be further substituted by other sugars. The ubiquitous mucin cores are 1 and 
2 (Wopereis et al., 2006). GalNAc is converted to core 1 (Galβ1-3GalNAc, also called the T antigen) by a 
core 1 β1-3 galactosyltransferase. In many serum glycoproteins and mucins, the T antigen is substituted by 
sialic acids at C-3 of galactose and at C-6 of GalNAc, which add a negative charge to the glycan and prevent 
further modifications of core 1. Core 2 mucin O-glycans are branched core 1 structures that are produced in 
many tissues, including the intestinal mucosa. The synthesis of cores 3 and 4 (GlcNAcβ1-3GalNAc and its 
branched analogue, respectively) appears to be restricted mostly to mucous epithelia from the 
gastrointestinal and respiratory tracts and the salivary glands. 
 
Although mucin-type O-glycosylation predominates in vertebrates, this is not the case in other eukaryotes 
where the alternative protein-glycan linkages mentioned earlier often predominate. Indeed, even in 
mammals, O-glycans attached via mannose, fucose or glucose, although rare, are important for certain 
functions (Varki et al., 2009). 
 
1.1.2 Glycosylation in prokaryotes 
 
Prokaryotes produce a variety of glycoconjugates and polysaccharides of enormous structural diversity and 
complexity. These glycans include many unusual sugars not found in vertebrates, including 3-deoxy-D-
manno-oct-2-ulosonic acid (Kdo), mannoheptose (Hep) and variously modified hexoses, which have 
important roles in the biology and pathogenicity of bacterial cells. Protein glycosylation was first 
demonstrated in the late 1930’s and was long thought to exist only in eukaryotes, but in 1970 the S-layer 
glycoproteins of Halobacterium salinarum (Mescher and Strominger, 1976) and some Clostridium species 
were found to be glycosylated (Messner, 2004). Diverse N- and O-linked glycans have now been identified 
and characterised in archaeal species (predominantly N-glycans) and in many bacteria (more O-glycans). 
The proteins modified in this way are found in the surface layer, the outer and inner membranes, the 
periplasm and pili and flagella or secreted from the cell. The glycans also undergo other modifications such 
as sulphation, acetylation and methylation. These glycoproteins have important roles including maintenance 
of shape, adhesion and antigenicity. 
 
1.1.2.1 Protein glycosylation in bacteria 
 
1.1.2.1.1 Overview 
 
Although bacterial glycans are more diverse than their eukaryotic counterparts, there are many similarities in 
the structures and biosynthetic pathways in mucosal pathogens, indicating that these modifications might 
have similar roles in multiple organisms (Szymanski and Wren, 2005). Studies of the biosynthetic pathways 
of prokaryotic glycoproteins are just beginning, but genetic information suggests that these systems range in 
complexity. For example, several species of Campylobacter contain gene clusters encoding a “general” 
glycosylation system that modify various proteins, whereas in other cases, the genes whose products modify 
a specific protein are located adjacent to the gene encoding the protein itself. C. jejuni has N- and O-linked 
glycosylation systems and is the cause of bacterial gastroenteritis worldwide and is thus used as a model 
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organism in bacterial glycosylation (Szymanski and Wren, 2005). The first protein N-glycosylation pathway 
was elucidated in C. jejuni and a cluster of 12 genes called the pgl locus (protein glycosylation) was found to 
be responsible for the synthesis of a heptasaccharide on bactoprenol and the transfer of the chain en bloc to 
asparagine residues. Discovery of the O-linked flagellin glycosylation system was based on the results of 
studies demonstrating that Campylobacter flagellins are sensitive to periodate oxidation and that they bind to 
a sialic-acid-specific lectin. The latter was shown to be due to the presence of pseudaminic acid and 
legionamic acid (analogs of sialic acid) decorating the flagella (Doig et al., 1996). Since then a wealth of 
information has been gathered about this system through studies in the native host, heterologous expression 
in E. Coli and in vitro analyses (Linton et al., 2005, Szymanski et al., 1999, Wacker et al., 2002, Young et al., 
2002). 
 
1.1.2.1.2 N-glycosylation in bacteria 
 
The N-linked protein glycosylation system in bacteria was originally thought to be involved in 
lipopolysaccharide (LPS) biosynthesis, but was subsequently shown to have a role in the glycosylation of 
multiple C. jejuni proteins (Szymanski et al., 1999). The N-glycans on C. jejuni glycoproteins were found to 
comprise a heptasaccharide and its biosynthetic precursors. The heptasaccharide is linked to Asn via 2,4-
diacetamido-2,4,6-trideoxyhexose (DATDH, also called bacillosamine) and has the sequence GalNAc-α1,4-
GalNAc-α1,4-[Glcβ1,3]-GalNAc-α1,4-GalNAc-α1,4-GalNAc-α1,3-DATDH-β1). In C. jejuni, the pgl gene 
cluster encodes, among others, five putative glycosyltransferases (PglA, PglC, PglH, PglI and PglJ) involved 
in the assembly of the heptasaccharide on a lipid carrier and PglB, responsible for the en bloc transfer of the 
glycan from the carrier to protein, in a pathway similar to that employed in eukaryotes (Figure 1.2) (Kelly et 
al., 2006, Linton et al., 2005). The central enzyme of the Pgl system is the oligosaccharyltransferase (OST) 
PglB, an integral membrane protein of 82kDa, which shares significant primary sequence similarity with Stt3 
of eukaryotic cells (Szymanski et al., 1999, Wacker et al., 2006, Wacker et al., 2002, Yan et al., 2003). PglB 
contains a conserved carboxy-terminal catalytic motif Trp-Trp-Asp-Tyr/Trp-Gly, of which the second and third 
amino acids are essential (Yan and Lennarz, 2002). In the C. jejuni OST, the eukaryotic sequon, N-X-T/S is 
N-terminally extended to Asp-Glu-X1-Asn-X2-Ser/Thr, where X1 and X2 can be any amino acid except proline 
(Kowarik et al., 2006), and although D-Q-N-A-T is the optimal bacterial acceptor sequence, not all sequons 
are glycosylated (Chen et al., 2007). 
 
In C. jejuni the heptasaccharide is built on the cytoplasmic side of the inner membrane on a lipid-linked 
precursor undecaprenyl phosphate (Und-P) (Linton et al., 2005, Reid et al., 2009, Alaimo et al., 2006, Kelly 
et al., 2006). The undecaprenyl pyrophosphate-linked heptasaccharide is assembled in the cytosol by the 
sequential addition of sugars from nucleotide-activated donors. The resulting lipid-linked oligosaccharide 
(LLO) is then translocated across the inner membrane into the periplasmic space by protein glycosylation K 
(PglK), an ATP-binding cassette (ABC)-type transporter “flippase” (Alaimo et al., 2006). The oligosaccharide 
is transferred to the amino group of Asn in the protein consensus sequence, or released into the periplasm 
as free oligosaccharides by the OST PglB (Figure 1.2b) (Wacker et al., 2002, Nothaft and Szymanski, 
2010). 
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Using synthetic glycan donors and a short acceptor peptide it was shown that PglB not only accepts 
saccharides of various lengths (2-7 sugars) in vitro but also accepts different sugars at the reducing end 
(Glover et al., 2005). X-ray crystallography and NMR of a C. jejuni glycoprotein showed glycosylation of a 
surface-exposed flexible loop that would be expected to be accessible to PglB (Nothaft and Szymanski, 
2010). Many diverse proteins are modified by the N-glycosylation pathway in C. jejuni, so it is not surprising 
that disruption of this pathway has pleiotropic effects for the bacterium, including reduced protein 
immunoreactivity with both human and animal sera (Szymanski and Wren, 2005, Szymanski et al., 1999), a 
reduced ability to adhere to and invade human epithelial cells in vitro and a decrease in mouse and chicken 
colonisation in vivo (Nothaft and Szymanski, 2010, van Sorge et al., 2009, Szymanski et al., 2002, 
Hendrixson and DiRita, 2004, Jones et al., 2004). 
 
The availability of an increasing number of complete bacterial genome sequences has revealed that 
organisms encoding orthologs of the C. jejuni N-glycan pathway constituents are much more widespread 
than originally predicted. Although the glycosyltransferase content and pgl gene distributions vary, the 
characteristic enzyme of the pathway, PglB is present in at least 49 species, with five species possessing 
two copies of pglB and all homologs containing the conserved Trp-Trp-Asp-Tyr/Trp-Gly motif that has been 
shown to be indispensable for PglB function in C. jejuni (Wacker et al., 2002, Szymanski and Wren, 2005). 
The apparent diversity in pgl gene distribution contrasts with the partial conservation of the neighbouring 
chromosomal DNA sequences and suggests that the pgl cluster has evolved under selective pressure in its 
host environment, a typical feature of pathogenicity-related gene clusters (Nothaft and Szymanski, 2010). 
The N-linked glycosylation locus is highly conserved among the proteobacteria and lacks putative phase-
variable genes and N-linked glycosylation takes place in the periplasm so that only proteins secreted across 
the inner membrane will become N-glycosylated suggesting that N-linked glycosylation allows for protection 
against proteolytic cleavage, enhancement of protein stability or signals for cellular sorting similar to 
eukaryotic N-linked glycans (Helenius and Aebi, 2001, Marceau and Nassif, 1999). 
 
1.1.2.1.3 O-glycosylation in bacteria 
 
O-Glycosylation is more widespread in bacteria than N-glycosylation and a detailed review of this type of 
glycosylation is outside the scope of this thesis. Some common themes are exemplified by the examples 
given below. 
 
C. jejuni modifies its flagellar proteins with unusual O-linked monosaccharides, which can constitute up to 
10% of the protein mass. The modifications are necessary for flagellum assembly and affect secretion of 
virulence-modulating proteins, bacterial colonisation of the gastrointestinal tract, auto-agglutination and 
biofilm formation (Guerry, 2007). The predominant sugars attached to the Campylobacter flagellum are 
derivatives of pseudaminic acid (Pse) or legionaminic acid (Leg), which are analogues of sialic acid. The 
flagellar apparatus of C. jejuni spans both the inner and outer membranes and O-linked glycoyslation of 
flagellin monomers is thought to occur at the cytoplasm interface. Cytidine monophosphate (CMP)-activated 
sugars including CMP-pseudaminic acid, CMP-legionaminic acid and their derivatives are individually added 
to surface exposed serine or threonine residues in the flagellin subunit, by glycosyltransferase FlaA (Nothaft 
and Szymanski, 2010). P. aeruginosa O-glycosylate their proteins in a similar manner to C. jejuni and their 
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pili contain O-linked pseudaminic acid derivatives, as do proteins of other Gram-negative pathogens, such as 
H. pylori and C. coli (Abu-Qarn et al., 2008a). 
 
In contrast to the above organisms Neisserial pathogens have an O-glycosylation machinery that has some 
of the hallmarks of protein N-glycosylation in C. jejuni. The pili of N. meningitidis (Stimson et al., 1995) and 
N. gonorrhoea (Hegge et al., 2004) contain galactosylated O-glycans linked to serine via DATDH, the same 
sugar that attaches the C. jejuni N-glycans to Asn (Section 1.1.2.1.2). The precursor O-glycan is assembled 
on the cytoplasmic side of the inner membrane on a lipid anchor, flipped into the periplasm where an O-
oligosaccharyltransferase, PglL then transfers the glycan en bloc to the protein acceptor (Nothaft and 
Szymanski, 2010, Faridmoayer et al., 2007). This is extremely unusual, since all other O-glycans studied to 
date are assembled via sequential addition of their monosaccharide constituents directly onto a protein 
acceptor (Aas et al., 2007, Dell et al., 2010). 
 
Another class of O-glycoproteins in bacteria are the surface-layer (S-layer) proteins. For glycobiologists S-
layer glycoproteins are of historical importance because they were the first prokaryotic glycoproteins to be 
identified over 40 years ago (Mescher and Strominger, 1976, Sleytr and Thorne, 1976), albeit the “bacteria” 
then studied were later classified as archaea (Section 1.1.1). Bacterial S-layer glycoproteins have been 
mainly found on Gram-positive organisms although recently they have been identified on a couple of Gram-
negative species (Ristl et al., 2011). Bacterial S-layer O-glycans have been found attached to tyrosine as 
well as serine and threonine. They contain both common and rare sugars as well as functionalities such as 
sulphate and phosphate. They are often comprised of repeating units reminiscent of bacterial 
polysaccharides (Section 1.1.2.2) and are therefore usually much larger than the O-glycans described 
above. 
 
1.1.2.2 Polysaccharides in bacteria 
 
1.1.2.2.1 Overview 
 
Bacterial polysaccharides are typically much more complex than those produced by plants and animals and 
they often contain unusual monosaccharides seldom seen elsewhere in nature. Bacterial polysaccharides 
have a variety of functions including roles as adhesion receptors, protection from desiccation, and resistance 
to infection by phage and resistance to destruction by their vertebrate hosts. Microbial polysaccharides are 
used in the food industry as thickeners, emulsifiers, gelling or viscosifying agents. Pathogenic bacteria 
commonly produce a thick, mucous-like layer of polysaccharide, which is like a capsule that cloaks antigenic 
proteins on the surface of the bacteria, which would otherwise produce an immune response. Capsular 
polysaccharides are usually water soluble, acidic and consist of regularly repeating subunits of 1-6 
monosaccharides. The assembly of capsules involves genes that are clustered in the bacterial chromosome 
in three continuous regions. This arrangement allows a simple mechanism for changing capsule types by 
merely swapping different serotype cassettes (Varki et al., 2009). LPS are the major constituent of the outer 
membrane of most Gram-negative bacteria. This class of bacterial polysaccharide is discussed in more detail 
below (Section 1.1.2.2.2) because one of the projects (Chapter 4) in this thesis is devoted to LPS 
characterisation. 
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Lipid A constitutes the hydrophobic component of LPS (Figure 1.4) which is located in the outer leaflet of the 
outer membrane. Attached to lipid A moieties, and displayed on the surface of bacterial cells, are 
polysaccharides composed of core oligosaccharides and variable numbers of O-antigen repeats (Raetz et 
al., 2007, Raetz and Whitfield, 2002). Lipid A comprises fatty acid residues linked both as esters and amides 
to C-3, C-3’ and C-2, C-2’ respectively of the β-1-6-linked-2-amino-2-deoxy-D-glucopyranose disaccharide. 
The C-1 and C-4’ of the backbone disaccharide are phosphorylated whereas the C-6’ is the site of 
attachment of the carbohydrate chain. The fatty acid residues that are directly linked to the disaccharide 
backbone (primary acyl groups) are 3-hydroxylated and hence can be esterified with non-hydroxylated or 
sometimes 2-hydroxylated fatty acids (secondary acyl groups) (Wang and Quinn, 2010). Lipid A usually 
constitutes a family of molecular species that differ in the type and/or the number of fatty acid residues. More 
frequently occurring fatty acids are 12:0 (3-OH), 14:0 (3-OH), 16:0 (3-OH), 10:0 (3-OH), 12:0 and 14:0. 
Longer-chain fatty acids as well as fatty acids with an odd carbon number or branched acyl groups have also 
been reported. Other possible sources of lipid A heterogeneity are oxidation of a 3-hydroxyl group of a fatty 
acid to a keto group, lack of a phosphate group (usually at C-4’) or the presence of further substituents on 
the phosphate groups, such as a monosaccharide, most commonly 4-amino-4deoxy-L-arabinose (α-L-
Ara4N). Lipid A is responsible for the major bioactivity of endotoxin and is recognised by the immune system 
as a pathogen-associated molecule, but the detailed structure of LPS varies from one bacterium to another 
and this variation could affect the virulence of the bacterium (Galanos et al., 1985). 
 
The carbohydrate moiety of LPS consists of two structurally and biosynthetically different parts, the core 
region, found in all LPS (Ogawa et al., 2007) and the O-antigen. LPS is designated as S or R type depending 
on whether O-antigen is present or not (Raetz and Whitfield, 2002). These are so-called because the 
presence or absence of the O-antigen determines the shape of the bacterial colony, which appears as 
smooth (S) or rough (R), respectively. The core oligosaccharide consists of up to 15 monosaccharide 
residues, and inner and outer moieties may be identified. The inner part generally begins with a 3-deoxy-D-
manno-oct-2-ulsonic acid (Kdo) residue, which is linked at C-6’ of the non-reducing glucosamine residue of 
lipid A. This first Kdo residue is either 4-phosphorylated or 4-glycosylated with the second Kdo residue or as 
in B. cepacia, a D-glycero-D-talo-octu-2-ulsonic acid (Ko) residue (Toman et al., 2004). In many bacteria the 
inner part contains several L-glycero-D-manno-heptose (Hep) residues (Ogawa et al., 2007). The outer core 
contains more traditional monosaccharides and is more structurally and compositionally diverse (Muller-
Loennies et al., 2003). The core oligosaccharide often shows heterogeneity owing to the presence of 
phosphate substituents and/or some constituent monosaccharides in non-stoichiometric amounts. 
 
The O-antigen is the most variable part of the LPS and usually represents a regular polysaccharide built up 
of repeating units consisting of one to six monosaccharide residues, whilst some O-antigens are 
homopolymers. The heterogeneity of the O-antigens with respect to the number of repeating units is 
responsible for the ladder-like profile of the smooth LPS in SDS-PAGE gels. Further decorations of the O-
antigens with non-sugar components, such as O-acetyl groups, various N-acyl groups, ether-linked methyl 
and carboxymethyl groups, pyruvic acid acetals, amino acids linked to carboxyl groups of hexuronic acids, 
amino alcohols linked via phosphate groups and other modifications are common. Sugar compositions of the 
O-antigens seem to have a relationship with the bacterial environment, for instance, 6-deoxy sugars appear 
to be prevalent in phytopathogenic bacteria (Toman et al., 2004), whereas acidic monosaccharides are 
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frequent in marine bacteria (Suits et al., 2008). Figure 1.4 shows a cartoon schematic of a 
lipopolysaccharide and modifications. 
 
 
Figure 1.4 – Cartoon representation of a lipopolysaccharide and modifications. 
The schematic shows a cartoon version of a lipopolysaccharide and its modifications, such as is found in B. pseudomallei 
K96243. The O-antigen is only found in smooth LPS and is lacking in rough LPS, whilst the core oligosaccharide is composed 
of an inner and outer core and the lipid A is embedded in the cell membrane. 
 
Most enzymes and genes coding for proteins responsible for the biosynthesis and export of LPS in E. coli 
have been identified and, based on genetic information, many are shared by most Gram-negative bacteria 
(Steeghs et al., 1997). Nevertheless, the detailed structure of LPS differs from one bacterium to another, 
consistent with the recent discovery of additional enzymes and gene products that can modify the basic 
structure of LPS in some bacteria, especially pathogens. These modifications are not required for survival 
but are tightly regulated in the cell and closely related to the virulence of bacteria. 
 
1.1.2.2.2 Biosynthesis of LPS 
 
The first stage of the LPS biosynthetic pathway in E. coli is the synthesis of Kdo2-lipid A (Doerrler, 2006, 
Raetz and Whitfield, 2002). This pathway is mediated by nine enzymes and takes place in the cytoplasm and 
on the inner surface of the inner membrane. Three soluble enzymes (LpxA, LpxC and LpxD) catalyse the 
addition of two 3:OH fatty acid chains to the C-2 and C-3 of the UDP-GlcNAc to form UDP-diacyl-GlcN 
(Buetow et al., 2007, Williams and Raetz, 2007). LpxH then hydrolyses UDP-diacyl-GlcN to form lipid X and 
LpxB condenses lipid X and its precursor UDP-diacyl-GlcN to form disaccharide-1-P (Crowell et al., 1987), 
whilst LpxK is a kinase that phosphorylates the C-4’ of the disaccharide-1-P to form lipid IVA (Garrett et al., 
1998). KdtA is a bifunctional enzyme that incorporates two Kdo residues at the C-6’ of the lipid IVA using the 
sugar nucleotide CMP-Kdo as a donor (Brozek et al., 1989). Kdo2-lipid IVA undergoes further reactions 
catalysed by LpxL and LpxM to form Kdo2-lipid A (Brozek and Raetz, 1990). The nine enzymes involved in 
the biosynthesis of Kdo2-lipid A all have relatively high specificity for their respective substrates. LpxA, LpxD, 
LpxL and LpxM are all acyltransferases, but they selectively catalyse different substrates and employ 
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different acyl donors. The minimal LPS structure needed for the viability of E. coli is lipid IVA although such E. 
coli mutants exhibit highly attenuated growth. LpxL adds a secondary lauroyl residue and LpxM adds a 
myristoyl residue to the distal glucosamine unit (Wang and Quinn, 2010). 
 
The core oligosaccharides are sequentially assembled on lipid A at the cytoplasmic surface of the inner 
membrane in a process that involves a number of membrane-associated glycosyltransferases, using 
nucleotide sugars as donors. The biosynthesis of core oligosaccharides is rapid and efficient, suggesting that 
the glycosyltransferases function in a coordinated complex. In E. coli and Salmonella, genes required for the 
biosynthesis of core oligosaccharides exist in three operons: gmhD, waaQ, kdtA operons (Roncero and 
Casadaban, 1992). In E. coli K-12, the gmhD operon contains four genes gmhD-waaF-waaC-waaL that are 
required for the biosynthesis of the inner core oligosaccharides (Schnaitman and Klena, 1993). The gmhD, 
waaF and waaC genes encode proteins involved in the biosynthesis and transfer of Hep (Whitfield et al., 
1997, Brozek et al., 1989). 
 
The O-antigen is synthesised on a lipid carrier on the cytoplasmic surface of the inner membrane, using 
sugar nucleotides as donors, After synthesis, both core-lipid A and O–antigen are transported to the 
periplasmic face of the inner membrane, where the O-antigen is polymerised by Wzy and Wzz and ligated to 
the core-lipid A by an enzyme encoded by the waaL gene, resulting in a nascent LPS (Abeyrathne et al., 
2005, Raetz et al., 2007). 
 
The transport of core-lipid A is carried out by a membrane protein MsbA (Doerrler et al., 2004). In E. coli 
MsbA is a homodimer and each monomer contains six transmembrane helices and a cytosolic ATP-binding 
domain, analogous to the ABC-type transporter-dependent pathway found in bacterial N-glycosylation (Ward 
et al., 2007). MsbA is highly conserved in Gram-negative bacteria and shares homology with the multidrug 
resistance (MDR) proteins of eukaryotes as such members of the large ABC-transporter superfamily are 
widely distributed in all domains of life. O-antigen transport across the inner membrane is mediated by Wzx 
protein (Alaimo et al., 2006, Raetz et al., 2007). Wzx proteins from different bacteria have similar hydropathy 
profiles and can complement each other in the translocation of different O-antigen sugar precursors but no 
sequence homology or conserved residues are found amongst Wzx proteins (Feldman et al., 1999). There is 
evidence that Wzx proteins might function by recognising the first sugar phosphate bound to Und-P (Marolda 
et al., 2004). 
 
LptA, LptB, LptC, LptF and LptG shuttle the nascent LPS from the periplasmic face of the inner membrane to 
the inner surface of the outer membrane, where LptD and LptE assemble LPS into the outer surface of the 
outer membrane (Ruiz et al., 2008, Sperandeo et al., 2007, Sperandeo et al., 2008). It appears that some of 
these proteins may function as complexes (Bos et al., 2004). The ABC-transporter LptBFG functioning with 
LptC and LptA translocates LPS to the inner leaflet of the outer membrane (Sperandeo et al., 2007, 
Sperandeo et al., 2008). When LptA or LptB, or both were depleted, LPS was found to accumulate in the 
periplasm (Sperandeo et al., 2007). The outer membrane, nascent LPS is exported to the outer leaflet by 
LptD and LptE (Bos et al., 2004, Ma et al., 2008, Sperandeo et al., 2007, Sperandeo et al., 2008, Wu et al., 
2006). The transport of the LPS into the periplasm and to the outer surface of the bacteria is described in 
Figure 1.5. 
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Figure 1.5 – LPS biosynthesis and transport across the bacterial membranes. 
The schematic depicts the enzymes involved in O-antigen transport, polymerisation and Lipid A-core transport across the 
inner membrane as well as O-antigen and Lipid A-core ligation to produce the LPS. Further, the enzymes responsible for 
shuttling the LPS across the periplasm and delivery to the outer membrane are shown. 
 
Bacteria have evolved mechanisms to modify their LPS structure, even the most conserved part, lipid A. It 
has been shown that modifications can involve both the hydrophilic disaccharide region as well as the 
hydrophobic acyl chain domain. Modifications to the lipid A usually occur at the periplasmic face of the inner 
membrane or in the outer membrane. The structure modification of lipid A might help the bacteria to resist 
the cationic antimicrobial peptides (CAMPs) released by the host immune system, or to evade recognition by 
the innate immune receptor TLR4 (Wang and Quinn, 2010). Some modifications of the lipid A are under the 
control of the PhoP-PhoQ system and/or PmrA-PmrB system (Guo et al., 1997). The PhoP-PhoQ is a two-
component system that governs virulence, mediates the adaption to Mg2+-limiting environment and regulates 
numerous cellular activities in Gram-negative bacteria (Gibbons et al., 2005, Guo et al., 1998). A PmrA-PmrB 
two-component system is also required for S. enterica virulence in mice. Several enzymes have been 
reported to modify the fatty acyl chain region of lipid A, such as the membrane proteins PgaP, PagL, LpxR 
and LpxO. The length of the fatty acid chains in the lipid A differs in different Gram-negative bacteria. For 
example, the fatty acyl chains of E. coli lipid A are 12 or 14 carbons long, while that of F. novicida lipid A are 
16-18 carbons long (Bainbridge et al., 2008, Shaffer et al., 2007). 
 
Changes to the hydrophilic region of lipid A can also occur. Lipid A usually contains two phosphate groups 
which impart a net negative charge to the molecule. The negative charges of lipid A allow the binding of 
positively charged CAMPs. To evade the attack by the immune system some bacterial pathogens have 
evolved less negatively-charged variation of lipid A. Modification to the hydrophilic region of lipid A focuses 
on the removal or decoration of the phosphate groups at the C-1 and C-4’ and can include the addition of the 
amine-containing residues such as α-L-Ara4N and phosphoethalonamine. These modifications result in 
resistance to CAMPs and polymyxin B and are controlled by the PmrA-PmrB two-component system (Wang 
and Quinn, 2010). To lower overall phosphate, these groups can also be removed by lpxE and lpxF 
encoding proteins (Wang et al., 2004, Wang et al., 2006). 
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1.1.2.3 Protein glycosylation in archaea 
 
1.1.2.3.1 Overview 
 
Archaea are single cell prokaryotes that have rigid cell walls with diverse structures. They contain many 
unusual lipids with repeating isoprenyl groups linked to glycerol and an S-layer of glycoproteins in a lattice-
like arrangement attached to the membrane. They lack the peptidoglycan found in almost all bacteria and 
instead contain a pseudomurein layer, which is similar to the peptidoglycan structure. Archaea have no 
nuclear membrane, possess unique ancient evolutionary history for which they are considered some of the 
oldest species of organisms on Earth and often characterised by living in extreme environments. Generally, 
archaea and bacteria are quite similar in size and shape; however despite these visual similarities to 
bacteria, archaea possess genes and several metabolic pathways that are more closely related to those in 
eukaryotes, notably the enzymes involved in transcription and translation. They exploit a much greater 
variety of energy sources than eukaryotes, which range from familiar organic compounds such as sugars, to 
using ammonia, metal ions or even hydrogen gas as nutrients. Salt-tolerant archaea, the halobacteria, use 
sunlight as a source of energy and other species of archaea fix carbon. They reproduce asexually and divide 
by binary fission, fragmentation or budding. Archaea are extremophiles that live in a broad range of habitats, 
such as soils, oceans and marshlands. Typical archaea include methanogens, which metabolise hydrogen 
and carbon dioxide into methane, halophiles that thrive in salt and thermoacidophiles, which grow in acid and 
high temperatures of up to 110ºC. Archaea express proteins that are able to remain properly folded and 
functional in the face of extremes of salinity, temperature and other adverse physical conditions that would 
normally lead to protein denaturation, loss of solubility and aggregation. No clear examples of archaeal 
pathogens or parasites are known, but they are often mutualists or commensals. They also have some 
importance in technology, with methanogens used to produce biogas and as part of sewage treatment, whilst 
enzymes from extremophiles are exploited in biotechnology for their ability to resist high temperature and 
organic solvents (Eichler and Adams, 2005). 
 
Glycosylation in archaea, similarly to eukaryotes and bacteria, has structural roles. This fits with the role for 
the sulphated S-layer glycoprotein oligosaccharide chains in maintaining the rod shape of Halobacterium 
salinarum cells and it was noted that similarities exist in the overall structures of the S-layer glycoprotein and 
proteoglycans (Wieland, 1988, Bernfield et al., 1999). Furthermore, the glycosylation of archaeal proteins 
has been implicated in protein assembly and function. In archaeal flagellins, glycosylation is associated with 
proper flagellar assembly, since upon bacitracin-mediated interference with flagellin glycosylation, a loss of 
Methanococcus deltae flagellation was observed microscopically (Kalmokoff et al., 1992). Coping with the 
often harsh environmental conditions encountered by archaea serves as the basis for yet another 
hypothesised role of archaeal protein glycosylation. In comparison of the glycosylation profiles of S-layer 
glycoproteins from the moderate halophile Haloferax volcanii and the extreme halophile H. salinarum, it was 
noted that the latter experiences a higher degree of glycosylation than the former (Mengele and Sumper, 
1992). Moreover, the glycan moieties of the extreme halophile were enriched in sulphated glucuronic acid 
subunits as opposed to the neutral sugars found in the moderate halophile, which provides the H. salinarum 
S-layer glycoprotein with a drastically increased surface charge density relative to its H. volcanii counterpart. 
The enhanced negative surface charge associated with protein glycosylation and the resulting  protection 
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that this would afford in the face of acidic conditions have been offered as the role of Sulfolobus 
acidocaldarius cytochrome b558/566 glycosylation (Hettmann et al., 1998, Zahringer et al., 2000). It has also 
been suggested that a significant amount of the protein surface is shielded from the pH 2 environment by the 
high degree of glycosylation (Zahringer et al., 2000, Voorhorst et al., 1996). Glycosylation has also been 
implicated in the stabilisation of thermophilic archaeal glycoproteins. 
 
1.1.2.3.2 N-glycosylation in archaea 
 
Like eukaryotic glycosylation, archaeal N-glycosylation occurs on Asn-X-Ser/Thr consensus sequences and 
it has been proposed that the elaborate process responsible for N-glycosylation in eukaryotes originated 
from a simpler archaeal system (Figure 1.2c). Indeed, many of the fundamental steps and central 
components involved in eukaryal protein N-glycosylation are also present in archaea (Eichler and Adams, 
2005). However there are important differences between the N-glycosylation machinery in the two kingdoms 
(Figure 1.2). For example although dolichyl pyrophosphate (Dol-PP) is the carrier in the cytoplasmic 
assembly of yeast LLO’s, both dolichol phosphate (Dol-P) and Dol-PP have been found as carriers in 
archaea (Abu-Qarn et al., 2008a, Chaban et al., 2006, Wieland, 1988). Also, while OSTs are found across 
the range of archaeal phenotypes, the N-glycosylation machinery of hyperthermophilic archaea may well rely 
on fewer components than do the parallel systems. 
 
Glycoproteins from about 25 species of archaea have been reported of which about ten have had their N-
glycans partially or fully characterized (Abu-Qarn et al., 2008a, Chaban et al., 2006). The best understood 
are the S-layers of the halophiles Halobacterium salinarum and Haloferax volcanii, together with the S-layers 
and flagellins of several methanogens. An overview of halophilic S-layer glycosylation is given later (Section 
1.2.2) because this is the subject of one of the projects in this thesis (Chapter 3). Here some general points 
about archael N-glycan structure are summarized. Most of the characterised archaeal N-glycans are 
unbranched and have fewer than six sugar residues. An exception to the latter is H. salinarum which, in 
addition to bearing a trisaccharide composed of monosulphated glucuronic acid linked via glucose at about 
ten consensus sites, has one N-linked site occupied by a GalNAc-linked polysaccharide comprised of 
multiple repeats of a sulphated pentasaccharide composed of GlcNAc, GalNAc, Gal, GalA, and 3-O-methyl-
GalA (Paul and Wieland, 1987). The N-glycans attached to the S-layer of Methanothermus fervidus are 
hexasaccharides containing 3-O-methylmannose, Man, and GalNAc (Karcher et al., 1993). In M. voltae the 
flagellins and S-layer proteins are glycosylated with a tri- or tetrasaccharide composed of GlcNAc, 
GlcdiNAcA, a threonine-substituted ManNAcA and an uncharacterized sugar (Chaban et al., 2009, Voisin et 
al., 2005). An even more unusual tetrasaccharide has been found on the pilins and flagellins of M. 
maripaludis. This has the sequence Sug-4-ManNAc3NAmA6Thr-4-GlcNAc3NAcA-3-GalNAc where Sug is a 
highly unusual aldolase diglycoside (Kelly et al., 2009). In contrast to these linear glycans which contain a 
great diversity of monosaccharides, a small number of extreme thermophiles have been reported to have 
branched N-glycans comprised of sugars such as mannose and GlcNAc (Peyfoon et al., 2010, Yang and 
Haug, 1979). Interestingly Sulfolobus species have glycosylation bearing some of the hallmarks of high 
mannose eukaryotic glycans, including branched mannose and a chitobiose core (Peyfoon et al., 2010, 
Zahringer et al., 2000). 
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1.1.2.3.3 O-glycosylation in archaea 
 
Extremely little is known of the O-glycosylation process in archaea, although S-layers containing N- and O-
linked glycans have been found to occur, such as was found to be the case in both H. salinarum and H. 
volcanii. Thr-rich regions adjacent to the predicted membrane spanning domain of the S-layer glycoprotein, 
were found to be modified with galactose-glucose disaccharides (Mescher and Strominger, 1976, Sumper et 
al., 1990, Calo et al., 2010b). There has not been much investigation since into the nature of O-linked 
glycosylation in archaea. 
 
1.2 THE HALOPHILIC ARCHAEON HALOFERAX VOLCANII 
 
Halobacteria are located throughout the world in salt ponds and lakes and may exist in the form of dormant 
or living cells, biopolymers in rocks, salt crystals or as evaporates in desert regions. Haloferax volcanii was 
first identified by Mullakhanbhai and Larsen in 1975 as an organism that resides largely in the bottom 
sediment of the Dead Sea, being the predominant organism there. They found that the organism possessed 
the properties of the halobacteria, but differed from known species in the fact that its cells were disc shaped 
and often cupped when grown under optimum conditions, and that the optimum requirements for sodium 
chloride for the organism was in the range 1.7-2.5M, close to the salinity found in the Dead Sea, which is 
about half of that generally reported for the halobacteria. They further discovered that the tolerance for 
magnesium chloride was very high, allowing the organism to grow well in media containing magnesium 
chloride in the concentrations found in the Dead Sea. The organism was assigned to the genus 
Halobacterium and described as Halobacterium volcanii (Mullakhanbhai and Larsen, 1975) and was later re-
named Haloferax volcanii. 
 
1.2.1 S-layer glycoproteins in haloarchaea 
 
S-layer proteins are among the most abundant proteins synthesised by the archaeal cell and have the 
unique feature of self-assembling into 2D lattices and can be isolated with relative ease in substantial 
amounts for biochemical and structural studies. Molecular masses of S-layer proteins typically range from 40 
to 170kDa (Sleytr and Beveridge, 1999, Sleytr et al., 2007) and N-glycosylation is the most frequent 
posttranslational modification these proteins undergo although O-linked glycans are sometimes present 
(Jarrell et al., 2010). Other covalent modifications include lipid attachment, phosphorylation and methylation 
(Schaffer and Messner, 2004, Claus et al., 2002, Eichler and Adams, 2005). Although found in numerous 
archaeal species, the S-layers of the haloarchaea remain the best studied (Eichler, 2003, Schaffer and 
Messner, 2001, Schaffer and Messner, 2004). Investigations of S-layer protein glycosylation of haloarchaea 
were initiated by Strominger and colleagues (Mescher and Strominger, 1976), extended by Sumper and 
Wieland and colleagues (Sumper et al., 1990) and is currently extensively being performed by Eichler in 
collaboration with our laboratory (Abu-Qarn et al., 2008a). 
 
The first description of an S-layer was reported in 1956 when electron microscopic examination of 
Halobacterium halobium (Halobacterium salinarum) cells revealed a surface presenting morphological units 
organised in a hexagonal pattern (Houwink, 1956). Later examination of thin-sectioned haloarchaeal cells 
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revealed the presence of a 17nm thick cell wall beyond the plasma membrane (Kirk and Ginzburg, 1972, 
Steensland and Larsen, 1969, Stoeckenius and Rowen, 1967). Blaurock and colleagues, later relied on X-
ray diffraction to demonstrate a protein layer lying beyond the haloarchaeal plasma membrane at a distance 
of 8nm, with a periplasmic-like space being formed from morphological subunits assuming an “inverted-
parabola shape” (Blaurock et al., 1976). Enzymatic iodination of the surface proteins, together with 
proteolytic treatment, revealed this surface (S)-layer to contain the S-layer glycoprotein. This was the first 
prokaryotic glycoprotein to be described in detail (Lechner and Sumper, 1987, Mescher and Strominger, 
1976). Kessel and colleagues next proposed a three-dimensional reconstruction of the Halobacterium 
(Haloferax) volcanii S-layer glycoprotein and cell envelope after considering the primary sequence of the H. 
salinarum S-layer glycoprotein, as well as the earlier X-ray diffraction data and electron microscopic images 
of negatively stained cell envelopes (Figure 1.6). Kessel and colleagues revealed the structure of the 
surface glycoprotein to a resolution of 2nm. The glycoprotein was found to be arranged on a p6 lattice with a 
lattice constant of 16.8nm and formed 4.5nm high, dome-shaped, morphological complexes with a narrow 
pore at the apex opening into a “funnel” towards the cell membrane. Six radial protrusions were found to 
emanate from each morphological complex and to join around the 3-fold axis to provide lateral connectivity 
(Kessel et al., 1988). 
 
 
Figure 1.6 – Schematic of the proposed structural presentation of the S-layer glycoprtoein of H. volcanii. 
The figure describes the H. volcanii S-layer glycorptoein organisation and view of the surface at different axes, as adapted 
from Kessel and colleagues (Kessel et al., 1988), which was proposed from all available structural information discovered at 
the time. The diagram combined information from X-ray studies of the envelope by Blaurock and colleagues (Blaurock et al., 
1976), the primary structure published by Sumper and colleagues (Lechner and Sumper, 1987) as well as the three 
dimensional information from electron microscopy by Kessel and colleagues. 
 
The gene coding for the S-layer protein of H. volcanii was first cloned and sequenced by Sumper and co-
workers (Sumper et al., 1990). The mature polypeptide is composed of 794 amino acids and is preceded by 
a typical signal sequence of 34 amino acid residues. A highly hydrophobic stretch of 20 amino acids at the 
C-terminal end is proposed to be the transmembrane domain. Clusters of threonine residues are located 
adjacent to this membrane anchor. The S-layer protein is a glycoprotein containing both N- and O-
glycosylation sites, as is shown in Figure 1.7. The primary structure of the S-layer glycoprotein from H. 
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volcanii and H. halobium were compared and found to exhibit distinct differences, despite the fact that three 
dimensional reconstruction from electron micrographs revealed no structural differences at least to the 
2.5nm level attained (Sumper et al., 1990). 
 
 
Figure 1.7 – Amino acid sequence of the H. volcanii S-layer glycoprotein. 
The sequence is derived from UniProtKB/SwissProt (Entry: P25062), as published by Sumper and colleagues (Sumper et al., 
1990). The signal peptide is coloured grey, whilst putative N- and O-glycosylation sites are shown in red and green 
respectively. The C-terminal region contains a threonine-rich region (purple), a PGF motif (yellow) as well as a suggested 
trans-membrane domain (pink). 
 
1.2.2 Glycosylation of the S-layer glycoprotein of H. volcanii 
 
Examination of H. volcanii proteins by SDS-PAGE and PAS or lectin staining revealed numerous putative 
glycosylated bands. A 190kDa protein was most intensely stained, although other protein bands were also 
clearly seen (Eichler, 2000). There are seven Asn-X-Ser/Thr sequons found in the H. volcanii S-layer 
glycoprotein that could potentially be glycosylated by N-glycans (Figure 1.7). Outputs of structural studies 
carried out more than twenty years ago by Mengele and colleagues suggested that at least four of these 
sites were occupied and that more than one type of N-glycan was present. They proposed that Asn-47 and 
Asn-532 were glycosylated with linear chains of β-1-4-linked glucose residues, that Asn-308 was modified by 
a glucose and idose-containing oligosaccharide, and that Asn-313 carried a polysaccharide composed of 
glucose, idose and galactose (Mengele and Sumper, 1992). 
 
When H. volcanii S-layer N-glycosylation was re-visited over a decade later using more powerful structural 
methods it became clear that these early compositional assignments were incorrect. Thus, at the time the 
work described in this thesis (Chapter 3) was initiated, it had been shown by glycoproteomic analyses at 
Imperial College London that the glycan at Asn-47 was actually a pentasaccharide comprising two hexoses, 
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two hexuronic acids and a 190Da subunit, possibly corresponding to a methylated hexuronic acid or a di-
methylated hexose (Abu-Qarn et al., 2007). The same glycan was found at the Asn-117 consensus site.  
 
In parallel to the mass spectrometric work, our collaborators in Israel (Eichler and colleagues) were 
undertaking characterisation of the N-glycosylation process. Some of the archaeal glycosylation (agl) genes 
implicated in this post-translational modification had been identified on the basis of their homologies to 
known N-glycosylation components in eukaryotes or bacteria (Szymanski and Wren, 2005) and their roles in 
N-glycan biosynthesis were being explored by the Eichler group. Thus, putative H. volcanii homologs of 
genes involved in the eukaryal or bacterial N-glycosylation were identified by bioinformatics and reverse 
transcription polymerase chain reaction confirmed that the proposed N-glycosylation genes were being 
transcribed. Deletion of some genes showed slower growth and interfered with S-layer glycosylation, 
represented by modified migration on SDS-PAGE and glycostaining and the structural consequences of 
gene deletion were investigated by glycoproteomics (Abu-Qarn and Eichler, 2006). Subsequently additional 
agl genes were identified either based upon their proximity to previously identified agl sequences or upon re-
annotation of the region of the genome where all but one of the previously identified agl sequences clustered 
(Abu-Qarn et al., 2008b, Yurist-Doutsch et al., 2008, Abu-Qarn et al., 2007, Yurist-Doutsch and Eichler, 
2009). Further characterisation of the N-glycosylation pathway has been achieved as part of this thesis 
(Section 3.4). 
 
In addition to N-glycosylation, the H. salinarum and H. volcanii S-layer glycoproteins also undergo O-
glycosylation. In each case, a threonine-rich region upstream of the predicted membrane-spanning domain 
of the protein (Figure 1.7) has been proposed to be a mucin-like domain that is decorated at numerous 
positions by glucosyl(1-2)galactose disaccharides (Mescher and Strominger, 1976, Sumper et al., 1990). 
Essentially nothing further is presently known of the archaeal O-glycosylation process. The O-glycan 
structures were re-investigated as part of this thesis (Section 3.3) in order to rule out the possibility that the 
limitations of the analytical procedures employed by these early workers had resulted in errors in O-glycan 
assignments, as was the case with the N-glycans (see above). 
 
1.2.3 Lipid as a potential posttranslational modification of the H. volcanii S-layer 
 
The covalent attachment of lipids is a common modification experienced by both eukaryal and bacterial 
proteins and can involve myristoyl or palmitoyl acyl groups and isoprenyl polymers of various lengths, or 
aminoglycan-linked phospholipids. These can be added at the amino terminus, the carboxy terminus or at 
internal residues via ester, thioester, thioether or amide bonds, or through mediating functionalities such as 
phosphodiesters. Lipid modification of proteins is largely a posttranslational event and serves a variety of 
roles, such as enhancing membrane affinity of the modified protein, signal transduction, embryogenesis and 
pattern formation, protein trafficking through the secretory pathway and evasion of the immune response by 
infectious parasites (Eichler and Adams, 2005). 
One of the defining traits of archaea distinguishing them from eukaryotes and bacteria is the chemical 
composition of their membrane phospholipids (Kates, 1993). Unlike eukaryal and bacterial phospholipids, 
which are built on a glycerol-3-phosphate backbone, archaeal phospholipids are based on the opposite 
steroisomer, glycerol-1-phosphate. The archaeal phospholipids contain polyisoprenyl side-chains rather than 
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the acyl groups employed by eukaryotes and bacteria. The archaeal phospholipids further rely on ether 
bonds to link the isoprenyl side chains to the glycerol-1-phosphate backbone (Eichler and Adams, 2005). 
Archaeal phospholipids are generally organised into the bilayer structure that is also present in eukaryal and 
bacterial cells, although tetra-ether lipid-based monolayers can also be found in thermophilic and 
hyperthermophilic archaea (Koga et al., 1993). Whereas phospholipids and other polar lipids 
(phosphoglycolipids, glycolipids and sulfolipids) account for the vast majority of archaeal membrane lipids, 
archaeal membranes also contain acetone-soluble nonpolar lipid species, primarily neutral squalenes and 
other isoprenoid-based polymers (Kates, 1978, Kates, 1992). 
 
Lipid-modified proteins have been reported from a wide range of species of archaea. In the haloalkaliphile 
Natronobacterium pharaonis, a small blue copper protein was proposed to undergo amino-terminal lipid 
modification based on the presence of the so-called lipopbox sequence motif near the start of predicted 
amino acid sequence (Mattar et al., 1994). Although widespread in eukaryotes, GPI-anchored proteins have 
not been observed in bacteria, but have been seen in archaea, as Sulfolobus acidocaldarius was shown to 
possess three proteins that incorporate radiolabeled precursors of the GPI anchor moiety (Kobayashi et al., 
1997). 
 
Growth of Halobacterium cutirubrum and Halobacterium salinarum in the presence of radiolabeled [3H] 
mevalonate, a precursor for the isoprene building block used to synthesise archaeal lipids (Boucher et al., 
2004, Smit and Mushegian, 2000), led to the appearance of several proteins radiolabeled through the 
covalent attachment of a lipid entity. Sagami and colleagues showed that a derivative of [3H] mevalonic acid 
is incorporated into a number of specific proteins in H. halobium and H. cutirubrum and that the major 
radioactive material released by treatment with methyl iodide was an unknown compound, which was 
analysed by reverse and normal phase high performance liquid chromatographies followed by mass 
spectrometry (Sagami et al., 1994). The identified parent ion showed the compound to be a 
diphytanylglyceryl methyl thioether, suggesting that Halobacteria contained specific proteins with a novel 
type of modification of a cysteine residue of proteins with a diphytanylglyceryl group in thioether linkage 
(Sagami et al., 1995). 
 
During further analysis of the isoprenoid-modified proteins in H. salinarum using other radiolabeled isoprenyl 
derivatives to obtain insight into the nature of the isoprenoid binding manner, radioactive PAS-stained 
peptides recovered from the gel were treated with methyl iodide. No radioactive materials were released 
from the peptides in the sulfonium salt cleavage reaction or under the acidic conditions at 37°C, however 
under the acidic conditions at 95°C, radioactive materials were released from the peptides with 90% 
recovery and revealed that the S-layer glycoprotein is modified by a second novel group, diphytanylglyceryl 
phosphate, which is attached through an as yet uncharacterised linkage. Amino acid sequencing placed the 
modification near an O-glycosylated Thr-rich stretch found in the C-terminal region of the protein, upstream 
of the single transmembrane domain (Kikuchi et al., 1999). Kessel and colleagues had speculated that the 
unusual structural threonine-rich cluster element in the S-layer of haloarchaea serves as a spacer between 
the membrane-binding domain and the extracellular domain of the cell-surface glycoprotein, thus creating an 
interspace that may be regarded as analogous to the periplasmic space of Gram-negative bacteria. The 
36 
 
Chapter 1  Introduction 
hydroxyl group of the side chain of serine or threonine next to each membrane-binding domain was therefore 
suggested as a possible modification site (Kessel et al., 1988). 
 
In H. volcanii, the S-layer glycoprotein was found to be first synthesised as an immature precursor, 
possessing a lower apparent molecular mass than the final version of the protein. Pulse-chase radio-
labelling and cell-fractionation studies were employed by Eichler and colleagues to reveal that newly 
synthesised S-layer glycoprotein seemed to undergo a maturation step following the translocation of the 
protein across the plasma membrane. Post-translational conversion into the mature form of the protein is 
largely completed within the first 10 min following the appearance of the full-length polypeptide. The S-layer 
glycoprotein modification was suggested to require Mg2+-dependent membrane association of the protein, as 
no maturation was detected in the absence of Mg2+, which is known to be involved in attachment of the S-
layer glycoprotein to the membrane (Sumper et al., 1990). This processing step was detected as an increase 
in the apparent molecular mass of the S-layer glycoprotein and was suggested to be unaffected by inhibition 
of protein synthesis and unrelated to glycosylation of the protein. Maturation resulted in an observed 
increase in hydrophobicity of the protein as revealed by enhanced detergent binding and modification of the 
H. volcanii S-layer glycoprotein was suggested to offer an explanation for these observations (Eichler, 2001). 
 
Eichler and Konrad suggest that the H. volcanii S-layer glycoprotein was also modified by a mevalonic acid-
based lipid moiety and that such modification was responsible for the maturation of the H. volcanii S-layer 
glycoprotein. H. volcanii cells were therefore incubated with a [3H]-radiolabelled version of the isoprene 
precursor, mevalonic acid. The [3H] mevalonic acid label appeared to remain associated with the S-layer 
glycoprotein peptide fragment after de-lipidation, proteolytic digestion and SDS-PAGE. Konrad and Eichler 
proposed that neither phosphate ester nor pyrophosphate ester lipids were released under the mild acidic 
conditions, which led to the suggestion that the mevalonic acid-derived moiety could be covalently linked to 
to the protein, rather than simply being loosely associated with it (Konrad and Eichler, 2002). 
 
It was hypothesised from the studies described above that the H.volcanii S-layer was likely to be substituted 
with a lipid moiety in the mucin-like domain. However, the S-layer has a C-terminal hydrophobic sequence 
which has all the properties required for it to be a robust membrane-spanning domain (Lechner and Sumper, 
1987, Sumper et al., 1990, Wakai et al., 1997). It was therefore puzzling that an additional membrane anchor 
in the form of a covalent lipid would be required. To cast more light on this issue we felt that it was important 
to rigorously establish whether the S-layer is, indeed, covalently modified with lipid. The chemical nature of 
the lipid association with the S-layer glycoprotein is therefore also explored in this thesis (Section 3.6). 
 
1.2.3.1 Characterisation of polar lipids of the halophilic archaeon H. volcanii  
 
As part of a study to identify novel lipids with immune adjuvant activity, a structural comparison was made by 
Sprott and colleagues between the polar lipids from two halophiles, Haloferax volcanii and Planococcus H8 
(Sprott et al., 2003). The total polar lipids of H. volcanii accounted for 83.5% by weight and fast atom 
bombardment mass spectrometry (FAB-MS) and thin layer chromatography were used to identify and 
quantify the major signals corresponding to the phospholipids. H. volcanii polar lipid extracts consisted of 
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44% archaetidylglycerol methylphosphate, 35% archaetidylglycerol, 4.7% of archaeal cardiolipin, 2.5% 
archaetidic acid, and 14% sulphated glycolipids 1 and 2 as are summarised in Table 1.1. 
 
Lipid moiety Name Structure % Abundance m/z +Na 
 
PA 
 
 
archaetidic acid 
  
 
2.5 
 
731.5 
 
 
PG 
 
 
archaetidylglycerol 
  
 
35.2 
 
805.6 
 
 
PGP-CH3 
 
 
archaetidylglycerol 
methylphosphate  
 
43.8 
 
899.5 
 
921.5 
 
S-GL-1 
 
 
sulphate-diglycosyl 
archaeol-1  
 
5.2 
 
1055.6 
 
 
S-GL-2 
 
 
 
sulphate-diglycosyl 
archaeol-2 
  
 
8.7 
 
1770.2 
 
1792.2 
Table 1.1 – Summary of H. volcanii lipid bilayer population. 
The table describes the total lipid population of H. volcanii, as characterised described by Sprott and colleagues (Sprott et al., 
2003). 
 
1.3 BURKHOLDERIA PSEUDOMALLEI 
 
1.3.1 Burkholderia pseudomallei the causative agent of melioidosis 
 
The genus Burkholderia comprises more than 40 different species and these occupy a wide array of 
ecological niches. Traditionally, the Burkholderia species are known as plant pathogens and soil bacteria 
with a couple of important exceptions, including Burkholderia mallei and Burkholderia pseudomallei, which 
are primary pathogens for humans and animals (Coenye and Vandamme, 2007). 
 
The Burkholderia genus, was formerly part of the genus Pseudomonas, which was first described more than 
100 years ago and its classification and description have been revised on several occasions. In 1973 its 
taxonomic heterogeneity was revealed by the work of Palleroni and co-workers who delineated five major 
species clusters, also referred to as rRNA homology groups (Palleroni et al., 1973). The name 
Pseuodomonas was confined to rRNA homology group I organisms because they comprised the type 
species, Pseudomonas aeruginosa, whilst Pseudomonas cepacia and six other species belonging to 
Pseudomonas rRNA group II (P. solanacaerum, P. pickettii, P. gladioli, P. mallei, P. pseudomallei and P. 
caryophylli) were transferred to the new genus Burkholderia (Yabuuchi et al., 1992). The name Burkholderia 
was chosen to honour Walter Burkholder’s seminal work in the 1940s and 1950s on a disease of onion bulbs 
that he termed “sour skin” or “slippery skin”, basing his description of the causative agent on this bacterial rot 
disease on seven isolates from decaying onion bulbs which he named Pseudomonas cepacia (Coenye and 
Vandamme, 2007). 
 
The saprophytic bacterium B. pseudomallei is the causative agent of melioidosis, a serious and often fatal 
infectious disease endemic in Southeast Asian countries and Northern Australia (Dance, 1991, Dance, 
2000). Melioidosis is also frequently reported in areas of China and the Far East and there have been 
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sporadic cases in areas of Asia and Central America (Section 1.3.2) (Cheng and Currie, 2005). The 
pathologist Alfred Whitmore and his assistant C. S. Krishnaswami first described melioidosis as a “glanders-
like” disease among morphia addicts in Rangoon, Burma in 1911 (Whitmore, 1913). They distinguished this 
disease causing agent from the organism causing glanders by its relatively rapid growth, motility and the lack 
of the Strauss reaction when it was injected to guinea pigs, used at the time to diagnose glanders (Whitmore, 
1913). The disease was later termed melioidosis by Stanton and Fletcher in 1932 (Cheng and Currie, 2005). 
This Gram-negative environmental bacterium has been variously known as Bacillus pseudomallei, Bacillus 
whitmorii (Bacille de Whitmore), Malleomyces pseudomallei, Pseudomonas pseudomallei and since 1992, 
Burkholderia pseudomallei (Yabuuchi et al., 1992). In the latter half of the 20th century, melioidosis emerged 
as an infectious disease of major public health importance in South East Asia and Northern Australia (Currie 
et al., 2000c, Chaowagul et al., 1989). 
 
B. pseudomallei induced melioidosis can present itself in various forms, including fever, septicaemia, 
pulmonary and other chronic diseases and melioidosis has a broad clinical spectrum, ranging from 
asymptomatic condition to acute fatal septicaemia (Section 1.3.3.1) (Sarkar-Tyson et al., 2007, Cheng and 
Currie, 2005). The organism is innately resistant to a large number of antibiotics and inadequate antibiotic 
treatment is associated with a high rate of relapse (Section 1.3.3.4) (Anuntagool et al., 2006). B. 
pseudomallei is also well adapted to its many hosts, with virulence factors such as the production of 
proteases, lipases and catalase (Section 1.3.7). Furthermore it produces a glycocalyx polysaccharide 
capsule suggested to be an important virulence determinant, alongside cell-associated antigens, such as pili 
and capsular polysaccharides (CPS), as well as lipopolysaccharides (LPS) (Section 1.3.5). 
 
1.3.2 Epidemiology 
 
B. pseudomallei is visualised as a Gram-negative bacillus with bipolar staining. It is vacuolated, slender, has 
rounded ends and has previously been described as having a “safety-pin” appearance. The bacterium is 2-
5μm length and 0.4-0.8μm in diameter and motile due to its capability of self-propulsion using flagella. In 
culture, the organism demonstrates differing colonial morphology with mostly smooth colonies initially and 
dry or wrinkled colonies on further incubation. 
 
B. pseudomallei is oxidase and gelatinase positive and can be distinguished from the closely related but less 
pathogenic Burkholderia thailandensis by its ability to assimilate arabinose (Smith et al., 1997). B. 
pseudomallei is a very resilient organism that is capable of surviving in hostile environmental conditions, 
including prolonged nutrient deficiency of up to 10 years (Wuthiekanun et al., 1995b) and antiseptic and 
detergent solutions (Gal et al., 2004). Furthermore it is able to survive in acidic environments, such as pH 4.5 
for up to 70 days (Dejsirilert et al., 1991) and in a wide temperature range from 24ºC to 32ºC. Cultures 
typically become positive in 24 to 48 hrs, a rapid growth rate, which differentiates the organism from B. 
mallei, which typically takes a minimum of 72 hours to grow. It is likely that harsh environmental conditions 
may confer a selective advantage for the growth of B. pseudomallei. 
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1.3.2.1 Geographical epidemiology 
 
Although the area where melioidosis is endemic has generally been regarded as restricted to the latitudes of 
20ºN and 20ºS in Southeast Asia and Northern Australia, large outbreaks have occurred outside this area 
(Dance, 1991, Dance, 2000). In Thailand, B. pseudomallei is widely distributed in soil and more particularly 
in pooled surface water such as in rice paddies as well as the roots of various plants (Wuthiekanun et al., 
1995a, Holden et al., 2004). Humans in prolonged contact with contaminated water and soil, such as rice 
farmers, are therefore more likely to contract the disease and most infections occur during the rainy season 
when bacteria are leached from the soil (Lazar Adler et al., 2009). B. pseudomallei is especially problematic 
in North-Eastern Thailand where approximately 20% of community-acquired septicaemias can be attributed 
to this bacterial pathogen (Chaowagul et al., 1989). In Ubon Ratchathani province in north-eastern Thailand, 
4.4 cases per 100’000 have been noted (Suputtamongkol et al., 1994). In this region up to 80% of children 
are positive for antibodies against B. pseudomallei by the age of four years. 
 
The global map of melioidosis continues to expand with examples of case clusters in Brazil, recognition that 
melioidosis is endemic in the pacific nation of New Caledonia and cases following the Asian tsunami. It was 
found that outbreaks of melioidosis occurred following typhoon season and flooding in several endemic 
areas (Chaowagul et al., 1989, Currie et al., 2000c). In endemic regions up to 85% of human infection occurs 
during the monsoon wet season (Currie and Jacups, 2003). 
 
Molecular tools used to infer genetic relatedness between isolates of B. pseudomallei have demonstrated 
that environmental isolates can be identical to epidemiologically related human or animal strains (Currie et 
al., 1994, Currie et al., 2001). Furthermore, it was found that recurrent infection is usually due to relapse with 
the same strain rather than re-infection with a different strain (Currie et al., 2000a, Desmarchelier et al., 
1993). These studies have demonstrated considerable diversity in isolates, suggesting that the introduction 
into the regions where B. pseudomallei is found is not a recent event (Pitt et al., 2000). This contrasts with 
clonal outbreaks in regions where the organism is not endemic (Currie et al., 1994). 
 
The finding that the antigenically similar B. thailandensis was relatively avirulent led to a suggestion that 
different strains of B. pseudomallei may have differing virulence. Two other studies have suggested that 
clinical presentation or outcome may depend on the strain type (Pitt et al., 2000). A sequence-based 
successor to multilocus enzyme electrophoresis, multilocus sequence typing has been developed for B. 
pseudomallei. This technique is based on allelic genetic analysis beyond the outbreak situation due to its 
reproducibility and the low rate of genetic change in the allelic sites, which allows for comparisons between 
strains typed at different laboratories through an internet-based database. This study confirmed the diversity 
seen in isolates worldwide and placed B. mallei within its wider B. pseudomallei group, both being distinct 
form B. thailandensis (Godoy et al., 2003). 
 
1.3.3 Clinical features of melioidosis 
 
B. pseudomallei is capable of causing a broad spectrum of diseases with protean clinical manifestations, but 
acute pulmonary and septicaemic forms are of particular concern due to the high incidence of mortality 
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associated with these cases even when vigorous chemotherapeutic intervention is implemented 
(Leelarasamee and Bovornkitti, 1989). 
 
1.3.3.1 Disease presentation and diagnosis 
 
Melioidosis may present as either a chronic or acute disease and there are no pathonomonic signs of 
infection, hindering prompt diagnosis. In an acute infection the symptoms include fever, malaise, abscess 
formation, pneumonia and sepsis. Even with aggressive antibiotic therapy, septicaemia caused by B. 
pseudomallei has a mortality rate of about 40%. The chronic version of melioidosis is often described as a 
milder version of the symptoms, but may last for months or years. It has been shown that reactivation of 
chronic B. pseudomallei infections have occurred in Vietnam veterans up to 18 years after their last 
exposure to the bacteria, which nicknamed the condition “the Vietnamese time bomb” (Koponen et al., 1991, 
Howe et al., 1971). Reactivation is correlated with the onset of other illnesses including influenza, Type 2 
diabetes or cancer (Mays and Ricketts, 1975). The majority of infected persons remain asymptomatic, 
however latent infection with subsequent reactivation is well recognised (Ngauy et al., 2005). 
 
Variation of the clinical presentation and severity of melioidosis was noted to be due to one or more of three 
factors. These include a variation in bacterial strains, including the presence or absence of virulence factors, 
a variation in the host immune response and a variation in acquisition. There is a large body of evidence that 
suggests that host factors, particularly age and comorbidites are of prime importance in determining the 
pattern of disease (Cheng and Currie, 2005). 
 
The mean incubation period of B. pseudomallei is about 9 days, but ranges from 1 - 21 days (Currie et al., 
2004). Patients with latent melioidosis may be symptom free for decades. Diagnosis is made by culturing the 
organism from a clinical sample and a complete screen inclusive of blood culture, sputum culture, urine 
culture, throat swab and culture of any aspirated pus is be performed on patients with suspected melioidosis. 
Mortality rates from melioidosis vary from 15% in centres where intensive care is available to greater than 
50% in regions with poor health care (Cheng and Currie, 2005, White, 2003). 
 
1.3.3.2 Infection by B. pseudomallei 
 
Infection by B. pseudomallei in humans usually occurs through percutaneous inoculations, abrasions of the 
skin or inhalation, while ingestion is more common in animals (Currie, 2008). Due to the fact that farmers in 
endemic regions rarely wear protective footwear when harvesting crops, the feet of the individuals often 
show signs of repeated trauma and injury, presenting the route of infection (Chaowagul et al., 1989), whilst 
inhalation of aerosols created by heavy rains presents a further route of infection. 
 
Inhalation was initially thought to be the primary mode of acquisition based on studies of US soldiers in 
Vietnam where it was noted that helicopter crews seemed to have high incidence of the disease and 
although sporadic cases have continued to surface in the US from remote exposure, the feared epidemic 
failed to materialise. The finding that periods of heavy rainfall are associated not only with higher numbers of 
cases but also pneumonic presentations and cases of increased severity may suggest a shift to inhalation 
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during extreme weather events (Currie and Jacups, 2003). It is now believed that inoculation is the major 
mode of acquisition. Ingestion has been suggested as a mode of infection and this route has been implicated 
in animals by findings of infected gastroheptaic nodes in pigs, which have also been noted in humans. The 
contribution of this route of infection, however, is undefined, although contamination of potable water has 
been implicated as the point source in two outbreaks (Currie et al., 2001). Acquisition of infection from 
animals has been described but is believed to be very uncommon as is person to person transmission and 
laboratory-acquired infection (Cheng and Currie, 2005, Dance, 2000). 
 
1.3.3.3 Melioidosis risk factors 
 
Approximately 20% of persons with disease have no apparent risk factors. However, epidemiological studies 
suggested patients with worsened physical wellbeing were more susceptible to infection, where individuals 
with diabetes, compromised liver or renal function showed to have increased risk of infection (Currie et al., 
2004). The use of steroids is associated with an increased risk of melioidosis and chronic obstructive 
pulmonary disease and the consumption of kava and alcohol have also been implicated (Currie et al., 2000b, 
Suputtamongkol et al., 1994, Suputtamongkol et al., 1999, White, 2003). A number of case studies have 
noted an intriguing association with chronic granulomatous disease that might highlight the under-recognised 
role of neutrophil defects in pathogenesis. The notable lack of an association between HIV infection and 
melioidosis severity and the very strong link to diabetes suggests that after initial infection with B. 
pseudomallei, phagocytic function and not cell-mediated immunity may be critical to prevent the dramatic 
progressive dissemination of the bacteria seen in acute septicaemic melioidosis (Currie, 2008). 
 
1.3.3.4 Antibiotic resistance and treatment 
 
B. pseudomallei exhibits resistance to diverse groups of antibiotics including third-generation 
cephalosporins, penicillins, rifamycins and aminoglycosides. In addition its relative resistance to quinolones 
and macrolides limits therapeutic options for the treatment of melioidosis (Cheng and Currie, 2005). B. 
pseudomallei is, however, susceptible to kanamycin although this antibiotic is no longer used in the 
treatment of clinical melioidosis as transposon mutation analysis has revealed that the efflux system AmrAB-
OprA confers resistance (Cheng and Currie, 2005). The choice of antibiotic regimen has not been shown to 
have an impact on mortality within the first 48 hours of admission and severe melioidosis in Thailand is still 
associated with a case fatality rate of approximately 50%, whilst in Australia mortality rate is still significant 
and approaches 20% of all patients with melioidosis (White, 2003, Currie et al., 2000b). The most common 
antibiotic resistance mechanisms that have been described in Burkholderia are those associated with limited 
permeability, thus inactivating enzymes and altered drug targets are rarely described. The role of limited 
permeability as an antibiotic resistance mechanism in Burkholderia may be related to its polysaccharide 
structures, limited porin size or multidrug efflux pumps, whereas biofilm mediated antibiotic resistance has 
been reported rarely (Coenye and Vandamme, 2007). 
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1.3.3.5 Relapse associated melioidosis 
 
Relapse after apparently successful treatment is well described and is associated with mortality similar to 
that for the initial episodes (Currie et al., 2000a). Factors associated with a higher risk of relapse included 
poor adherence to therapy, the use of doxycycline monotherapy or amoxicillin-clavuanate in the eradication 
phase and severe disease. In the majority of cases, relapse was due to reactivation of the original infecting 
strain. Relapses be due to re-infection with a different strain was demonstrated in 4-7% of cases in Thailand 
and Australia, or the initial infection being caused by multiple strains (Currie et al., 2000a, Maharjan et al., 
2005). This means that an effective vaccine against the pathogen would have to encompass all important 
strains. 
 
1.3.4 Burkholderia genomes and species variation 
 
Examination of the completed Burkholderia genome sequences has shown that for most species capture 
and retention of foreign DNA is essential to their genome evolution. The conservation of the guanine-
cytosine (GC) content is a defining feature of bacterial species, where essential genes that are core to the 
genome have a consistent GC composition that is reflective of the average of the species as a whole. 
Foreign regions of DNA can be identified by several signatures within the DNA sequence, where looking for 
regions of atypical GC content is frequently predictive of DNA that has been recently acquired in evolutionary 
terms (Coenye and Vandamme, 2007). The genomes of both B. mallei ATCC 23344 and the clinical strain 
K96243 of B. pseudomallei have been sequenced and annotated (Holden et al., 2004, Nierman et al., 2004). 
The latter is composed of two circular chromosomes of 4.07Mb and 3.17Mb, showing significant functional 
partitioning of the genes between them (Figure 1.8). 
 
 
Figure 1.8 – Circular diagrams of the B. pseudomallei chromosomes. 
The figure shows chromosome 1(4.07mbp) and chromosome 2 (3.17mbp) of B. pseudomallei K96243 as described by Holden 
and colleagues (Holden et al., 2004) 
 
Chromosome 1 contains a higher proportion of coding sequences involved in core functions, such as 
macromolecule biosynthesis, amino acid metabolism, cofactor and carrier synthesis, nucleotide and protein 
biosynthesis, chemotaxis and mobility. Chromosome 2, by contrast, contains a greater proportion of genes 
encoding accessory functions associated with adaption to atypical conditions, osmotic protection and iron 
acquisition, secondary metabolism, regulation and laterally acquired DNA. In addition chromosome 2 
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contains a greater proportion of coding sequences with matches to hypothetical proteins or proteins that 
have no database matches at all (Holden et al., 2004). At 7.2 Mb, the B. pseudomallei genome is large in 
comparison with the typical prokaryotic genome and horizontal acquisition of DNA appears to have been 
intrinsic to the evolution of this organism. Many regions within both chromosomes showed some of the 
characteristics of genomic islands acquired through very recent lateral transfer, such as anomalies in the 
percentage of GC content or dinucleotide frequency signature of the DNA in these regions. 
 
1.3.4.1 B. pseudomallei and B. mallei genomes in comparison 
 
B. mallei is the causative agent of the highly infectious equine disease known as glanders. It has no known 
reservoir other than horses, mules and donkeys and is a host-adapted pathogen that does not persist in the 
environment outside its equine host. The contagious and potentially lethal nature of human infection with B. 
mallei also makes this species well suited for use as an agent of bioterrorism and B. mallei was one of the 
first biological weapons of the 20th century, being used by Germany during World War I. Glanders has since 
been eradicated from most countries due to stringent infection control measures, including the immediate 
slaughter of affected animals. 
 
Genomic comparisons of B. pseudomallei with closely and more distantly related bacteria revealed a greater 
level of gene order conservation and a greater number of orthologous genes on the large chromosome, 
suggesting that the two replicons have distinct evolutionary origins. The investigation revealed 16 genomic 
islands that together make up 6.1% of the genome, which were shown to be variably present in a collection 
of invasive and soil isolates but entirely absent from the clonally related organism B. mallei. These 
comparative analyses of B. pseudomallei and B. mallei have identified many coding regions that may 
contribute to the phenotypic differences between the two species. These phenotypes include known 
virulence determinants, such as flagella and type III secretion systems (T3SS) as well as potential virulence 
determinants such as surface polysaccharides, exoproteins, fimbriae, pili and putative adhesisn. Further 
determinants include drug resistance and potential environmental survival functions including various 
secondary metabolite pathways, numerous catabolic pathways, transport systems and stress response 
proteins (Holden et al., 2004). 
 
Although B. mallei strains appear to have recently evolved from a B. pseudomallei ancestor, there are large 
differences in the sizes of the genomes, the B. pseudomallei genome is 1.31 Mb larger than that of B. mallei, 
reflecting the adaption of the pathogen to grow in a restricted infectious environment (Coenye and 
Vandamme, 2007). The absence of genomic islands in the B. mallei genome suggests that gene acquisition 
does not play as significant a role in the genetic variation of this species as it does in B. pseudomallei. 
Holden and colleagues propose that gene loss appears to have been an important source of genetic 
variation in the recent evolution of B. mallei (Holden et al., 2004), whilst Nierman and colleagues, suggest 
that numerous insertion sequences and simple sequence repeats point to an alternate mechanism for 
genetic variability in B. mallei (Nierman et al., 2004). 
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1.3.4.2 B. pseudomallei and B. thailandensis genomes in comparison 
 
Environmental isolates from central and north-eastern Thailand were collected and tentatively identified as B. 
pseudomallei strains, based on their growth on selective media, biochemical profiling and latex agglutination 
assays (Smith et al., 1995, Wuthiekanun et al., 1995a). However, Brett and colleagues, whilst attempting to 
develop a transposon based mutagenesis system for B. pseudomallei observed a number of phenotypic and 
genotypic dissimilarities between clinical isolates and some of the environmental isolates, specifically the 
differences associated with the decreased virulence for Syrian golden hamsters in comparison to the true B. 
pseudomallei strains (Brett et al., 1997, DeShazer et al., 1997). These environmental isolates had a more 
than 105 fold decrease in virulence relative to B. pseudomallei in this animal model of acute melioidosis 
(Brett et al., 1997). Wuthiekanun and co-workers demonstrated differences in the biochemical characteristics 
of B. pseudomallei isolates and true isolates, suggesting that these environmental isolates may represent a 
new species of B. pseudomallei (Brett et al., 1998). Brett and colleagues cloned and sequenced more than 
95% of the 16S rDNA from B. pseudomallei 1026b, which is a virulent clinical isolate similar to K96243 and 
the newly isolated B. pseudomallei-like E264, to assess the relatedness of these organisms to each other, 
finding 15 nucleotide dissimilarities in all 1488 base pairs of the 16S rRNA upon alignment of the two 16S 
rRNA alleles, thus confirming the presence of a new Burkholderia species to which they proposed the name 
B. thailandensis. 
 
B. thailandensis has colonies which are smooth and glossy with pink pigmentation, in comparison to the 
rough, wrinkled and dark purple pigmentation found in B. pseudomallei colonies and is capable of 
assimilating L-arabinose (Brett et al., 1997). It is sensitive to tetracycline, ceftayidime and trimethoprim, but 
resistant to aminoglycosidases. B. thailandensis and B. pseudomallei strains are structurally and 
immunologically similar to one another and the differences in virulence were further investigated to identify 
the genetic factors responsible for  the enhanced virulence of B. pseudomallei (Brett et al., 1998). 
 
The genomes of B. pseudomallei and B. thailandensis both comprise two highly syntenic chromosomes with 
comparable numbers of coding regions, protein family distributions and horizontally acquired genomic 
islands. They share an extensive repertoire of genes involved in core metabolism, accessory pathways, 
structure-based superfamilies and bacterial virulence factors, however virulence related genes appear to 
have undergone accelerated change, to adapt to the challenge of infecting and surviving in human or animal 
hosts in B. pseudomallei. The B. thailandensis chromosomes are 3.8Mb and 2.9Mb (Yu et al., 2006). 
 
The B. thailandensis genome contains at least 15 regions exhibiting either atypical GC content or stretches 
of bacteriophage related genes and phage-like integrases, which collectively encompass 4-5% of the entire 
genome. These genomic islands are not found in B. pseudomallei and B. mallei, consistent with their 
acquisition by B. thailandensis subsequent to the B. pseudomallei-B. thailandensis divergence. The genomic 
islands of B. thailandensis seem to occur in the same relative genomic location as those in B. pseudomallei, 
suggesting that these locations may represent genomic hot spots or landmarks for the acquisition of 
horizontally acquired sequences. Thus the acquisition and loss of large-scale genomic material seems to 
represent a major driving force in bacterial evolution and often plays a critical role in the development of 
novel microbial phenotypes. 
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Although B. thailandensis and B. pseudomallei occupy similar ecological niches, biochemical analysis has 
identified several phenotypic differences between the species including the ability of B. thailandensis but not 
B. pseudomallei to assimilate the carbon sources arabinose and xylose (Moore et al., 2004, Smith et al., 
1997). B. thailandensis was shown to contain an eight-gene arabinose assimilation operon on chromosome 
2 that is absent in B. pseudomallei, where this region has been replaced by protein clusters. Introduction of 
this operon into B. pseudomallei resulted in the downregulation of a number of type III secretion genes and 
the strain displayed reduced virulence in Syrian hamsters (Brett et al., 1998, Reckseidler et al., 2001, 
Wuthiekanun et al., 1996, Wiersinga and van der Poll, 2009). Similarly B. thailandensis contains a 64kb 
region on chromosome 1 encoding several genes involved in xylose metabolism, which is absent and 
replaced in B. pseudomallei. This suggests an evolutionary model where the horizontal acquisition by B. 
pseudomallei may have also resulted in the deletion of the xylose gene cluster, demonstrating how 
horizontal transfer events can often result in simultaneous gene acquisition and loss (Whitfield and Roberts, 
1999). 
 
Variations in surface component proteins have been shown to contribute to virulence in several pathogenic 
species, such as is seen with fimbriae, short pilus structures allowing bacteria to adhere to environmental 
surfaces and host cells (Kespichayawattana et al., 2004). B. pseudomallei contains twice as many fimbrial 
gene clusters as B. thailandensis and has been shown to be more efficient than B. thailandensis in adhering 
to and invading host cells. Furthermore it has been shown that B. pseudomallei contains a large gene cluster 
involved in the synthesis and export of capsular polysaccharides, a major determinant of virulence and this 
cluster is absent in B. thailandensis. The specific location of the B. pseudomallei capsular gene cluster within 
its genome is likely to be non-random, as it replaces a pre-existing 10-gene cluster in B. thailandensis 
already dedicated toward the metabolism and processing of polysaccharide structures (Figure 1.9). The 
original cluster in B. thailandensis contains several genes involved in polysaccharide assembly, raising the 
possibility that a key event in the pathogenic evolution of B. pseudomallei was to replace a pre-existing or 
ancestral polysaccharide coat with an alternative pathogenic variant capable of resisting challenges by the 
immune system of infected hosts (Reckseidler et al., 2001). 
 
Strong conservation between the B. pseudomallei and B. thailandensis proteomes were found in the core 
metabolic pathways such as amino acid metabolism, cofactor and carrier synthesis, nucleotide and protein 
biosynthesis, consistent with the ability of B. pseudomallei and B. thailandensis to occupy similar 
environmental niches (Smith et al., 1997). Unexpectedly, the B. pseudomallei and B. thailandensis 
proteomes also appear to share significant similarities in their virulence components and 71% of potential 
virulence genes found in B. pseudomallei are also present in B. thailandensis at an average similarity of 
greater than 80%, including two type III secretion systems (T3SS2 and T3SS3), antibiotic resistance genes, 
type IV pili-generating proteins, hemolysin-related genes ad several adhesion factors and proteases (Holden 
et al., 2004). However, even though both B. pseudomallei and B. thailandensis share two T3SS, required for 
the full virulence of B. pseudomallei in a hamster model of infection (Warawa and Woods, 2002), it has 
recently been shown that arabinose exposure may downregulate T3SS expression and activity (Moore et al., 
2004). The absence of an arabinose assimilation operon in B. pseudomallei might thus have contributed to 
the increased virulence of this species. 
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Figure 1.9 – B. pseudomallei and B. thailandensis polysaccharide biosynthesis clusters. 
The schematic was adapted from the genomic comparison study by Yu assessing the genome of B. pseudomallei K96243 and 
B. thailandensis E264 (Yu et al., 2006). The diagram shows the capsular polysaccharide biosynthesis cluster of B. 
pseudomallei K96243 (top – pink) with an ancestral polysaccharide cluster of B. thailandensis E264 (bottom – red). 
 
Genomic comparisons between pathogens and non-pathogenic relatives have played an important role in 
identifying the mechanisms responsible for acquisition of virulence in the natural environment. Yu and 
colleagues discuss that gene mutation, gene deletion and gene acquisition on the part of B. pseudomallei 
are likely to represent the major evolutionary drivers of virulence and that other proposed mechanisms of 
pathogen evolution including chromosomal rearrangement and bacteriophage-mediated recombination may 
thus play a less relevant role in the pathogenic evolution (Yu et al., 2006). 
 
B. pseudomallei can only be experimentally manipulated under biosafety level 3 (BSL 3) conditions, but B. 
thailandensis is non-pathogenic for humans and animals although it displays several phenotypic 
characteristics similar to B. pseudomallei. As suggested by Nierman and colleagues research on the 16S 
rRNA phylogeny studies, B. thailandensis is closely related to B. pseudomallei, whilst the phylogenetic 
similarity between B. pseudomallei and B. mallei suggested it to be a derivative or clone of B. pseudomallei 
(Nierman et al., 2004). B. thailandensis on the other hand, was thought to have diverged from B. 
pseudomallei and B. mallei approximately 47 Million years ago, suggesting that although B. thailandensis is 
avirulent, it is likely to be highly evolutionary related to virulent B. pseudomallei and thus a good candidate 
for comparative genomic analysis (Yu et al., 2006). 
 
1.3.4.3 B. pseudomallei as an accidental pathogen 
 
The B. pseudomallei genome shares a core set of 2590 genes with other members of the Burkholderia 
family and was recently shown to be highly dynamic (Lin et al., 2008, Sim et al., 2008, Tuanyok et al., 2007, 
Tumapa et al., 2008). It was found that 86% of the B. pseudomallei K96243 genome is common to all strains 
across the 94 Southeast Asian strains isolated from a variety of clinical, environmental and animal sources. 
These represent the core genome including genes common to all strains in a population and those involved 
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in essential functions. The remaining 14% of the genome were found to be variably present across the strain 
panel investigated by Sim and co-workers. Core genes were significantly over-represented in several 
functions necessary for basic bacterial growth and survival, including amino acid metabolism, inorganic ion 
transport, nucleotide metabolism and protein translation. Besides these basic housekeeping functions the B. 
pseudomallei core genes were also significantly enriched in commonly encountered virulence related genes 
such as those involved in the production of secretion proteins, capsular polysaccharides, exoproteins, 
adhesions, fimbriae and pili. This would suggest that most if not all B. pseudomallei isolates are likely to 
possess a common “virulence” machinery and notably many of these conventional virulence genes are also 
found in other related species such as B. thailandensis that although non-infectious in mammals, are able to 
infect other species such as nematodes. This is consistent with the possibility that B. pseudomallei might 
have descended from a pathogenic ancestor with a non-mammalian host (Sim et al., 2008). 
 
It is very likely that the “virulent” combination of genes found in B. pseudomallei has emerged for reasons 
other than to cause human disease, particularly since cases of human or animal infection are relatively rare 
compared to the density of B. pseudomallei in the soil. In contrast to bacteria which are obligately associated 
with eukaryotic hosts, soil bacteria such as B. pseudomallei commonly face extreme and unpredictable biotic 
and abiotic challenges including extreme temperature shifts, solar radiation, variable humidity, competition 
for nutrients and the requirement to survive ingestion by predatory protozoa, nematodes, the production of 
bacteriocides from other bacteria and phage infection. It thus seems entirely plausible that genes facilitating 
survival against these environmental challenges might have also indirectly enhanced the microbes’ ability to 
colonize and “accidently” infect human host, particularly when the host is immunocompromised (Sim et al., 
2008). 
 
At 7.2Mb, the genome of B. pseudomallei represents one of the most complex bacterial genomes sequenced 
to date. Certain environmental microorganisms can cause severe human infections, even in the absence of 
an obvious requirement for transition through an animal host for replication, which is termed accidental 
virulence. Nandi and co-workers compared eleven isolate genomes of B. pseudomallei and the existence of 
several new genes in the B. pseudomallei reference genome were found by mRNA transcripts, database 
homologs and presence of ribosomal binding sites. These exhibited significant levels of positive selection 
distributed across many cellular pathways including carbohydrate and secondary metabolism (Nandi et al., 
2010). Functional experiments revealed that certain positively selected genes might enhance mammalian 
virulence by interacting with host cellular pathways or utilising host nutrients. Evolutionary modifications 
improving B. pseudomallei environmental fitness may thus have indirectly facilitated the ability to colonise 
and survive in mammalian hosts. 
 
1.3.4.4 B. pseudomallei typical and atypical serotypes 
 
Diagnosis of melioidosis remains a problem and definitive diagnosis still relies on the isolation and 
identification of bacteria from clinical specimens. Attempts to develop reliable immunologic and molecular 
assays to replace the more time-consuming bacteriologic diagnosis have been made, but these new 
diagnostic methods remain non-validated (Anuntagool et al., 2000b, Wuthiekanun et al., 2002). B. 
pseudomallei is generally considered a rather homogenous species, but colony variation occurs, and 
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variation in antibiotic susceptibility profiles and biochemical profiles using a number of commercial 
bacteriological identification systems have been reported (White, 2003, Cheng and Currie, 2005). In addition 
to these phenotypic variations, physicochemical and antigenic heterogeneity of the LPS prepared from B. 
pseudomallei was reported, which would be responsible for false seronegativity in the patients with B. 
pseudomallei infection (Anuntagool et al., 2000a, Anuntagool et al., 1998). 
 
In a highly pathogenic bacterial species such as B. pseudomallei, LPS has a major role in stimulating host 
innate immune response during infection (Nelson et al., 2004). Previous studies have shown that B. 
pseudomallei LPS is required for serum resistance and virulence (DeShazer et al., 1998). It has been well 
established in many bacterial diseases that overstimulation of the host cells by LPS can lead to the features 
of septic shock and septicaemia is a major cause of death. Cellular recognition of LPS by the innate immune 
system triggers the proinflammatory cytokines by host cells, which aids in the clearance of the pathogen. 
With high concentrations of antibodies to LPS associated with survival in severe melioidosis demonstrated a 
potential role for B. pseudomallei LPS in protective immunity (Ho et al., 1997). The LPS mutant B. 
pseudomallei strain SRM117, which lacked the O-antigenic polysaccharide moiety, was more susceptible to 
macrophage killing during the early phase of infection than its parental strain 1026b (Arjcharoen et al., 2007). 
 
Anuntagool and collaborators reported 96% of the LPS from clinical isolates possessed a sodium dodecyl 
suflate-polyacrylamide gel electrophoresis (SDS-PAGE) silver staining ladder profile referred to as a typical 
ladder and approximately 3% that exhibited different ladder characteristics referred to as an atypical ladder. 
The remaining 1% had no ladder detectable in the high molecular weight region but possessed a low 
molecular weight silver-staining band below the 29kDa marker that was designated as a no ladder LPS. All 
three LPS types were antigenically distinct as evident from immunoblot reactivity against pooled sera from 
patients from whom the typical or atypical LPSs were isolated (Anuntagool et al., 2000a). To investigate the 
possible biological significance of the different LPS phenotypes, Anuntagool and colleagues then expanded 
their study to include environmental isolates as well as clinical isolates form patients with different clinical 
manifestations. They extracted LPS from 1327 isolates and tested with pooled patient sera (Anuntagool et 
al., 1998). In this larger series of isolates, the proportion of isolates possessing different LPS patterns was 
similar to that in the initial report, showing a ratio of 97:2:1, reflecting typical, atypical and no-ladder LPS 
ratios. Overall 99% of the isolates possessed smooth type LPS exhibiting two different ladder profiles as well 
as being serologically distinct, most likely reflecting two different repeating polysaccharide side chains, 
termed O-antigens. 
 
The most common serotype is referred to as serotype A (97%), whilst the less abundant one (2%) is known 
as serotype B, referring to the previous terms of typical and atypical LPS respectively (Anuntagool et al., 
2000a). The remaining 1% without a ladder profile and exhibiting negative seroreactivity, against sera from 
patients infected with serotype A and B isolates, was suggested to represent only a lipid A-core 
oligosaccharide, known as rough LPS (Anuntagool et al., 2006). Figure 1.10 shows the SDS-PAGE gel and 
silver stain of B. pseudomallei 576 (serotype B), B. pseudomallei K96243 (serotype A) and B. thailandensis 
with their respective ladder profiles. 
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Figure 1.10 –Silver stain and SDS-PAGE of B. pseudomallei and B. thailandensis. 
The figure shows the silver stain and SDS-PAGE gel of B. pseudomallei 576 (serotype B), B. pseudomallei K96243 (serotype A) 
as well as B. thailandensis E264 (serotype A) as run on a 10% novex SDS 1.5mm, 10 well gel alongside a precision plus 
kaleidoscope standard. The gels were run by our collaborators at dstl. 
 
A much higher proportion of the Australian isolates possessed the two less common serotype B and rough 
LPS types (19.3%) in comparison with the Thai isolates (2.7%). The LPS of clinical isolates were more 
heterogeneous than the LPS of environmental isolates, whilst all environmental isolates had the smooth type 
LPS and all except one belonged to serotype A. When quantitated for the capacity to produce biofilm the 
three LPS types differed from one another. Those with a rough LPS exhibited the highest biofilm-producing 
capacity and those with a smooth type serotype A profile showed the lowest mean biofilm producing 
capacity. The increased capacity to produce biofilm by rough type LPS serotypes, may allow the organism to 
evade host defences and therefore survive better inside the host. Whether biofilm production is important in 
the pathogenesis of melioidosis is still unclear (Taweechaisupapong et al., 2005, Anuntagool et al., 2006). 
 
Since LPS has been implicated as one of the virulence factors for a number of Gram-negative bacteria, 
including B. pseudomallei (DeShazer et al., 1998), possible associations between the LPS types and various 
clinical parameters of the patients from whom these isolates were obtained were investigated. Anuntagool 
and co-workers found no association between the LPS type and disease severity, clinical manifestations or 
underlying risk factors. The two less abundant LPS patterns were found more in isolates obtained from 
patients with relapse melioidosis than from those with primary infection, suggesting that the bacteria with the 
less common LPS (serotype B) are able to survive better in their host in comparison to those with the more 
common LPS type (serotype A). Since each LPS type was found to be antigenically distinct, antigenic 
polymorphism among the B. pseudomallei LPS may allow the bacteria to evade host immunity. These 
uncommon LPS types were not associated with a survival advantage ex-vivo because bacteria with different 
LPS phenotypes were equally resistant to killing and equally able to replicate in 30% normal human serum 
(Anuntagool et al., 2006). 
 
Due to the importance of LPS phenotypic diversity for serology and diagnostics Tuanyok and co-workers 
investigated the genetic and molecular basis of differential LPS phenotypes in a large B. pseudomallei 
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population using bioinformatics, phenotypic characterisation as well as population genetics approaches 
(Tuanyok et al., 2012). Comparative analysis was used to assess the diversity of genes responsible for the 
biosynthesis of the O-antigen moiety of LPS in B. pseudomallei using publicly available genomes to identify 
differences within LPS biosynthetic genes. A total of 27 B. pseudomallei, 10 B. mallei and 3 B. thailandensis 
and two B. oklahomensis isolates were compared to identify the LPS O-antigen biosynthesis genes. Three 
different O-antigen biosynthesis gene categories, or genotypes, were identified. The B. pseudomallei O-
antigen biosynthesis genes were assigned to two major groups; group A referring to LPS genotype A, was 
identical or very similar to the O-antigen biosynthesis operon observed in B. pseudomallei 1026b and 
K96243, and group B, referring to LPS genotype B, which was found in an atypical LPS strain 576 (Figure 
1.11). 
 
DeShazer and colleagues had previously identified seven genes in the O-antigen biosynthesis operon in B. 
pseudomallei 1026b by Tn5-OT182 mutagenesis, which were responsible for O-antigen biosynthesis and 
serum resistance and included mlB, mlD, wbiA, wbiC, wbiE, wbiG and wbiI. The gene wbiE of B. 
pseudomallei strain K96243 and gene BUC_3396 of strain 576 were used to represent the presence of LPS 
genotypes A and B, respectively and a total of 999 B. pseudomallei strains from different geographic 
locations and epidemiological origins, including clinical, animal and environmental strains, were tested for 
their LPS genotypes. Tuanyok and collaborators further observed a frame-shift mutation in the O-antigen 
biosynthesis wbiI gene of B. pseudomallei strains MSHR1655, which was correlated with its rough 
phenotype. The mutation was found to encode an oligosaccharide epimerase/dehydratase and was 
conserved in all O-antigen biosynthesis gene clusters of B. pseudomallei, suggesting that a mutation in this 
gene probably impacts on the synthesis of the O-antigen (Cheng et al., 2004). 
 
 
Figure 1.11 – Biosynthesis gene cluster for the O-antigen moiety in B. pseudomallei K96243 and 576. 
The schematic is adapted from Tuanyok and colleagues (Tuanyok et al., 2012) who compared the LPS O-antigen biosynthesis 
gene cluster of B. pseudomallei K96243 of serotype A (top) with that of B. pseudomallei 576 of serotype B (bottom). 
 
The LPS genotype A was found in most B. pseudomallei and all B. mallei and B. thailandensis genomes 
examined. It was also the most common genotype found in both Australian (85.3%) and Southeast Asian 
(97.7%) strain populations, whilst the LPS genotype B was relatively rare in Southeast Asian strains (2.3%), 
but was found in 13.8% of Australian strains. Additionally, five of the Australian strains were not able to be 
typed using PCR and they were further analysed for O-antigen biosynthesis gene identification using whole 
genome sequencing. Comparative genomics demonstrated that many genes in this new cluster were similar 
to those of the LPS genotype B genes of B. pseudomallei 576 and were distinct from K96243 LPS genotype 
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A genes. They were therefore newly identified as a variant of LPS genotype B and were designated as 
genotype B2. Because the LPS genotypes B and B2 were frequently found in Australia but not in Southeast 
Asia, it could be argued that this finding may be due to different therapies used for clinical cases in these two 
endemic locations, however, most of the samples were collected before antibiotic treatment and some of the 
B strains were collected form soil and animals, thus confirming that the occurrence of LPS types B and B2 in 
Australia is not associated with the exposure to antibiotics or treatment therapy. B2 strains were also killed in 
growth media containing 30% N-hydroxysuccinimide (NHS), whereas the LPS genotype B strains were 
resistant (Tuanyok et al., 2012). 
 
The LPS of B. pseudomallei was not assumed to readily switch its LPS phenotype from A to B as the gene 
composition of the different genotypes are very different and a simple switching mechanism is difficult to 
envision, whilst some rough LPS strains were even found to have mutations in their O-antigen biosynthesis 
genes. Further biochemical characterisation and structural elucidation of the different O-antigens and lipid A 
of B. pseudomallei LPS should provide additional insights into the possible role of LPS in pathogenesis, 
diagnosis and vaccine development and these investigations are a focus of this thesis (Chapter 4). 
 
1.3.5 B. pseudomallei polysaccharide antigens and their structures 
 
B. pseudomallei produces several surface-associated molecules that have been proposed for use as vaccine 
components and serological diagnostic agents. These include lipopolysaccharides (LPS), capsular 
polysaccharides (CPS), expopolysaccharides (EPS) and flagella (Brett et al., 1994, Brett and Woods, 1996, 
Bryan et al., 1994). The immunological importance of the polysaccharides has been demonstrated by the 
reduction in the lethality of infection in mice and diabetic rats when passively immunised with antibodies to 
the LPS or CPS. Immunisation of mice with LPS or CPS provides protection against subsequent challenge 
with B. pseudomallei, suggesting that these polysaccharides have potential as vaccine candidates (Sarkar-
Tyson et al., 2007). 
 
The LPS and CPS of B. pseudomallei have been intensively studied and their gene clusters have been 
identified (Sarkar-Tyson et al., 2007, Cheng and Currie, 2005). The LPS O-antigen seems to have properties 
typical for bacterial O-antigens, such as providing resistance to serum killing, whilst the function of the CPS 
is less clear but it may provide resistance to phagocytosis by reducing levels of complement C3 deposition. 
Further putative gene clusters of polysaccharides termed type III O-PS and type IV O-PS were also reported 
(Cheng and Currie, 2005, Sarkar-Tyson et al., 2007). These clusters are not found in B. mallei, but are 
conserved in B. thailandensis and their putative functions are polysaccharide biosynthesis and transport, 
indicating that these putative polysaccharide clusters have a possible role in environmental survival. 
Furthermore there is an already previously reported exopolysaccharide (DeShazer et al., 1998) and studies 
have shown glycosylation of the B. pseudomallei flagella (Scott et al., 2011). 
 
The O-antigen is the most structurally diverse LPS component within a species and over 170 known 
structures have been found in E. coli. The complication with LPS as a potential vaccine target is the fact that 
there are four different B. pseudomallei O-antigen genotypes, including LPS genotypes A, B, B2 and a rough 
LPS type. Furthermore, sero-crossreactivity is common among O-antigens of Burkholderia species (Stone et 
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al., 2012). As previously discussed, most B. pseudomallei strains express the genotype A O-antigen, making 
it the most abundant structure, whilst the atypical genotypes B and B2 are related serologically, but have 
distinct ladder banding profiles on SDS-PAGE (Tuanyok et al., 2012). The only LPS O-antigen that has been 
characterised is serotype A, whilst LPS type B has not been found in any other species, other than B. 
pseudomallei and type B2 was recently described in a B. thailandensis species, found in soil and water in 
northern Australia. 
 
1.3.5.1 LPS structures 
 
Knirel and collaborators were the first group to structurally characterise the polysaccharides of B. 
pseudomallei in 1992. They demonstrated the presence of two partially O-acetylated O-antigenic 
polysaccharides, which they named PS-I and PS-II. Their methylation analysis and 1H and 13C NMR 
spectroscopy including NOE experiments showed PS-I to have the structure [-3)-β-D-glucopyranose-(1-3)-6-
deoxy-α-L-talopyranose-(1-] and PS-II to have the structure [-3)-2-O-acetyl-6-deoxy-β-D-manno-
heptopyranose-(1-] (Knirel et al., 1992). In 1995, Perry and co-workers further characterised the structures of 
the serologically typical strain of B. pseudomallei strain 304b. They reported two smooth type LPS, and 
termed them O-PS I and O-PS II reflective of Knirel’s annotation. They found that 33% of the L-6dTalp 
residues in O-PS II bear 2-O-methyl and 4-O-acetyl substituents while the other L-6dTalp residues carry only 
2-O-acetyl substituents (Table 1.2) (Figure 1.4) (Perry et al., 1995, Knirel et al., 1992). Rabbit polyclonal 
antibody and a monoclonal antibody raised against a tetanus toxoid conjugate of B. pseudomallei O-PS II 
were found to be protective against challenge in an animal model of infection. The same antibodies 
recognised more than 40 strains of B. pseudomallei isolated from infected patients in North-Eastern 
Thailand, indicating the presence of a common antigen. 
 
A cluster of 15 genes was located that is required for biosynthesis of the type II O-PS moiety of LPS in B. 
pseudomallei and seems to provide resistance to complement-mediated bacteriolysis. Furthermore, it was 
found that B. pseudomallei has the ability to invade and survive within the bloodstream, which is important in 
the pathogenesis of septicaemic melioidosis (DeShazer et al., 1998). DeShazer and colleagues were the first 
to suggest that type I and II O-PS were not both LPS moieties and that type I O-PS was in fact a CPS 
(Section 1.3.5.2), whilst the type II O-PS was the LPS. Serum sensitive mutants SRM108, SRM109 and 
SRM117 were deficient in the LPS moiety but produced the CPS moiety and were less virulent than the 
parental strain 1026b in three animal models of melioidosis. The C5b-C9 membrane attack complex (MAC) 
was also found to be deposited on the bacterial surface and on serum sensitive mutants implying a 
correlation between LPS presence and serum resistance. Immunogold electron microscopy studies further 
demonstrated that the lack of LPS altered the distribution and appearance of the CPS. DeShazer and 
colleagues explained this by suggesting that the CPS was responsible for preventing the integration of the 
MAC complex into the bacterial outer membrane and that the LPS moiety plays an indirect, supportive and 
maintaining, role by influencing the organisation and or arrangement of the CPS to effect MAC complex 
formation far away from the bacterial surface or preventing its insertion into the outer membrane. This was 
assumed as the closely related B. thailandensis wasn’t shown to produce CPS, yet was resistant to 30% 
NHS (DeShazer et al., 1998). 
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The O-antigen of B. mallei, is virtually identical to the LPS of B. pseudomallei except that it lacks acetyl 
modifications at the O-4 position of the L-6d-Talp residues. The genes required for the synthesis of the B. 
mallei LPS O-antigen have been identified (Burtnick et al., 2002). These genes are clustered on an 
approximately 19kb region of chromosome 1 and encode 16 ORFs (Nierman et al., 2004). These ORFs are 
identical to those encoding the LPS O-antigen of B. pseudomallei (DeShazer et al., 1998). Sequence 
alignment of the B. pseudomallei and B. mallei LPS biosynthetic regions revealed 99% identity at the 
nucleotide level and the genes comprising the B. mallei O-antigen biosynthetic operon were named as per 
the identical genes found in B. pseudomallei. As there are no differences between the O-antigen loci, it has 
been suggested that the different pattern of O-acetylation is due to the presence of an unlinked locus that is 
either not present or non-functional in the genome of B. mallei (Burtnick et al., 2002, Coenye and 
Vandamme, 2007). The presence of O-acetyl groups on the LPS moiety was concluded to have 
consequences when the O-antigen is considered as a component of a vaccine that protects against both B. 
mallei and B. pseudomallei (Burtnick et al., 2002, Brett et al., 2003). 
 
B. thailandensis and B. pseudomallei also have similar O-antigens, and B. thailandensis has similar 
modification patterns as B. pseudomallei (Cheng and Currie, 2005, Sarkar-Tyson et al., 2007). The wbiA 
allele in B. thailandensis and B. pseudomallei showed conserved amino acid motifs that define a family of 
inner membrane trans-acylases, suggesting that the function of the wbiA gene would be similar in both 
species. Brett and colleagues investigated whether the wbiA gene was required for the expression of the 
LPS moiety (Brett et al., 2003). A protective monoclonal antibody reacted with the LPS of the wild-type B. 
pseudomallei, but not with a B. pseudomallei wbiA null mutant. It was shown that WbiA activity was required 
for the acetylation of the L-6dTalp residues at the O-2 position and that such structural modification of the 
LPS was critical for the recognition with the antibody (Brett et al., 2003). It was further reported that the O-
antigen acetylase (OacA) gene is known to be involved in the acetylation at the O-4 position of B. 
thailandensis, with its homolog in B. pseudomallei K96243 being identified as BPSL1936 (Brett et al., 2011). 
Point mutations were inserted in the oacA genes of both species, to determine if the gene played only a 
single role in the side group modifications of the talose residues or a dual role in combination with the 
synthesis of the O-antigen. Both strains were tested for O-antigen production and immunogenic specificity 
and OacA was found not to be involved in the synthesis of the O-antigen, as the mutations still showed 
bands and strong interaction with B. mallei LPS-specific monoclonal antibody. However the OacA was 
speculated to possess both acetyletransferase and methyltransferase activites, as both modifications of O-
antigens were affected (Brett et al., 2011). 
 
Anuntagool and colleagues found variable serotypes in the heterogeneity among the B. pseudomallei LPS, 
where bacteria with the less common LPS survive better in hosts than those with the more common LPS 
type (Anuntagool et al., 2006, Sarkar-Tyson et al., 2007). Since each LPS type is antigenically distinct, 
antigenic polymorphism among the B. pseudomallei LPS may allow the bacteria to evade host immunity. 
Therefore, structural elucidation of the different O-antigens and the lipid A of B. pseudomallei LPS should 
provide additional insights into the possible role of LPS in pathogenesis, diagnosis and vaccine 
development. The O-antigen repeating unit of serotype A LPS has been characterised (Anuntagool et al., 
2000a, DeShazer et al., 1998, Knirel et al., 1992, Perry et al., 1995, Brett et al., 2003), as well as its lipid A 
structure (Novem et al., 2009). The O-antigens of the strains of serotypes B and B2 have not been 
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structurally characterised, and the O-antigen repeat unit structure of serotype B, strain B. pseudomallei 576, 
is presented in this thesis (Chapter 4). 
 
1.3.5.2 Capsular polysaccharides 
 
The capsule forming polysaccharide of B. pseudomallei K96243 was reported to be an unbranched 
homopolymer with the structure [-3)-2-O-acetyl-6-deoxy-β-D-manno-heptopyranose-(1-] by Knirel and 
colleagues (Table 1.2) (Knirel et al., 1992). However, as described in the previous section, Perry and 
colleagues subsequently suggested that this sequence as the O-antigen component of a second LPS found 
on B. pseudomallei which they called O-PS I. They suggested that simultaneous production of two or more 
LPS O-antigens by a Gram-negative bacterium was not unusual, such as is seen with Salmonella boecker 
(group H), which produced two distinct O-antigens, whilst Salmonella madelia has been demonstrated to 
produce three structurally different LPS O-antigens (Perry et al., 1995). Nevertheless, Reckseidler and co-
worker’s later investigations suggested that this polysaccharide is a capsule rather than an O-antigen moiety. 
An important piece of evidence was the discovery that the genes involved in the production of this 
polysaccharide demonstrated strong homology to the genes involved in the production of CPS in many 
organisms including E. coli, N. meningitides and H. influenza (Perry et al., 1995, Reckseidler et al., 2001). 
 
1.3.5.3 Other oligo- and polysaccharides  
 
Further types of glycopolymers, in addition to LPS and CPS, are expressed on the surface of B. 
pseudomallei. These are exopolysaccharides (EPS) and glycoproteins. 
 
It remains to be determined whether more than one EPS is expressed by this organism. EPS has been 
reported to be comprised of an unbranched polymer of repeating tetrasaccharide units with the structure [-3)-
2-O-acetyl-β-D-Galp-(1-4)-α-D-Galp-(1-3)-β-D-Galp-(1-5)- β-D-KDOp-(2-] (Table 1.2) (DeShazer et al., 1998, 
Masoud et al., 2009). However, upon genomic analysis of B. pseudomallei, further to the already 
characterised LPS (type II O-PS) and CPS (type I O-PS), two additional putative gene clusters implicated in 
polysaccharide biosynthesis termed type III O-PS and type IV O-PS were reported (Cheng and Currie, 2005, 
Sarkar-Tyson et al., 2007). The type III O-PS is encoded by a cluster of 13 genes to which have been 
assigned putative functions related to polysaccharide biosynthesis and transport (Holden et al., 2004), whilst 
type IV O-PS genes show putative functions of CPS biosynthesis and polysaccharide transport proteins. The 
EPS structure described above is present in both B. pseudomallei and B. mallei yet the genome of the latter 
did not contain the putative type III and type IV O-PS clusters, suggesting that these clusters are not 
responsible for the EPS biosynthesis. (Sarkar-Tyson et al., 2007). Further work is required to establish the 
function of the type III and IV gene clusters. 
 
Like EPS, the extent of protein glycosylation in B. pseudomallei is poorly understood. However it is now 
firmly established that the flagellins in this organism are O-glycosylated. Scott and colleagues used a gel-
based glycoproteomics approach to identify glycoproteins of B. pseudomallei and the closely related but non-
pathogenic B. thailandensis, and found that the flagellin proteins of both species were modified by novel 
glycans (Scott et al., 2011). The identification of the major flagellar filament protein FliC as a putative 
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glycoprotein is not without precedent as this protein has been shown to be glycosylated in a range of other 
bacteria such as H. pylori, C. botulinum, C. difficile, C. jejuni and P. aeruginosa. Previous work had indicated 
that the FliC proteins of four B. pseudomallei strains have experimentally determined masses some 3.3kDa 
larger than expected and it was suggested that posttranslational modifications might explain this 
discrepancy. Inactivation of rmlB resulted in non-glycosylated FliC in B. pseudomallei and also to abrogate 
motility. Interestingly rmlB mutants still have flagellar filaments on their surfaces visible by transmission 
electron microscopy, indicating that the loss of motility is not due to defects in export and assembly but 
rather in the function of the flagellar filament itself. Furthermore it was shown that the rmlB mutation also 
resulted in loss of O-antigen synthesis of the LPS, as the rmlB gene is located within the gene cluster 
responsible for LPS O-antigen. This, however, would also suggest that the defects in motility could be due to 
defects in membrane structure. 
 
Species Serotype Antigen Structural details 
BP A CPS -3)-2-O-acetyl-6-deoxy-β-D-manno-heptopyranose-(1- 
BP A O-PS III Genetic locus only 
BP A O-PS IV Genetic locus only 
BP A EPS -3)-2-O-acetyl-β-D-Galp-(1-4)-α-D-Galp-(1-3)-β-D-Galp-(1-5)-β-D-KDOp-(2- 
BP A LPS -3)-β-D-glucopyranose-(1-3)-6-deoxy-α-L-talopyranose-(1- 
33% variable L-6dTalp: 2-O-methyl / 4-O-acetyl 
BP B LPS uncharacterised 
BP B2 LPS uncharacterised 
BT A LPS -3)-β-D-glucopyranose-(1-3)-6-deoxy-α-L-talopyranose-(1- 
variable L-6dTalp 4-O-acetyl 
BM A LPS -3)-β-D-glucopyranose-(1-3)-6-deoxy-α-L-talopyranose-(1- 
variable L-6dTalp 2-O-acetyl 
Table 1.2 – Summary of polysaccharide structures of B. pseudomallei and B. thailandensis known to date. 
 
1.3.6 Infection models employed in the study of melioidosis 
 
Melioidosis has several disease outcomes ranging from asymptomatic, acute, chronic or latent. These are 
determined by the host immune response. The use of infection models is central to the study of microbial 
pathogenesis; in combination with genetic, immunologic and antigen purification techniques, much can be 
learned regarding the pathogenesis of disease due to microbes. A number of animal models have been 
developed in order to understand the pathogenesis of melioidosis to function as a systems for assessing the 
efficacy of antibiotics and vaccine candidates in vivo (Coenye and Vandamme, 2007). 
 
One of the most frequently used animal models for the study of B. pseudomallei pathogenesis is the Syrian 
golden hamster model of acute B. pseudomallei infection. It was demonstrated many years ago that a 
number of animals could be infected with B. pseudomallei and the hamster proved to be the most 
susceptible and was used to assess the lethality of a number of strains. Rats have been shown to be 
relatively resistant to B. pseudomallei infection, however recently a number of mouse models have been 
developed in order to represent the various manifestations of melioidosis and the major routes of infection by 
B. pseudomallei (Coenye and Vandamme, 2007). 
 
Murine models of acute (BALB/c) and chronic (C57BL/6) infections mimic these immune states in humans. 
The acute melioidosis of BALB/c mice is characterised by a significantly stronger innate immune response 
(Hoppe et al., 1999, Ulett et al., 2000) where hyperproduction of proinflammatory cytokines result in an 
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inappropriate cellular response that fails to control the infection and contributes to tissue destruction and 
multiple organ failure. Chronic infection (C57BL/6 mice) demonstrates moderate cytokine increase that 
allows mice to temporarily confine B. pseudomallei within phagocytes, allowing time for an adaptive immune 
response to occur (Hoppe et al., 1999, Ulett et al., 2000). 
 
Most studies conducted to investigate treatments or therapies for melioidosis have involved murine models 
using BALB/c or C57BL/6 mice. BALB/c mice are highly susceptible to infection and are less resistant to 
infection, as compared to C57BL/6 mice. The Th1 response of C576BL/6 mice is important for macrophage 
activation, whereas BALB/c mice provoke a Th2 biased response inhibiting macrophage activation and 
stimulation of antibody production. These variations in disease presentation, suggest macrophage activation 
to be of importance in combating melioidosis (Titball et al., 2008). 
 
Murine model studies have also shown protective immunity against B. pseudomallei to be induced by a 
range of living and nonliving immunogens, however the strongest response was induced by live attenuated 
immunogens. The problem with such vaccines lies with concerns about latency, thus making it unlikely that 
such vaccines will be appropriate for use in humans (Sarkar-Tyson and Titball, 2010). 
 
1.3.7 B. pseudomallei virulence factors 
 
A number of virulence factors have been proposed to be involved in the pathogenesis of B. pseudomallei. 
These include: CPS, LPS, type III secretion systems (T3SS), flagella and quorum-sensing (QS) molecules, 
type IV pili-mediated adherence and secreted proteins, including haemolysin, olipases and proteases, the 
type VI secretion system (T6SS), secreted factors and regulatory genes, which play a more moderate role in 
virulence (Essex-Lopresti et al., 2005, Wiersinga et al., 2006, Lazar Adler et al., 2009). LPS as a potential 
virulence factor is discussed below because of the relevance to the work described in this thesis. 
 
As described earlier (Section 1.3.4.4), four distinct antigenic types of LPS of B. pseudomallei have been 
reported. These showed no immunological cross reactivity, but they shared similar endotoxic levels in the 
limulus amoebocyte lysate assay as well as the levels of macrophage activation (Anuntagool et al., 2000a, 
Anuntagool et al., 2006). Furthermore, LPS was shown to play a role in the resistance of B. pseudomallei to 
host cationic antimicrobial peptides and complement-mediated killing by DeShazer and colleagues, who 
showed that serum sensitive mutants of B. pseudomallei lack the LPS moiety. The LPS-deficient mutants 
were attenuated in hamsters, guinea pigs and diabetic rats, due to being susceptible to complement 
mediated killing. The proteins lacking in the serum-sensitive mutants were involved in bacterial 
polysaccharide biosynthesis, suggesting the LPS to be essential for B. pseudomallei serum resistance and 
virulence (DeShazer et al., 1998). In addition, B. pseudomallei mutants with transposon insertions within 
genes responsible for LPS core biosynthesis (waaF) and the regulation of the peptidoglycan and 
phospholipid synthesis (lytB) were identified as polymyxin-B sensitive (Burtnick and Woods, 1999). 
 
Patients with localised and septicaemic melioidosis produce antibodies against both the CPS and LPS, 
however, the most potent immunogen in both types of infection was shown to be the LPS moiety (Ho et al., 
1997), which would indicate that the LPS may be a critical constituent of any vaccine designed for the 
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prevention of melioidosis (Brett and Woods, 1996). In-vitro studies in mouse macrophage cell lines using 
LPS mutants suggested a further possible role for the O-antigenic polysaccharide moiety of LPS in 
internalisation and intracellular survival of B. pseudomallei. In comparison to E. coli LPS, however, the LPS 
of B. pseudomallei is a less potent activator of macrophages (West et al., 2008, Utaisincharoen et al., 2000, 
Arjcharoen et al., 2007). 
 
1.3.8 Host defence and response during melioidosis 
 
The compartmentalised gene-expression profile of important inflammatory molecules has been described in 
murine and human melioidosis (Wiersinga et al., 2008c, Wiersinga et al., 2007a). Interferon-γ (IFN-γ) is 
essential for resistance against B. pseudomallei infection with additionally vital roles played by tumour 
necrosis factor α (TNF-α), interleukin (IL)-12 and IL-18, whilst murine studies on CD4+ and CD8+ T cells, 
highlighted the importance of CD4 (Barnes et al., 2008, Easton et al., 2007, Haque et al., 2006b, Wiersinga 
et al., 2007c, Haque et al., 2006a). 
 
 
Figure 1.12 – Molecular and cellular pathogenesis of melioidosis. 
The schematic as adapted from Lazar-Adler and colleagues (Lazar Adler et al., 2009) represents the current understanding of 
B. pseudomallei pathogenesis from the environment, to epithelial attachment by LPS, CPS and flagella followed by the 
invasion of epithelial cells. Within these cells, the T3SS effectors assist in vacuolar escape, thus evading host autophagy and 
BimA-mediated actin polymerisation allows for intracellular motility. Reruitment of innate immune cells is stimulated by the 
activation of TLR2 and TLR4 by B. pseudomallei LPS and flagella, which result in proinflammatory cytokine release and 
provide an intracellular niche for replication of the bacteria. Secondary spread occurs via the lymphatic or capillary vessels. 
With the progression of the infection, the adaptive immune response with T cells and B cells occurs. 
 
Antibody formation is important for protection against infection by B. pseudomallei, but does not seem to be 
essential for primary resistance (Haque et al., 2006b). Neutrophils on the other hand are rapidly recruited to 
the primary site of infection after infection and depletion of neutrophils is associated with a 1000-fold 
increase in pulmonary bacterial loads within 4 days (Barnes et al., 2001, Easton et al., 2007, Wiersinga et 
al., 2008a, Wiersinga et al., 2008d). The myeloid differentiation primary response gene 88 (MyD88) is the 
key signalling adaptor for most toll-like receptors (TLRs) and the IL-1 and IL-18 receptors are crucially 
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involved in protective neutrophil recruitment (Wiersinga et al., 2008d). Macrophage-depleted mice further 
showed an accelerated mortality during experimentally induced melioidosis compared with untreated mice, 
suggesting an important role for macrophages in early host defence (Breitbach et al., 2006). Figure 1.12 
shows a summary of the molecular and cellular basis of pathogenesis of melioidosis as caused by B. 
pseudomallei as described in the following sections (Section 1.3.8.1 and Section 1.3.8.2) 
 
1.3.8.1 B. pseudomallei interaction with the innate immune system 
 
B. pseudomallei activates the alternative complement pathway, but as previously established the membrane 
attack complex is deposited on the capsular polysaccharide and is therefore not bactericidal. Furthermore 
opsonisation with a complement enhances, but is not essential for uptake by phagocytes and does not 
necessarily result in intracellular killing of the bacteria (Kespichayawattana et al., 2000). The CPS and LPS 
further explain B. pseudomallei resistance to lysosomal defensins and cationic peptides, which also allow the 
bacteria to survive within phagocytes and human serum (Gan, 2005). 
 
Following infection with B. pseudomallei, mouse tissue shows rapid influx and activation of neutrophils and 
acute infection is established upon depletion of neutrophils in C57BL/6 mice showing their importance in 
immunity (Easton et al., 2007). Macrophages were shown to be essential for the control of B. pseudomallei 
as the depletion of macrophages in BALB/c or C57BL/6 mice significantly increased mortality rates 
(Breitbach et al., 2006). However B. pseudomallei infection in BALB/c mice failed to attract macrophages to 
the same extent as in C57BL/6 mice and these cells were proposed to temporarily contain B. pseudomallei, 
resulting in chronic melioidosis (Barnes et al., 2001). In comparison to healthy individuals, the macrophages 
from patients showed reduced levels of lysosomal fusion, which resulted in a higher number of bacterial 
numbers, suggesting acute melioidosis to stem from an ineffective cellular innate immune response 
(Puthucheary and Nathan, 2006). 
 
1.3.8.1.1 Toll-like receptors and B. pseudomallei recognition 
 
Toll-like receptors (TLRs) are innate immune receptors that together with other pattern recognition receptors 
(PRRs) are the first to detect host invasion by pathogens and form the crucial link between the innate and 
adaptive immunity. TLRs and PRRs recognise conserved motifs on pathogens termed “pathogen-
associated-molecular-patterns” (PAMPs), which in B. pseudomallei include LPS, lipid A, the peptidoglycan of 
the bacteria, flagella, T3SS as well as DNA and mediate an inflammatory immune response (West et al., 
2008, Wiersinga et al., 2007b). Activation of TLRs occurs via various signalling adaptor proteins, including 
MyD88 and TRIF. MyDD88 knock-out mice showed increased susceptibility to B. pseudomallei infection due 
to reduced neutrophil recruitment and activation (Wiersinga et al., 2008d). 
 
B. pseudomallei LPS is suggested to be the prototypical bacterial ligand for TLR4. The lipid A usually 
interacts with TLR4 in addition to proteins CD14 and MD-2 to induce a pro-inflammatory signal. MD-2 is a 
soluble molecule that is associated with the extracellular domain of TLR4 and is generally regarded as 
essential for LPS recognition by TLR4. Both TLR2 and TLR4 signal via the adaptor molecule MyD88 
although TLR4 may also signal in a MyD88-independent fashion via the adaptor molecule TIR-domain-
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containing adaptor-inducing interferon-β (TRIF) (West et al., 2008). It is still not clear whether purified B. 
pseudomallei LPS signals via TLR2, TLR4 or both; however, during experimental melioidosis CD14 and 
TLR2 deficient mice displayed a markedly improved host defence. This was reflected by strong survival 
advantages together with decreased bacterial loads, reduced proinflammatory cytokine levels and reduced 
organ injury. TLR4 deficient mice, however, were indistinguishable from wild type mice with respect to 
bacterial outgrowth and survival in experimentally induced melioidosis, which undermines TLR4 as main 
receptor (West et al., 2008, Wiersinga et al., 2008b). However other MyD88-dependent signalling pathways 
may also be important in the host response to B. pseudomallei infection. 
 
1.3.8.2 B. pseudomallei and the adaptive immune response 
 
Human memory T cell responses to B. pseudomallei was investigated by Tippayawat and co-workers, who 
tested blood from 133 healthy individuals who lived in endemic areas with no history of melioidosis. In animal 
models of melioidosis, the production of IFN-γ is critical for resistance, but in humans the characteristics of 
IFN-γ production and the bacterial antigens that are recognised by the cell-mediated immune response have 
not been defined. B. pseudomallei is a potent activator of human peripheral blood natural killer (NK) cells for 
innate production of IFN-γ. Healthy individuals in this study, with serological evidence of exposure to B. 
pseudomallei and patients recovered from active melioidosis developed CD4+ and CD8+ T cells that 
recognised whole bacteria and purified proteins LolC, OppA and PotF, which are members of the B. 
pseudomallei ABC transporter family. The response was primarily mediated by terminally differentiated T 
cells of the effector-memory phenotype and correlated with the titre of anti-B. pseudomallei antibodies 
present in the serum. Individuals living in a melioidosis-endemic region therefore showed clear evidence of T 
cell priming for the ability to make IFN-γ, correlating with their serological status. The ability to detect T cell 
responses to defined B. pseudomallei proteins in large numbers of individuals now provides the opportunity 
to screen candidate antigens for inclusion in protein or polysaccharide-conjugate subunit vaccines against 
this important disease (Tippayawat et al., 2009). 
 
1.3.9 B. pseudomallei as a bioweapon 
 
The lack of a vaccine against B. pseudomallei and melioidosis makes this a potential candidate for 
bioweaponisation. With the high rate of infectivity via aerosols and resistance to many common antibiotics, 
both B. pseudomallei and B. mallei have been classified as category B priority pathogens by the US National 
Institutes of Health (NIH) and the US Centres for Disease Control and Prevention (CDC), which spurred a 
dramatic interest in the microorganism for research into virulence factors and vaccine development 
(Jeddeloh et al., 2003, Warawa and Woods, 2002, Coenye and Vandamme, 2007, Rotz et al., 2002). B. 
mallei was used as a bioweapon in both World War I and II, specifically in the first World War, where B. 
mallei was used by the Central Powers to infect Russian horses with glanders on the eastern front, with 
significant effects (Cheng and Currie, 2005, Bondi and Goldberg, 2008). It is also believed that biological 
weapons research using B. pseudomallei occurred in the former USSR, although the extent of this effort and 
the possibility of engineered antibiotic resistant strains remain unknown. Other countries with military interest 
in B. pseudomallei included the United States and possibly Egypt (Cheng and Currie, 2005). 
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The potential risk posed by B. pseudomallei as a bioweapon is uncertain. Melioidosis carries a potentially 
high mortality rate and its causative agent has intrinsic antibiotic resistance and a wide host range. However 
weaponisation has not been known to have been performed, the disease does not spread from person to 
person and the susceptibility of immunocompetent individuals after inhalation is not clear. Attempts to create 
a vaccine for this infection have been made, which would benefit military personnel, the group targeted most 
likely by intentional release, as well as individuals that live in areas where melioidosis is endemic (Bondi and 
Goldberg, 2008). 
 
1.3.10 Glycoconjugate vaccines 
 
Reports exist dating back to 200BC in China and India of people purposely inoculating themselves with 
infections in order to protect themselves from other diseases, but the modern era of human vaccination is 
ascribed to Edward Jenner’s discovery in 1796 using cowpox to protect against smallpox (Guo and Boons, 
2009). Louis Pasteur acknowledged Jenner’s pioneering research by retaining the word vaccination to 
describe his own efforts in the prevention of rabies and anthrax in his immunological research. Vaccines 
have since become a vastly important and successful countermeasure to the threat of infectious disease, 
providing protection by inducing humoral and/or cellular immunity to disease-causing pathogens (Astronomo 
and Burton, 2010). 
 
The field of carbohydrate vaccines can be traced back to the 1920’s and 1930’s. Heidelberger and Avery 
made the connection between Pneumococcal serotypes and a “soluble specific substance”, the capsular 
polysaccharides (Heidelberger and Avery, 1923). Francis and Tillet further noted that patients immunised 
intradermally with serotype-specific polysaccharides, would elicit antibodies against heterologous types of 
pneumococcal species (Tillett and Francis, 1929). In 1931 Avery and Goebel demonstrated that non-
immunogenic carbohydrates could become antigenic when covalently attached to proteins. They created the 
first conjugate of the Streptococcus pneumoniae type 3 polysaccharide by linking it to horse serum globulin, 
which induced specific antibodies in rabbits that were previously unresponsive to the pure polysaccharide 
(Guo and Boons, 2009, Avery and Goebel, 1931). Heidelberger further established that vaccination with 
Pneumococcal capsular polysaccharide could be used to elicit persistent antibody-mediated immunity 
(Heidelberger et al., 1950). Due to the advent in chemotherapeutics and antibiotics, research into 
carbohydrate vaccines remained idle, but renewed interest was shown upon the steady increase in antibiotic 
resistance by many pathogenic bacteria. 
 
Half a century after initial discoveries, Jennings used bacterial capsular polysaccharides coupled to a carrier 
protein to render it immunogenic and produced a commercial vaccine (Jennings, 1983). PneumoVax® was 
launched by Merck as the first polysaccharide vaccine, composed of unconjugated capsular polysaccharides 
isolated from 14 pneumonia serotypes (now upgraded to 23 out of approximately 90 serotypes in 
PneumoVax 23®). This vaccine induces protection against approximately 90% of infections caused by these 
pathogens, but high risk groups, including neonates, children under 2 years of age, elderly and 
immunocompromised population, generally elicit a poor antibody response and do not induce adequate 
protection (Merck & Co., 2012). 
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Glycoconjugate vaccine creation requires the full structural characterisation of one or multiple antigens of a 
specific pathogen, its synthesis or isolation as well as its conjugation via a linker to an appropriate 
immunogenic carrier protein or other immunostimulant, all the while maintaining the immunological integrity 
of the antigen. The conjugate vaccine has to clear immunological studies in animal models, where host 
response is further studied and assessed on antibodies elicited, target interaction and efficacy, before 
entering clinical trial evaluation, prior to widespread use (Guo and Boons, 2009). 
 
1.3.10.1 Carbohydrate-based antigens 
 
Glycans contribute to the immune system, through their recognition as carbohydrate antigens, as is 
exemplified by the ABO(H) blood group system. The common epitope is the H antigen, which is found in 
individuals with the O blood type. This can be elaborated with a GalNAc or a Galactose residue to produce 
the structures that specify the A and B blood types respectively. Individuals will develop antibodies to the 
antigen epitope (A or B) not synthesised by their own body, because similar glycans are found in various 
food substances (Taylor and Drickamer, 2011, Guo and Boons, 2009). Differences in carbohydrate 
structures found on the cells of humans and other animal species can also cause an antibody response. For 
example, where most vertebrates contain a gene for a α-galactosyltransferase, capping various glycan 
structures by forming a Galα1-3Gal linkage, this gene, albeit present in humans, is not expressed. Again 
exposure to similar epitopes on food substances will induce antibody production against the α-galactosyl 
residue, also posing as an obstacle for xenotransplantation of organs, as α-gal specific natural antibodies 
bind to the endothelium of vascularised xenografts and the complement system is activated, which leads to 
the activation of the coagulation cascade and rapid graft rejection (Guo and Boons, 2009, Taylor and 
Drickamer, 2011). 
 
In nature animals and humans mount massive humoral responses against the polysaccharides of Gram-
negative bacteria, in part due to the abundant range of possibly varying glycan epitopes decorating the lipid 
A and the presence of unusual monosaccharide components (Guo and Boons, 2009). Bacterial glycosylation 
therefore presents a relatively easy target for vaccine development, due to the characteristic differences 
between these microbial and human glycans. However, the difficulties in creating effective vaccines 
composed of non-toxic, immunogenic polysaccharides lie with just this chemical diversity found among the 
serologic variability displayed by O-antigens, where a broad acting O-antigen targeted vaccine must 
effectively consist of a highly complex mixture of well-defined characterised glycans (Guo and Boons, 2009), 
presenting the main aim of the work described in Chapter 4. 
 
1.4 MASS SPECTROMETRY IN GLYCOBIOLOGY 
 
1.4.1 Overview 
 
The analytical technique of mass spectrometry dates back to the early 20th century, when Sir Joseph John 
Thomson, was the first person to demonstrate the mass to charge ratio of the electron in 1906 using his 
“positive ray parabola” and becoming the first person to obtain a mass spectrum. The concept was first put 
into practice by his student Francis W. Aston, working in the Cavendish Laboratory in Cambridge in 1919, 
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who designed an instrument to measure the mass of elements, especially isotopes. In the past four decades 
tremendous advances and developments in mass spectrometry have led to its status as one of the most 
powerful analytical tools in structural glycobiology. Mass spectrometry is the current method of choice for the 
structural analysis of glycoconjugates, due to its ultra-high sensitivity and ability to characterise individual 
components within complex, heterogeneous mixtures (Morris et al., 1978) and its accurate molecular weight 
determination of minute quantities, sometimes requiring less than femtomole (10-15 mole) amounts of 
material. 
Mass spectrometry involves the production of gas-phase ions from analytes, where the resulting ions are 
accelerated out of the ionisation source into a mass analyser, where they are separated according to their 
mass to charge ratio (m/z) and detected. The three main components of a mass spectrometer are the 
ionisation source, one or more mass analysers and the ion detector. The separated ions reach the detector 
where signals are recorded generating a mass spectrum consisting of the m/z rations and their relative 
abundances. 
 
Mass spectrometry has been used for many years to define carbohydrate structures found on prokaryotic 
glycoconjugates. More recently, knowledge of genome sequences has led to the development of new 
strategies for the analysis of glycoproteins that exploit genomic information (Hitchen and Dell, 2006) and 
proteomics has become an invaluable high-throughput technique for functional genomics. The techniques of 
electrospray ionisation (ESI) and matrix-assisted laser desorption/ionisation (MALDI) mass spectrometry 
have become the routine methods of choice for prokaryote glycoconjugate analysis. The key to both 
techniques is the ability to analyse large biological molecules without degradation. 
 
1.4.2 Ionisation techniques 
 
There are various types of ionisation modes that are available and used depending on the type of compound 
analysed and the specific information required. In mass spectrometry, different mass analysers can be used 
in combination with a range of different ionisation techniques.  
 
Structural analysis of glycans using mass spectrometry dates back to the 1960’s, when analysis of low 
molecular weight volatile molecules was carried out using electron impact (EI) and chemical ionisation (CI) 
techniques. EI is a “hard” ionisation technique also known as electron bombardment, used to identify small 
molecules up to 1000Da by extensive energy input and creation of numerous fragment ions, making this 
technique unsuitable for analysis of molecular ions (Ando et al., 1977). CI on the other hand is a “soft” 
ionisation technique, with a similar ion source to EI. However, the ionisation is less energetic upon 
interaction of the sample with the reagent gas and the ions produced are molecular ions with little 
fragmentation. Both ionisation techniques are limited by the requirement for the sample to be in the gaseous 
phase before ionisation. On the other hand, if samples are sufficiently volatile, for example if polar groups 
are derivatised, then these methods are very powerful for structure analysis. 
 
Field desorption (FD) ionisation was developed in the late 1960’s (Beckey, 1969), which allowed the study of 
non-volatile compounds of masses up to 5000Da, yet the technique proved difficult to use and was only 
employed in a handful of laboratories (Linscheid et al., 1981). In 1976 plasma-desorption mass spectrometry 
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(PD-MS) was introduced by MacFarlane and Torgerson (Macfarlane and Torgerson, 1976), which allowed 
the detection of biomolecules of up to 20’000Da and was used for the mass determination of proteins. 
However, PD-MS relied on fission products of radioactive Californium for ionisation/desorption and was 
accompanied by poor resolution and peak broadening, due to the large kinetic energy distribution carried by 
the molecular ions and was therefore not used widely. It was not until the introduction of the high field 
magnet by Howard Morris and colleagues in 1977 (Morris et al., 1981a) and fast atom bombardment mass 
spectrometry (FAB-MS) by Barber and co-workers in the 1980’s (Barber et al., 1981), that routine structural 
characterisation of large involatile glycoconjugates was feasible (Dell and Ballou, 1983, Egge et al., 1983, 
Morris et al., 1981a, Morris et al., 1981b). FAB-MS was widely used for glycan analysis for over twenty 
years, but has since been superseded by the more versatile technologies of MALDI (Karas and Hillenkamp, 
1988) and ESI (Fenn et al., 1989). 
 
In the following sections the three ionisation techniques (EI, ESI, MALDI) employed in the two projects 
reported this thesis are described (Section 1.4.2.1, Section 1.4.2.3 and Section 1.4.2.4, respectively). FAB-
MS is also briefly introduced, because glycan fragmentation pathways seen in current MALDI and ESI 
experiments were originally defined by FAB-MS (Section 1.4.2.2.) Also many sample handling 
methodologies optimised for FAB-MS are still employed in conjunction with other ionisation techniques 
today. 
 
1.4.2.1 Electron impact mass spectrometry (EI-MS) 
 
Electron impact has enjoyed considerable success in the analysis of small carbohydrates, particularly 
monosaccharides and is still valuable as the ionisation method in combined gas chromatography/mass 
spectrometry systems (GC-MS) for the determination of composition and linkage. Linkage analysis is a 
technique whereby polysaccharides are permethylated, hydrolysed and then further acylated for structural 
investigation (Hellerqvist, 1990, Lindberg and Lonngren, 1978). In GC-EI-MS the gaseous sample is 
introduced into the source from an online gas chromatograph where it is bombarded with electrons from 
Rhenium or Tungsten filaments with energy of 70eV, well above the covalent bond strength of molecules, to 
form highly energetic radical molecular cations and imparting enough internal energy to fragment the 
molecular ion into stable fragments by the ejection of an unpaired electron. 
 
Quantitative monosaccharide analysis provides estimated molar ratios of individual sugars and may suggest 
the presence of specific oligosaccharide classes. This involves cleavage of all glycosidic linkages, 
fractionation of the resulting monosaccharides, detection and quantification. The monosaccharides are first 
chemically modified at their hydroxyl and aldehyde groups. Reduction of the aldehyde of a free 
monosaccharide followed by acetylation of its hydroxyl groups provides a “peracylated alditol acetate”. 
These monosaccharides may be analysed and compared with authentic standards. The hydroxyl groups of 
free monosaccharides generated by glycan hydrolysis can also be converted to trimethylsilyl ethers (TMS). 
These per-O-trimethylsilyl derivatives are widely used for monosaccharide compositional analysis by GC-
MS. 
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Linkage analysis was previously also known as “methylation analysis” and is a well-established approach for 
determining linkage positions. The principle of this method is to introduce a stable substituent onto each free 
hydroxyl group of the native glycan, which in this case is an ether-linked methyl group (Figure 1.13). The 
glycosidic linkages which are much more labile than the ether-linked methyl groups are then cleaved by acid 
hydrolysis, producing individual methylated monosaccharides with free hydroxyl groups at the positions that 
were previously involved in a linkage. The partially methylated monosaccharides are further derivatised to 
produce volatile molecules amenable to GC-MS analysis (Dell and Morris, 2001). The most common strategy 
involves reduction of the monosaccharides to produce alcohols at C-1, by eliminating the formation of ring 
structures, followed by derivatisation of the free hydroxyl groups, usually by acetylation. The individual 
components of the mixture of partially methylated alditol acetates can then be identified by a combination of 
GC retention time and EI-MS fragmentation pattern. The limitation of this technique is that it does not provide 
information on the oligosaccharide sequence or anomericity of the monosaccharide linkages (Varki et al., 
2009). 
 
 
Figure 1.13 – Example of linkage analysis. 
The schematic shows the procedure of linkage analysis of a α1,4-linked glucose chain with an α1,6-linked glucose branch. The 
terminal α1,6 glucose gives rise to glucitol, which is acetylated at C-1 and C-5, whilst the two α1,4 glucose units on either side 
of the branching monosaccharide are acetylated at C-1, C-4 and C-5. The branching glucose is acetylated at C-1, C-4, C-5 and 
C-6. The schematic was adapted from Varki and colleagues (Varki et al., 2009) 
 
1.4.2.2 Fast atom bombardment mass spectrometry (FAB-MS) 
 
Fast atom bombardment (FAB) was introduced in 1981 by Barber and colleagues (Barber et al., 1981) and 
was the major ionisation method for oligosaccharides for the next decade opening the field to most areas of 
biomedical research. Although it is still used to monitor products of chemical synthesis, it is now regarded as 
mainly of historical interest with the advent of ESI and MALDI. This method was one of the first techniques 
that allowed large intact carbohydrates to be ionised efficiently (Dell, 1987, Dell and Morris, 2001, Morris et 
al., 1981b). 
 
With FAB the sample is dissolved in a suitable solvent and an aliquot is added to a drop of a relatively non-
volatile liquid matrix on the target. The most common FAB matrices are glycerol, thioglycerol or 3-nitrobenzyl 
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alcohol. The probe is then inserted into the mass spectrometer. The matrix is then bombarded with a beam 
of high kinetic energy atoms, such as inert gases xenon or argon or ions, such as Caesium (Cs+). The 
bombarding atoms or ions destroy the surface monolayer and energy is transferred to underlying layers 
resulting in ionisation of the sample molecules, which are “sputtered” from the surface. This allows 
desorption and ionisation either through protonation/deprotonation through the coupling with cations or 
anions in a positive or negative mode and entrance into the gas phase. Gas-phase ions are therefore 
generated without prior volatisation of the sample, allowing the analysis of polar, involatile and thermally 
labile compounds (Figure 1.14). Both positive and negative ions are produced during the sputtering process, 
and either can be recorded by the appropriate choice of instrumental parameters. Molecules are ionised by 
the addition of a proton or cation such as sodium, potassium, ammonium (positive ion formation) or by the 
loss of a proton or addition of an anion such as chloride (negative ion formation). During ionisation some 
internal energy is imparted to the molecule resulting in fragmentation of labile bonds and these molecular 
and fragment ions are accelerated and detected. FAB-MS can yield information on the degree of 
heterogeneity and the type and sites of glycosylation and branching patterns of N- and O-linked glycans and 
was primarily used to identify polar molecules such as peptides and oligosaccharides up to 6000Da using a 
high field magnet double focusing ZAB instrument developed in this laboratory (Dell et al., 1993). 
 
 
Figure 1.14 – Fast atom bombardment ionisation mechanism. 
The schematic representation shows the fast atom bombardment mechanism. The diagram was adapted from Dell and 
colleagues (Dell et al., 1993) 
 
1.4.2.3 Electrospray ionisation (ESI-MS) 
 
Electrospray ionisation is one of the so-called atmospheric pressure ionisation (API) techniques and was first 
described by Malcolm Dole and collaborators in the late 1960’s, but came into prominence in the late 1980’s 
when John Fenn and colleagues demonstrated the use of electrospray for the ionisation of high mass 
biopolymers, for which he was honoured with a share in the 2002 Nobel Prize in Chemistry (Fenn et al., 
1989). ESI has now become one of the most widely used ionisation techniques for proteomic and 
glycoproteomic analyses. 
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ESI-MS is a method by which a stream of liquid containing the sample of interest is directly injected into the 
atmospheric pressure ion source of a mass spectrometer. For pure samples dissolved in the mobile phase, a 
direct injection “loop” can be used, especially when interfaced to chromatographic procedures such as 
capillary zone electrophoresis (CZE), high performance liquid chromatography (HPLC) and in particular 
“nanospray” ESI. The sample is dissolved in a mobile phase, pumped through a fine stainless steel capillary 
and is introduced into the source in solution through a narrow golden-tipped glass capillary. The potential 
difference, of typically 3-6kV, is applied between the capillary and counter electrode situated at the entrance 
cone. A spray of microdroplets is therefore generated with the assistance of nitrogen. These then traverse a 
series of “skimmers”, imposing a charge accumulation on the liquid surface and form highly charged 
droplets. Upon evaporation, the surface charge density is increased whilst droplet size decreases, resulting 
in the Raleigh stability limit being reached, overcoming the surface tension to cause breakdown into even 
smaller droplets and the creation of a charged molecular species, devoid of solvent, ready for analysis either 
by magnetic sector or more commonly quadrupole analysers (Figure 1.15). Large molecules such as 
proteins and glycoproteins tend to carry multiple charges and since the mass spectrometer is really an 
instrument which measures mass to charge ratio (m/z) rather than mass, even very large molecules 
exceeding 100kDa can be amenable to ESI-MS analysis. ESI-MS is particularly valuable as a method to 
review whether a protein is post-translationally modified by examination of any mass difference between the 
observed signal and that calculated as the sum of the amino acids present in the sequence. There is a 
distribution of signals carrying varying numbers of net positive (or negative if working in the negative ion 
mode) charges on basic (or acidic) sites in the molecule (Dell et al., 1993). 
 
 
Figure 1.15 – Electrospray ionisation mechanism. 
The schematic representation shows the electrospray ionisation mechniams in the positive ion mode. The diagram was 
adapted from Dell and colleagues (Dell et al., 1993) 
 
The compatibility of electrospray with liquid separation techniques has resulted in LC-MS becoming 
extensively used for protein and carbohydrate analysis and micro-separation methods suitable for glycan 
analysis have been developed in many laboratories (Wuhrer et al., 2005, Mechref and Novotny, 2006, 
Novotny and Mechref, 2005, Greer and Morris, 1997, Morris et al., 1996, Dell et al., 2000). Normal-phase 
separations provide good correlation between structure, molecular weight and retention time (Royle et al., 
2002), allowing some structural information to be obtained directly from the elution profile, although the 
buffers often result in doubly charged ions in the mass spectra. Wuhrer and colleagues have described a 
nanoscale LC-MS technique using normal-phase (NP) LC-MS that is capable of producing fragmentation 
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data from small N-linked glycans at the low-femtomole level (Wuhrer et al., 2004). Early ESI sources ran at 
flow rates of a few μl/min, but newer nanospray sources operate at flow rates of 10-30nl/min increasing 
sensitivity and the possibility for online nanoLC for complex mixtures. Furthermore the Z-spray nanospray 
source of some commercial instruments moves the ions in a Z-formation, allowing the removal of neutral 
elements prior to sample focusing and resulting in the enhancement of sensitivity. 
 
1.4.2.4 Matrix assisted desorption ionisation mass spectrometry (MALDI-MS) 
 
Ionisation based on laser desorption was introduced in the early 1960’s and later developed and adapted for 
the analysis of biomolecules, however its limitations in poor ionisation and high molecular ion fragmentation 
were only overcome in the 1980’s with supplementary use of a matrix, leading to the matrix-assisted laser 
desorption ionisation (MALDI) technique. Koichi Tanaka was later honoured with part of the 2002 Nobel 
Prize in Chemistry for showing that proteins can be ionised by MALDI. The use of MALDI to ionise 
carbohydrates was first reported by Karas and Hillenkamp (Karas and Hillenkamp, 1988) in one of their early 
papers on the technique and applied to N-linked glycans by Mock and colleagues in 1991 (Mock et al., 
1991). It has since become one of the most popular techniques for glycan analysis. 
 
Unlike FAB-MS this process uses a crystalline, rather than liquid matrix and a pulsed beam of photons, 
rather than a continuous beam of atoms or ions. The sample is embedded in a low molecular weight UV 
absorbing “crystalline” matrix. The matrix is chosen to have an absorption maximum near the wavelength of 
the pulsed laser that is used to ionise the sample. Nitrogen lasers with a wavelength of 337nm at 10Hz are 
widely used, as also are solid state lasers which can give similar wavelengths upon frequency tripling. The 
matrix absorbs the pulsed laser energy and enough energy is transferred to the sample to ionise it at room 
temperature, resulting in a dramatic increase in both sensitivity and mass range of analysable compounds. 
Irradiation of the crystals by the laser causes the accumulation of a large amount of excitation energy in the 
matrix molecules, resulting in the desorption of the sample and matrix ion formation from the surface of the 
crystal, by proton or cation transfer between the photo-excited matrix and analyte (Figure 1.16) 
(Knochenmuss, 2006). MALDI is a “softer” ionisation technique than FAB and produces mainly singly 
charged molecular ions of the form [M+H]+ or [M+Na]+, with little fragmentation, making this an ideal 
technique for “fingerprinting” or mass profiling of complex glycan mixtures. However, fragmentation can 
occur or be induced with higher laser intensity or acceleration voltage, either by in-source decay (ISD) or 
post-source decay (PSD) (Dell and Morris, 2001, Harvey, 2006). 
 
Early MALDI experiments were characterised by poorly resolved spectra where ions of similar m/z ratio could 
not be separated, due to the kinetic energy distribution of ions. This meant that ions with the same m/z value 
but different kinetic energies reached the detector at slightly different times, resulting in peak broadening. 
This was improved by “delayed extraction”, where the pulse of ions is kept in the source for a short time after 
the laser pulse in order to normalise their energies by collision processes (Hoffmann et al., 2007). After the 
delay, an extraction pulse applied to the now monoenergetic ions leaving the source with the same m/z value 
thus improves resolution. 
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Figure 1.16 – Matrix assisted laser desorption ionisation mechanism. 
The schematic representation shows the matrix assisted laser desorption ionisation mechanism in the positive ion mode. 
 
The choice of matrix is crucial in imparting efficient ionisation of a given sample and many matrices have 
been developed, but one of the earliest, 2,5-dihydroxybenzoic acid (DHB), is still the most popular for 
carbohydrate and glycoprotein analysis (Harvey, 2006, Mock et al., 1991, Harvey, 1999, Mohr et al., 1995). 
Furthermore α-cyano-4-hydroxy cinnamic acid (CHCA) is used for peptides and glycopeptides, whereas 
sinapinic acid (SA) is the matrix of choice for higher molecular weight proteins or glycoproteins. Analysis with 
diaminobenzophenone (DABP) and 2-(4’-hydroxylbenzeneazo) benzoic acid (HABA) are important for 
analysis of glycolipids. 
 
1.4.3 Mass Analysers 
 
A number of mass analysers are commonly used in biopolymer mass spectrometry including double focusing 
instruments, quadrupole mass analysers, time-of-flight (TOF), quadrupole ion traps and Fourier transform ion 
cyclotron resonance (FT-ICR). Field instruments utilise the behaviour of charged particles moving through 
field regions, whilst sector instruments incorporate an electromagnetic field and an electric field for energy 
focusing. Quadrupole and ion trap instruments incorporate a combination of radiofrequency and direct-
current fields. Ions entering a field experience a deflecting force, depending on the strength of the field and 
the m/z ratio of the molecular ion. By scanning the field strength all the ions produced in the same ion source 
are sequentially focused at the detector, which is usually a photomultiplier, an electron multiplier or a 
multichannel plate array, creating a mass spectrum. In time-of-flight instruments the time taken for an ion to 
travel a set distance is measured very accurately, as it is directly related to the m/z value of the ion. 
 
Double focusing analysers consist of magnetic sectors, that separate the ions of different m/z values and 
electrostatic analysers that focus ions according to their kinetic energy, allowing high resolution mass 
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spectrometric analysis (Dell et al., 1993). The introduction of MALDI and ESI ionisation techniques 
stimulated the development of new analysers and double-focusing analysers have now been largely 
superseded by more versatile and sensitive instrumentation. EI sources are most commonly found on 
quadrupole instruments or on magnetic sector instruments, whilst FAB sources are most commonly found 
with magnetic sector instruments. MALDI and ESI sources are most commonly found with TOF and triple 
quadrupole, ion trap or Q-TOF instruments respectively. 
 
1.4.3.1 Ion traps and ion mobility 
 
Ion traps allow the “trapping” of a small mass range of m/z values using oscillating electric fields generated 
by radiofrequency (RF) voltages applied to electrodes of opposite polarity. Scanning the RF or magnetic field 
allows ions to be detected sequentially. For ion detection, the voltages are altered to destabilise ion motions, 
resulting in the ejection of the ions from the storage cell to the detector. There are two types of ion trap 
analysers, the 3D quadrupole ion trap (QIT) or the 2D linear ion trap (LIT). 
 
Fourier transform ion cyclotron resonance (FT-ICR) allows for the determination of multiple ions at once with 
the highest resolution mass analyser and most powerful ion trap (Marshall et al., 1998). FT-ICR ions are 
subjected to a simultaneous RF electric field perpendicular to the magnetic field of a static, superconducting 
high field magnet, causing the ions to follow spiral paths. The m/z values are measured based on their 
cyclotron frequencies, which is the frequency of an ion moving perpendicular to the direction of a uniform 
magnetic field, where the frequency of ion rotation is inversely proportional to the m/z ratio. The instruments 
are however, hugely expensive and the maintenance of the high magnetic field is difficult, which resulted in 
their disuse. The high resolution and mass accuracy is currently being exploited with the recently developed 
electron capture dissociation (ECD) soft fragmentation technique, which mainly induces fragmentation of the 
peptide backbone, retaining the more labile modifications such as glycosylation and thus defining site 
attachment (Hakansson et al., 2001). The electrostatic trap, “Orbitrap”, is a high-resolution mass analyser, 
which was initially proposed by Makarov and later commercially produced, which electrostatically maintains 
the ions in orbit around a central electrode similar to the FT-ICR mass spectrometer, but does not require an 
expensive superconducting magnet, still providing high resolution and mass accuracy of data. In combination 
with a linear ion trap, it has since proved a powerful tool for glycomics and proteomics. 
 
1.4.3.2 Quadrupole Analysers 
 
The quadrupole mass filter was invented in the mid 1950’s but not used until the 1970’s. This analyser uses 
a quadrupolar electrical field comprising RF and DC components to separate the ions. It consists of four 
parallel rods with circular or hyperbolic cross-sections. An electrical field is created by the application of a 
fixed direct current component and an oscillating radiofrequency perpendicular to each other, producing 
opposite current polarity in adjacent rods. Changing the voltage on the field, allows only certain ions with the 
correct m/z value pass through the filters without obstruction towards the detector, unlike those with different 
m/z values which will collide with the rods and are lost (Figure 1.17). Thus in the quadrupole mass analyser, 
ion separation is based on the stability of the ion trajectory through the four parallel rods. 
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Figure 1.17 – Ion path through a quadrupole analyser. 
The schematic shows a quadrupole analyser where the red ion possesses the selected m/z value, thus passing out of the 
quadrupole into the mass detector, whereas the path of the blue ion is intercepted by a quadrupole rod, which results in the 
ion being discharged before reaching the mass detector and thus not being detected. 
 
Quadrupole mass filters can detect m/z values of up to about 4000, are very cost effective and robust. They 
have the advantage of rapid scanning and operate at relatively high pressures and can therefore be readily 
interfaced with a wide variety of inlet systems, which is useful in combination with gas chromatography and 
thus ideal for GC-MS and ESI-MS. However, its drawbacks include the relatively low resolution and limited 
mass range, yet due to its efficient selectivity of molecules at specific m/z values; quadrupole mass 
analysers are considered mass filters and often used as the first analyser in tandem mass spectrometry. 
 
1.4.3.3 Time-of-flight 
 
In time-of-flight analysers, the ions are separated by differences in velocities as they move in a field-free, 
“flight tube” towards the detector, which allows for analysis of an “unlimited” mass range. The separation 
principle of TOF analysers is based on the fact that ions of different m/z values will traverse the field-free 
region at different velocities and hence reach the detector at different times. To determine the flight time, all 
ions, regardless of their m/z values must enter the flight tube simultaneously, which is achieved in a pulsed 
process. However, due to the spread of kinetic energies originally imparted to the ions during the ionisation 
process and time taken for ion formation, ions of the same m/z value will have a spread of velocities that 
contribute to a spread in the signal detected, resulting in reduced resolution. To improve the resolution two 
developments have been introduced to compensate for such variation, such as the previously discussed 
delayed extraction and a reflectron. 
 
A reflectron, or ion mirror, is a reflecting electric field consisting of a series of rings/grids with voltages that 
increase up to a value slightly greater than the voltage of the ion source, so that the more energetic ions 
penetrate further into the field to such an extent that their increased path length just compensates for their 
increased velocity, resulting in a reduction of the spread of initial kinetic energies of the ions produced and 
an improvement in resolution (Figure 1.18). High mass, slow moving ions cannot penetrate the reflectron 
and so high resolution reflectron mode comes at the expense of sensitivity, due to the physical constraints 
applied by the reflectron and limits the mass range to about 5’000Da as well as causing fragmentation of 
molecules accompanied by a decrease in detection levels. This means that reflectrons are used for the 
analysis of low to medium molecular weight molecules, but deactivated in favour of the sensitivity of linear 
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analysis to detect larger ions. The pulsed nature and delayed extraction mechanisms employed in MALDI-
MS make this technique ideally suited to being coupled to a TOF mass analyser. MALDI-TOF mass 
spectrometers with delayed extraction and reflectron as well as linear operation modes were used for much 
of the data collection in the projects discussed in this thesis. 
 
 
Figure 1.18 – Base components of a TOF analyser. 
The above schematic depicts a Voyager-DETM STR System with a time-of-flight analyser. 
 
1.4.4 Tandem mass spectrometry 
 
In mass spectrometry the molecular ion annotations can yield information on the theoretical composition in 
monosaccharides, amino acids or lipids and confirm the presence or absence of modifying groups such as 
sulphate or phosphate. However fragmentation of the molecular ion allows for rigorous sequencing, including 
branch determination and site occupation in glycoproteomics. Both MALDI-MS and ESI-MS are soft 
ionisation techniques, yielding very few fragment ions and are thus ideal for mass profiling of glycan and 
glycopeptide mixtures, however for further sequence analysis, molecular ion fragmentation is central and is 
induced by employing two mass analysers in tandem. 
 
Many modern mass spectrometers contain two or more mass analysers in tandem, the term MS/MS referring 
to such coupling when used for induced fragmentation studies. These can consist of the same or different 
types of analysers. Most MS/MS experiments are performed on instruments equipped with triple quadrupole, 
hybrid quadrupole with time-of-flight (Q-TOF) (Morris et al., 1996) and more recently time-of-flight with time-
of-flight (TOF-TOF) analysers (Vestal and Campbell, 2005). 
 
In MS/MS experiments, the first mass analyser performs the mass selection of a precursor ion of interest 
from the mixture of ions produced at the source. The selected ion is then passed into a pressurised collision 
cell containing an inert gas such as argon or xenon and undergoes collision-induced dissociation (CID), also 
known as collisionally activated dissociation (CAD). This collision promotes fragmentation of the precursor 
ion and these fragments are subsequently re-accelerated towards the second mass analyser, which is used 
to separate the resulting fragment ions and finally detected. These fragment ions present a unique fingerprint 
pattern of the selected precursor ion. Tandem mass spectrometers have now become an indispensable tool 
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affording detailed structural characterisation of individual components as well as protein or glycan 
sequencing. 
 
The data acquired in this thesis was obtained using an API ESI quadrupole orthogonal acceleration time of 
flight (Q-STAR Pulsar) mass spectrometer, a Waters Xevo G2S Q-TOF mass spectrometer, an Applied 
Biosystems MALDI-TOF-TOF mass spectrometer as well as a Voyager-DE STR System MALDI-TOFTM 
mass spectrometer. 
 
1.4.4.1 Quadrupole orthogonal acceleration time of flight (Q-TOF) 
 
One of the instruments used in the work for this thesis is the API Q-STARTM Hybrid LC-MS/MS system, a 
high performance hybrid quadrupole orthogonal acceleration time of flight (Q-TOF) mass spectrometer 
coupled to an ESI source, which is linked to a nanoLC column, enabling high sensitivity MS/MS experiments 
in an online fashion. This instrument consists of a first quadrupole used as a mass filter, coupled with a 
hexapole collision cell enabling low energy fragmentation, together with an orthogonal time-of-flight analyser. 
In MS mode the quadrupole analyser and collision cell act only as ion guides whilst the TOF acts as the only 
mass analyser, however with MS/MS the ion filter capability of the first quadrupole analyser is used to select 
the precursor ions of interest, which are then accelerated into the hexapole collision cell, where they undergo 
fragmentation via collision with nitrogen or argon gas, with the TOF used to mass analyse the resulting 
fragment ions before they reach the detector (Figure 1.19). 
 
 
Figure 1.19 – Schematic of a Q-TOF analyser. 
The diagram depicts a quadrupole analyser, hexapole collision cell and orthogonal acceleration time-of-flight (TOF), as are 
found in the API QSTARTM Pulsar Hybrid LC-MS/MS system. 
 
The Q-STAR is a “second generation” orthogonal acceleration instrument with improved scanning rate, ion 
optics, transmission and sensitivity. Furthermore it possesses a novel linear accelerating high pressure 
collision cell (LINAC) that enables the pressure of the collision cell to be raised to an extent where ion 
fragmentation and collection can be obtained with almost 100% efficiency. 
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1.4.4.2 Tandem time-of-flight 
 
Most MS/MS and ion trap fragmentations have been limited by multiple low energy CID collisions. High 
energy CID on the other hand is sufficient to cause fragmentation as the result of a single collision, thus 
providing additional information-rich cleavage products. MALDI-TOF/TOF instruments are capable of 
producing CID fragments at both low and high energies, whilst preserving the resolution and sensitivity of the 
single TOF instrumentation (Vestal and Campbell, 2005), their only disadvantage being the relatively low 
parent ion resolution compared to a Q-TOF geometry. The MALDI-TOF/TOF instrument used in the 
production of data described in this thesis was an Applied Biosystems 4800 MALDI-TOF/TOFTM (Figure 
1.20). 
 
 
Figure 1.20 – Schematic of a MALDI-TOF/TOF analyser. 
The 4800TM Analyzer from Applied biosystems is a double focusing instrument with linear and reflectron flight tubes, allowing 
for the selection of individual precursor ions for further fragmentation in the collision cell. 
 
MALDI-TOF/TOF instruments are made up of a linear delayed extraction MALDI-TOF, a collision cell and a 
second TOF analyser. The ion source optics and electronics of the initially developed MALDI-TOF remain 
essentially unchanged but additional elements incorporated for the MS/MS mode include a time-ion selector 
(TIS). In the MS mode, ions are extracted and guided directly to the detector; however, in the MS/MS mode 
the molecular ions produced in the source pass through the first TOF and are then focused at the timed-ion-
selector (TIS). This enables the selection of a precursor ion according to its velocity through the first TOF 
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analyser, termed the Bradbury-Neilson gate, whilst other ions are deflected away. A time delay generator is 
programmed to open the TIS at the lightest mass of interest reaches the gate, and closed when the highest 
mass of interest has passed through, resulting in the retardation of selected ions by the deceleration lens 
and the entrance into the collision cell at a designated collision energy defined by the potential energy 
between the source and the collision cell (i.e. 1kV, 2kV). Variation in the collision energy is achieved by the 
adjusting of the ion source potential to that of the collision cell, where the pressure of the inert gas, such as 
argon, is controlled to provide satisfactory fragmentation. Fragment ions produced in the collision cell 
therefore travel with the same velocity as the decelerated precursor ions, until they are re-accelerated by a 
high voltage pulse into the second TOF analyser, reaching the detector via the reflectron and providing high 
resolution MS/MS data of the selected m/z parent ion. 
 
1.4.5 Characterisation of peptides, glycopeptides and carbohydrates 
 
Fragment ions can be formed within the ion source of the mass spectrometer [in-source decay (ISD)], within 
the flight tube of the time-of-flight instruments [post-source decay (PSD)], or by collisional activation (CID) in 
a collision cell. ISD, which is common with FAB spectra, can be a problem because Y-type ions are isobaric 
with native glycans, thus distorting the glycan profile. PSD ions are sometimes difficult to observe, are often 
poorly resolved and generally require relatively large amounts of sample. CID-produced ions, on the other 
hand, suffer from none of these disadvantages. 
 
1.4.5.1 Fragmentation of peptides 
 
If an ion is created by cationisation (protonation or sodiation) the inherent stability of an even electron 
oxonium (O-protonated) or ammonium (N-protonated) ion allows for a “quasimolecular ion” to be formed that 
normally presents minimal natural fragmentation. Such creation of charge is the basis for further analysis 
and detection. In MALDI and ESI sources positively charged peptides are formed as so called [M+H]+ or 
quasimolecular ions. Initially this is thought to occur at amine groups in amino acid side chains (Lys or Arg) 
or at the peptide amino-terminus itself (R-NH2 + H+ → R-NH3+). The charge may then be passed around the 
molecule due to its flexibility, including the peptide bond where fragments of interest are generated. In 
negative mode, the functional groups that readily lose protons include carboxylic acids (R-CO2-H → R-CO2- 
+ H+) and alcohols (R-OH → R-O- + H+) and these more susceptibly form negatively charged [M-H]- 
molecular ions. 
 
As discussed previously, ESI and MALDI allow the examination of intact molecules to provide molecular 
weight information, yet this is of limited use in detailed structural studies where it was found that digestion 
strategies were needed to break the problem down into a series of solvable structural units, the peptides and 
glycopeptides. The digestion of proteins by various enzymes, will thus form peptide fragments, such as in the 
case of trypsin digestion, which cleaves after lysine or arginine amino acids and will create peptide 
fragments that possess a C-terminal NH2, which are often observed as [M+H]+ molecular ions in the positive 
ion mode. Further derivatisation methods for protein and peptide samples are discussed in Chapter 2. 
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Peptides fragment in a reasonably well-documented manner, and fragments may be classified into two 
categories of peptides that are derived from cleavage of bonds within the peptide backbone chain, to give 
amino-terminal (N-) and carboxy-terminal (C-) fragment ions (Morris et al., 1981b, Marino et al., 1988) and 
are annotated using the nomenclature described by Roepstorff, Fohlman and Biemann (Biemann, 1988, 
Roepstorff and Fohlman, 1984, Morris et al., 1981a). 
 
Using appropriate low collision energy, three types of cleavages can occur within the peptide chain at three 
different types of bonds, such as NH-CH, CH-CO and CO-NH. In singly charged species, any bond cleavage 
gives rise to two species, one charged and one neutral, with only the charged species being able to be 
accelerated and detected by the mass spectrometer. The position of the charged moiety is dependent on the 
chemistry and related proton affinity of the two species and thus six types of fragments can be observed, that 
are respectively labelled an, bn, cn, when the charge is retained on the N-terminus, and xn, yn and zn ions 
when the charge is maintained on the C-terminus (Figure 1.21). The CO-NH peptide bond is the most 
susceptible cleavage site, thus b and y” ions are the most prominent fragments observed during MS/MS 
analysis on peptides. The mass difference between two adjacent b or y” ions provides information on the 
mass and thus identity of the amino acid residue, allowing sequencing of the peptide in question. A summary 
of the most common amino acids including their composition, structure and monoisotopic masses is shown 
in Table 1.3. The two other types of fragments found in most spectra of doubly or higher charge states result 
from cleavage of at least two internal bonds in the peptide chain. An internal fragment will have lost the initial 
N- and C-terminal of the peptide, whilst a single amino acid internal fragment with just one side chain is 
called an immonium ion. 
 
 
Figure 1.21 – Fragmentation of the peptide backbone. 
The nomenclature of the peptide backbone was first proposed by Roepstorff and Fohlman (Roepstorff and Fohlman, 1984). 
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1 letter 
code 
3 letter 
code 
Name and 
composition 
Residue structure Average 
Mass (Da) 
 
G 
 
Gly 
 
Glycine 
C2H3NO  
 
57.05 
 
A 
 
Ala 
 
Alanine 
C3H5NO  
 
71.08 
 
S 
 
Ser 
 
Serine 
C3H5NO2  
 
87.08 
 
 
P 
 
Pro 
 
Proline 
C5H7NO  
 
97.12 
 
 
V 
 
Val 
 
Valine 
C5H9NO  
 
99.13 
 
T 
 
Thr 
 
Threonine 
C4H7NO2  
 
101.12 
 
C 
 
Cys 
 
Cysteine 
C3H5NOS  
 
103.14 
 
I 
 
Ile 
 
Isoleucine 
C6H11NO  
 
113.16 
 
L 
 
Leu 
 
Leucine 
C6H11NO  
 
113.16 
 
N 
 
Asn 
 
Asparagine 
C4H6N2O2  
 
114.10 
 
 
D 
 
Asp 
 
Aspartic acid 
C4H5NO3  
 
115.09 
 
 
Q 
 
Gln 
 
Glutamine 
C5H8N2O2  
 
128.13 
 
 
K 
 
Lys 
 
Lysine 
C6H12N2O  
 
128.17 
 
 
E 
 
Glu 
 
Glutamic acid 
C5H7NO3  
 
129.17 
 
 
M 
 
Met 
 
Methionine 
C5H9NOS  
 
131.20 
 
 
H 
 
His 
 
Histidine 
C6H7N3O  
 
137.14 
 
 
F 
 
Phe 
 
Phenylalanine 
C9H9NO  
 
147.18 
 
 
R 
 
Arg 
 
Arginine 
C6H12N4O  
 
156.19 
 
 
Y 
 
Tyr 
 
Tyrosine 
C9H9NO2  
 
163.17 
 
 
W 
 
Trp 
 
Tryptophan 
C11H10N2O  
 
186.21 
 
Table 1.3 – Amino acid residues, compositions, structures and monoisotopic masses. 
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1.4.5.2 Glycan derivatisation 
 
Purified native carbohydrates can directly be analysed by mass spectrometry, but due to their extensive 
inter-molecular hydrogen bonding and the lack of primary amino functions, they do not transfer into the gas 
phase as efficiently as other biomolecules (Dell et al., 1993, North et al., 2010). It is therefore advantageous 
to derivatise glycans prior to analysis in order to remove hydrogen bonding and allow high sensitivity 
structural analysis. Furthermore, the increased stability of labile bonds imparted on glycans by derivatisation 
allows for characteristic and predictable fragmentation patterns, important in de novo sequencing of glycans. 
Table 1.4 summarises some of the monosaccharide families reviewed in this thesis along with their 
composition, ring structure of an example moiety as well as their underivatised or derivatised monoisotopic 
masses. 
 
Symbol / 
Code 
Name / Composition / 
Example 
Exemplar ring 
Structure 
Underivatised 
monoisotopic 
mass (Average) 
Permethylated 
monoisotopic 
mass 
(Average) 
Perdeutero-
methylated 
monoisotopic 
mass 
(Average) 
Pent 
 
Pentose 
C5H10O5 
(Xyl) 
 
 
132.12 
 
160.17 
 
166.13 
dHex 
 
DeoxyHexose 
C6H12O5 
(Rha) 
 
 
146.06 
 
174.20 
 
180.13 
Hex 
 
Hexose 
C6H12O6 
(Glc) 
 
 
162.14 
 
204.22 
 
213.16 
HexN 
 
Hexosamine 
C6H13NO5 
(GlcN) 
 
 
161.16 
 
217.27 
 
229.07 
HexA 
 
Hexuronic Acid 
C6H10O7 
(GlcA) 
 
 
176.13 
 
218.21 
 
227.03 
Hep 
 
D-glycero-D-manno-heptose 
C7H17O9 
(ManHep) 
 
 
192.12 
 
248.14 
 
260.15 
Kdo 
 
D-glycero-D-talo-octu-2-
ulsonic acid 
C8H14O8 
(Kdo) 
 
 
220.06 
 
276.08 
 
288.09 
Ko 
 
D-glycero-D-talo-octu-2-
ulsonic acid 
C8H14O9 
(Ko)  
 
236.09 
 
306.07 
 
321.11 
Table 1.4 – Monosaccharide residues, composition, structure and masses. 
 
Derivatisation of the reducing terminus, usually by reductive amination is necessary for detection of 
carbohydrates by optical methods and is frequently used for mass spectral analysis for purposes such as 
enhancement of signals or modification of fragmentation patterns. Small aromatic amines such as 2-
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aminobenzamide (2-AB), 2-aminoacridone (AMAC), benzylamine, or 2-AP are used extensively for 
fluorescent detection and increase the proton affinity of the molecules such that [M+H]+ ions are formed 
sometimes in preference to the more usual [M+Na]+, particularly with ESI where they have been reported to 
enhance signal strength (Harvey, 2010). Protection of functional hydroxyl and amide groups in carbohydrate 
characterisation is carried out by permethylation or peracetylation (Section 2.4.8.1). Permethylation involves 
the exchange of protons in such functional groups with hydrophobic methyl groups, as was first introduced 
by Hakomori and colleagues (Hakomori, 1964). 
 
1.4.5.3 Fragmentation of carbohydrates 
 
Carbohydrate fragmentation pathways were established using EI-MS and FAB-MS instrumentation (Dell et 
al., 1993) and are preserved, regardless of the ionisation methods used. The accepted nomenclature for 
describing the fragmentation of carbohydrates was introduced by Domon and Costello in 1988 (Domon and 
Costello, 1988, Spina et al., 2004, Stephens et al., 2004). The simplest fragmentation at low collision energy, 
results from cleavage of glycosidic bonds to yield reducing and non-reducing end fragment ions. Ions that 
retain the charge at the reducing terminus are designated X (cross-ring), Y and Z (glycosidic linkage), 
whereas ions with the charge at the non-reducing terminus are A (cross-ring), B and C (glycosidic linkage). 
Sugar rings are numbered from the non-reducing end for A, B and C ions and from the reducing end for the 
others (Figure 1.22) (Harvey, 2010). 
 
 
Figure 1.22 – Systematic nomenclature of carbohydrate fragmentation. 
Cleavage of the oligosaccharide occurs by breaking of the glycosidic bonds (B, C, Y, Z), and across rings (A and X). Fragment 
ions containing the non-reducing terminal are A, B and C types, whilst the reducing end fragments are X, Y and Z types. The 
subscripts of A and X denote the bonds broken in order to form the respective fragments. This nomenclature was first 
published by Domon and Costello (Domon and Costello, 1988). 
 
In the positive ion mode some native samples and most permethylated or peracetylated derivatives undergo 
A-type cleavages on the non-reducing side of glycosidic bonds to produce an oxonium ion, which occurs 
predominantly at amino sugar residues, such as HexNAc residues are present in the sequence (see A-type 
cleavage in Figure 1.23). In the case of cleavage at the reducing side of a residue, a rearrangement is often 
observed via β-elimination in which the loss of a water molecule and the formation of a double bond between 
C-1 and C-2 can be observed (Dell et al., 1993). The second most common type of glycosidic cleavage, β-
cleavage, occurs when the charge on the fragment ion is not located at the point of cleavage. Both positive 
and negative mode mass spectrometry can produce β-cleavages and the resulting fragment ions can be 
reducing or non-reducing, depending on which of the two bonds to the glycosidic oxygen was cleaved, thus 
providing sequence and branching information (see β-cleavage in Figure 1.23) (Dell, 1987). At higher 
collision energy, cross-ring cleavages are observed. Ring cleavages arise from the sequential movement of 
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electron pairs around the ring resulting in the breakage of single bonds and the formation of double bonds 
(see Ring cleavages in Figure 1.23) (Dell et al., 1993). Cross-ring cleavages are helpful for assigning 
linkages and fragment ions can occur from two or more cleavage events in different parts of the molecule. 
This is seen when fragment ions arise from ring cleavages when they are formed together with β-cleavage 
ions, are sodium cationised or occurring some distance from a site carrying a permanent positive or negative 
charge (sulphate or phosphate moiety), in which case these dominate the mass spectrum observed. 
 
 
Figure 1.23 – Fragmentation and cleavages of oligosaccharides. 
Glycosidic cleavages with hydrogen transfer are known as β-cleavages, where the fragment ions can be either reducing 
(upper panel) or non-reducing (lower panel). A type cleavages arise from β-elimination from the 3-position and form oxonium 
ions. Examples of ring cleavages are shown in the bottom three panels. These schematics are adapted from Dell and 
colleagues (Dell et al., 1993) 
 
1.5 NUCLEAR MAGNETIC RESONANCE IN GLYCOBIOLOGY 
 
1.5.1 Overview 
 
In the study of prokaryotic carbohydrates, whilst mass spectrometric glycoproteomic techniques can provide 
details on the nature of the glycan and the site of attachment, there is often insufficient information to define 
carbohydrate structures rigorously, without ancilliary studies involving for example glycosidases to define 
anomeric configuration or sugar identity. Detailed structural characterisation of a novel prokaryotic glycan 
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requires further techniques and proves difficult due to the fact that few biosynthetic pathways have been 
determined in detail for prokaryotes, as opposed to eukaryotes. However, complementary techniques can be 
employed to overcome these limitations and supplement mass spectrometric information, such as using 
chemical degradations to characterise structural features such as sugar type and branching. Furthermore, 
nuclear magnetic resonance (NMR) spectroscopy is often essential in the determination of novel or unusual 
sugars that are a common feature of prokaryotic glycoconjugates (Castric et al., 2001). The greatly 
increased sample amounts required for NMR analysis can prove problematic but the introduction of 
cryoprobe technology for increased sensitivity in NMR analysis has shown potential for detailed structural 
information from limited amounts of material (Voisin et al., 2005). 
 
NMR is a powerful tool for de novo structural characterisation of a glycan. Because this method is non-
destructive, the same sample can later be used for other destructive approaches, such as mass 
spectrometry and linkage analysis. NMR spectroscopy is based on the observation that magnetic nuclei such 
as 1H, 13C, 31P and 15N can absorb energy at characteristic radiofrequencies when placed in a strong 
magnetic field. The resonance frequency of a particular nucleus, expressed as the chemical-shift (δ), is 
sensitive to its chemical environment, making NMR a valuable technique for structural studies. Furthermore, 
for isolated glycans, such as hydrolysed repeat units, the resonance lines show fine structure, referred to as 
spin-spin (or scalar) coupling, originating from interactions with the spin states of nearby nuclei sharing 
bonding electrons. This, however, may be lost in the analysis of larger macromolecular compounds, even 
with the advantages of modern nuclear Overhauser and 2D methods. A molecule typically has a 
characteristic NMR spectrum that can be used as a fingerprint (Hard and Vliegenthart, 1993). 
 
When enough sample is available, the anomericity of a particular monosaccharide residue in a glycan can 
usually be determined by 1H-NMR spectroscopy. The anomeric resonances (H-1 signals) appear in a well-
resolved region in a spectrum, where the number of signals is an indicator of the number of residues present 
in a sample. These signals show characteristic doublets with a splitting (J constant) that is significantly larger 
for β anomers than for α-anomers.  A simple 1H-NMR spectrum can provide the entire primary structure of a 
glycan if 1H-NMR spectra of well-characterised glycans of related structures are available for comparison. 
Complete structural elucidation requires full assignment of both the 1H and 13C NMR spectra of a glycan. 
This is accomplished by a combination of two-dimensional NMR techniques such as correlation 
spectroscopy (COSY) and total correlation spectroscopy (TOCSY) for 1H. These techniques allow the 
assignment of the 1H signals of individual monosaccharide residues, after which the heteronuclear single-
quantum coherence (HSQC) experiment can be used to extend the assignment to the 13C spectrum. A 
further NMR approach for glycan sequencing relies exclusively on two dimensional 1H-NMR spectroscopy 
using through space coupling effects, such as nuclear Overhauser effects (NOEs), as the sole source of 
evidence for linking, position and sequence (Varki et al., 2009). 
 
The range of detailed information provided by NMR experiments is invaluable in the studies of both covalent 
structures and the conformational properties accompanying their dynamics. Unlike proteins, polysaccharides 
are not folded into stable globular structure in which inter-residue linkages have fixed or highly restricted 
conformations, but are to some extent flexible as a result of rotation around glycosidic bonds. 
Polysaccharides from bacteria give remarkably good NMR spectra despite their high molecular weight, due 
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to their internal mobility and it is often possible to determine the structure of the repeat unit by NMR without 
need for depolymerisation. Of all the structurally determined classes of polysaccharides bacterial 
polysaccharides form the most numerous, particularly LPS O-antigens, CPS and other exopolysaccharides 
of Gram-negative bacteria (Schiller et al., 2012). 
 
1.5.2 NMR theory 
 
When a sample is placed in a static external magnetic field (B0) all nuclei will be aligned in the applied field, 
in which spins aligned with the external field will possess a slightly lower energy than those oriented in the 
opposite direction, leading to a small net population difference between the two states. In a 1D experiment 
the application of a short, high-power, radiofrequency pulse perpendicular to the z-axis gives rise to an 
additional transient magnetic field (B1), which exerts a torque on the net magnetisation of the sample and 
forces it into the x-y plane to give transverse magnetisation, exciting a broad range of 1H frequencies (Figure 
1.24a). The net magnetisation can now be visualised as a vector representing the spin of a nucleus A that is 
moving (precessing) in the x-y plane (Figure 1.24b), which induces the oscillating radiofrequency signal in 
the x-y plane measured in NMR. Owing to relaxation processes, the signal will decay and return to 
equilibrium and is therefore called the free induction decay (FID) (Figure 1.24c). The total FID is the sum of 
all frequencies from spins in the sample and can be converted by Fourier transformation into the frequency 
domain giving rise to signals in the spectrum (Figure 1.24d). The resonance positions of these peaks are 
called their chemical-shifts (δ) and are expressed as parts per million (ppm) of the spectrometer frequency 
(Hard and Vliegenthart, 1993). 
 
 
Figure 1.24 – Theory of 1D NMR. 
In this schematic vector A describes the net magnetisation of a sample in a magnetic field, which after a 90° pulse precesses 
in the x-y plane producing a decaying signal that can be converted into a frequency-domain signal by Fourier transform. The 
schematic was adapted from Hård and colleagues (Hard and Vliegenthart, 1993) 
 
The basic difference between 1D and 2D NMR spectroscopy is the addition of radiofrequency pulses and 
delay (t1), which are incremented after every acquisition, thus most 2D NMR experiments can schematically 
be divided into four time periods: preparation, evolution (t1), mixing and acquisition (t2). The various 2D 
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pulse sequences differ mainly in the type of mixing period, which is the period during which spins are 
induced to interact with each other. The two types of interactions which can be selected during the mixing 
period are through-space interactions due to cross-relaxation (NOEs) and through-bond interactions, termed 
spin-spin (J)-coupling. During the preparation period the spins are allowed to return to thermal equilibrium 
and during the acquisition period the transverse magnetisation created by the last pulse is detected. The 
systematic augmentation of t1 gives rise to a modulation in the amplitude of the peaks in the spectra 
obtained after Fourier transformation in the t2 direction. If the peaks are modulated only by their own 
frequency a second Fourier transformation in the t1 direction gives rise to so-called diagonal peaks. 
However, if during the mixing period the spins have interacted with each other the second Fourier 
transformation will also reveal off-diagonal peaks, the so-called cross-peaks (Hard and Vliegenthart, 1993). 
 
1.5.3 NMR Spectroscopy 
 
All NMR spectrometers consist of a magnet that can produce an intense and homogeneous field, a 
radiofrequency transmitter for perturbation of the nuclei in the sample and receiver coils for the observation 
of their responses, which are placed close to the sample in the magnet. Furthermore, a radio-frequency 
receiver, a computer for manipulation of the radiofrequency pulses, as well as storage and handling of the 
acquired data are required. 
 
The correlated spectroscopy (COSY) experiment was the first 2D NMR experiment to be proposed. COSY 
spectra provide information on directly coupled protons. From the fine structure of the cross-peaks in COSY-
type experiments information can be extracted about coupling constants, which in turn can be used to 
estimate dihedral angles in small carbohydrates in a pure sample. With larger polysaccharides or 
macromolecular complexes investigated, such fine structure is more difficult to elucidate, due to slower 
tumbling in solution, requiring longer 90º pulses, which is accompanied by the loss of resolution. Total 
correlation spectroscopy (TOCSY) is a spin-locked version of the COSY experiment. This experiment 
extends the information on all correlated spins, that are directly or indirectly coupled within a spin system, 
such as a monosaccharide. Nuclear Overhauser effect spectroscopy (NOESY) methods have been widely 
applied in structural work on oligosaccharides because cross-peaks are obtained between protons close in 
space and this information can be used in the form of structural constraints when calculating three-
dimensional structures of oligosaccharides. NOEs are often used to determine linkage positions between 
monosaccharides, but the results should be examined critically since the strongest NOE between adjacent 
monosaccharide residues need not always be the proton at the linkage carbon. However, the observed 
NOEs are ensemble averages originating from all different conformations present of the oligosaccharide in 
solution. The heteronuclear single-quantum coherence spectroscopy (HSQC) experiment belongs to a family 
of heteronuclear inverse (proton detected) experiments (heteronuclear decoupling), where it is possible to 
observe carbon resonances split by their directly bonded protons, thus allowing assignment of carbon type. 
Heteronuclear multiple-bond spectroscopy (HMBC), on the other hand generates cross-peaks between 13C 
and 1H atoms separated by several chemical bonds. The way of sequencing oligosaccharides is to use long-
range 1H-13C couplings over the glycosidic linkages, allowing the unambiguous determination of linkage 
positions (Hard and Vliegenthart, 1993). 
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1.5.4 Carbohydrate NMR 
 
Due to the complexity of their structures, no single technique will provide enough information on the 
characteristics of specific glycoconjugates and thus a multi-technique approach of a combination of 
analytical techniques is often applied to the study of bacterial glycoconjugates. Oligosaccharides are usually 
investigated using NMR spectroscopy as deuterium-exchanged samples, so that only non-exchangeable C-
linked protons are observed in 1H NMR spectra. The majority of monosaccharide protons of the constituent 
residues resonate between 3.2 and 4.1ppm, as is visible as the bulk region in a 1D spectrum. Protons that 
do not resonate in this region include anomeric protons, acetyl and fatty acyl groups or protons shifted out of 
the envelope of unresolved signals (bulk region) under the influence of substituents such as phosphate, 
methyl or acetyl groups. 
 
The chemical shift patterns and couplings can be translated into structural information, based on comparison 
to patterns in a library of relevant reference compounds, but the successful application of this approach 
requires careful calibration of the experimental technique. In COSY experiments, spin systems 
corresponding to monosaccharide constituents can be traced and interpretation starts from an anomeric 
signal or from any other well resolved signal. COSY and TOCSY spectra do not provide monosaccharide 
sequence information, due to the absence of coupling over the glycosidic linkage, and often NOESY and 
ROESY spectra are used for this purpose. 13C spectroscopy is at least three orders of magnitude less 
sensitive than 1H spectroscopy, partly because of the low natural abundance of 13C (1.1%) and partly 
because the 13C nucleus is inherently less sensitive than 1H, however 13C spectra have a wider chemical 
shift range than 1H spectra, mitigating the problem of overlapping signals (Schiller et al., 2012). HSQC 
spectra provide important correlations and owing to the unusually large dispersion of the 13C signals, these 
spectra have great value for interpretation. In the determination of the structure of the repeating unit of 
polysaccharides the HSQC experiment is very helpful; however it is currently not feasible to elucidate the 
distribution of the acetyl groups over the polysaccharide chain. The HMBC experiment is tuned at small (1-
10Hz) heteronuclear couplings, such as is useful for sequence information as it yields through bond 
correlations, providing cross-peaks between each anomeric carbon atom and the proton of the adjacent 
sugar residue as well as between the anomeric proton and the ring carbon atom of the adjacent sugar 
residue. This is extremely useful in the assignment of the repeating structure of a typical LPS O-antigen 
(Vliegenthart and Woods, 2006). 
 
With advances in genomics alongside rapid technological improvements in MS and NMR analysis, 
prokaryotic glycomics has taken on a new life, with many novel glycan structures being identified and 
opening up possibilities for glycoengineering. The assignment of genetic information to glycan biosynthetic 
pathways is complex, combining bioinformatic analysis, linked to systematic mutagenesis and functional 
analysis of individual genes and structural analysis from MS or NMR, all of which ultimately creates a 
challenging task to weave the different strands of information together to provide a holistic understanding of 
the roles that glycans play in prokaryotes (Kay et al., 2010). 
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1.6 PROJECT AIMS 
 
The main objectives of this PhD project are to apply and improve high sensitivity methodologies for the 
characterisation of bacterial and archaeal glycopolymers by focusing on the the S-layer glycoprotein of the 
halophilic archaeon H. volcanii and the LPS O-antigen of B. pseudomallei serotype 576. The specific aims of 
each project are: 
 
1.6.1 Haloferax volcanii 
 
• to functionally characterise several agl genes in the agl gene cluster of the S-layer glycoprotein of 
the halophilic archaeon H. volcanii in order to provide a better understanding of the N-glycan 
biosynthetic pathway 
• to definitively establish N- and O-glycan heterogeneity 
• to map the S-layer glycoprotein using state of the art mass spectrometric techniques in order to 
define N-glycosylation occupancy and putative lipid modification 
 
1.6.2 Burkholderia pseudomallei 
 
• to characterise the structure of the B. pseudomallei 576 LPS O-antigen repeat unit using various 
mass spectrometric and NMR techniques to provide information for glycoconjugate vaccine creation 
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2 MATERIALS AND METHODS 
 
2.1 MATERIALS 
 
2.1.1 Chemical reagents 
 
• Alfa Aesar (Lancashire, UK): acetic anhydride ((CH3CO)2O) and methyl iodide (CH3I), deuterated 
methyl iodide (CD3I) 
• BDH (Gilingham, UK): hydrochloric acid (HCl) 
• BOC (Guildford, UK): nitrogen and argon gases 
• Cambridge isotope Laboratories, Inc. (Andover, USA): Dodecylphosphocholine (D38, 99%) 
• Fisher Scientific (Loughborough, UK): Slide-A-Lyzer® dialysis cassettes (3.5kDa MWCO) 
• Fluka (Poole, UK): ammonium hydrogen carbonate (ambic; NH4HCO3), dithioreitol (DTT), sodium 
hydroxide pellets, ‘Dowex' 50W-X8 (H+) 50-100 mesh, ‘Dowex’ 1X8 chloride form (Cl-) 20-50 mesh, 
sodium periodate, pyridine (C5H5N), ethylene glycol (C2H6O2), potassium hydroxide (KOH) 
• Invitrogen (Paisley, UK): NuPAGE® SDS-PAGE Midi Gel System (Tris-acetate, pre-cast), 
NuPAGE® LDS sample buffer, NuPAGE® reducing agent, NuPAGE® Tris-Acetate SDS Running 
Buffer Novex Colloidal blue staining Kit and Coomassie R-250. 
• NBS Biologicals (Cambridgeshire, UK): Spectra/Por® Float-A-Lyzer® G2 (with biotech cellulose 
ester membranes; 0.1-0.5 MWCO) 
• NORRELL Inc. (Landisville, UK): NMR tubes 
• Pierce (Rockford, USA): tri-Sil ‘Z’ Derivatising agent (TMS), Snakeskin® dialysis tubing (7kDa 
molecular weight cut off (MWCO)), Float-A-Lyzer G2, 8M guanidine hydrochloride (GuHCl) 
• Purite Ltd. (Oxfordshire, UK): ultrapure 18 MΩ.cm3 distilled/deionised (MilliQ®) water from Purite 
Neptune ultrapure water purification system was used for the preparation of all aqueous solutions 
• ROMIL (Waterbeach, UK): acetonitrile (ACN), ammonia (NH4), acetic acid (CH3COOH), methanol 
(CH3OH), chloroform (CHCl3), propan-1-ol (C3H7OH), 1-butanol (C4H9OH), dimethylsulfoxide 
(DMSO), sodium hydroxide (NaOH) and trifluoroacetic acid (TFA), formic acid (HCO2H) 
• Sigma-Aldrich Corporation (Poole, UK): α-cyano-4-hydroxycinnaminic acid (HCCA), 2,5-
dihydroxybenzoic acid (DHB), sinapinic acid (SA), 2-(4-hydroxyphenylazo)benzoic acid (HABA), 
iodoacetic acid (IAA), potassium borohydride (KBH4), sodium acetate (CH3COONa), hexanes 
(C6H14), sodium borodeuteride (NaBD4), 2-amino-2-hydroxymethyl-propane-1, 2-diol (Tris; 
(HOCH2)3CNH2), sodium chloride (NaCl), sodium dodecyl sulphate (SDS), pyridine (C5H5N), acetic 
anhydride ((CH3CO)2O), ammonium acetate (CH3COONH4), deuterium oxide (D2O, 99%), deuterium 
oxide (D2O, “100%”, 99.990%) 
 
2.1.2 Enzymes 
 
• Promega Corporation (Hampshire, UK): trypsin (porcine), chymotrypsin (bovine pancreas), Glu-C 
(S. aureus V8), endoproteinase Lys-C (L. enzymogenes), Asp-N (P. fragi), proteinase K (T. album 
limber), pepsin (porcine stomach), cyanogen bromide (CNBr) 
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• Roche Applied Science (Sussex, UK): pronase (S. griseus) 
• Sigma-Aldrich Corporation (Poole, UK): trypsin (porcine EC 3.4.21.4), chymotrypsin (EC 
3.4.21.1), Benzonase® nuclease (E. coli EC 3.1.30.2), prolidase (porcine kidney EC 3.4.13.9), 
elastase (porcine pancreas EC3.4.21.36) 
 
2.1.3 Lipopolysaccharide, peptide and saccharide standards 
 
• Applied Biosystems (Warrington, UK): 4700 Mass Standards kit, including the peptide standards: 
bradykinin, fragment 1-8 (FW 904.0), angiotensin I (FW 1296.5), adrenocorticotropic hormone 
fragment (ACTH) 1-17 (FW 2093.4, ACTH fragment 18-39 (FW 2465.7), ACTH fragment 7-38 (FW 
3659.2), linear MALDI-TOF BSA Calibration Standard Kit containing lyophilised bovine serium 
albumin and [Glu1]-Fibrinopeptide B human (FW 1570.7) 
• Dextra Laboratories (Reading, UK): oligosaccharide standards (Manα1-3(Manα1-6)Man, Galα1-
3Glcα1-3Glc, Galα1-3Gal, Galβ1-4Gal) 
• Sigma-Aldrich Corporation (Poole, UK): monosaccharide standards (inositol, arabitol, 
mannoheptose, neuraminic acid, glucuronic acid, galacturonic acid, N-acetylglucosamine, N-
acetylgalactosamine, mannose, glucose, galactose, rhamnose, fucose, xylose, arabinose), LPS from 
E. coli O26:B6 (purified by phenol extraction), LPS from E. coli O128:B12 (purified by phenol 
extraction) 
 
2.2 EQUIPMENT AND CONSUMABLES 
 
2.2.1 Equipment 
 
• Perkin Elmer Clarus 500 GC-MS instrument fitted with either Rtx®-5MS (crossbond® 5% 
dimethylpolysiloxane, 30m, 0.25mmID, 0.25µm df) or a Stabilwax® (crossbond® Carbowax® 
polyethylene glycol, 30m, 0.32mmID, 0.25µm df) 
• PerSeptive Biosystems Voyager-DE STR System MALDITM mass spectrometer 
• Applied Biosystems 4800 MALDI-TOF/TOFTM mass spectrometer 
• Dionex, Sunnyvale, USA UltiMate 3000 with a probot spotter and fitted with a Pepmap analytical C18 
nanocapillary (75µm ID x 15cm length) for offline-nanoLC separation prior to MALDI-TOF/TOF 
analysis 
• API Q-STARTM Hybrid LC-MS/MS system linked to a nanoLC column 
• Xevo G2S Q-TOF LC-MS/MS mass spectrometer on-line to a Waters Acquity UPLC with microbore 
reverse phase column 
• Bruker Avance III 600 MHz, fitted with a TXI/TCI cryoprobe 
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2.2.2 Consumables 
 
• Bennett Scientific (Devon, UK): culture tube caps 
• Bruker – Michrom Bioresources, Inc. (Auburn, CA, USA): “protein concentration and desalting” 
and “titanium dioxide phosphopeptide” MicroTraps 
• Fisher Scientific (Loughborough, UK): 10ml glass syringes 
• Owens Polyscience Ltd. (Cheshire, UK): Teflon inserts 
• Presearch (Basingstoke, UK): C18 microtrap peptide cartridges 
• Sigma-Aldrich (Poole, UK): Lo-bind® eppendorf tubes 
• Thermo Scientific (Basingstoke, UK): Thermo Savant SPD121P Speed Vac connected to a 
RVT4104 refrigerated vapour trap and Edwards XDS10 pump for volume reduction and 
concentration, Thermo Savant ModuloD freeze dryer for lyophilisation, IEC Centra CL3 centrifuge for 
centrifugation 
• VWR International Ltd (Leicestershire, UK): automatic multi-tube vortexer used for shaking, screw 
cap glass culture tubes (13x100mm corning, 7.5ml), eppendorfs, glass Pasteur pipettes (150mm and 
230mm) 
• Waters Ltd. (Hertfordshire, UK): reverse phase Classic C18 (360mg, 55-150µm), Oasis® HLB, C18 
(Plus) Sep-Pak cartridges 
 
2.3 SAMPLE PREPARATRION 
 
All biological samples used in the projects discussed in this thesis were prepared by research collaborators. 
Methods for their preparation are briefly given in Section 2.3.1 and Section 2.3.2. 
 
2.3.1 H. volcanii samples 
 
All H. volcanii S-layer glycoproteins were kindly supplied by Prof. Jerry Eichler and purified by the Eichler 
laboratory at Ben-Gurion University of the Negev, Israel. These are summarised in Table 2.1. 
 
Species Strain 
H. volcanii S-layer glycoprotein WR536 (WT) 
H. volcanii S-layer glycoprotein ΔAglM (HVO_1531) 
H. volcanii S-layer glycoprotein ΔAglP (HVO_1522) 
H. volcanii S-layer glycoprotein ΔAglJ (HVO_1517) 
Table 2.1 – Table summarising all the H. volcanii glycoprotein samples provided by the Eichler group 
 
2.3.1.1 H. volcanii cell growth conditions 
 
The H. volcanii strain WR536 (H53) wild type/parent strain was obtained from M. Mevarech (Tel Aviv 
University). All wild type S-layer glycoprotein samples and gene deleted samples were grown in complete 
medium containing 3.4M NaCl, 0.15M MgSO4.7H2O, 1mM MnCl2, 4mM KCl, 3mM CaCl2, 0.3% (w/v) yeast 
extract, 0.5% (w/v) tryptone, 50mM Tris-HCl at pH 7.2 at 40°C (Mevarech and Werczberger, 1985). 
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2.3.1.2 H. volcanii S-layer glycoprotein release from cells 
 
The S-layer glycoprotein was released using EDTA. The cell pellet was washed with 2M NaCl, 50mM Tris–
HCl at pH 7.2 and resuspended in minimal medium to which 0.5M EDTA was added. The cells were further 
incubated for 3-4hrs at 37°C and harvested by centrifugation. The supernatant was dialyzed against 50mM 
Tris-HCl at pH 7.2, precipitated and lyophilised. In the case of gene deletion strains, these were run on a 
10% SDS-PAGE gel and the bands cut out and provided for analysis. 
 
2.3.1.3 S-layer glycoprotein gene deletions 
 
For the deletion of the H. volcanii agl genes in question, regions flanking the coding sequences were 
amplified and restriction sites introduced upstream and downstream. To confirm the deletion of the agl gene 
at DNA level, PCR amplification was performed using primers against an internal region of the respective agl 
gene (Kaminski et al., Magidovich and Eichler, 2009, Yurist-Doutsch et al., 2008). 
 
2.3.2 Burkholderia samples 
 
All B. pseudomallei, B. thailandensis and B. mallei samples were kindly supplied by Dr. Joann Prior and her 
team at the Defence Science and Technology Laboratory (dstl), part of the Ministry of Defence (MOD) at 
Porton Down, Wiltshire, United Kingdom. These are summarised in Table 2.2. 
 
Species Strain 
B. pseudomallei K96243 purified LPS 
B. pseudomallei K96243 ΔCPS 
B. pseudomallei 576 purified LPS 
B. pseudomallei 576 ΔLPS 
B. pseudomallei 576 ΔCPS 
B. thailandensis E264 purified LPS 
B. mallei WT 
Table 2.2 – Table to summarise all Burkholderia samples provided by dstl 
 
2.3.2.1 Burkholderia bacterial growth 
 
Bacteria were cultured on nutrient agar (bioMérieux) or statically in nutrient broth at 37°C for 18hrs. For 
enumeration of bacteria, samples were serially diluted in nutrient broth before plating. The Advisory 
Committee on Dangerous Pathogens (ACDP) lists B. pseudomallei and B. mallei as category III pathogens. 
All manipulations were carried out in class III microbiological safety cabinets located in designated ACDP 
containment level III laboratories (Nelson et al., 2004). 
 
2.3.2.2 Burkholderia LPS extraction 
 
LPS was extracted from lyophilised Burkholderia strains or mutants using a combination of previously 
published methods (Westphal and Luderitz, 1953, Paul et al., 1987). Bacterial cell pellets were digested for 
16hrs at 4°C with 15’000Units of lysozyme (Sigma, UK) per mg of bacteria,  prior to digestion with 20µg/ml of 
90 
 
Chapter 2  Materials and Methods 
DNase I and RNase A (Sigma, UK) for a further 16hrs at room temperature. A modified hot phenol method 
followed (Nelson et al., 2004). 
 
2.3.2.3 Gel electrophoresis and silver staining of Burkholderia LPS 
 
The LPS was separated by SDS-PAGE, where 10μl of each sample were electrophoresed for approximately 
2hrs at 100mV in a 12.5% separating gel with 4.5% stacking gel and visualised by silver staining (Chart, 
1994). 
 
2.4 METHODS 
 
2.4.1 Gel electrophoresis of H. volcanii S-layer glycoprotein 
 
For gel electrophoresis of H. volcanii S-layer glycoprotein samples, the NuPAGE® SDS-PAGE Midi Gel 
System, Tris-acetate pre-cast polyacrylamide gels were used (Invitrogen, Paisly, UK), allowing for separation 
of a wide range of molecular weight proteins. The samples were denatured at 70°C for 10 mintues prior to 
electrophoresis and run on 3-8% Tris-acetate gels (pH 8.1) with NuPAGE® LDS sample buffer and reducing 
agent, as well as NuPAGE® Tris-Acetate SDS Running Buffer, at 150V (constant) for approximately 1hr. The 
gels, samples and molecular weight markers were stained with the Novex Colloidal blue staining Kit and 
Coomassie R-250. 
 
2.4.2 Preparation of H. volcanii S-layer glycoproteins for MS analysis 
 
For in-gel digestion of S-layer glycoproteins, the bands of interest were excised (if not provided) and 
destained in 400µl of 50% (v/v) acetonitrile in 0.1M ammonium bicarbonate at pH 8.4. If cysteine residues in 
the amino acid sequence of the protein in question are likely to be present, disulphide bridges will generally 
need to be reduced (10mM dithiothreitol at 56ºC for 30mins) and carboxymethylated (55mM iodoacetic acid 
at room temperature for 30mins). However, since there were no cysteines reported in the predicted amino 
acid sequence of the H. volcanii S-layer glycoprotein and therefore this step was not normally performed. 
 
2.4.3 Proteolytic digests and glycopeptide purification of the H. volcanii S-layer 
 
For both in-gel and in-solution digestion of the purified S-layer glycoprotein of H. volcanii the sample was 
incubated with the appropriate enzyme at a suitable concentration ratio, in the respective optimal buffer pH 
and temperature overnight as is described below. 
 
2.4.3.1 Trypsin 
 
For digestion, the S-layer glycoprotein was incubated with trypsin at 37°C overnight in 50mM ammonium 
bicarbonate buffer at pH 8.5 at a protease:protein ratio of 1:20 (w/w). Trypsin hydrolyses the peptide bonds 
at the carboxyl side of lysine and arginine residues, unless they are followed by a proline residue. 
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2.4.3.2 Chymotrypsin 
 
For digestion, the S-layer glycoprotein was incubated with chymotrypsin at 37°C overnight in 50mM 
ammonium bicarbonate buffer at pH 7.8 at a protease:protein ratio of 1:20 (w/w). Chymotrypsin selectively 
hydrolyses the peptide bonds on the C-terminal side of tyrosine, phenylalanine, tryptophan and leucine and 
secondary hydrolysis may occur on the C-terminal side of methionine, histidine and asparagine. 
 
2.4.3.3 Glu-C 
 
For digestion, the S-layer glycoprotein was incubated with Glu-C at 37°C overnight in 50mM ammonium 
bicarbonate buffer at pH 7.8 at a protease:protein ratio of 1:20 (w/w). Glu-C is a serine protease that 
specifically cleaves at the C-terminus of glutamic acid and at a 300-fold lower rate also aspartic acid. 
 
2.4.3.4 Pronase 
 
Pronase allows for the total degradation of proteins and the production of small glycopeptides from purified 
glycoproteins. The peptides are digested to the size of only a few amino acids. The S-layer glycoprotein was 
incubated with pronase at 37°C overnight in 50mM ammonium bicarbonate buffer at pH 7.8 at a 70000 u/g 
working concentration (0.5-2mg/ml solution). 
 
2.4.3.5 AspN 
 
For digestion, the S-layer glycoprotein was incubated with AspN at 37°C overnight in 50mM ammonium 
bicarbonate buffer at pH 7.8 at a protease:protein ratio of 1:20 (w/w). AspN is a zinc metalloendopeptidase, 
which selectively cleaves peptide bonds on the N-terminal side of aspartic acid residues. 
 
2.4.3.6 Prolidase 
 
For sequencing of the C-terminal region of the S-layer glycoprotein, it was digested with prolidase. Prolidase 
is a cytosolic exopeptidase that cleaves on the N-terminal side of proline of small peptides. The requirement 
of smaller peptides warranted for the sample to first be digested with Glu-C (Section 2.4.3.3) and then 
further digested with prolidase at 37°C overnight in 50mM ammonium bicarbonate buffer at pH 8.4 at a 
protease:protein ratio of 1:100 (w/w). 
 
2.4.3.7 Elastase 
 
For sequencing of the C-terminal region of the S-layer glycoprotein, it was digested with elastase, a protease 
that cleaves specific peptide bonds on the carboxyl side of small hydrophobic amino acids such as glycine, 
alanine and valine. The sample was incubated with elastase at 37°C for 3hrs in 50mM ammonium 
bicarbonate buffer at pH 8.4 at a protease:protein ratio of 1:100 (w/w). 
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2.4.3.8 Cyanogen bromide 
 
For sequencing of the C-terminal region of the S-layer glycoprotein, it was digested with cyanogen bromide, 
which hydrolyses peptide bonds at the C-terminus of methionine residues, except when followed by a 
threonine residue, or if methionine is oxidised. This reaction is used to reduce the size of polypeptide 
segments for identification and sequencing. The sample was incubated with a suitable concentration of CNBr 
in H2O for 4hrs. The incubation was stopped by drying under nitrogen. 
 
2.4.3.9 Double digests  
 
In the case of double digests being performed on the S-layer glycoprotein of H. volcanii, the first enzyme 
incubation was stopped by heat deactivation of the enzyme used and the sample dried down in a Thermo 
Savant SpeedVac concentrator (Thermo Fisher Scientific Inc., Waltham, USA). This was followed by re-
suspension of the sample in the appropriate buffer for the subsequent enzymatic digest. 
 
2.4.4 Purification and concentration of digested H. volcanii S-layer glycopeptides 
 
For the removal of contaminant, such as reagents, enzymes as well as salts, the digested glycopeptides 
were purified and concentrated for mass spectrometric analysis. Various techniques were employed for the 
purification of H. volcanii S-layer glycopeptides. 
 
2.4.4.1 Sep-Pak® purification propan-1-ol / 5% acetic acid system 
 
Sep-Pak® Classic C18 cartridges were attached to 10ml glass syringes and conditioned by eluting 
sequentially with 5ml methanol, 5ml 5% (v/v) acetic acid, 5ml propan-1-ol and 15ml 5% (v/v) acetic acid. The 
sample was loaded, washed with 20ml of 5% (v/v) acetic acid for the removal of hydrophilic contaminants 
and eluted sequentially with 4ml of each 20%, 40%, and 100% (v/v) propan-1-ol in 5% (v/v) acetic acid. The 
glycopeptides were eluted in the 20% and 40% (v/v) propan-1-ol fractions, which were combined, dried down 
on a SpeedVac® and lyophilised. 
 
2.4.4.2 Michrom MicroTrap™ cartridge purification 
 
Michrom trap cartridges are packed with application specific HPLC column packing material for the 
concentration, desalting and detergent removal from samples prior to analysis by HPLC, LC-MS and MALDI-
MS. The two traps used were the “peptide concentration and desalting” trap as well as the “titanium dioxide 
phosphopeptide” trap. 
 
The “protein concentration and desalting” column contains a medium pore, large particle, polymeric 
reversed-phase packing material with retention similar to a C8 phase and is designed to bind protein digests, 
peptides and other small molecules. It was washed with 5-10 trap volumes (25µl) of Solvent B (90% ACN, 
10% H2O, 0.1% TFA, v/v/v), equilibrated with 5-10 trap volumes (25µl) of Solvent A (2% ACN, 98% H2O, 
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0.1% TFA, v/v/v). The sample was dissolved in 20µl of Solvent A and loaded, whilst the salt was removed by 
flushing the cartridge with 5 trap volumes of Solvent A and the concentrated sample eluted with Solvent B. 
 
The “titanium dioxide phosphopeptide” trap contains a medium pore, large particle titanium dioxide material 
and is designed to bind negatively charged phosphopeptides, while most other peptides pass through due to 
their net positive charge. It was used to concentrate the N-glycosylated S-layer glycopeptides, due to the 
HexA presence, which resemble such phosphopeptides. The trap was washed with 500µl of the Elutant 
Buffer (1% NH4OH, 2% ACN, 97% H2O, v/v/v, pH 12) and equilibrated with 500µl of the Load Solvent (5% 
TFA, 2% ACN, 93% H2O, v/v/v). The sample was dissolved in 20µl of Load Solvent and the cartridge flushed 
with 500µl of Wash Solvent (5% TFA, 80% ACN, 15% H2O, v/v/v). The non-phosphorylated peptides were 
removed with 100µl Load Solvent, whilst the phosphorylated peptides/N-glycopeptides were eluted with 
100µl of Elutant Buffer. 
 
2.4.5 Release of glycans from H. volcanii S-layer glycopeptides 
 
Eukaryal N-glycans are all built on the chitobiose core, which links the first GlcNAc residue to the Asn 
residue of the peptide backbone. This constant and predictable linkage can be exploited using various 
enzymes, including peptide-N-glycanase F (PNGase F) (Kelly et al., 2009). Furthermore, O-glycosidase is 
available and capable of releasing some O-glycans, specific to certain core types. These conserved linkages 
to the peptide backbone, however, are not found in prokaryotic glycoproteins and are thus not applicable for 
the study of the N- and O-glycosylation of the S-layer glycoprotein of H. volcanii. Due to the specificity of the 
O-glycosidase enzyme, most O-glycans in eukaryotes are chemically released by way of alkaline β-
elimination (Dell et al., 1993). The following methods were employed in this thesis in order to release the 
glycans from the protein for further analysis. 
 
2.4.5.1 Reductive elimination 
 
The β-elimination reaction is carried out under reducing condition to prevent glycan degradation by the 
“peeling” effect of reducing the terminal/linking residues to their alditol forms and hence is commonly referred 
to as reductive elimination. This can be carried out directly after enzymatic digests to release both N- and O- 
glycans, albeit N-glycans are more difficult to visualise. The samples, post enzymatic digests and propanol 
Sep-Pak® purification, were dissolved in 800µl of 1M potassium borohydride (KBH4) in a 0.1M solution of 
potassium hydroxide (KOH) and incubated at 45°C for 20-22hrs. The reaction was terminated by dropwise 
addition of glacial acetic acid. 
 
2.4.5.2 Ion exchange clean-up 
 
Cationic salts, amino acids and peptides were removed from the sample using a Dowex® (50W-X8 (H+) 50-
100 mesh) column. The Dowex cation exchange column was constructed using a Pasteur pipette plugged at 
the tapered end with a small amount of glass wool, where a piece of silicon tubing was placed with a flow-
blocking adjustable clip. The Dowex was washed with 15ml of 5% (v/v) acetic acid and the sample was 
loaded and eluted with 2x2ml of 5% (v/v) acetic acid. The collected eluate was lyophilised and the excess 
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borates were removed as volatile methyl borate compounds by co-evaporation with acetic acid in methanol 
10% (v/v) under a stream of nitrogen (4x500µl). 
 
2.4.6 H. volcanii S-layer glycoprotein lipid purification and derivatisation 
 
The speculated lipid association of unidentified lipid moieties with the S-layer glycoprotein was investigated 
using the S-layer glycoprotein sample grown and purified as previously discussed (Section 2.3.1). The 
nature of association of the lipid with the S-layer glycoprotein was investigated using a variety of hydrolysis 
and separation techniques, discussed below. 
 
2.4.6.1 Purification of lipids by chloroform extraction 
 
Due to the hydrophobic nature of glyco- and phospholipids, simple separation of chloroform and water 
fractions would remove lipid moieties from the more hydrophilic peptides. The S-layer glycoprotein sample 
was dissolved in 50% chloroform in water (v/v) and the two fractions separated (2x), isolating non-covalently 
attached lipids from the S-layer glycoprotein in the chloroform fraction. 
 
2.4.6.2 Hydrofluoric acid (HF) hydrolysis 
 
Hydrofluoric acid treatment was employed to hydrolyse any phosphodiester linkages that might be present 
between the lipid moieties and the S-layer glycoprotein. The sample was transferred to Lo-bind® eppendorf 
tubes and the dried sample was incubated with 200µl of hydrofluoric acid (HF) on ice for 24hrs at 4°C. The 
reaction was terminated by drying under a gentle stream of nitrogen and the protein and lipid moieties 
separated by chloroform extraction prior to MALDI-MS and MS/MS analysis. 
 
2.4.6.3 Base hydrolysis 
 
For base hydrolysis, the S-layer glycoprotein was combined with 0.8ml PBS, 1ml CHCl3 and 2ml methanol 
(MeOH) in a glass tube with a Teflon-lined cap to yield a single phase solution (CHCl3:MeOH:PBS = 1:2:0.8, 
v/v/v). Following addition of 200μl (15N) KOH and intermittent mixing by vortex for 5mins, the mixture was 
sonicated in a water bath for 15mins at room temperature. The sample was further centrifuged (3000rpm) for 
5mins at room temperature and the supernatant was transferred to a fresh glass tube with a Teflon-lined 
cap. 1ml CHCl3 and 1ml PBS were added to yield a two-phase Bligh-Dyer mixture (CHCl3:MeOH:PBS = 
2:2:1.8, v/v/v). After mixing, the sample was again centrifuged (3000rpm) for 5mins at room temperature to 
separate the phases (Kandiba et al., 2013). The upper phase was removed and the lower CHCl3 phase was 
dried under a stream of nitrogen. Both lipid and protein fractions were analysed by MALDI-MS and MALDI-
MS/MS. 
 
2.4.7 B. pseudomallei LPS hydrolysis procedures and de-lipification 
 
Generally lipopolysaccharides are too large to be analysed intact by mass spectrometry. Furthermore, the 
amphiphilic nature of LPS renders them difficult to dissolve in aqueous solutions or solvents, which 
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complicates their analysis. In addition, the heterogeneity of LPS, arising from the number and length of fatty 
acyl chains and phosphate substitutions favours the removal of lipid A prior to the study of O-antigens. The 
most prominent hydrolysis techniques employed is mild acid hydrolysis, but various other suitable hydrolysis 
techniques were investigated, due to the unusual LPS characteristics of B. pseudomallei 576. 
 
2.4.7.1 Mild acetic acid hydrolysis 
 
The purified LPS sample was hydrolysed in 1%, 2% and 3% (v/v) acetic acid and heated at 100ºC for 1 or 
2hrs and centrifuged at 3500rpm for 30mins to remove the polysaccharides in the supernatant from the lipid 
A in the pellet. Mild acid hydrolysis acts on the acid-labile ketosidic bond of Kdo to the GlcN backbone, 
linking the core oligosaccharide to lipid A in most LPS. The mild nature of this procedure prevents cleavage 
of other glycosidic bonds in the rest of the LPS. 
 
2.4.7.2 Methanolysis 
 
For methanolic acid hydrolysis, samples were incubated in various concentrations of methanolic-hydrogen 
chloride prepared by adding a suitable volume of acetylchloride to dry methanol. Samples were incubated at 
a range of different temperatures and for different lengths of time and the reaction terminated by removing 
the reagent under a gentle stream of nitrogen prior to MALDI-MS and MS/MS analysis to monitor hydrolysis 
(Grobe et al., 2013). 
 
2.4.7.3 Ammonolysis 
 
Ammonolysis refers to any reaction with ammonia that is analogous to hydrolysis, in which a bond is broken 
and an NH2 group is appended to one fragment. LPS was hydrolysed in 200µl of 10M ammonium hydroxide 
at 150ºC for 18hrs. The sample was further cooled, dried and concentrated under a constant stream of 
nitrogen, dissolved in water and the insoluble components removed by centrifugation (3000g x 30mins at 
4ºC). The supernatant was recovered and dried down (Mattos et al., 2005). 
 
2.4.7.4 SDS combined hydrolysis 
 
This technique was devised from a combination of published and previously used hydrolysis techniques 
applied to bacterial LPS de-lipification (Novem et al., 2009). The LPS was hydrolysed in 1% SDS (sodium 
dodecyl sulphate) in 10mM sodium acetate (pH 4.5) at 100°C for 1hr. The sample was freeze dried and the 
sodium dodecyl sulphate (SDS) removed by re-suspension in distilled water followed by sonication for 
dispersal of the sample. The sample was further centrifuged at 2000g for 30mins in acidified ethanol (0.5% 
HCl in ethanol) to separate the lipid A (pellet) from the polysaccharide (supernatant). The polysaccharide 
sample was further dialysed in 50mM ammonium bicarbonate buffer at pH 8.4 to remove any further traces 
of SDS using a Float-A-Lyzer® G2 for 24hrs, lyophilised and hydrolysed by mild acid hydrolysis (1% acetic 
acid (v/v), 100°C, 2hrs). The sample could then be further derivatised prior to MALDI-MS and MS/MS 
analysis. 
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2.4.8 Chemical derivatisation of carbohydrates for MS analyses 
 
As discussed in Chapter 1, native glycans can be analysed directly by mass spectrometry, but do not ionise 
as efficiently due to their hydrophilic nature and are thus derivatised prior to analysis by mass spectrometry. 
Derivatisation methods can either employ a reducing end tag or protect most or all of the functional groups of 
the carbohydrates. 
 
2.4.8.1 Permethylation 
 
Permethylation involves the exchange of protons in hydroxyl and amide groups for hydrophobic methyl 
groups and involves the successive base-catalysed ionisation of these functional groups followed by 
methylation. The technique was introduced by Hakomori and colleagues (Chou and Yang, 1979) who 
described the use of methylsulphinyl carbanion from dimethyl sulphoxide (DMSO) as the base and methyl 
iodide as the methyl donor and the chemistry was optimised for high sensitivity application to peptides and 
carbohydrates by the discovery in isotope dilution MS experiments that the kinetics is on the second 
timescale rather than the hours and days originally used (Morris, 1972). This led to all subsequent methods 
utilising permethylation times of minutes in order to minimise byproducts and maximise sensitivity. 
Permethylation is now commonly catalysed by weaker bases such as sodium hydroxide and has become the 
staple derivatisation step in many glycomic strategies (Dell, 1990). 
 
For specific oligosaccharide analysis, samples were methylated using the sodium hydroxide procedure. A 
slurry of NaOH-anhydrous DMSO (1ml) was added to the sample, followed by 0.5ml iodomethane. The 
reaction mixture was agitated on an automatic multi-tube vortexer for 30mins at room temperature and the 
reaction quenched by dropwise addition of water. The permethylated glycans were extracted in 1ml of 
chloroform, washing with 4ml of water (4x) and dried under a gentle stream of nitrogen gas. The resulting 
glycans were then purified by Sep-Pak® C18 using the aqueous ACN system. 
 
2.4.8.2 Deutero-permethylation 
 
The sample was deuteropermethylated using the sodium hydroxide procedure. A slurry of NaOH-anhydrous 
DMSO (1ml) was added to the sample, followed by 0.5ml deuterated iodomethane-d3. The reaction mixture 
was agitated on an automatic multi-tube vortexer for 30mins at room temperature and quenched by dropwise 
addition of water. The deuteropermethylated glycans were extracted in 1ml of chloroform, washing with 4ml 
of water (4x) and dried under a gentle stream of nitrogen gas. The resulting glycans were then purified by 
Sep-Pak® C18 using the aqueous ACN system as described below. 
 
2.4.8.3 Reduction 
 
To reduce the oligosaccharides prior to methylation, they were incubated with 10mg/ml of NaBH4 (in 2M 
aqueous NH3) at room temperature for 2hrs. After borate removal with acidified methanol co-evaporation, 
they were permethylated as described previously (Section 2.4.8.1). 
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2.4.8.4 Deutero-reduction 
 
To deuteroreduce the oligosaccharides prior to methylation, they were incubated with 10mg/ml of NaBD4 (in 
2M aqueous NH3) at room temperature for 2hrs. After borate removal with acidified methanol co-evaporation, 
they were permethylated as described previously (Section 2.4.8.1). 
 
2.4.8.5 Sep-Pak® clean up: Aqueous acetonitrile system 
 
Purification of the permethylated sample was achieved by reverse-phase chromatography using C18 Sep-
Pak® cartridges. Sep-Pak® Classic C18 cartridges were attached to 10ml glass syringes and conditioned 
successively with 5ml of methanol, water, ACN and 15ml of water. The sample was dissolved in 200µl of 
50% (v/v) H2O/MeOH and loaded onto the cartridge. The sample was washed with 5ml of water and then 
eluted stepwise with 3ml of each 15%, 35%, 50%, 75% and 100% (v/v) aqueous ACN. The fraction volumes 
were reduced on the SpeedVac® and lyophilised. 
 
2.4.8.6 TMS derivatisation 
 
For sugar composition, trimethylsiylated (TMS) derivatives of the polysaccharides were prepared by 
methanolysis (1M methanolic-acetylchloride, 80ºC, 16hrs) and dried under nitrogen. The samples were re-N-
acetylated (methanol/pyridine/acetic acid (50/1/5, v/v/v), room temperature, 15mins) with the reagent 
removed by drying under nitrogen. Trimethylsiylation was carried out with tri-Sil ‘Z’ Derivatising agent (room 
temperature, 30mins). The samples were purified by centrifugation and the supernatant was re-dissolved in 
hexanes prior to GC-MS analysis. 
 
2.4.8.7 Alditol acetates 
 
For compositional analysis by alditol acetate, the non-permethylated samples were hydrolysed (2M TFA, 
121ºC, 2hrs), dried under nitrogen and the monosaccharides reduced (10mg/ml NaBD4 in 2M aqueous NH3, 
room temperature, 2hrs). After borate removal with acidified methanol co-evaporation, they were re-
acetylated (acetic anhydride, 100ºC, 1hr), purified by washing with chloroform and water (4x) and prepared 
for GC-MS by suspension in hexanes. 
 
2.4.8.8 Linkage analysis 
 
Linkage information was achieved by the analysis of partially methylated partially acetylated alditol acetate 
derivatives. Samples were permethylated as described followed by hydrolysis (2M TFA, 121ºC, 2hrs) and 
reduction (10mg/ml NaBD4 in 2M aqueous NH3, room temperature, 2hrs). After borate removal with acidified 
methanol co-evaporation, the monosaccharide samples were re-acetylated (acetic anhydride, 100ºC, 1hr), 
purified by washing with chloroform and water (4x) and prepared for GC-MS by suspension in hexanes 
(Albersheim, 1967). 
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2.4.8.9 Fatty acid methyl ester analysis 
 
Fatty acid methyl esters were produced for lipid analysis and samples were hydrolysed in 200μl methanolic-
acetylchloride (1M) overnight in 80ºC and the reaction terminated by drying under a stream of nitrogen. The 
samples were dissolved in chloroform and washed several times with water (4x), then dried under nitrogen 
and ultimately prepared for GC-MS by suspension in hexanes. 
 
2.4.8.10 Esterification of carboxylic groups using methanolic HCl 
 
This procedure was employed for the identification of the 190Da moiety contained in the N-glycan of the H. 
volcanii S-layer glycoprotein. The digested glycopeptides were incubated with 2M HCl/MeOH for 15mins, 
dried under nitrogen, then purified by nanoLC and analysed by MALDI-TOF. 
 
2.4.9 B. pseudomallei polysaccharide preparation for NMR analysis 
 
Similarly to mass spectrometry, contaminations in the sample preparation for NMR can be caused by 
reagents and salts and will affect data collection. Purification of the polysaccharides prior to NMR analysis is 
discussed below (Section 2.4.9.1). Initially the hydrolysed polysaccharide fractions (O-antigen and core) 
assessed, were found to produce very heterogeneous spectra, due to hydrolysis at different monosaccharide 
linkages, where too much information was presented in a crowded spectrum. To avoid these problems of 
heterogeneity and solubility of the LPS sample, a different approach was devised for obtaining suitable NMR 
data in the form of mixed micelles. 
 
2.4.9.1 Ion-exchange purification 
 
Polysaccharide purification and separation of the hydrolysed O-antigen and core fractions of the 
polysaccharide was achieved by ion-exchange chromatography. The separation was based on the 
carboxylic acid group of the Kdo and Ko components of the core, where Kdo has a pKa of 2 - 3. A column 
was assembled by packing a Pasteur pipette fitted with a piece of silicone tubing at its tapered end with Cl- 
Dowex® beads. The column was eluted with 20ml of water. The sample was loaded onto the column and 
eluted with 10ml of H2O, 5 ml of 5% acetic acid (v/v) and 5ml of 0.1M HCl into separate glass culture tubes. 
The O-antigen was found in the H2O fraction, whilst the core was found in the 5% acetic acid (v/v) and the 
0.1M HCl fraction. The fractions were lyophilised and deuterium exchanged for NMR analysis. 
 
2.4.10 Creation of mixed micelles 
 
The method employed for creating mixed LPS-micelles was derived from and originally performed by Sandro 
Sonnino and Domenico Acquotti (Acquotti and Sonnino, 2000). Their ganglioside-micelles were created by 
mixing the ganglioside sample (dried) with perdeuterated dodecylphosphocholine (DPC), where synthetic 
DPC mixed with a small amount of gangliosides formed small spherical micelles. The gangliosides were 
mixed with DPC at a molar ratio of 1:40. As these mixed-micelles have only previously been used in relation 
99 
 
Chapter 2  Materials and Methods 
to gangliosides, and not been seen with LPS, a pilot study was created to assess the feasibility of this 
technique. 
 
2.4.10.1 Pilot study to create mixed micelles using E. coli LPS O26 and O128 
 
2mg of the acquired LPS standards of E.coli LPS (serotypes O26 and O128) were mixed with 3.2mg of DPC 
in the presence of deuterated potassium phosphate buffer (50mM, 0.4ml, p2H 6). The mixed-micelle-LPS 
samples were further lyophilised and deuterium exchanged for NMR analysis. 
 
2.4.10.2 Creating mixed micelles for B. pseudomallei 576 LPS 
 
10mg of B. pseudomallei LPS was mixed with 16mg of DPC in the presence of deuterated potassium 
phosphate buffer (50mM, 1ml, p2H 6). The mixed-micelle-LPS samples were further lyophilised and 
deuterium exchanged for NMR analysis. Upon identification of RNA and DNA nucleotide signals in the NMR 
spectra, the micelles were further treated with Benzonase® endonuclease (250 Units, in 50nM Tris-HCl, 
1mM MgCl2, 0.1mg/ml BSA) for 6hrs at 37°C. The Benzonase was then digested with pronase (250µl of 
20mg/ml) overnight at 37°C and dialysed in potassium phosphate buffer (50mM, 0.4ml, pH 6) for 48hrs. The 
mixed-micelle-LPS samples were lyophilised and deuterium exchanged again for NMR analysis. 
 
2.4.10.3 Deuterium exchange 
 
In NMR, oligosaccharides are usually visualised as deuterium-exchanged samples, so that only non-
exchangeable C-linked protons are observed in NMR spectra. The purified polysaccharides and mixed-
micelle-LPS, core and O-antigen fractions, as separated by ion-exchange chromatography, were lyophilised 
and re-dissolved in 100% D2O for removal of exchangeable protons. This was repeated 3 times to ensure 
minimal 1H proton exchange throughout NMR analysis. 
 
2.4.11 Mass spectrometric analysis 
 
The mass spectrometric techniques employed in this thesis were introduced in Section 1.4, and consisted of 
an approach utilising the following instruments: GC-MS, MALDI-TOF, MALDI-TOF/TOF and ESI Q-TOF 
mass spectrometers. Details of the operating parameters are described as follows. 
 
2.4.11.1 GC-MS 
 
GC-MS analysis was carried out on a Clarus 500 GC-MS instrument (Perkin Elmer, Cambridgeshire, UK). 
The sugar samples were dissolved in hexanes and injected on a RTX-5MS fused silica capillary column 
(30mx0.25mm internal diameter). For analysis of the TMS derivatives, the oven was held at 65ºC for 1min 
before being increased to 140ºC at a rate of 25ºC min-1, then to 200ºC at a rate of 5ºC min-1 and finally to a 
temperature of 300ºC at a rate of 10ºC min-1 and held for 5mins. For analysis of the alditol acetate 
derivatives, the oven was held at 60ºC for 1min and increased to 190ºC at 20ºC min-1, from where the 
temperature is increased to 230ºC at 1ºC min-1. The final temperature increment is to 300ºC raised at 25ºC 
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min-1 and held for a total of 5mins. The programme for the linkage analysis is started at 60ºC for 1 minute, 
and increased to 300ºC in a single ramp at 8ºCmin-1 and held for 5 minutes. For FAME GC-MS analysis, the 
capillary column of the GC-MS instrument was changed to a Stabilwax Crossbond® Carbowax® 
polyethylene glycol column (30m x 0.32mm internal diameter). The oven programme used starts at 90°C, 
which is held for 4mins. This is increased to 130°C at a rate of 20°C min-1 and held for 1 minute and finally 
increased to 250°C at a rate of 5°C min-1 and held for 5mins. 
 
2.4.11.2 MALDI-TOF MS and TOF/TOF MS/MS of carbohydrates 
 
Derivatised samples were dissolved in 10-20µl of methanol and 1µl aliquots were combined with an equal 
volume of the sample specific matrix (10mg/ml) in their appropriate solvents (typically DHB for glycans and 
lipids, and HCCA for peptides) and spotted onto a MALDI target plate, before drying under vacuum. MALDI-
TOF was performed using a Voyager-DE STR Elite mass spectrometer workstation equipped with delayed 
extraction technology (Perseptive Biosystems, Hertfordshire, UK). MALDI-TOF MS and TOF/TOF MS/MS 
were also performed using a 4800 MALDI-TOF/TOF™ Analyser (Applied Biosystems, Darmstadt, Germany) 
mass spectrometer. The 4700 Calibration Standard Kit, calmix was used as the external calibrant for both 
instruments. In the linear mode where sinapinic acid was used as a matrix for analysis of carbohydrates in 
the 60-70kDa range, the BSA Calibration Standard Kit was used. For MALDI-TOF/TOF the molecular ions 
were selected and subjected to collision induced dissociation (CID), where the collision energy was set to 
1kV and pressurised argon was used as the collision gas (3.5x10-6 Torr). 
 
2.4.11.3 Offline LC-MALDI-TOF MS and TOF/TOF MS/MS of glycopeptide 
 
For offline liquid chromatography matrix-assisted laser desorption ionization-time of flight (MALDI-TOF/TOF-
MS Analysis), the protease-generated peptides were separated by using an UltiMate 3000 LC system 
(Dionex, Sunnyvale, CA), fitted with a Pepmap analytical C18 nanocapillary (15cm length x 75µm internal 
diameter; Dionex). The digests were loaded onto the column and eluted using Solvent A (0.1% (v/v) 
trifluoroacetic acid in 2% ACN and Solvent B (0.1% TFA in 90% ACN), in the following gradient: 0–60% 
Solvent B (0– 36min), 60–90% Solvent B (36–37min), 90% Solvent B (37–40min) and 100% Solvent A (40–
41min). Eluting fractions were mixed with α-cyanohydroxy-cinnamic acid matrix at a concentration of 
3.3mg/ml and spotted onto a metal MALDI target plate. MALDI TOF/TOF MS profiling was performed using 
the 4800 MALDI-TOF/TOF™ Analyser (Applied Biosystems, Darmstadt, Germany) in the positive reflectron 
mode and set for delayed extraction, with major peaks selected using a data dependent acquisition method 
for collision induced dissociation (CID) and sequencing by tandem mass spectrometry. 
 
2.4.11.4 Online LC-ESI MS and MS/MS with Q-STAR and Q-TOF mass spectrometers 
 
Enzymatic digests of glycopeptides were also analysed by online liquid chromatography and were 
resuspended in 0.1% (v/v) formic acid and were analysed by nano-LC-ESI-MS/MS using a reverse-phase 
nano-HPLC system (LC Packings, Dionex Ltd., Camberley, UK) connected to a quadrupole TOF mass 
spectrometer (API Q-STAR® Pulsar, Applied Biosystems/MDS Sciex, Toronto, Canada). Online peptide 
separation was achieved by a binary nano-HPLC gradient generated by an UltiMate pump fitted with a 
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Famos autosampler and a Switchos microcolumn switching module (Dionex Ltd., Camberley, UK), utilising a 
pre-microcolumn C18 cartridge and an analytical C18 nanocapillary (15cm x 75mm ID, PepMap). The digests 
were first loaded onto the precolumns and eluted with 0.1% formic acid prior to transferral onto the analytical 
nanocapillary HPLC column and eluted using a gradient of Solvent A (0.05% (v/v) formic acid in a 99.5% 
(v/v) ACN mixture). The instrument was pre-calibrated using 10-100fmol/µl of [Glu1]-fibrinopeptide B human / 
5% (v/v) acetic acid (1:3, v/v). In the MS/MS mode, the collision gas utilised was nitrogen and the pressure 
was maintained at 3.5x10-6 Torr). In Q-TOF experiments on the Xevo G2S similar procedures were used. 
 
2.4.12 NMR analysis 
 
One and two dimensional NMR spectra were obtained on a Bruker Avance III 600 MHz Ultra-Shield DRX50 
NMR spectrometer fitted with a TXI/TCI cryoprobe, run on Linux computers with Bruker Topspin software. All 
NMR spectra were recorded at room temperature in 100% D2O. The internal chemical shift reference used 
for calibration of individual experiments was acetone at 2.04 ppm. 
 
2.4.13 Data processing and interpretation 
 
The GC-MS data acquired were processed and analysed using TurboMass 5.4 GC-MS Software (Perkin 
Elmer, Cambridgeshire, UK), whilst the obtained MALDI-TOF MS and TOF/TOF MS/MS data were 
processed using Data Explorer® 4.9 Software (Applied Biosystems, Darmstadt, Germany) and 4800 Series 
Explorer™ Software (Matrix Science, London, UK). The MS data were generally noise filtered (correction 
factor of 0.7). For data handling of ESI Q-STAR MS and MS/MS data Analyst QS Software (Applied 
Biosystems, Darmstadt, Germany) with an automatic information-dependent-acquisition (IDA) function was 
used. 
 
To aid in the assignment of peptide molecular ion peaks MassLynx Mass Spectrometry Software (Waters, 
Hertfordshire, UK) was used for in-silico digestion of the protein in question, allowing virtual digestion with 
various enzymes and predicting peptide molecular ions, missed cleavages, methionine oxidation and 
cysteine carboxymethylation. For correct identification of the protein being analysed Mascot searches were 
performed. Data from all MS/MS spectra were used to search the Swiss Prot database for peptide 
sequences consistent with the fragment ions using the Mascot Search Engine (Matrix Science, London, UK). 
The “gold standard” of manual/visual inspection was used to oversee all interpretations. 
 
NMR 1D and 2D data was processed and presented using MestreNova® (Mestrelab Research, Chemistry 
Software Solutions). All spectral and structural assignments were carried out manually with CorelDraw X3 
Graphics Suite Software. 
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3 HALOFERAX VOLCANII S-LAYER GLYCOPROTEIN ANALYSIS 
 
3.1 EXPERIMENTAL STRATEGY 
 
This section describes efforts made in profiling the S-layer glycoprotein of the halophilic archaeon H. 
volcanii, including investigations made into defining the N-glycosylation site occupancy and heterogeneity as 
well as a putative lipid modification. Furthermore, several agl genes of the agl gene cluster of the S-layer N-
glycan biosynthesis pathway were functionally characterised. 
 
 
Figure 3.1 – Simplified representation of the experimental strategy employed in this section. 
Methods employed in the study of the S-layer glycoprotein of H. volcanii, including the glycan monosaccharide composition, 
O-glycan linkage and structure, protein and glycosylation site mapping, potential lipid modification and functional studies. 
 
This work has been carried out in collaboration with Prof. Jerry Eichler from the Eichler laboratory at Ben-
Gurion University of the Negev, Israel. All H. volcanii S-layer glycoprotein samples were grown, purified and 
provided by our collaborators (Section 2.3.1.1). The wild type strain WR536 was provided as released by 
EDTA and either purified by dialysis and delivered as a lyophilised sample or as bands run on SDS-PAGE 
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gels (Section 2.3.1.2). For the study of the functional roles of certain agl genes, the deletion of the H. 
volcanii agl genes in question was achieved by our collaborators and provided as gel bands cut out of SDS-
PAGE gels run (Section 2.3.1.3). The gene-deleted strains analysed included ΔAglM (ΔHVO_1531), ΔAglP 
(ΔHVO_1522) and ΔAglJ (ΔHVO_1517). 
 
The approaches employed in the experimental strategy in this project are two-fold (summarised in Figure 
3.1). The functional characterisation of the genes responsible for the N-glycosylation of the S-layer 
glycoprotein was performed by comparing gene deleted strains with the wild type H. volcanii S-layer 
glycoprotein as purified by gel electrophoresis, enzymatically digested, separated by liquid chromatography 
and analysed by MALDI-MS and MALDI-MS/MS. In the venture to gain further understanding by fully 
profiling the S-layer glycoprotein, various techniques were employed shedding light in a site-specific analysis 
strategy on the composition of the glycan moieties N- and O-linked to the S-layer glycoprotein, as well as the 
confirmation of the amino acid sequence and investigation into the possible role of lipids as a 
posttranslational modification. This required a range of analysis techniques including GC-MS, MALDI-MS 
and MS/MS and ESI-MS, ESI-MS/MS, as well as MSE, post enzymatic and or chemical derivatisation or 
hydrolysis. 
 
3.2 COMPOSITIONAL ANALYSIS OF ALL S-LAYER GLYCANS 
 
For insight into the composition of the N- and O-linked glycoprotein of the S-layer of H. volcanii, a series of 
compositional analysis techniques were employed, where wild type samples for the WR536 S-layer N- and 
O-glycans decorating the S-layer protein were assessed for composition by GC-MS. The wild type WR536 
sample as extracted and purified by the Eichler group (Section 2.3.1), was digested with pronase enzyme, 
an enzyme that hydrolyses the peptide backbone into short peptides of only a few amino acids (Section 
2.4.3.4). This was done to improve solubility and allow for further steps of hydrolysis of the glycopeptides into 
monosaccharides for subsequent derivatisation by TMS or alditol acetate methods (Section 2.4.8.6 and 
Section 2.4.8.7). 
 
TMS and alditol acetate derivatised samples were analysed by GC-MS and run alongside commercial 
standards using the retention times of elution on the chromatogram as well as the specific mass 
spectrometric fingerprints of each monosaccharide in order to determine the monosaccharide composition of 
the glycans present on the S-layer glycoprotein. Notably, hexuronic acid monosaccharides are less easily 
assessed using the alditol acetate procedure, because acidic sugars are not easily amenable to analysis by 
GC-MS without additional manipulation, as adequate chromatography cannot be easily achieved for 
compounds containing a carboxyl group. Considering that the N-glycan of the S-layer glycoprotein of H. 
volcanii contains hexuronic acids, the digested S-layer glycoprotein was therefore derivatised with a 
trimethylsilyl reagent prior to TMS analysis by GC-MS (Section 2.4.8.6). 
 
The GC-MS chromatograms for TMS derivatives of the S-layer derived glycans plus standards are shown in 
Figure 3.2. Comparison of the two chromatograms as well as examination of the mass spectrometric 
fingerprints of each moiety eluted from the gas chromatography column allowed for full annotation of the 
chromatogram showing the monosaccharide composition of the S-layer glycans of H. volcanii. 
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Figure 3.2 – GC-MS chromatogram of TMS derivatised glycans of the H. volcanii S-layer glycoprotein. 
The glycan composition of the H. volcanii S-layer glycoprotein (top panel) was run alongside commercially obtained 
standards, at 50nM each (bottom panel), as run on a Perkin Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column. 
Both preparations were supplemented with 50nM of the internal standard inositol. 
 
The N- and O-glycans of the S-layer glycoprotein, were found to contain mannose (elution time: 12.63, 
Figure 3.3), galactose (elution time: 13.41 and 13.96), glucose (elution time: 14.42), galacturonic acid 
(elution time: 14.78 and 14.88, Figure 3.4) and glucuronic acid (elution time: 15.05). The TMS 
chromatogram peaks and fingerprints were checked for the possible presence of naturally present sugar 
modifications, such as O-methylation that would be expected to be preserved during sugar release from the 
S-layer. No naturally occurring modification was observed in the TMS chromatogram. 
 
 
Figure 3.3 – Mass spectrometric fingerprint of TMS derivatised mannose. 
The fingerprint is from the GC-MS chromatogram of the TMS derivatised mannose moiety (top panel) and that of the 
commercially obtained standard for mannose (bottom panel), as run on a Perkin Elmer Clarus 500 GC-MS instrument fitted 
with a RTX-5MS column. The fingerprint is magnified from m/z 231 onwards and is highlighted in red. 
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Figure 3.4 – Mass spectrometric fingerprint of TMS derivatised galacturonic acid. 
The fingerprint is from the GC-MS chromatogram of the TMS derivatised galacturonic acid moiety (top panel) and that of the 
commercially obtained standard for galacturonic acid (bottom panel), as run on a Perkin Elmer Clarus 500 GC-MS instrument 
fitted with a RTX-5MS column. The fingerprint is magnified from m/z 231 onwards and is highlighted in red. 
 
3.2.1 Summary discussion of TMS compositional analysis 
 
The O-glycan disaccharide of the S-layer glycoprotein was previously suggested to be composed of a 
glucose and galactose disaccharide (Sumper et al., 1990) and this is supported by their presence in the GC-
MS chromatogram. However, the H. volcanii S-layer N-glycan also contains two hexose moieties, of which 
only the final hexose has been identified to be a mannose monosaccharide (Calo et al., 2011, Girrbach et al., 
2000, Cohen-Rosenzweig et al., 2012) (Figure 3.2 and Figure 3.3) (Section 3.7.2). The hexose moiety 
linked to the asparagine residues in the S-layer glycoprotein has not been identified yet, and could therefore 
be considered to be any of the hexose moieties present in the TMS chromatogram. Furthermore the 
hexuronic acid moieties present in the N-glycan pentasaccharide of the H. volcanii S-layer glycoprotein were 
previously suggested to be consistent with glucuronic acid moieties, however, the presence of galacturonic 
acid moieties in the TMS chromatogram indicates that the N-glycan pentasaccharide contains both 
glucuronic and galacturonic acid moieties (Figure 3.2 and Figure 3.4) (Magidovich et al., 2010, Yurist-
Doutsch et al., 2010). 
 
Unfortunately, no suitable enzymatic or chemical hydrolysis method is available for the selective release of 
the N- and O-glycans from the S-layer. Therefore, the lack of such separation did not aid in the 
discrimination of the monosaccharide identifications in the N- and O-glycan moieties. Interestingly, however, 
the amount of glucuronic acid and galacturonic acid is not substantially less than the mannose, galactose 
and glucose. The uronic acids are confined to the N-glycans whilst the hexoses are in both the N- and O-
glycans. Their comparable abundance suggests that the stoichiometry of the O-glycans is unlikely to be very 
different from the N-glycans. The proposal that the O-glycan disaccharides occupy multiple sites in the 
threonine-rich region towards the C-terminal of the H. volcanii S-layer (Mescher and Strominger, 1976, 
Sumper et al., 1990), therefore does not seem to be supported by the TMS data in Figure 3.2. 
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3.3 ANALYSIS OF THE O-GLYCAN OF THE S-LAYER GLYCOPROTEIN 
 
In the analysis to investigate the O-glycan moiety initially identified by Mescher and Sumper and colleagues, 
the extracted and purified S-layer glycoprotein was digested by trypsin (Section 2.4.3.1). The 
peptide/glycopeptide sample mixture was further purified and contaminants removed by the Sep-Pak® 
purification propan-1-ol / 5% acetic acid system (Section 2.4.4.1). The glycopeptides were further treated to 
release the glycan moieties by the reductive β-elimination reaction (Section 2.4.5). The glycan moieties 
were permethylated, purified and separated using the aqueous acetonitrile Sep-Pak® system (Section 
2.4.8). Analysis by MALDI-MS and MALDI-MS/MS allowed for confirmation of the O-glycan structure, whilst 
further derivatisation of the O-glycan bearing ACN fraction into partially methylated alditol acetates analysed 
by GC-MS allowed for verification of the published linkage information of the O-glycan moiety of the H. 
volcanii S-layer glycoprotein. 
 
3.3.1 MALDI mass spectrometry of H. volcanii S-layer O-glycans 
 
The purified and derivatised glycans were analysed by a 4800 MALDI-TOF/TOF™ Analyser mass 
spectrometer. The released O-glycan moiety of the S-layer glycoprotein of H. volcanii was found in the 35% 
ACN fraction of the Sep-Pak® clean up and the MALDI-MS spectrum of the 35% ACN fraction is shown in 
Figure 3.5. A single O-glycan molecular ion of composition Hex-Hexitol was identified at m/z 493.24 and 
confirmed by MALDI-MS/MS (Figure 3.6). Furthermore, upon investigation of the MALDI-MS spectrum, no 
extended version of the hexose disaccharide was identified. 
 
 
Figure 3.5 – MALDI-MS spectrum of H. volcanii S-layer O-glycans. 
The spectrum shows the O-glycan moieties of the H. volcanii S-layer glycoprotein as digested by trypsin and released from 
their respective serine/threonine amino acid residues by β-elimination and further derivatised by permethylation (Sep-Pak 35% 
ACN). The sample was analysed on an Applied Biosystems 4800 MALDI-TOF/TOF mass spectrometer. Non-annotated peaks 
correspond to partial degradation products which did not relate to the O-glycan moiety investigated. 
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Figure 3.6 – MALDI-MS/MS spectrum of molecular ion at m/z 493 of H. volcanii S-layer O-glycans. 
The H. volcanii S-layer glycoprotein as digested by trypsin and released from their respective serine/threonine amino acid 
residues by β-elimination and further derivatised by permethylation (Sep-Pak 35% ACN). The sample was analysed on an 
Applied Biosystems 4800 MALDI-TOF/TOF mass spectrometer. Non-annotated peaks correspond to partial degradation and 
cross-ring cleavages of the disaccharide. 
 
3.3.2 Linkage analysis of the O-glycan moieties of the S-layer glycoprotein 
 
To confirm the linkage profile published previously, the O-glycan containing sample fraction recovered by β-
elimination and Sep-Pak purification was further derivatised to create partially methylated alditol acetates 
that were analysed by GC-MS (Section 2.4.8.8). Linkage analysis was performed on the O-glycan and the 
linkage possibilities identified ab initio using the mass spectrometric fingerprints and known fragmentation 
pathways as well as comparisons with the mass spectrometric fingerprints of standards. Figure 3.7 shows 
the linkage chromatogram obtained from the O-glycan containing fraction of the sample, clearly showing a 2-
linked galactitol (Figure 3.8) and terminal glucose (Figure 3.9). It is to be noted that upon release from the 
peptide by β-elimination, the linking sugar is converted into a galactocitol moiety, thus rendering a different 
mass spectrometric fingerprint to one of a 2-linked hexose. 
 
 
Figure 3.7 – GC-MS chromatogram of the linkage anlysis of the H. volcanii O-glycan. 
The linkage analysis chromatogram shows the presence of the 2-linked galactositol and terminally linked glucose moiety, as 
run on a Perkin Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column.The annotation was completed using the 
mass spectrometric fingerprints and fragmentation pathways of the monosaccharide structures and in comparison to 
standards. Non-sugar impurities present in the chromatogram are labelled x. 
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Figure 3.8 – Mass spectrometric fingerprint of the 2-linked galactositol in the H. volcanii O-glycan. 
The mass spectrometric fingerprint of the 2-linked galactositol was obtained from the linkage analysis chromatogram run on a 
Perkin Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column.The fragmentation pattern of the monosaccharide is 
annotated, showing the main fragments (pink) of the molecule as well as sub-fragments arising from the loss of functional 
groups (green). The structure of the derivatised monosaccharide is shown in the schematic. 
 
 
Figure 3.9 – Mass spectrometric fingerprint of the terminal glucose in the H. volcanii O-glycan. 
The mass spectrometric fingerprint of the terminal glucose was obtained from the linkage analysis chromatogram run on a 
Perkin Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column.The fragmentation pattern of the monosaccharide is 
annotated, showing the main fragments (pink) of the molecule as well as sub-fragments arising from the loss of functional 
groups (green). The structure of the derivatised monosaccharide is shown in the schematic. 
 
3.3.3 Summary discussion of S-layer glycoprotein O-glycan analysis 
 
The O-glycan moiety of the S-layer glycoprotein was initially characterised by Sumper and colleagues, who 
degraded the S-layer by alkaline β-elimination, liberating the disaccharide O-glycan (Sumper et al., 1990). 
The saccharide fraction identified in their study contained galactose and glucose in a 1:1 stoichiometry. They 
identified the galactose moiety, as the monosaccharide directly linked to threonine or serine in an O-
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glycosidic linkage. This information was confirmed by the purification of the O-glycans of the H. volcanii S-
layer glycoprotein and their derivatisation for analysis by MALDI-MS and MALDI-MS/MS as well as further 
analysis by linkage analysis by GC-MS. The results presented here confirm that the O-glycan is composed of 
a glucose(1-2)galactose disaccharide and that no other O-glycans are present. 
 
3.4 FUNCTIONAL CHARACTERISATION OF AGL GENES BY MS ANALYSIS 
 
In H. volcanii, N-glycosylation is mediated by the products of the agl gene cluster. The members of the agl 
gene cluster are responsible for the assembly and attachment of the pentasaccharide. The characterisation 
of the N-glycosylation process in H. volcanii was undertaken by Abu-Qarn and co-workers (Section 1.2.2). 
The putative H. volcanii homologs of genes involved in the eukaryal or bacterial N-glycosylation were 
identified by bioinformatics and reverse transcription polymerase chain reaction confirmed that the proposed 
N-glycosylation genes were being transcribed. Deletion of some genes showed slower growth and interfered 
with surface layer glycosylation, represented by modified migration on SDS-PAGE and glycostaining (Abu-
Qarn and Eichler, 2006). Subsequently additional agl genes were identified either based upon their proximity 
to previously identified agl sequences or upon re-annotation of the region of the genome where all but one of 
the previously identified agl sequences clustered (Table 3.1) (Abu-Qarn et al., 2008b, Yurist-Doutsch et al., 
2008, Abu-Qarn et al., 2007, Yurist-Doutsch and Eichler, 2009). 
 
Encoded Protein Suggested function 
AglB oligosaccharyltransferase 
AglD, AglE, AglG, AglI glycosyltransferases 
AglF glucose-1-phosphate uridyltransferase 
AglM uncharacterised 
AglP uncharacterised 
AglJ uncharacterised 
Table 3.1 – Previous Agl proteins found to be involved in the assembly of the pentasaccharide 
 
To deduce the function of the members of the agl gene cluster responsible for the assembly and attachment 
of the pentasaccharide, samples of parent (wild type) and mutant (gene-deleted) S-layer glycoproteins were 
analysed and compared. SDS-PAGE gel pieces received from the Eichler group, containing the S-layer 
glycoprotein from the H. volcanii parent and mutant strains, were subjected to in-gel tryptic digestion 
(Section 2.4.2). The obtained peptides were then separated by liquid chromatography and examined by 
MALDI mass spectrometry (Figure 3.10). 
 
The products generated in this manner included the N-terminal ‘ERGNLDADSESFNK’ peptide (m/z 1581) 
with a missed cleavage (Sumper et al., 1990), encompassing the glycosylated Asn-47 residue. The MALDI-
MS analysis of the wild type WR536 glycoprotein shows the S-layer glycoprotein-derived peptide containing 
Asn-47 decorated with a pentasaccharide and its precursors, including a hexose (glycopeptide at m/z 1743), 
two hexuronic acids (glycopeptides at m/z 1919 and 2095, respectively), a 190Da species (glycopeptides at 
m/z 2285) and a final hexose subunit (glycopeptides at m/z 2448). The N-glycopeptide shown in Figure 3.11 
was used as a “reporter” molecule for investigating changes in glycosylation resulting from targeted 
mutations of the agl genes described in the next three sections. 
 
111 
 
Chapter 3  H. volcanii S-layer glycoprotein analysis 
 
Figure 3.10 – Experimental strategy employed for functional characterisation of H. volcanii agl genes. 
Methods employed in the study of the agl genes responsible for the biosynthesis of the H. volcanii S-layer glycoprotein N-
glycan. 
 
 
Figure 3.11 – S-layer Asn-47 glycopeptide N-glycan. 
The annotated m/z values in the schematic correspond to the molecular ions of the peptide alone and together with all 
intermediates of the mature pentasaccharide 
 
3.4.1 Function of AglM 
 
AglM (HVO_1531) was thought to participate in the addition of the hexuronic acid located at position two of 
the pentasaccharide decorating the S-layer glycoprotein. The involvement of AglM (HVO_1531) in this post-
translational modification was tested by comparison of H. volcanii parent strain with the AglM-deleted cells. 
Comparative data for the wildtype and mutant are presented in Figure 3.12. Data from the wildtype are in 
the lower panel. As explained above, molecular ions are observed for the pentasaccharide and its 
biosynthetic precursors. The relative abundances of the five glycoforms seen in this spectrum were 
characteristic of all wildtype samples examined. In the case of the aglM (HVO_1531) gene deleted strain 
(Figure 3.12 - ΔHVO_1531 – ΔaglM – upper panel), the Asn-47-containing peptide is only decorated with 
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one monosaccharide moiety (m/z 1743), which allows for the conclusion that AglM is involved in the 
biosynthesis of the hexuronic acid found at position two of the native pentasaccharide decorating the H. 
volcanii S-layer glycoprotein. With the involvement of HVO_1531 in protein N-glycosylation thus verified, the 
gene was renamed aglM, according to the nomenclature first proposed by Chaban and colleagues (Chaban 
et al., 2006) for genes involved in archaeal N-glycosylation. 
 
 
Figure 3.12 – MALDI-MS of the Asn-47-containing tryptic peptide (AglM). 
The samples were derived from gel pieces containing the H. volcanii S-layer glycoprotein from the parent (WR536) and aglM--
deleted strains (ΔaglM – ΔHVO_1531). The sample was analysed on an Applied Biosystems 4800 MALDI-TOF/TOF mass 
spectrometer after in-gel trypsin digestion and separation by an offline UltiMate 3000 LC system. Non-annotated signals are 
not glycopeptides. 
 
3.4.2 Function of AglP 
 
Previous analysis had assigned the 190Da species at position four of the glycoprotein-linked 
pentasaccharide to either a dimethylated hexose or a methylated hexuronic acid (Abu-Qarn et al., 2007). To 
determine how the absence of AglP affected N-glycosylation in H. volcanii, mass spectrometry was 
employed to compare the N-linked glycan profile of the S-layer glycoprotein in cells of the parent (Figure 
3.13 – parent - WR536 – lower panel) and those lacking the AglP producing gene (HVO_1522). The same 
peptide derived from the AglP deleted S-layer glycoprotein, shows a smaller glycan (Figure 3.13 – ΔaglP – 
ΔHVO_1522 – upper panel). The tetrasaccharide found on this S-layer glycoprotein, contains the Asn-linked 
hexose (m/z 1743) and the two hexuronic acids (m/z 1919 and m/z 2095, respectively). The 190Da species 
observed in the parent strain is replaced by a 176Da species (m/z 2271). The aglP deletion therefore results 
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in a glycan moiety of the mutant strain that does not only lack the final hexose, but also presents a subunit at 
position four that is 14Da smaller than the 190Da species in the parent strain at this position. 
 
 
Figure 3.13 – MALDI-MS analysis of the Asn-47-containing tryptic glycopeptides (AglP). 
The samples were derived from gel pieces containing the H. volcanii S-layer glycoprotein from the parent (WR536) and aglP-
deleted strains (ΔaglP – ΔHVO_1522). The sample was analysed on an Applied Biosystems 4800 MALDI-TOF/TOF mass 
spectrometer after in-gel trypsin digestion and separation by an offline UltiMate 3000 LC system. Non-annotated signals are 
not glycopeptides. 
 
As such, it would appear that in cells lacking AglP, the 176Da saccharide found at position four of the 
pentasaccharide is lacking a methyl group, as observed by the decrease in mass of this reporter 
glycopeptides by 14 mass units, yielding either methylated hexose or hexuronic acid. To distinguish between 
these possibilities, methyl esterification of the S-layer glycopepetides derived from the aglP-deleted cells was 
performed, as described in Section 2.4.8.10 (Abu-Qarn et al., 2007). As a result of such treatment, 
carboxylic acid groups are converted to their methyl esters, reflected as a 14Da mass shift for each 
carboxylic acid moiety. The trisaccharide-bearing Asn-47-containing S-layer glycopeptide derived from the 
parent strain, showed a shift of m/z 98 for this peptide following esterification, explained by the 
transformation of the seven carboxylic acid groups found on the two Glu, the two Asp and the C-terminal 
residue of the peptide, as well as on the two hexuronic acids found at positions two and three of the N-linked 
saccharide (data not shown). 
 
When methyl-esterification of the Asn-13-containing S-layer glycoprotein peptide derived from aglP-deleted 
cells was performed (Figure 3.14), the mono-, di- and trisaccharide-bearing peptides were shifted 70, 84 and 
98Da, respectively, consistent with the same glycopeptides derived from the background strain, reflecting the 
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presence of five, six and seven target carboxylic groups, respectively. However, unlike the tetrasaccharide-
bearing glycopeptide from the background strain, the m/z 2271 peak from the AglP-lacking cells was shifted 
by 112 mass units to m/z 2383, reflecting the presence of eight carboxylic moieties. This corresponds to an 
additional methyl group on the tetrasaccharide glycan derived from the AglP-lacking cells. It can thus be 
concluded that the 176 Da species found at position four of the tetrasaccharide linked to the S-layer 
glycoprotein derived from the aglP-deleted cells corresponds to a hexuronic acid. By extension, the 190Da 
saccharide found at position four of the N-linked pentasaccharide in the parent strain corresponds, therefore, 
to the methyl ester of a hexuronic acid (Figure 3.14). 
 
 
Figure 3.14 – MALDI-MS analysis of the Asn-47-containing tryptic glycopeptides (AglP - esterified). 
The samples were derived from gel pieces containing the H. volcanii S-layer glycoprotein from the aglP-deleted strains (ΔaglP 
– ΔHVO_1522) as well as the aglP-deleted strains (ΔaglP – ΔHVO_1522) post esterification by 1M methanolic acetylchloride. 
The sample was analysed on an Applied Biosystems 4800 MALDI-TOF/TOF mass spectrometer after in-gel trypsin digestion 
and separation by an offline UltiMate 3000 LC system and esterification. The clusters of signals below each of the annotated 
molecular ions are due to incomplete esterification of a portion of the sample under the conditions used and/or lactonization 
(intervals of 14 and 18Da, respectively). 
 
3.4.3 Function of AglJ 
 
To examine the effect of the absence of AglJ on N-glycosylation of the S-layer glycoprotein in H. volcanii, the 
glycan profile of the parent (Figure 3.15 – parent - WR536 – lower panel) was compared with that of the S-
layer glycoprotein in cells lacking the AglJ protein. Examination of the glycopeptide derived from cells lacking 
aglJ (Figure 3.15 – ΔaglJ – ΔHVO_1517 – upper panel) shows only a minor peak for the glycopeptides 
decorated with one attached hexose (m/z 1743), a peak, which is much smaller than that observed of the 
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Asn-linked hexose in the parent strain. Furthermore, there is a major peak corresponding to the nonmodified 
peptide (m/z 1581), whilst peaks corresponding to di-, tri-, tetra-, and pentasaccharide-modified peptides 
were completely absent in this sample. 
 
 
Figure 3.15 – MALDI-MS analysis of the Asn-47-containing tryptic glycopeptides (AglJ). 
The samples were derived from gel pieces containing the H. volcanii S-layer glycoprotein from the parent (WR536) and aglJ-
deleted strains (ΔaglJ – ΔHVO_1517). The sample was analysed on an Applied Biosystems 4800 MALDI-TOF/TOF mass 
spectrometer after in-gel trypsin digestion and separation by an offline UltiMate 3000 LC system. Non-annotated signals are 
not glycopeptides. 
 
3.4.4 Summary discussion of functional characterisation of agl genes 
 
For H. volcanii, AglB, AglD, AglE, AglF, AglG and AglI were shown to participate in the assembly and 
attachment of a pentasaccharide to select Asn residues of the S-layer protein, a reporter of N-glycosylation 
in this species. Specifically, AglG, AglI, AglE and AglD are thought to be glycosyltransferases involved in 
adding the second, third, fourth and fifth pentasaccharide subunits, respectively (Abu-Qarn et al., 2008b, 
Abu-Qarn et al., 2007, Yurist-Doutsch et al., 2008), whilst AglF was shown to be a glucose-1-phosphate 
uridyltransferase (Yurist-Doutsch et al., 2008). The functional characterisation of the three investigated agl 
genes, AglM, AglJ and AglP, expand the limints of the agl cluster to include AglM (HVO_1531), AglJ 
(HVO_1531) and AglP (HVO_1522). The gene encoding AglM was found in the open reading frame lying 
directly downstream to aglB and is currently the last gene of the cluster. 
 
When assessing the product AglM from the open reading frame downstream from the agl gene cluster, it 
was found that AglM participates in the biosynthesis of hexuronic acids contained within the S-layer 
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pentasaccharide. In complementation to mass spectrometric studies, bioinformatics-based approaches and 
activity assays were carried out to suggest that AglM is a sugar nucleotide dehydrogenase, responsible for 
formation of the hexuronic acid located at position two of the pentasaccharide that decorates the H. volcanii 
S-layer glycoprotein. It was further shown that aglB, aglF, aglG and aglI show a coordinated transcription 
response in the face of various growth conditions, despite the fact that they do not share a common 
promoter (Yurist-Doutsch et al., 2010). This suggests that the agl gene cluster acts as a functional genomic 
unit, and like many other archaeal biochemical pathways, could imply that the N-glycosylation process of H. 
volcanii is regulated at the gene level. 
 
Studies by our collaborators showed that AglM acts as a UDP-glucose dehydrogenase, able to transform 
UDP-glucose into UDP-glucuronic acid in a NAD+-dependent manner across a wide range of salt 
concentrations. AglM was also able to utilize UDP-galactose or GDP-mannose as substrates, albeit to a 
much lesser extent than UDP-glucose. AglF, on the other hand, was shown to function as a glucose-1-
phosphate uridyltransferase, catalyzing the biosynthesis of UDP-glucose from glucose-1-phosphate and 
UTP. Through the use of a coupled assay developed for this study, it was shown that the two enzymes are 
able to function in a sequential manner, forming UDP-glucuronic acid from glucose-1-phosphate and UTP, in 
the presence of NAD+. The ability of AglM and AglF to function in unison implies that AglM is involved in the 
biosynthesis of the hexuronic acids found at both positions two and three of the pentasaccharide decorating 
the H. volcanii S-layer glycoprotein. By contrast, AglF only participates in the biogenesis of the hexuronic 
acid found at position three (Yurist-Doutsch et al., 2010) 
 
Deletion of the aglP-encoding gene resulted in an S-layer glycoprotein modified by a tetrasaccharide rather 
than the pentasaccharide detected on the native protein. The fact that in the tetrasaccharide observed in the 
ΔaglP cells that contained a 176Da species, rather than the 190Da species found at position four of the 
pentasaccharide in the parent strain corresponded to the contribution of a methyl group (14Da difference). 
Previous studies had  identified the 190Da species to correspond to either a dimethylated hexose or a 
methyl ester of hexuronic acid (Abu-Qarn et al., 2007). Methanolic acetylchloride based methyl esterification 
prior to MS analysis of the carboxylic groups was undertaken, confirming the presence of a methyl-ester of 
hexuronic acid at position four of the N-linked oligosaccharide. This indicates that AglP functions as a 
methyltransferase. With in vitro assays for AglP by our collaborators, the SAM-dependent methyltransferase 
activity of the protein was shown (Magidovich et al., 2010). 
 
Moreover, it was found by our collaborators that AglP-mediated methylation occurs on the lipid-linked 
tetrasaccharide precursor of the pentasaccharide, which is eventually transferred to the S-layer glycoprotein. 
With the cytoplasmic location of AglP, it is further also unlikely that the methyltransferase modifies the 
oligosaccharide after its transfer to the S-layer glycoprotein, a process thought to occur on the external 
surface of the cell (Lechner and Wieland, 1989). On the other hand, the active site of AglD, responsible for 
adding the final hexose to the pentasaccharide transferred to the S-layer glycoprotein, was found to face the 
cytoplasm (Plavner and Eichler, 2008). 
 
The methylation of a monosaccharide in the H. volcanii S-layer glycoprotein, is not the first example of such 
modification of an oligosaccharide and in H. salinarum, SAM-dependent methylation of a glucose subunit 
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was previously reported (Lechner et al., 1985). It was further shown that inhibition of such methylation 
prevented transfer of the oligosaccharide to its target protein. The work presented in this thesis shows that 
the H. volcanii S-layer glycoprotein is modified by a tetrasaccharide in cells deleted of aglP and hence 
incapable of oligosaccharide methylation, arguing against a role for methylation as a delivery mechanism 
(Magidovich et al., 2010). 
The combination of the deletion of aglJ gene (HVO_1517) with mass spectrometric analysis, collected 
evidence showing the participation of AglJ in adding the first hexose to the pentasaccharide, as is shown by 
the smaller peak of the Asn-linked hexose. The deletion of aglJ, however did not fully prevent the attachment 
of this hexose residue to the S-layer glycoprotein. Furthermore, in cells lacking AglJ, no further sugar 
subunits were added to the monosaccharide-modified S-layer glycoprotein, pointing to the importance of the 
sugar added through the actions of AglJ for proper N-glycosylation (Kaminski et al., 2010). 
 
The following Agl proteins have been added to the repertoire of proteins found to be involved in the 
assembly of the pentasaccharide (Table 3.2) and the current working model of the H. volcanii S-layer 
glycoprotein N-glycan biosynthesis was extended with information of the work described in this thesis and is 
shown in Figure 3.16. 
 
Encoded Protein Suggested function 
AglB oligosaccharyltransferase 
AglD, AglE, AglG, AglI glycosyltransferases 
AglF glucose-1-phosphate uridyltransferase 
AglM addition of hexuronic acid (position 2, 3) - dehydrogenase 
AglP modification of 190Da species - methyltransferase 
AglJ addition of hexose (position 1) - glycosyltransferase 
Table 3.2 – Current understanding of Agl proteins involved in the assembly of the pentasaccharide. 
 
 
Figure 3.16 – Working model of H. volcanii S-layer glycoprotein 
 
3.5 S-LAYER SEQUENCE PROFILING AND N-GLYCOSYLATION SITE 
OCCUPANCY 
 
The H. volcanii S-layer glycoprotein amino acid sequence was initially investigated and published by Sumper 
and colleagues who analysed the purified and enzymatically digested S-layer glycopeptides by an 
automated gas phase sequencer (Sumper et al., 1990). In this work, in order to confirm the protein sequence 
published and identify the site specific occupation of N-glycosylation sites, a comprehensive map of the H. 
volcanii S-layer glycoprotein was generated using a series of biochemical techniques coupled with high 
sensitivity MALDI-MS, MALDI-MS/MS, ESI-MS, ESI-MS/MS as well as MSE methods. The S-layer 
glycoprotein sequence is 827 amino acids in size, prior to signal peptide cleavage of the first 34 amino acids, 
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creating a mature polypeptide of 793 amino acids, with an expected calculated molecular weight of circa 
81’732Da. 
 
A range of enzymatic digests were performed in the aim to produce suitably sized peptide fragments 
accessible for characterisation by both MALDI and ESI ionisation for manual annotation of the peptide 
sequences. The enzymes used in the production of all datasets included: trypsin, chymoptrypsin, Glu-C (V8), 
AspN, prolidase and elastase (Section 2.4.3). For chemical digestion cyanogen bromide was also used 
(Section 2.4.3.8). These enzymatic and chemical degradation procedures were used separately or in 
tandem. The resultant mixture of peptide fragments from each of the single or double digests investigated 
was submitted to purification using offline or online liquid chromatography separation methods prior to 
analysis by MALDI-MS and MS/MS as well as ESI-MS, ESI-MS/MS and MSE either at Imperial College or at 
the MS-RTC facility in St. Saviour, Jersey (Figure 3.17). 
 
 
Figure 3.17 – Methods employed in mapping the S-layer glycoprotein sequence and glycosylation. 
 
3.5.1 S-layer glycoprotein coverage by MALDI-MS and ESI-MS using various 
proteolytic digests 
 
To allow for sequencing of the whole S-layer glycoprotein the lyophilised sample sent by the Eichler group 
was dissolved in H2O and slowly adjusted to the required pH for enzymatic and treatment, due to the ease 
with which the protein precipitated and its absolute insolubility at acidic pH. The H. volcanii S-layer sample 
was further digested in solution, with a series of enzymes in the appropriate pH and protein:protease 
concentration as required for optimal enzyme activity. The enzymatic digests were commonly incubated at 
37°C overnight, unless otherwise stated (Section 2.4.3). Due to the absence of cysteines in the protein 
sequence, the samples were not reduced or carboxymethylated. The published protein sequence was in 
silico digested using MassLynx to predict the molecular ions created by the specific enzymes employed in 
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the elucidation of the peptide map, giving insight into the expected molecular ions assessed by mass 
spectrometry and aiding with manual annotation of spectra. 
 
The H. volcanii S-layer glycoprotein was digested with trypsin, hydrolysing the peptide bonds at the carboxyl 
side of lysine and arginine residues (except if followed by a proline residue). Bearing in mind the published 
S-layer protein sequence, digestion with trypsin produced rather large peptides and was therefore also 
coupled with Glu-C enzyme, cleaving at the C-terminus of glutamic acid and at a 300-fold lower rate also 
aspartic acid, to create a second dataset of smaller, more amenable peptides for analysis in a second series 
of experiments. Further digestion by chymotryspin was achieved for MALDI and ESI analysis. Chymotrypsin 
selectively hydrolyses the peptide bonds on the C-terminal side of tyrosine, phenylalanine, tryptophan and 
leucine and secondary hydrolysis occurs on the C-terminal side of methionine, histidine and asparagine, thus 
creating a series of smaller peptides that are amenable to mass spectrometric ionisation. Finally the S-layer 
glycoprotein was also digested using AspN enzyme, a zinc metalloendopeptidase, which selectively cleaves 
peptide bonds on the N-terminal side of aspartic acid residues, producing small peptides allowing for 
information on N-glycosylation. 
 
Upon encountering difficulties in sequencing the C-terminal region of the S-layer glycoprotein, it was 
digested with prolidase and elastase due to the recurring presence of their substrate residues in the C-
terminal region. Prolidase is a cytosolic exopeptidase that cleaves on the N-terminal side of proline of small 
peptides. The requirement of smaller peptides warranted for the sample to first be digested with Glu-C and 
then further digested with prolidase. Furthermore, elastase was used as a protease that cleaves specific 
peptide bonds on the carboxyl side of small hydrophobic amino acids such as glycine, alanine and valine. In 
addition, the C-terminal region of the S-layer glycoprotein was investigated using CNBr, which hydrolyses 
peptide bonds at the C-terminus of methionine residues, except when followed by a threonine residue, or if 
methionine is oxidised. CNBr digested peptides are generally quite large, with the exception of the N-
terminal, as suggested by MassLynx information from in silico digestion and the digest was both performed 
by CNBr only as well as on a previously trypsin digested sample. 
 
The digests were initially concentrated and desalted using Michrom MicroTraps™ and run in a solution of 
40µl 0.1% TFA, where a 1µl injection was used for offline LC-MALDI-MS and MS/MS analysis. However, 
upon comparison between samples desalted and purified using the michrom microtraps and those separated 
by only LC-MS, this technique was abandoned in favour of offline and online LC-MS. The samples were 
generally assessed in the positive ion mode using both MALDI and ESI techniques, except in the case of 
AspN, where the negative ion mode was used additionally for data collection (data not shown). The sugar 
residues identified in such glycoproteomic experiments are analysed underivatised and therefore retain their 
underivatised mass, which differ from the masses of the same permethylated monosaccharides (Table 1.4). 
 
Upon separation by offline liquid chromatography and analysis by MALDI-MS and MALDI-MS/MS, the 
spectra generated were evaluated by Mascot, a program allowing for identification of constituent proteins by 
database comparisons of raw mass spectrometric data against molecular sequence databases. This was 
done to verify the protein analysis and exclude contaminations throughout manual processing. All enzymatic 
digests were correctly identified as S-layer glycoproteins of H. volcanii, thus ruling out the presence of 
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contaminating glycoproteins, although manual interpretations did later find some evidence of minor amounts 
of other H. volcanii protein sequences. The rest of the mass spectra were manually assessed for further 
sequence information and compiled. Figure 3.18 shows all amino acid residues and sequences identified 
from the chymotryptic digest. An example of MALDI-MS/MS annotation for the peptide sequence 
283QNDATTEQAKEVF295, from the molecular ion at 1480.7 is shown in Figure 3.19, which allowed for the 
identification of the sequence by annotation of the mass differences between two consecutive ions within a 
series (eg. b-ions and y” ions). 
 
 
Figure 3.18 – S-layer mapping coverage by MALDI-MS/MS post chymotryptic digest. 
Partial mapping coverage of H. volcanii S-layer glycoprotein by chymotryptic digest, where the identified peptide sequences 
are highlighted in purple. Separation was achieved by offline liquid chromatography and analysis by MALDI-MS and MALDI-
MS/MS. 
 
 
Figure 3.19 – MALDI-MS/MS spectrum of the molecular ion at m/z 1480.7. 
The S-layer glycoprotein was digested with chymotrypsin and separated by an offline UltiMate 3000 LC system and assessed 
by MALDI-MS and MALDI-MS/MS on an Applied Biosystems 4800 MALDI-TOF/TOF mass spectrometer. The peptide sequence 
assignment of 283QNDATTEQAKEVF295 is shown in the schematic. Fragment b and y” ions are labelled in blue and red 
respectively. 
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MALDI-MS and MALDI-MS/MS analysis for obtaining peptide sequence information was limited to the fact 
that generally only singly charged molecular ions are generated, thus restricting the number of molecular 
ions generated from which information was to be gained by MALDI-MS/MS. With this in mind, the enzymatic 
digests were further analysed by online nano-LC ESI-MS and data-dependent MS/MS. The MS and MS/MS 
data across the elution profiles were then manually examined for information on peptide sequences 
corresponding to in silico expected fragments either glycosylated or unglycosylated, where all spectra 
exhibiting putative carbohydrate fragment ions were scrutinised for the presence of molecular ions 
corresponding to glycopeptides. 
 
As a feature of the ESI ionisation process, the formation of a series of multiply charged ions is common, 
creating molecular ions of the form [M+nH]n+ or [M-nH]n-. The charge state of each ion can be used to 
determine the actual mass of the peptides or glycopeptides instead of their m/z ratio. Whereas the isotopic 
peak distribution will be identical to the one of singly-charged peaks in MALD-MS, multiply-charged ions on 
the other hand, will exhibit different m/z increments according to the charge state, such that doubly, triply or 
quadruply charged isotopic peak distribution will show m/z increments between isotopes of m/z 0.5, 0.33 or 
0.25, respectively. The relative molecular weight (Mr) of the identified peptides from individual peaks with a 
range of proton distributions allows for identification of different peaks with the same composition, yet 
differently charged. The various enzymatic digest preparations of the S-layer glycoprotein were further 
manually assessed for sequence information by online nano-LC-ESI-MS/MS data. 
 
 
Figure 3.20 – Mapping coverage of all enzymatic digests. 
Complete comprehensive mapping coverage of H. volcanii S-layer glycoprotein by enzymatic digests, including trypsin, 
chymotrypsin, trypsin/Glu-C, prolidase, elastase, CNBr and trypsin/CNBr, separation by offline/online liquid chromatography 
and analysis by MALDI-MS and MALDI-MS/MS or online nano-ESI-MS and ESI-MS/MS. 
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The data and information from all enzymatic digests as analysed by offline LC-MALDI-MS/MS and online 
nano-ESI-MS/MS techniques were collated and Figure 3.20 shows the S-layer glycoprotein amino acid 
sequence highlighting the combined information map as derived from enzymatic tryptic, chymotryptic, double 
tryptic and Glu-C as well as elastase and prolidase digests and chemical digestion by CNBr and trypsin, 
followed by CNBr methods. The N-terminal signal sequence was not mapped, as it is cleaved prior to the 
mature status of the sample extracted by the Eichler group. The map in Figure 3.20 shows roughly 90% of 
the protein mapped, including six of the seven putative N-glycosylation sites (Section 3.5.2). The C-terminal 
region of the sequence including the threonine rich region that is thought to be O-glycosylated as well as the 
final N-glycosylation site were not able to be described at the time of thesis submission. This was, despite 
extensive investigations directed at detecting C-terminal peptides taking into account possible glycan and 
lipid modifications, which were perhaps obscuring access to the C-terminal region. Some of these 
experiments have called into question the proposed lipid modification of the S-layer (described in Section 
3.6). 
 
3.5.2 Comprehensive map of N-glycosylation sites of H. volcanii S-layer 
 
Work carried out in Section 3.4 for the functional characterisation of the agl genes in the agl gene cluster of 
H. volcanii only focused on the first of the seven putative N-glycosylation sites and throughout previous 
investigations into the S-layer glycoprotein and its N-glycan, only two of the seven putative N-glycosylation 
sites were found to be occupied. This was possibly due to the ease with which the peptides containing these 
sites could be isolated and investigated and the focus of these studies, which lay with the identification of the 
N-glycan decorating these glycosylation sites, rather than the sites themselves. The N-linked glycosylation 
sites were shown to be occupied by a pentasaccharide N-glycan containing two hexoses, two hexuronic 
acids and a methylated hexuronic acid, which was found at Asn-47 and Asn-117, whilst Asn-404 was only 
identified as an unglycosylated peptide (Abu-Qarn et al., 2007). Prior to the work in this thesis, no studies 
had been undertaken to create a comprehensive map of these seven putative N-glycosylation sites. This 
was undertaken as described in this section with the aim to get a broad understanding on the N-glycosylation 
site occupancy and the heterogeneity of glycan occupation in the H. volcanii S-layer glycoprotein. 
 
With the S-layer glycoprotein mapping data achieved using a series of enzymatic digests and assembled 
using MALDI-MS and ESI-MS techniques, information on the N-glycosylation sites on their respective 
peptide fragments could be gathered similarly (Section 3.5.1). Within the mapped protein sequence of the S-
layer glycoprotein, which includes the first six putative N-glycosylation sites, all have been found to be 
occupied by the full pentasaccharide N-glycan. A selection of tables are listed here to represent the findings 
from enzymatic digests, including chymotrypsin and trypsin followed by Glu-C as analysed by ESI-MS and 
ESI-MS/MS and AspN data accumulated by MSE analysis, to summarise the relevant glycan occupation of 
significant N-glycosylation sites (Table 3.3, Table 3.4 and Table 3.5) 
 
A selection of relevant ESI-MS/MS spectra are further presented here to show N-glycosylation site 
occupation and annotation of the peptide sequences and the respective glycan moieties (Figure 3.21 and 
Figure 3.22). ES-MS/MS and high energy MSE spectra provide definitive evidence for glycosylation and also 
offer additional information about the nature of the peptide backbone, such as is seen from the b and y” ion 
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signals annotated in the spectra in blue and red respectively. Further indications of glycosylation come from 
the presence of major low mass singly charged signals corresponding to carbohydrate fragments, however 
such signals are limited to well stabilised fragments from carbohydrate monosaccharides, with ionisable 
functional groups, such as HexNAc. 
 
H. volcanii S-layer glycoprotein digested by chymotrypsin (ESI-MS and ESI-MS/MS) 
RT (min) Observed (m/z) Charge Calculated MW Assignment Glycosylation 
26.4 1066.0 2 2130.0 47-57 Hex2.HexA2.MeHexA 
24.8 984.9 2 1967.8 47-57 Hex.HexA2.MeHexA 
23.9 889.9 2 1777.8 47-57 Hex.HexA2 
22.1 801.9 2 1601.8 47-57 Hex.HexA 
65.4 1170.2 3 3507.6 106-131 Hex2.HexA2.MeHexA 
63.4 1116.2 3 3345.6 106-131 Hex.HexA2.MeHexA 
52.5 1726.0 3 5175.0 296-330 (Hex2.HexA2.MeHexA) x 2 
51.4 1672.0 3 5013.0 296-330 Hex2.HexA2.MeHexA, 
Hex.HexA2.MeHexA 
49.9 1618.0 3 4851.0 296-330 (Hex.HexA2.MeHexA) x 2 
77.3 930.1 3 2787.3 396-416 Hex.HexA2.MeHexA 
53.9 1776.8 2 3551.6 515-542 Hex2.HexA2.MeHexA 
52.5 1695.8 2 3389.6 515-542 Hex.HexA2.MeHexA 
Table 3.3 – List of molecular ions observed in S-layer glycopeptides digested by chymotrypsin. 
Summary of the observed m/z values used to calculate the relative molecular weight of the peptides and glycan moieties as 
corroborated from ESI-MS/MS data. The glycosylation annotations in italics were derived from MS data only. 
 
H. volcanii S-layer glycoprotein digested by trypsin and Glu-C (ESI-MS and ESI-MS/MS) 
RT (min) Observed (m/z) Charge Calculated MW Assignment Glycosylation 
15.1 681.2 2 1360.4 45-48 Hex2.HexA2.MeHexA 
84.5 1515.7 5 7573.5 56-124 Hex.HexA2.MeHexA 
47.6 994.8 3 2981.4 99-124 Hex.HexA2 
50.0 1053.5 3 3157.5 99-124 Hex.HexA 
50.8 1116.8 3 3347.4 99-124 Hex.HexA2.MeHexA 
52.6 1170.9 3 3509.7 99-124 Hex2.HexA2.MeHexA 
33.0 1835.2 2 3668.4 304-324 (Hex2.HexA2.MeHexA) x 2 
32.5 1754.1 2 3506.2 304-324 Hex2.HexA2.MeHexA, 
Hex.HexA2.MeHexA 
31.3 1673.1 2 3344.3 304-324 (Hex.HexA2.MeHexA) x 2 
82.9 1328.0 4 5308.0 505-549 Hex.HexA2.MeHexA 
82.9 1368.5 4 5470.0 505-549 Hex2.HexA2.MeHexA 
Table 3.4 – List of molecular ions observed in S-layer glycopeptides, digested by trypsin and Glu-C. 
Summary of the observed m/z values used to calculate the relative molecular weight of the peptides and glycan moieties as 
corroborated from ESI-MS/MS data. The glycosylation annotations in italics were derived from MS data only. 
 
H. volcanii S-layer glycoprotein digested by AspN (MSE) 
RT (min) Observed (m/z) Charge Calculated MW Assignment Glycosylation 
2.9 1008.9 2 2015.8 42-53 Hex.HexA2.MeHexA 
2.9 1089.9 2 2177.8 42-53 Hex2.HexA2.MeHexA 
6.8 1288.1 2 2574.1 108-126 Hex.HexA2.MeHexA 
6.8 1369.1 2 2736.2 108-126 Hex2.HexA2.MeHexA 
5.8 1975.2 2 3948.4 300-326 (Hex.HexA2.MeHexA) x 2 
0.9 1569.85 1 1568.5 402-410 Hex2.HexA2.MeHexA 
1.2 1731.6 1 1730.6 402-410 Hex2.HexA2.MeHexA 
12.0 1191.0 2 2380.1 530-546 Hex.HexA2.MeHexA 
12.3 1272.1 2 2542.1 530-546 Hex2.HexA2.MeHexA 
Table 3.5 – List of molecular ions observed in S-layer glycopeptides, digested by AspN. 
Summary of the observed m/z values used to calculate the relative molecular weight of the peptides and glycan moieties on 
the specific peptides as corroborated from MSE data. 
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Figure 3.21 shows the ESI-MS/MS spectrum of the molecular ion found at m/z 1081.92+, a doubly charged 
signal selected from the MS data, showing the tryptic peptide 37GNLDADSESFNK48, encompassing the first 
putative N-glycosylation site at Asn-47. The calculated relative molecular weight of this doubly charged 
molecular ion is 2161.8 mass units and with the peptide in question only having a theoretical mass of 1295.6 
mass units, this peptide is glycosylated with the pentasaccharide (Hex2.HexA2.HexAMe at a mass of m/z 
866). Using the b and y” ions ions generated, the signals can be mapped to the N- and C-terminal of this 
tryptic glycopeptide. Furthermore, the spectrum in Figure 3.21 allows for annotation of the N-glycan 
monosaccharide units as labelled in green. 
 
Figure 3.22 shows the ESI-MS/MS spectrum of the molecular ion with an m/z observed at 1170.93+, a triply 
charged signal selected from the MS data, showing the doubly digested peptide 
99NQPLGTYDVDGSGSATTPNVTLLAPR124 after enzymatic treatment with trypsin and Glu-C enzyme, 
displaying two missed cleavages. This peptide contains the second putative N-glycosylation site at Asn-117. 
The calculated relative molecular weight of this triply charged MS ion is 3509.7 mass units and with the 
peptide in question only having a theoretical mass of 2643.9 mass units, this peptide is glycosylated with the 
pentasaccharide (Hex2.HexA2.HexAMe at a mass of m/z 866). Using the b and y” ions generated, the signals 
can be mapped to the N- and C-terminal of this S-layer glycopeptide, whilst the N-glycan monosaccharide 
units are seen attached to the stable proline y” ion at m/z 980.6 and are labelled in green. 
 
The N-glycosylation sites Asn-308 and Asn-313 are not shown here, as MS/MS data for these sites could 
only be obtained as per their occupation by the first four subunits of the N-glycan pentasaccharide, and thus 
only show tetrasaccharide occupation. However, the occupation of these sites by the pentasaccharide was 
clear from the MS data, as highlighted in italics in the tables above (Table 3.3 and Table 3.4). This is often 
the case for glycopeptides terminating in simple sugars such as hexose, where the hexose is partially lost 
due to the internal energy uptake on ionisation and the automated MS/MS software then choses the more 
abundant des-Hex signal for MS/MS analysis. 
 
MSE technology allows for the generation of fragment ions on every sample moiety or molecular ion detected 
simultaneously, thus recording exact mass precursor and fragment ion information, whilst at the same time 
obtaining accurate quantitative profiles from every detectable component in any sample. This is achieved by 
rapid alternating between two functions and recording two channels of data continuously. The first channel at 
low energy acquires low energy precursor ion spectra, such as is normally seen in MS spectra, whilst the 
second high energy channel complemented with collision energy, records elevated energy fragment ion 
spectra, similar to MS/MS spectra. MSE records data without discrimination and every mass in the sample is 
measured. The spectra for each component can be aligned in time, providing comprehensive data and 
quantitative information on the sample. 
 
Further information was derived from MSE analysis of an AspN digest. This was done in both the positive and 
negative ion modes allowing for the assignment of N-glycosylation on all first six N-glycosylation sites in the 
protein (Table 3.5). Presented here are two spectra of the N-glycosylation sites Asn-404 (Figure 3.23), 
acquired at high energy, and Asn-532 for which low energy MSE data is shown (Figure 3.24). 
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Figure 3.21 – ESI-MS/MS spectrum of m/z 1081.92+ showing the S-layer N-glycan site Asn-47. 
The ESI-MS/MS spectrum allows for peptide sequence assignment of 37GNLDADSESFNK48, such as is represented in the 
schematic, whilst b and y” ions are respectively labelled and highlighted in blue and red. Signals for the N-glycan units 
decorating this peptide are labelled in green. The data was accumulated post tryptic digest followed by separation on a 
reverse-phase nano-HPLC system and analysis on an Applied Biosystems API Q-STAR® Pulsar mass spectrometer. The data 
was accumulated in the positive ion mode. 
 
 
Figure 3.22 – ESI-MS/MS spectrum of m/z 1170.93+ showing the S-layer N-glycan site Asn-117. 
The ESI-MS/MS spectrum allows for peptide sequence assignment of 99NQPLGTYDVDGSGSATTPNVTLLAPR124, such as is 
represented in the schematic, whilst b and y” ions are respectively labelled and highlighted in blue and red. Signals for the N-
glycan units decorating this peptide are labelled in green. The data was accumulated post tryptic and Glu-C digest followed by 
separation on a reverse-phase nano-HPLC system and analysis on an Applied Biosystems API Q-STAR® Pulsar mass 
spectrometer.The data was accumulated in the positive ion mode. 
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Figure 3.23 – High energy MSE spectrum of m/z 1731.6+ showing the S-layer N-glycan site Asn-404. 
The MSE high energy spectrum allows for peptide sequence assignment of 402DINGTATSS410, such as is represented in the 
schematic, whilst b and y” ions are respectively labelled and highlighted in blue and red. Signals for the N-glycan units 
decorating this peptide are labelled in green. The data was accumulated post AspN digest followed by separation on a Waters 
Acquity UPLC with microbore reverse phase column and analysis on a Waters Xevo G2S Q-TOF mass spectrometer. The data 
was accumulated in the positive ion mode. 
 
 
Figure 3.24 – Low energy MSE spectrum showing the S-layer N-glycan site Asn-532. 
The MSE low energy spectrum is expanded around the signals representing the N-glycosylation site Asn-532 with m/z 1272.12+ 
showing the fully occupied peptide sequence 530DINGTASGANSVLVIF546 with the pentasaccharide N-glycan. This is 
represented in the schematic, whilst signals for the N-glycan units decorating this peptide are labelled in green. The data was 
accumulated post AspN digest followed by separation on a Waters Acquity UPLC with microbore reverse phase column and 
analysis on a Waters Xevo G2S Q-TOF mass spectrometer. The data was accumulated in the positive ion mode. 
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Figure 3.23 shows the high energy MSE spectrum of the molecular ion with an m/z observed at 1731.6, a 
singly charged molecular ion, showing the peptide 402DINGTATSS410 after enzymatic treatment with AspN in 
the positive ion mode. This peptide contains the fifth putative N-glycosylation site at Asn-404. The calculated 
relative molecular weight of this molecular ion is 1730.6 mass units and with the peptide in question only 
having a theoretical mass of 864.4 mass units, this peptide is shown to be glycosylated with the 
pentasaccharide (Hex2.HexA2.HexAMe at a mass of m/z 866). Annotation of the b and y” ions generated, as 
labelled in blue and red respectively, allow for these signals to be mapped to the N- and C-terminal of this 
glycopeptide, whilst annotation of the N-glycan monosaccharide units are labelled in green. 
 
A low energy MSE spectrum is shown in Figure 3.24, exhibiting assignment of the S-layer glycopeptide 
530DINGTATSGANSVLVIFV546, as digested by AspN in the positive ion mode. The spectrum presented is 
expanded around the doubly charged molecular ions, labelled and highlighted in green, representing 
molecular ions of this peptide glycosylated with various intermediates of the N-glycan pentasaccharide 
(Hex2.HexA2.HexAMe). This spectrum demonstrates the sixth putative N-glycosylation site at Asn-532 to be 
glycosylated with the full pentasaccharide moiety. 
 
3.5.3 Summary discussion of the comprehensive mapping of the S-layer glycoprotein 
 
The results presented in this section confirm the amino acid sequence published previously by Sumper and 
colleagues, as far as could be identified by mass spectrometric techniques of approximately 90% of the S-
layer glycoprotein. Previously only two of the seven putative N-glycosylation sites were proposed to be 
occupied by the N-glycan pentasaccharide, Asn-47 and Asn-117, whilst Asn-404 was suggested to be 
unoccupied (Abu-Qarn et al., 2007). However, the research presented here shows the occupation of the first 
six N-glycosylation sites, comprising Asn-47, Asn-117, Asn-308, Asn-313, Asn-404 and Asn-532. The C-
terminal region was not characterised, despite various approaches and thus, the final N-glycosylation site 
cannot be commented on. All occupied N-glycosylation sites, were found to be glycosylated with the full N-
glycan pentasaccharide, although there was also some evidence of shorter structures occurring naturally in 
the sample that were not generated by MS decomposition. 
 
All N-glycosylation sites were found to be occupied by the pentasaccharide as well as its biosynthetic 
precursors. From overall assessment and comparison of the MS data accumulated throughout this series of 
experiments, the various intermediates of the N-glycan pentasaccharide (Hex2.HexA2.HexAMe) were found 
to be amongst the glycoforms of the S-layer. However it seems that occupation with the full N-glycan 
pentasaccharide is more difficult to achieve than its tetrasaccharide precursor (Hex.HexA2.HexAMe). The 
last hexose of the pentasaccharide was recently identified as mannose and was found to be added onto the 
growing N-glycan from a separate dolichol carrier, whereas the previous four monosaccharide moieties 
making up the N-glycan pentasacharide are assembled, modified and transferred from a distinct dolichol 
carrier en bloc (Cohen-Rosenzweig et al., 2012). The matter of this observation of heterogeneity of the N-
glycan of the H. volcanii S-layer glycoprotein is further discussed at the end of this chapter (Section 3.7.2). 
 
Despite many efforts, the C-terminal domain was not observed and the S-layer glycoprotein sample was 
therefore investigated for potential modifications such as lipids. 
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3.6 STUDIES ON S-LAYER GLYCOPROTEIN LIPID ASSOCIATION 
 
With the mapping of the S-layer glycoprotein resulting in a comprehensive map only short of the C-terminal 
region, further investigation was made into the reasons for this absence. This section describes the 
experimentation undertaken to seek information to confirm or discount the suggested lipid modification of the 
S-layer glycoprotein. 
 
The sample provided as extracted by the Eichler group was investigated for possible lipid moieties and if 
discovered, any information on a possible covalent linkage. In Eichler’s laboratory the S-layer glycoprotein 
was released using EDTA, to inhibit protease activity, after washing of the cell pellets with 2M NaCl, 50mM 
Tris–HCl at pH 7.2 (Section 2.3.1.2). 
 
 
Figure 3.25 – Methods investigating the potential lipid modification of the S-layer glycoprotein. 
This schematic describes the various approaches employed in the investigation of the S-layer glycoprotein C-terminal region, 
as proposed to be modified by lipid moieties. 
 
Figure 3.25 summarises the methods employed in this section. The sample was washed in chloroform and 
water to separate any unbound lipid moieties from the S-layer glycoprotein (Section 2.4.6.1) and whilst the 
chloroform fraction was assessed by MALDI-MS and MALDI-MS/MS, the protein-containing fraction was 
further hydrolysed to separate the protein from any covalently linked lipid moieties present. The methods of 
choice were HF treatment to hydrolyse any phosphodiester linked moieties and an alkaline treatment 
described by the Eichler group (Section 2.4.6.2 and Section 2.4.6.3) (Kandiba et al., 2013), upon which a 
further chloroform:water separation aimed to give rise to a pure protein fraction and a lipid fraction of the 
released lipids. Both hydrolysis techniques were optimised in a series of repeat attempts to ensure full 
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release of any lipid moieties covalently linked to any portion of the S-layer glycoprotein. These methods were 
assessed alongside controls of unhydrolysed samples. The lipid fractions were further concentrated and 
spotted in conjunction with their water fraction counterparts containing the S-layer glycoprotein using a series 
of matrices for analysis by MALDI-MS and MALDI-MS/MS in both the negative and positive ion mode. The 
matrices employed included DHB, HABA and DABP for the lipid moieties used on their own and in suitable 
combinations, as well as HCCA and SA matrices for assessment of the water fraction containing any 
peptides. 
 
3.6.1 Lipid population of H. volcanii found in the S-layer glycoprotein extract 
 
To investigate the lipid presence acting as a modification of the S-layer glycoprotein, the sample was 
processed as described in Figure 3.25. All fractions were examined for the potential identification of any lipid 
moieties, if present, expected to be covalently linked directly to the peptide or via the O-glycans. These 
experiments were repeated multiple times and the hydrolysis and separation procedures optimised to assure 
maximum confidence in the results presented here. FAME analysis was initially performed on the S-layer 
glycoprotein samples (data not shown), confirming the presence of lipid moieties in the sample. 
 
The free, non-covalently bound lipid fraction as separated from the S-layer glycoprotein sample by 
chloroform:water extraction was shown to contain archaetidylglycerol (PG, m/z 805.68), archaetidylglycerol 
methylphosphate (PGP-Me, m/z 899.66) as visible separately or in adducts with sodium (PGP-Me +Na, m/z 
921.65), sulphate-diglycosyl archaeol-1 (S-GL-1, m/z 1055.74) and sulphate-diglycosyl archaeol-2 in 
aggregation with sodium (S-GL-2, m/z 1792.24), as is shown in Figure 3.26. These lipid moieties were 
identified as freely associated with the S-layer glycoprotein sample as extracted by the Eichler group and are 
equivalent to the lipid moieties classified as belonging to the lipid bilayer of H. volcanii cells published by 
Sprott and colleagues (Sprott et al., 2003). 
 
 
Figure 3.26 – MALDI-MS spectrum of the H. volcanii S-layer glycoprotein free lipid fraction. 
The MALDI-MS spectrum shows the free lipids present in the purified S-layer glycoprotein sample as separated from the 
protein by chloroform:water extraction, analysed in the negative ion mode as was accumulated on an Applied Biosystems 
4800 MALDI-TOF/TOF mass spectrometer. The highlighted and labelled peaks show the lipid moieties present in the fraction. 
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The molecular ion at m/z 1231.73 was assessed by MS/MS, but did not yield the expected S-GL-1 covalently 
linked to a hexose. The assignment of the lipid moieties presented was verified by MALDI-MS/MS of each of 
the molecular ions, such as is shown for the MALDI-MS/MS spectrum of the molecular ion at m/z 1055.74, of 
the S-GL-1 moiety (Figure 3.27). 
 
 
Figure 3.27 – MALDI-MS/MS spectrum of the molecular ion at m/z 1055.74, S-GL-1 (free lipid fraction). 
The MALDI-MS/MS spectrum shows the fragmentation of molecular ion at 1055.74, S-GL-1 from the free lipid fraction, present 
in the purified S-layer glycoprotein sample as separated from the protein by chloroform:water extraction, analysed in the 
negative ion mode as was accumulated on an Applied Biosystems 4800 MALDI-TOF/TOF mass spectrometer. The structure of 
the glycolipid is shown in a separate box with indications to fragmentations observed. 
 
The sample fraction obtained post HF treatment presented MALDI-MS and MS/MS data similar to the lipid 
assessment of the non-covalently associated lipid population, in as much that no newly identified lipid 
moieties related to modification of the S-layer glycoprotein could be observed in the spectrum. Figure 3.28 
shows the MALDI-MS spectrum of the lipid moieties extracted post HF hydrolysis. HF treatment allows for 
the hydrolysis of any phosphodiester linkage, such as are observed in archaetidylglycerol methylphosphase 
(PGP-Me, m/z 899.66) and sulphate-diglycosyl archaeol-2 (S-GL-2, m/z 1770.24, +Na m/z 1792.24), 
explaining the absence of these signals in the spectrum. 
 
 
Figure 3.28 – MALDI-MS spectrum of the S-layer glycoprotein released lipid moieties. 
The MALDI-MS spectrum shows lipid moieites released or generated by HF treatment of the purified S-layer glycoprotein 
sample as separated from the protein by chloroform:water extraction post hydrolysis, analysed in the negative ion mode, as 
was accumulated on an Applied Biosystems 4800 MALDI-TOF/TOF mass spectrometer. The highlighted and labelled peaks 
show the lipid moieties present in the fraction. 
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The presence of archaetidic acid (PA, m/z 733.66), could be suggested to represent a new lipid moiety 
released from the S-layer glycoprotein by HF treatment, however, such hydrolysis of the S-GL-2 glycolipid 
will yield the archaetidic acid and S-GL-1 moieties, and thus cannot be definitively proposed as such and 
further investigations will be required for elucidation of the archaetidic acid moiety from different sample 
extractions and purifications. Comparison with control samples of unhydrolysed S-layer glycoprotein and 
analysis of the peptide containing counterpart fractions in water, which contained the same group of lipid 
moieties, suggested these lipids though tightly associated with the S-layer glycoprotein, were not 
phosphodiester-linked to the protein. The reproduction of the alkaline hydrolysis procedure described by 
Kandiba and colleagues did not yield any informative data, even though this procedure was repeated 
multiple times (Kandiba et al., 2013). 
 
To exclude the possibility that the lipid moieties found potentially covalently linked to any glycan or peptide 
region, were too large to be identified, due to the sizes of these modified sections of the S-layer glycoprotein, 
the sample was digested by pronase enzyme, an enzyme that hydrolyses the peptide backbone into short 
peptides of only a few amino acids. This should allow the identification of any lipid moieties, even if linked via 
the disaccharide O-glycan or directly to any peptide, as the presence of such monosaccharides or amino 
acids would be observable in the MALDI-MS and MS/MS spectra in the positive or negative ion mode. This 
however, also did not yield any evidence for covalent attachment of the lipid moieties present in the sample, 
as the resultant mass spectra showed the same peaks as found in the other fractions (data not shown). 
 
From the series of experiments described above, no further evidence of the C-terminal region of the S-layer 
glycoprotein was found and the sample purified and extracted by the Eichler group was found to contain the 
lipid moieties, previously identified by Sprott and colleagues as consistent with the major lipid populations of 
the H. volcanii membrane bilayer (Table 1.1), when the samples were assessed by MALDI-MS and MALDI-
MS/MS in both the positive and negative ion mode. The only differences observable were that in both ion 
modes, the relative abundances of each of the lipid moieties identified were not consistent with the published 
works by Naparstek and Sprott (Sprott et al., 2003, Naparstek et al., 2012). The high abundance of the m/z 
1055 S-GL-1 glycolipid compared with the barely visible m/z 1770 S-GL-2 glycolipid, suggests that the 
presence of the additional lipid moiety on the latter prevents tight association with the S-layer. 
 
3.6.2 S-layer glycoprotein electrophoresis studies 
 
The mature S-layer glycoprotein, as published by Sumper and colleagues, was shown be composed of 793 
amino acids with an expected calculated molecular weight of approximately 81,732Da. However, upon 
analysis of the extracted and deglycosylated S-layer glycoprotein on an SDS-PAGE gel, the apparent 
molecular mass of the polypeptide running at approximately 170kDa, is nearly double the expected size of 
the protein (Sumper et al., 1990). Even with the herein presented information on N- and O-glycosylation of 
the H. volcanii S-layer glycoprotein contributing to additional molecular mass, such an extreme irregularity in 
electrophoretic behaviour seems unlikely to be explained by glycosylation. The abnormal electrophoretic 
behaviour was also seen in the S-layer glycoprotein of H. halobium, where Kikuchi and colleagues had 
suggested covalent lipid attachment to H. halobium in (Kikuchi et al., 1999), which brought about 
suggestions on the electrophoretic retardation being due to a proposed lipid moiety. Eichler and colleagues 
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therefore also suggested lipid modification of H. volcanii as the reason for the aberrant electrophoretic 
mobility of the S-layer glycoprotein (Konrad and Eichler, 2002). 
 
The S-layer glycoprotein was run on Tris-Acetate 3-8% gradient gels due to the large mass of the 
glycoprotein and run alongside an unstained HiMarkTM ladder, for mass annotation and stained with 
Coomassie blue stainer (Section 2.4.1) (Figure 3.29, well number 2 and 3 and Figure 3.30, well number 5). 
To further elucidate the unusual electrophoretic migration of the S-layer glycoprotein, the S-layer 
glycoprotein was treated with alkaline and HF treatment described for the release of any covalently linked 
lipids and separated using chloroform and water (Section 2.4.6) and run alongside the untreated S-layer 
glycoprotein separated from non-covalently linked lipid moieties (Figure 3.29). These experimental fractions 
were run in wells 7-10, however, no protein moieties could be visualised. Furthermore, the aspect of a 
possible dimerisation was investigated by chemical denaturing of the protein prior to electrophoresis, which 
however, did not present any different data and the protein ran identically to the control sample and the S-
layer glycoprotein could be visualised at roughly 170kDa again (data not shown), dismissing the concept of 
possible dimerization. In addition, the sample was reduced and carboxymethylated in case mis-annotation of 
the amino acid sequence had occurred and cysteine residues were to be present in the S-layer glycoprotein, 
which could allow dimersiation via cystine formation (Figure 3.30, well number 3). However, this experiment 
also proved negative. 
 
 
Figure 3.29 – Tris-Acetate (3-8%) gel of H. volcanii S-layer glycoprotein (hydrolysed lipid moieties). 
The samples run on the gel included a HiMarkTM unstained standard, the control sample of purified S-layer glycoprotein, as 
separated by chloroform:water and post alkaline and HF treatment (both fractions). The gel was run at 150V for 60mins and 
stained with Coomassie blue stain. Annotated in red is the H. volcanii S-layer glycoprotein size as visualised on the gel. 
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Figure 3.30 – Tris-Acetate (3-8%) gel of H. volcanii S-layer glycoprotein (reduced/carboxymethylated). 
The samples run on the gel included a HiMarkTM unstained standard, the control sample of purified S-layer glycoprotein, as 
well as reduced and carboxymethylated prior to electrophoresis. The gel was run at 150V for 60mins and stained with 
Coomassie blue stain. Annotated in red is the H. volcanii S-layer glycoprotein size as visualised on the gel. 
 
3.6.3 Further investigation into the C-terminal region of the S-layer glycoprotein 
 
The lack of information obtained on the C-terminal region, as well as the irregular and inconclusive behaviour 
of the S-layer glycoprotein during electrophoresis, highlighted the importance of knowing the true molecular 
weight of the S-layer. Determining this by MALDI-MS was therefore attempted. The S-layer glycoprotein was 
therefore spotted on MALDI plates with a series of appropriate matrices, for linear-TOF analysis in both the 
negative and positive ion modes. To supplement this, the sample was further investigated by MALDI-MS and 
MS/MS, post hydrolysis by trypsin and CNBr, which were aimed to have created peptide fragments of the C-
terminal domain. This C-terminal region was assessed by MALDI-MS, keeping in mind its glycosylation with 
one N-glycan and a few O-linked disaccharides, potentially resulting in a high molecular weight 
peptidoglycolipid. MALDI-MS was used, as there is less prospect of obtaining ESI data with the charges 
predicted for the C-terminal tryptic peptide. Unfortunately, despite considerable experimentation none of 
these molecular weight investigations produced meaningful MALDI spectra (data not shown). Therefore, no 
new in formation of any covalently linked glycolipid or phospholipid moiety on the elusive C-terminal region of 
the S-layer glycoprotein was obtained. 
 
3.6.4 Summary discussion on lipid association studies of the S-layer glycoprotein 
 
Based on the data collected by the various hydrolysis and enzymatic procedures employed in the elucidation 
of the C-terminal region suggested to be modified by a lipid moiety, the MALDI-MS data does not provide 
any evidence that the lipids present in the S-layer glycoprotein sample are covalently linked to the S-layer 
glycoprotein, but would rather suggest that lipid moieties of the lipid bilayer are in strong non-covalent 
association with the protein. 
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The lipid moieties observed coincide with the published lipid population identified by Sprott and colleagues 
from the H. volcanii lipid bilayer (Sprott et al., 2003). H. volcanii polar lipids were found to be composed of 
phospholipids and sulphated glycolipids S-GL-1 and S-GL-2. The phospholipids are archaetidylglycerol (PG 
805.6Da) and archaetidylglycerol-methyl-phosphate (PGP-CH3 899.5Da and with sodium 921.5Da) were the 
major signals identified. Further, a major signal of 1055.6 m/z was detected as expected for a sulphate-
diglycosyl archaeol, characteristically found in the polar lipids extracted from archaeal extreme halophiles 
(Kamekura and Kates, 1999). The sulphated diglycosyl lipid S-GL-1 from H. volcanii was characterized by 
detailed NMR analysis and found to be 6-HSO3-D-Manp-a1-2-D-Glcp-a1,1-[sn-2,3-di-O-phytanylglycerol. 
The structural identity of S-GL-1 to a portion of the S-GL-2 molecule suggests a precursor relationship during 
biosynthesis of S-GL-2 (Sprott et al., 2003). To date, however the enzymes responsible for adding the 
glucose and mannose residues to the diphytanylglycerol moiety have not been identified, although a putative 
biosynthesis pathway has been proposed. Naparstek and colleagues tested whether AglB or any of the 
glycosyltransferases involved in H. volcanii S-layer glycoprotein N-glycosylation were also involved in the H. 
volcanii glycolipid biogenesis by deletion of the known agl genes using NMR. The results showed different 
glcyosyltransferases were involved in the biosynthesis of N-linked glycoproteins and glycolipids in archaea 
(Naparstek et al., 2010). 
 
The lipids found to be present in the herein examined sample are more likely to be co-extracted with the 
EDTA procedure used by the Eichler group, where 0.5M EDTA was used to release the S-layer from the H. 
volcanii cells. Such methods could lead to the release of the S-layer glycoprotein in close association with 
the lipid bilayer, through its transmembrane domain at the C-terminal, and thus presented in strong 
association with such moieties, rather than by covalent attachment. This is further explained by the 
independently published works of Kandida and colleagues of the Eichler group, suggesting differences in the 
S-layer presentation upon the use of two separate extraction procedures, EDTA and Triton X-100 (Kandiba 
et al., 2013). The investigations carried out by Kandida and colleagues suggested that two distinct 
populations of the S-layer glycoprotein could be observed upon solubilisation with the different methods, 
presenting mass spectrometric data proposing that only the EDTA-solubilised version of the protein was 
modified by an archaetidic acid. This lipid moiety, however, will also be produced upon alkaline hydrolysis of 
the S-GL-2 sulphate-diglycosyl archaeol lipid found in the lipid bilayer of H. volcanii (Sprott et al., 2003, 
Naparstek et al., 2012).  
 
For further assessment of such differences in extraction techniques and to confirm the data presented here, 
additional sample preparations are required for analysis. Such S-layer preparations were requested from our 
collaborators but were not received by the time of thesis submission. 
 
On another note, our detection of non-covalent lipids in the S-layer preparations whilst finding no evidence 
for their covalent attachment, has prompted us to question the hypothesis that an archaeosortase 
mechanism could be involved in the putative lipid modification of the S-layer (Haft et al., 2012, Kandiba et al., 
2013). As mentioned earlier, Eichler’s laboratory has recently reported that the S-layer glycoprotein 
solubilised by EDTA, has an archaetidic acid moiety that could be detected after base hydrolysis. Eichler has 
proposed that the S-layer glycoprotein could be initially synthesized as an integral membrane protein that 
subsequently undergoes a processing event in which the extracellular portion of the protein is separated 
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from the membrane-spanning domain and transferred to a waiting lipid moiety (Kandiba et al., 2013). This 
was explained by the proposed identification of an enzyme suspected to catalyse a cleavage or transfer 
reaction as is found parallel to the protein processing system found in Gram-positive bacteria using sortases 
(Haft et al., 2012). Sortases in bacteria recognize a carboxyl terminal sequence motif, the PGF-motif, 
immediately upstream of a C-terminal membrane-spanning domain in the target protein, cleave the protein at 
this site and then covalently attach the released proteins to the cell wall and facilitate their transfer to a 
waiting lipid moiety. In the H. volcanii S-layer glycoprotein, a PGF motif is present just upstream of the 
predicted C-terminal trans-membrane domain and is thought to be recognized by a bioinformatically 
identified archaeosortase, ArtA. (Kandiba et al., 2013, Haft et al., 2012). It is thought that the transpeptidation 
catalysed by the archaeosortase would parallel a similar protein processing system found in Gram-positive 
bacteria, where the sortases recognise this PGF motif for cleavage of the protein at such a site followed by 
covalent attachment of the released proteins to a waiting lipid moiety in the cell wall. This process requires 
high activation energy and the process by which such transpeptidation would occur has not been studied in 
archaea. 
 
The presence of a membrane-spanning domain in the amino acid sequence of the S-layer glycoprotein of H. 
volcanii, however, would make the activity of archaeosortases redundant. Furthermore, if this theory was in 
fact feasible, it has to be noted that archaeosortases might be non-specific and could cleave anywhere, with 
the remaining C-terminal region of the S-layer glycoprotein being too small to visualise by the mass 
spectrometric techniques employed. A potential lipid modification of membrane inserted proteins in archaea 
may reflect a primitive version of a model of protein membrane association widely used in eukaryotes, such 
as is seen in C-terminal GPI-anchors, however, this still maintains the role of the membrane spanning 
domain present. Furthermore, in view of the solubility problems encountered throughout the various 
experiments, the C-terminal region of the S-layer glycoprotein and its associated modifications by lipid 
moieties could preferentially precipitate and thus would not be observable in the experiments conducted. A 
final possibility for the lack of C-terminal mapping data is that the gene sequence may be incorrect. Further 
work will be required to determine whether this might be the case. 
 
3.7 GENERAL DISCUSSION 
 
3.7.1 Roles of post-translational modifications of the S-layer glycoprotein in H. 
volcanii 
 
In the S-layer glycoprotein of H. volcanii, the use of deletion strains has provided considerable insight into 
the importance of N-glycosylation to the cell. Strains lacking the ability to perform N-glycosylation, due to the 
absence of the oligosaccharyltransferase, AglB, or only able to partially recruit the N-glycosylation pathway, 
due to an absence of other Agl proteins, presented various phenotypes, including an S-layer of modified 
architecture, showing increased susceptibility to proteolytic digestion, enhanced S-layer glycoprotein release 
into the growth medium and slower growth in medium of increasing salt (Abu-Qarn et al., 2008b, Abu-Qarn 
et al., 2007, Yurist-Doutsch et al., 2008). Indeed, differential transcription of various Agl proteins in response 
to differing growth conditions, reflected by reverse transcription or real time PCR, points to N-glycosylation as 
being an adaptive process in H. volcanii (Jarrell et al., 2010). 
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As discussed by Mengele and Sumper, halophilic archaeal proteins are enriched in acidic amino acids to 
cope with life in hypersaline environments, however, this strategy wouldn’t offer a response to transient 
changes in salinity, as would post-translational modifications. The S-layer glycoprotein was suggested to 
undergo differential glycosylation in terms of the N-glycan decorating the N-glycosylation sites, upon growth 
in distinct environments of salinity (Guan et al., 2012). Guan and colleagues investigated the Dol-P carriers 
involved in the assembly of the N-glycan, as well as the S-layer glycoprotein by LC-ESI-MS in cells grown in 
high and low salt concentrations of 3.4M NaCl and 1.75M NaCl respectively. Guan and colleagues found that 
in high salt Asn-47 and Asn-117 were modified by a pentasaccharide, while dolichol phosphate was modified 
by a tetrasaccharide comprising the first four pentasaccharide residues. When the same targets were 
considered from cells grown in low salt, substantially less pentasaccharide was detected and cells grown at 
low salinity contained dolichol phosphate modified by a distinct tetrasaccharide absent in cells grown at high 
salinity. This tetrasaccharide composed of a deoxyhexose, two hexoses and a sulphated or phosphorylated 
hexose was found to modify Asn-532 in cells grown in low salt, whereas no glycan was found to decorate 
this residue in cells grown in the high salt-medium. Guan and Eichler therefore suggested that H. volcanii 
modulated the N-linked glycans in response to changes in environmental salinity, which however, is 
surprising as sulphated or phosphorylated monosaccharide moieties would be expected in high salt 
environment rather than lower concentrations of salinity. The presently investigated samples were grown at 
3.4M NaCl, corresponding to the high salt environment discussed by Guan and colleages of the Eichler 
group. However, the data presented by Guan and colleagues suggested Asn-404 to be unoccupied, which is 
rectified in the data presented here. 
 
3.7.2 Functional characterisation of N-glycan biosynthesis of the H. volcanii S-layer 
 
In the effort to elucidate the biosynthesis pathway and the gene products involved in the N-glycosylation of 
the S-layer glycoprotein of H. volcanii, Eichler and colleagues in collaboration with our laboratory previously 
attempted to functionally characterise the putative homologs of genes involved in the eukaryal or bacterial N-
glycosylation, with the studies described below (Abu-Qarn et al., 2008b, Abu-Qarn et al., 2007, Yurist-
Doutsch et al., 2008). 
 
The combination of gene deletion and mass spectrometry of a reporter glycopeptide carrying the 
pentasaccharide, demonstrated the involvement of AglD and AglB in the N-glycosylation of the S-layer 
glycoprotein. AglB was identified as the sole component of the oligosaccharide transferase complex. AglD 
was shown to be involved in the loading of the final hexose residue onto the tetrasaccharide. AglD includes a 
soluble, cytoplasmic-facing N-terminal half, associated with the membrane via the integral C-terminal portion 
of the molecule, spanning the membrane six times. This represents a topology reminiscent of those eukaryal 
glycosyltransferases containing active sites facing the ER lumen, responsible for the transfer of mannose or 
glucose residues from charged dolichol carriers to the heptasaccharide following its reorientation from the 
cytoplasm to the lumen of the ER membrane (Abu-Qarn et al., 2007). Kaminski and Eichler further attempted 
to identify the residues of importance for the activity of AglD who designed an in vivo assay. Site-directed 
mutagenesis at positions encoding residues conserved in archaeal homologs showed the restoration of AglD 
function in H. volcanii aglD deletion strains that were transformed to express the plasmid-encoded versions 
of AglD. This showed that Asp-110 and Asp-112 were elements of the Asp-X-Asp motif of AglD, which 
137 
 
Chapter 3  H. volcanii S-layer glycoprotein analysis 
interacts with metal cations associated with nucleotide-activated sugar donors, whilst Asp-201 was predicted 
to be the catalytic base of the enzyme (Kaminski and Eichler, 2010). 
 
In addition to these genes, H. volcanii was found to encode at least nine other putative glycosyltransferases, 
such as aglE, which is located only eight ORFs upstream from aglB. Upon gene deletion experiments in 
combination with mass spectrometric techniques, it was suggested that AglE was involved in the loading the 
190 Da sugar subunit of the H. volcanii S-layer glycoprotein onto the growing trisaccharide. This process 
was presumed to be achieved by loading of the 190Da sugar subunit onto a lipid carrier followed by 
transferral onto the 176Da sugar species of the three-membered pentasaccharide precursor via the actions 
of a distinct transferase, or that AglE directly adds the 190Da sugar subunit to the growing oligosaccharide. 
Topological analysis assigned AglE as an integral membrane protein, with its N-terminus and putative active 
site facing the cytoplasm, suggesting the latter option (Abu-Qarn et al., 2008b). 
 
Examination of those ORFs found upstream of aglB revealed further sequences and the gene products of 
aglF, aglI and aglG were found to be involved in the biosynthesis of the S-layer pentasaccharide. These 
three genes are found immediately upstream from the gene encoding the archaeal oligosaccharide 
transferase, AglB. It was shown that AglF and AglI are involved in the addition of the hexuronic acid found at 
position three of the pentasaccharide, whilst AglG was shown to contribute to the addition of the hexuronic 
acid found at position two (Yurist-Doutsch et al., 2008). Given their proximities in the H. volcanii genome, the 
transcription profiles of aglF, aglI, aglG and aglB were considered and whilst aglF and aglI share a common 
promoter, transcription of the four genes is co-ordinated, as was demonstrated by variation in growth 
conditions and the consequent analysis of transcript levels in H. volcanii cells. Such changes in N-
glycosylation gene transcription levels offer additional support for the adaptive role of this post-translational 
modification in H. volcanii. Furthermore, the deletion of these three gene products did not compromise H. 
volcanii survival, but presented a modified S-layer (Yurist-Doutsch et al., 2008). 
 
Yurist-Doutsch and colleagues re-addressed the annotation of the gene clusters that includes aglB, aglE, 
aglF, aglG, aglI and aglJ and found further genes encoding AglS, AglQ and AglR (Yurist-Doutsch and 
Eichler, 2009), whilst the actions of AglM, AglP and AglJ are discussed in this thesis. 
 
Whilst investigations in this project focussed on the full profiling of the S-layer glycoprotein and the possibility 
of a lipid modification, the Eichler group continued research into further genes identified by Yurist-Doutsch. 
Their research led to further published findings on AglR and AglS. The function of the AglR protein in the 
biosynthesis of the N-glycan was suggested to be similar to that of its homologue Wzx, which acts as a 
flippase in LPS bioysnthesis. AglR was found to be responsible for delivering the dolichol phosphate linked 
mannose as the final subunit of the N-linked glycan to be transferred to the nascent pentasaccharide. It was 
found that in cells lacking AglR, glycan-charged dolichol phosphate, including mannose-charged dolichol 
phosphate accumulated, resulting in the S-layer not incorporating mannose into its N-glycan (Kaminski et al., 
2012). 
 
Furthermore, the role of AglS was also found to be required for the final mannose addition to the N-glycan 
pentasaccharide, by acting as a dolichol phosphate-mannose mannosyltransferase and thus mediating the 
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transfer of mannose from its dolichol carrier to the nascent tetrasaccharide (Cohen-Rosenzweig et al., 2012). 
This further underlines the difference in biosynthesis pathways of H. volcanii to the related H. marismortui S-
layer glycoprotein (Section 3.7.2.1). 
 
The current understanding of the N-glycosylation biosynthesis pathway in H. volcanii S-layer glycoprotein is 
represented in Figure 3.31. 
 
 
Figure 3.31 – Current understanding of N-glycosylation biosynthesis in the S-layer glycoprotein. 
Schematic of up to date knowledge of various gene functions of the agl gene cluster in H. volcanii as adapted and summarised 
from Jarrell and colleagues (Guerry, 2011, Jarrell et al., 2010). 
 
3.7.2.1 The biosynthesis of the N-glycan of the S-layer glycoprotein and glycoengineering 
 
Kunz and colleagues first reported the presence of C55 and C60 dolichol phosphates in H. volcanii including 
glycan-modified species (Kuntz et al., 1997). Guan and colleagues then used high sensitive LC-MS to detect 
and characterise glycan-charged phosphodolichols in H. volcanii (Guan et al., 2010, Guan and Eichler, 
2011). Apart from the complete pentasaccharide, H. volcanii was found to contain dolichol phosphates 
charged with the same glycan series as found N-linked to the S-layer glycoprotein and cells lacking 
components of the N-glycosylation machinery presented dolichol phosphates void of, or bearing truncated 
glycans. In contrast to the sequential assembly of the first four pentasaccharide subunits onto a common 
dolichol phosphate, the fifth subunit of the pentasaccharide, mannose, was detected on its own distinct lipid 
carrier, suggested by the finding that AglD, involved in the addition of the fifth pentasaccharide subunit, acts 
in a manner seemingly independent of the other Agl proteins. This is not unexpected, as aglD is the only 
gene not found in the agl gene island present in the H. volcanii genome (Yurist-Doutsch and Eichler, 2009). 
It was found to be unlikely for there to be a short lived pentasaccharide-modified phosphodolichol species, 
as such entities were readily observed in another halophilic archaea originating from the dead Sea, such as 
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Haloarcula marismortui (Calo et al., 2011). H. marismortui is a second haloarchaeon also originating from the 
Dead Sea, which similar to H. volcanii decorates the S-layer glycoprotein with the same N-linked 
pentasaccharide and employs dolichol phosphate as lipid glycan carriers. In H. marismortui the complete 
pentasaccharide is assembled on dolichol phosphate and only then transferred the N-glycan to the target 
protein en bloc, unlike the biosynthesis process explored by H. volcanii, reminiscent of the process observed 
in eukaryal N-glycosylation (Calo et al., 2011, Guerry, 2011).  
 
The H. volcanii complete genome sequence has been made available and shows homologs to many other 
agl gene sequences, which are often clustered into gene islands. Calo and colleagues detected OST-
encoding aglB genes in numerous species and suggested that the N-glycosylation seen in the N-linked 
glycans of archaeal glycoproteins identified to date implies that an enormous array of enzymes are involved 
in this posttranslational modification. The relatively well-defined N-glycosylation pathway and molecular tools 
for gene manipulation of the H. volcanii S-layer glycoprotein, proposed this archaeon as a promising 
candidate for glycoengineering. The ability of three haloarchaeal homologs of H. volcanii AglD to replace the 
native enzyme was further considered. AglD is involved in adding the final hexose of the pentasaccharide N-
linked to the S-layer glycoprotein. H. volcanii ΔaglD cells were transformed with the AglD homologs from H. 
marismortui rrnAC1873, H. walsbyi 1489A and H. salinarum OE1782 to restore the S-layer glycosylation as 
was assessed by SDS-PAGE migration, glycostaining and mass spectrometry profiles. All three homologs of 
AglD were found to introduce the final hexose to the N-linked S-layer glycoprotein pentasaccharides even 
though not all were found to be functional and transcribed in their native host under the tested conditions. H. 
volcanii was therefore shown to express foreign enzymes and incorporate them into its N-glycosylation 
pathway, even though such enzymes were not central to this posttranslational modification in the native host. 
These results represent the first steps in assessing the suitability of H. volcanii as a platform for the synthesis 
of variable N-linked glycans relying on introduced N-glycosylation pathway components originating from 
other archaeal species (Calo et al., 2010a). 
 
3.8 FURTHER DIRECTIONS 
 
At the time of the submission of this thesis, unfortunately the C-terminal of the S-layer glycoprotein of H. 
volcanii was still undetermined, along with its potential modifications associated with the C-terminal region. 
Further investigations into the S-layer glycoprotein of H. volcanii will be focused on such characterisation of 
the C-terminal region along with the final putative N-glycosylation site. In the search for the C-terminal region 
of the S-layer glycoprotein matters of potential lipid modification, cleavage of the region and transfer onto 
lipid moieties by archaeosortases as well as assessment of different S-layer glycoprotein preparations in 
terms of extraction from the H. volcanii cells will be investigated. 
 
With regards to glycosylation sites, the last putative N-glycosylation site has not been able to be described in 
work presented in this thesis, and with further investigations into the C-terminal domain, this last N-
glycosylation site will be explored for occupation by the N-glycan. With the continued aim of creating a full 
comprehensive map of the S-layer glycoprotein, the O-glycosylation sites present a further goal yet to be 
investigated. 
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On the subject of potential lipid modification as discussed in various published papers, the exact sample 
preparations described in the published works will need to be investigated for the potential covalent 
association of any lipid moieties linked to the S-layer glycoprotein, which could also be responsible for 
obscuring the C-terminal region. 
 
A recent study on the archaeosortase ArtA protein in H. volcanii by Halim and colleagues suggests the S-
layer glycoprotein as one of its substrates, where artA deletion strains show poor growth, differences in cell 
shape and S-layer architecture, as well as impaired motility of the cells (Abdul Halim et al., 2013). 
Furthermore, their identification of two peptides in the C-terminal region of the S-layer glycoprotein by LC-
MS/MS in the artA deleted strains of H. volcanii lead, and the absence of said peptides in the wild type 
parent strains, led them to suggest ArtA to proteolytically process the S-layer glycoprotein and anchor it in 
the lipid bilayer. No further identification of any other C-terminal peptide sequences, or glyco-lipo-protein 
could be identified. It is therefore clear that similar problems are encountered by other groups in the study of 
the H. volcanii S-layer glycoprotein. 
 
This means that thorough mass spectrometric analysis of all S-layer glycoprotein preparations, including lipid 
extractions and archaeosortase deleted strains should be conducted. Improvement of mass spectrometric 
data collection could be geared towards enhancing the ionisation capacity of peptides post enzymatic or 
chemical digestion by esterification, whilst hydrolysis procedures aimed at the release of chemical bonds 
responsible for the covalent attachment of such moieites, without the degradation of the rest of the protein 
will also need to be developed for characterisation of both potential modifications and the S-layer 
glycoprotein. Further sample preparations with consideration given to extraction procedures and growth 
conditions (high and low salinity), will be investigated upon their receipt from the Eichler group and assessed 
for glycosylation patterns and protein sequence to allow for full understanding of the processing and 
assembly of the S-layer glycoprotein of H. volcanii. 
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Chapter 4  B. pseudomallei 576 LPS analysis 
4 BURKHOLDERIA PSEUDOMALLEI 576 LPS ANALYSIS 
 
4.1 EXPERIMENTAL STRATEGY 
 
This chapter focuses on the structural elucidation of the B. pseudomallei 576 LPS O-antigen to provide 
information for the creation of a comprehensive glycoconjugate vaccine against all melioidosis causing 
bacterial agents. Due to the ACDP listing of B. pseudomallei as a category III pathogen, the work on this 
project was was carried out in collaboration with Dr. Joann Prior and her team at the Defence Science and 
Technology Laboratory (dstl), part of the Ministry of Defence (MOD) at Porton Down, Wiltshire, United 
Kingdom. The LPS samples investigated derived from strains including B. thailandensis E264, B. 
pseudomallei K96243 (serotype A) and 576 (serotype B). Whilst the capsule mutants (ΔCPS) of both B. 
pseudomallei K96243 and 576 were analysed in comparison, the B. pseudomallei 576 (ΔLPS) strain was 
examined for assessment of background carbohydrate contamination (Section 2.3.2). All strains were 
investigated for compositional and linkage information and used for data comparison with B. pseudomallei 
576 LPS, which remained the focus for structural characterisation by MALDI mass spectrometry and NMR 
techniques. 
 
As previously discussed the structural characterisation of glycosylation in prokaryotes cannot rely on 
predictable biosynthesis pathways as is often the case for eukaryotes, which makes the elucidation of 
unknown structures, such as presented by this project on the structural characterisation of the B. 
pseudomallei LPS O-antigen, a much more difficult task (Figure 4.1). 
 
Although most of the methodologies employed in the structural description of the O-antigen repeat unit  are 
widely used in LPS characterisation, their implementation was not necessarily straightforward. Hydrolytic 
methods in particular had to be developed as the project and understanding of the LPS evolved. In the 
elucidation of the B. pseudomallei 576 LPS O-antigen repeat unit a variety of structural analysis techniques 
were combined. Our approach included determination of the monosaccharide composition by GC-MS 
analysis of TMS and alditol acetate derivatives (Section 2.4.8.6 and Section 2.4.8.7), prepared from 
hydrolysed material, complemented by linkage analysis which provided insight into the arrangement of the 
monosaccharaides within the O-antigen repeat unit (Section 2.4.8.8). For MALDI-MS and MALDI-MS/MS 
sequencing of the O-antigen repeat unit, the polysaccharide portions of the LPS of B. pseudomallei 576 had 
to be released from the lipid A moiety to allow for solubilisation and hydrolysis of the polysaccharide for 
analysis. A multitude of hydrolysis techniques were employed, adapted and created in order to achieve lipid 
A release and polysaccharide hydrolysis into manageable and observable repeat units (Section 2.4.7). Mass 
spectrometric techniques allowed for the postulation of a proposed repeat unit structure of the O-antigen, yet 
with an assortment of choices. NMR spectroscopy techniques aimed to support these structural proposals by 
providing further information on the linkage and anomeric stereochemistry of the B. pseudomallei 576 LPS 
O-antigen (Section 2.4.9 and Section 2.4.10). 
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Figure 4.1 - Experimental strategy employed in O-antigen structural characterisation. 
The schematic describes the methods employed in the elucidation of the O-antigen repeat unit of the B. pseudomallei LPS 
serotype 576 
 
4.2 B. PSEUDOMALLEI LPS COMPOSITIONAL AND LINKAGE ANALYSIS 
 
The B. pseudomallei LPS samples were analysed by TMS and alditol acetate analysis and run alongside 
commercial standards using the retention times of elution on the chromatogram as well as the specific mass 
spectrometric fingerprints of each monosaccharide in order to determine the monosaccharide composition of 
the O-antigen (Figure 4.2 and Figure 4.6 respectively). Linkage analysis was performed on the LPS and 
various linkage possibilities were identified ab initio using the mass spectrometric fingerprints and known 
fragmentation pathways as well as comparisons with the mass spectrometric fingerprints of standards 
(Figure 4.10). 
 
The B. pseudomallei 576 LPS was also compared to the LPS of B. pseudomallei K96243, K96243 ΔCPS, 
576 and B. thailandensis, all prepared by TMS, alditol acetate and linkage techniques and analysed by GC-
MS alongside each other. This way the samples for B. pseudomallei strains K96243, 576, K96243 ΔCPS 
(K96423 without capsule) and B. thailandensis wild type strain were assessed for quality and composition 
and linkage (Figure 4.12, Figure 4.13, Figure 4.14). 
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4.2.1 Compositional analysis of B. pseudomallei 576 LPS by TMS 
 
The LPS of B. pseudomallei 576 was derivatised by the TMS technique described previously (Section 
2.4.8.6). The samples were analysed by GC-MS fitted with an RTX-5MS column and run alongside 
commercially obtained standards encompassing a range of monosaccharides (Figure 4.2). Comparison of 
the two chromatograms as well as examination of the mass spectrometric fingerprints of each moiety eluted 
from the gas chromatography column allowed for full annotation of the chromatogram showing the 
monosaccharide composition of the B. pseudomallei 576 LPS. The monosaccharides present in the sample 
of B. pseudomallei 576 were shown to be the pentose xylose (elution time: 10.38min, Figure 4.3), 
deoxyhexose rhamnose (elution time: 9.15min, Figure 4.4), hexoses galactose and glucose (elution time: 
13.68/14.43mins, Figure 4.5). 
 
The deoxymannoheptose peak was assigned in comparison with other LPS chromatograms of another B. 
pseudomallei serotype K96243 (Figure 4.12), which were known to contain such a monosaccharide moiety 
as part of their capsule as described in literature (Knirel et al., 1992, Perry et al., 1995). The galactose 
moiety present in the chromatogram was investigated using an LPS free sample of B. pseudomallei 576 (B. 
pseudomallei ΔLPS) run alongside the wild type B. pseudomallei 576 LPS. This experiment illustrated that 
the galactose moiety arose from the background environment during the growth of the bacteria, as it was 
also found to be present in the TMS chromatograms of B. pseudomallei ΔLPS as well as L-broth medium 
used in the preparation of the sample (results not shown). 
 
 
Figure 4.2 – GC-MS analysis of TMS derivatised LPS of B. pseudomallei 576. 
The sample (top panel) was run alongside commercially obtained standards, at 50nM each (bottom panel) on a Perkin Elmer 
Clarus 500 GC-MS instrument fitted with a RTX-5MS column. Both preparations were supplemented with 50nM of the internal 
standard inositol and non-sugar impurities present in the chromatogram are labelled x. 
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Figure 4.3 – Mass spectrometric fingerprint of xylose from the GC-MS chromatogram. 
The mass spectrometric fingerprint of xylose was obtained from TMS derivatised LPS of B. pseudomallei 576 (top panel) and 
presented with that of the commercially obtained standard for xylose (bottom panel), as run on a Perkin Elmer Clarus 500 GC-
MS instrument fitted with a RTX-5MS column. The fingerprint is magnified from m/z 231 onwards and is highlighted in red. 
 
 
Figure 4.4 – Mass spectrometric fingerprint of rhamnose from the GC-MS chromatogram. 
The mass spectrometric fingerprint of rhamnose was obtained from TMS derivatised LPS of B. pseudomallei 576 (top panel) 
and presented with that of the commercially obtained standard for rhamnose (bottom panel), as run on a Perkin Elmer Clarus 
500 GC-MS instrument fitted with a RTX-5MS column. The fingerprint is magnified from m/z 231 onwards and is highlighted in 
red. 
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Figure 4.5 – Mass spectrometric fingerprint of glucose from the GC-MS chromatogram. 
The mass spectrometric fingerprint of glucose was obtained from TMS derivatised LPS of B. pseudomallei 576 (top panel) and 
presented with that of the commercially obtained standard for glucose (bottom panel), as run on a Perkin Elmer Clarus 500 
GC-MS instrument fitted with a RTX-5MS column. The fingerprint is magnified from m/z 231 onwards and is highlighted in red. 
 
4.2.2 Compositional analysis of B. pseudomallei 576 LPS by the alditol acetate method 
 
The LPS of B. pseudomallei 576 was hydrolysed and derivatised to form alditol acetates and analysed by 
GC-MS (Section 2.4.8.7) (Figure 4.6). Comparison of the two chromatograms as well as examination of the 
mass spectrometric fingerprints of each moiety eluted from the gas chromatography column allowed for full 
annotation of the chromatogram showing the monosaccharide composition of the B. pseudomallei 576 LPS. 
The mass spectrometric fingerprints (Figure 4.7, Figure 4.8 and Figure 4.9) were assessed to determine 
the structures of the monosaccharide moieties as per the fragmentation and further losses of functional 
groups from the fragments, such as is observed by the loss of ketenes and acetate groups. The 
monosaccharides present in the sample of B. pseudomallei 576 were shown to be the pentose xylose 
(elution time: 19.94min, Figure 4.7), deoxyhexose rhamnose (elution time: 19.41min, Figure 4.8), and 
hexoses galactose and glucose (elution time: 23.71mins, Figure 4.9). 
 
Similarly to the TMS chromatograms the deoxymannoheptose peak was assigned in comparison with B. 
pseudomallei K96243 chromatogram (Figure 4.13) and information from literature, whilst the galactose 
moiety seemed to arise from the sample preparation employed by our collaborators using L-broth media 
containing galactose, as was explained by an alditol acetate experiment using an LPS free sample of B. 
pseudomallei 576 (B. pseudomallei ΔLPS) run alongside the wild type B. pseudomallei 576 LPS (data not 
shown). The mannoheptose peak identified in the chromatogram is understood to potentially arise from the 
core portion of the LPS, which is known to contain mannoheptose moieties. The structure of the core 
polysaccharide of the B. pseudomallei 576 LPS has not been defined or published yet. 
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Figure 4.6 – GC-MS alditol acetate analysis of B. pseudomallei 576 LPS. 
The sample (top panel) was run alongside commercially obtained standards, at 50nM each (bottom panel). The samples were 
run on a Perkin Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column. The standards preparation was 
supplemented with 50nM of the internal standard Inositol. Non-sugar impurities present in the chromatogram are labelled x. 
 
 
Figure 4.7 – Mass spectrometric fingerprint of xylose from the GC-MS chromatogram. 
The mass spectrometric fingerprint of xylose was obtained from alditol acetate derivatives of the B. pseudomallei 576 LPS 
(top panel) and presented with that of the commercially obtained standard for xylose (bottom panel). The samples were run on 
a Perkin Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column. The fragmentation pattern of the monosaccharide 
is annotated in the top panel, showing the main fragments (pink) of the molecule as well as sub-fragments arising from the 
loss of functional groups (blue and green). The structure of the derivatised monosaccharide is shown in a separate schematic 
(bottom panel). 
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Figure 4.8 – Mass spectrometric fingerprint of rhamnose from the GC-MS chromatogram. 
The mass spectrometric fingerprint of rhamnose was obtained from alditol acetate derivatives of the B. pseudomallei 576 LPS 
(top panel) and presented with that of the commercially obtained standard for rhamnose (bottom panel). The samples were run 
on a Perkin Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column.The fragmentation pattern of the 
monosaccharide is annotated in the top panel, showing the main fragments (pink) of the molecule as well as sub-fragments 
arising from the loss of functional groups (blue and green). The structure of the derivatised monosaccharide is shown in a 
separate box (bottom panel). 
 
 
Figure 4.9 – Mass spectrometric fingerprint of glucose from the GC-MS chromatogram. 
The mass spectrometric fingerprint of glucose was obtained from alditol acetate derivatives of the B. pseudomallei 576 LPS 
(top panel) and presented with that of the commercially obtained standard for glucose (bottom panel). The samples were run 
on a Perkin Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column. The fragmentation pattern of the 
monosaccharide is annotated in the top panel, showing the main fragments (pink) of the molecule as well as sub-fragments 
arising from the loss of functional groups (blue and green). The structure of the derivatised monosaccharide is shown in a 
separate box (bottom panel). 
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4.2.3 Linkage analysis of B. pseudomallei 576 LPS 
 
Linkage analysis allows for the determination of the carbon atoms involved in a linkage, where free hydroxyl 
groups in the glycan are substituted by an ether-linked methyl group. The glycosidic linkages are then 
hydrolysed by acid and the implicated hydroxyl groups can be further acetylated to produce partially 
methylated alditol acetates (Dell and Morris, 2001, McNeil et al., 1982). The B. pseudomallei LPS was 
derivatised into partially methylated alditol acetates to provide insight into the potential linkages present in 
the O-antigen repeat unit (Section 2.4.8.8). The samples were analysed by GC-MS fitted with an RTX-5MS 
column (Figure 4.10). Examination of the mass spectrometric fingerprints of each moiety eluted from the gas 
chromatography column allowed for full annotation of the chromatogram showing the monosaccharide 
linkages of the B. pseudomallei 576 LPS. The mass spectrometric fingerprints, such as is demonstrated for 
the terminal pentose, 2-linked deoxyhexose, 3,4-linked deoxyhexose and 3-linked hexose (Figure 4.11), 
were assessed to determine the linkages of the monosaccharide moieties as per the fragmentation and 
further losses of functional groups from the fragments, such as is observed by the loss of ketenes and 
acetate groups. The linkage data revealed a terminal pentose and a terminal hexose moiety. The 
deoxyhexose linkages include 2-, 3-, 4-, 3,4- and 2,3-linked moieties. Further hexose moieties show 3-, 6- 
and 2,6-linkages. Compared with what would be expected for the typical strain K96243 (serotype A) LPS 
(Figure 4.14a), the serotype B 576 LPS chromatogram is remarkably complex, with double linkages 
indicating a potentially branched structure. It is to be noted, though, that some of the annotated 
chromatogram peaks will have arisen from monosaccharide linkages found in the LPS core, so further 
information is required to fully annotate the linkage arrangement of the O-antigen of the LPS. 
 
 
Figure 4.10 – GC-MS linkage analysis of B. pseudomallei 576 LPS with 50nM of inositol. 
The samples were run on a Perkin Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column. The annotation was 
completed using the mass spectrometric fingerprints and fragmentation pathways of the monosaccharide structures. Non-
sugar impurities present in the chromatogram are labelled x. 
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Figure 4.11 – Mass spectrometric fingerprints of linkage signals. 
The mass spectrometric fingerprints of a terminal pentose, 2-linked deoxyhexose, 3,4-linked deoxyhexose and 3-linked hexose were obtained from the GC-MS chromatogram of the linkage 
analysis of the B. pseudomallei 576 LPS, run on a Perkin Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column. The fragmentation patterns of the monosaccharides are 
annotated, showing the main fragments (pink) of the molecule as well as sub fragments arising from the loss of functional groups (blue and green). The structures of the derivatised 
monosaccharides are shown in a separate box. 
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Figure 4.12 – GC-MS analysis of TMS derivatised LPS from B. pseudomallei and B. thailandensis. 
The chromatograms for the wild type and capsule mutant of strain K96423 are shown in (a) and (b) respectively. The chromatogram for the B. thailandensis wild type is shown in (c) and that of 
B. pseudomallei strain 576 in (d). All samples were run on a Perkin Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column. Non-sugar impurities present in the chromatogram are 
labelled x. 
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Figure 4.13 – GC-MS alditol acetate analysis comparisons. 
The figure presents alditol acetate chromatograms for B. pseudomallei strains K96423 (a), capsule mutant (b) and 576 (d) as well as B. thailandensis (c). All samples were run on a Perkin 
Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column. Non-sugar impurities present in the chromatogram are labelled x. 
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Figure 4.14 – GC-MS of linkage analysis comparisons. 
The figure presents alditol acetate chromatograms for B. pseudomallei strains K96423 (a), capsule mutant (b) and 576 (d) as well as B. thailandensis (c). ). All samples were run on a Perkin 
Elmer Clarus 500 GC-MS instrument fitted with a RTX-5MS column. Non-sugar impurities present in the chromatogram are labelled x. 
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4.2.4 Comparison of 576 LPS composition and linkage with related strains 
 
The derivatised B. pseudomallei 576 LPS was further compared to the derivatised LPS moieties of related B. 
pseudomallei and B. thailandensis. All LPS were analysed by GC-MS as TMS, alditol acetate and partially 
methylated alditol acetate derivatives in order to assess the composition and linkage of the serotype B (576) 
as it differs from related serotype A LPS (B. pseudomallei K96243 and B thailandensis E264). The samples 
analysed included the LPS of B. pseudomallei K96243, K96243 ΔCPS (K96243 without capsule), 576 and B. 
thailandensis E264. 
 
4.2.4.1 Comparisons of TMS findings 
 
The evaluated chromatograms indicate the composition of the B. pseudomallei samples consisting of 
deoxytalose and glucose in both the K96423 wild type (Figure 4.12a) and capsule mutant (Figure 4.12b) of 
that same strain. Peaks for both deoxytalose and methylated deoxytalose are observable in the B. 
pseudomallei samples. All chromatograms for B. pseudomallei K96243, K96243 ΔCPS as well as B. 
thailandensis (Figure 4.12c) show compositions consistent with published data for serotype A (Brett et al., 
1998, Knirel et al., 1992, Perry et al., 1995). Galactose was identified and is thought to arise from either 
background carbohydrate contamination from L-broth medium, however it is to be noted that the core of the 
B. pseudomallei LPS has not yet been identified and thus galactose could potentially be present in the LPS 
core. The composition of the B. pseudomallei 576 (Figure 4.12d), was previously identified to contain 
rhamnose and glucose. The mannoheptose moiety is most likely from the core unit of the LPS. The data 
described earlier for strain 576 confirmed the presence of the pentose moiety, xylose, which was not 
observed in the B. pseudomallei strain K96423 or B. thailandensis LPS. Furthermore the glucose moiety is 
present at equal relative ratios to talose in strain K96243, in strain 576 the rhamnose moiety is relatively 
more abundant as compared to the rest of the monosaccharide moieties identified. 
 
4.2.4.2 Comparisons of alditol acetate analysis 
 
The chromatograms for B. pseudomallei and B. thailandensis serotype A LPS support the compositional 
understanding from the TMS results and confirm the published structure for B. pseudomallei K96423 (Figure 
4.13a). Again, two separate peaks for the deoxytalose moiety are identified, with slight differences in their 
mass spectrometric fingerprints, due to partial 2-O-methylation, as suggested in literature (Reckseidler et al., 
2001). Peaks for rhamnose, galactose and mannoheptose, presumably from the LPS core are also present, 
or in the case of galactose also from the growth media. As suggested by the TMS results, glucose is present 
at a similarly high intensity as the deoxytalose moiety to make up the repeating heteropolymer unit of the O-
antigen. A deoxymannoheptose peak can be seen around 23.39mins on the chromatogram as the main 
component of the capsule. The B. pseudomallei capsule mutant (Figure 4.13b) shows many similarities to 
that of its wild type, but is missing the deoxymannoheptose peak representing the capsule, similar to the B. 
thailandensis (Figure 4.13c) chromatogram where the peak for the capsule sugar moiety is also absent. The 
B. pseudomallei strain 576 (Figure 4.13d) chromatogram shows a rhamnose peak as well as a xylose peak. 
There is also a capsule sugar component as shown by the peak around 23.54mins, which has a 
deoxymannoheptose mass spectrometric fingerprint. The rhamnose peak is much larger when compared to 
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the deoxyhexose moieties in compositional analysis of the other LPS samples, suggesting increased 
presence in the O-antigen repeat unit. 
 
4.2.4.3 LPS linkage analysis and comparisons 
 
Linkage analysis on the Burkholderia samples gave insight into the organisation of the repeating 
oligosaccharide units making up the O-antigen chain on each strain and serotype. The B. pseudomallei wild 
type O-antigen forms a disaccharide unit of 3-linked glucose with 3-linked deoxytalose linked to the core 
structure of the LPS via the deoxytalose unit. The non-reducing terminal glucose is also observed in the 
chromatogram (Figure 4.14a). The linkage data of the capsule mutant B. pseudomallei LPS (Figure 4.14b) 
is similar to its wild type and the repeating heteropolymer unit is made up of 3-linked glucose and 3-linked 
deoxytalose components, with the latter linked to the core element of the LPS. The B. thailandensis wild type 
strain (Figure 4.14c) supports a similar composition, where 3-linked glucose and 3-linked deoxytalose are 
prominent in the chromatogram, accompanied by the terminal glucose peak that suggests the deoxytalose 
linkage to the core unit. The core structure of these LPS strains has not yet been characterised and thus the 
2-, 2,4-linked and 3-linked hexose moieties in excess of these assignments cannot be assigned precisely. It 
has been established that galactose is present in these samples as per the sample preparation procedures 
used by our collaborators however, due to the possibility of as of yet unidentified moieties arising from core 
signals, these cannot be definitively assigned. The complex linkage chromatogram of B. pseudomallei 576 
strain (Figure 4.14d) supports initial findings from TMS and alditol acetates about the complexity of the O-
antigen heteropolymer, with a terminally linked pentose, deoxyhexose as well as a terminal hexose evident 
in the chromatogram. Furthermore, the deoxyhexoses seem to be 2-, 3-, 4-, 2,3- and 3,4-linked, of which 
some of the signals will most probably be determined as arising from the rhamnose moiety in the O-antigen 
repeat unit, but care has to be taken as some signals will possibly have arisen from core linkages. The main 
hexose peaks show a 3-linked and 6-linked hexose mass spectrometric fingerprint, while the 2,6-linked 
hexose peak is proposed to arise from the core unit linkages or the galactose polymer arising from the 
growth medium. 
 
4.2.5 Compositional and linkage analysis summary and discussion 
 
The purified samples of B. pseudomallei and B. thailandensis were analysed for sugar composition as TMS 
derivatised monosaccharides in order to assess the quality of the sample and get an idea of the composition 
of the O-antigen sugars in the unknown strain B. pseudomallei 576 O-antigen. The two peaks observed for 
deoxytalose shown in the B. pseudomallei chromatograms are consistent with the discussed literature, 
where it was found that 33% of the deoxytalose residues have been shown to contain 2-O-methyl and 4-O-
acetyl substituents, while the other deoxytalose residues contain only 2-O-acetyl substituents (Brett et al., 
2003, Reckseidler et al., 2001). While the assignment of the known structures proved the sample’s suitable 
quality, the unknown strain 576 LPS of B. pseudomallei, showed relatively higher variation in 
monosaccharide peaks, as compared to K96423 and B. thailandensis. Xylose was observed in strain 576 but 
not in any of the other samples, indicating a more complex repeat unit for this strain. 
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The alditol acetate information further substantiates the published data on the B. pseudomallei K96243 LPS 
composition and monosaccharide modifications, as seen by the distinct deoxytalose peaks for the 2-O-
methylated and non-methylated units, while the prepared minimal capsule sample seems identical, bar the 
capsule deoxymannoheptose moiety. Furthermore, the experiments reinforce the notion that the B. 
thailandensis LPS has a similar enough structure to be potentially used for protection studies, as suggested 
by complementary immunological studies (Ngugi et al., 2010). The differences seem to lie in the missing 
capsule moiety, most likely contributing to its lower virulence nature. A summary of the proposed 
composition of the O-antigens investigated is shown in Table 4.1. 
 
The B. pseudomallei strain K96243 wild type and minimal capsule strain LPS both show matching linkage 
chromatograms, consistent with the published data on the heteropolymer illustrating it to consist of 3-linked 
glucose and 3-linked deoxytalose to make up the O-antigen part of the LPS (Knirel et al., 1992, Perry et al., 
1995). The linkage information on the B. thailandensis LPS, shows a similarly simple chromatogram, differing 
in the presence of a 2-linked hexose peak, which most likely derives from the core polysaccharide. On the 
other hand, the B. pseudomallei strain 576, shows linkage data of higher complexity compared to the other 
samples. The xylose unit revealed from the TMS and alditol acetate analysis presents itself as a terminal 
sugar in the O-antigen polymer, in addition to the terminal deoxyhexose and hexose moieties. This leads to 
the conclusion that the repetitive oligosaccharide unit, unlike the typical LPS of the K96243 strain, is 
branched; as is further supported by the possible 2,3- or 3,4-linked deoxyhexose peak, providing the basis 
for such branching on the repeat unit of the O-antigen. 
 
Burkholderia sample Suggested sugar Composition 
B. pseudomallei K96243 LPS & CPS O-antigen: glucose and deoxytalose 
Core: rhamnose, galactose, mannoheptose 
Capsule: deoxymannoheptose 
B. pseudomallei K96243 LPS only (ΔCPS) O-antigen: glucose and deoxytalose 
Core: rhamnose, galactose, mannoheptose 
Capsule: N.A. 
B. pseudomallei 576 LPS & CPS O-antigen: xylose , rhamnose, glucose 
Core: mannoheptose 
Capsule: deoxymannoheptose 
B. thailandensis WT LPS O-antigen: glucose and deoxytalose 
Core: rhamnose, mannoheptose 
Capsule: N. A. 
Table 4.1 – Suggested sugar compositions of Burkholderia samples. 
 
The suggested difference in deoxyhexose monosaccharide subunits employed in the O-antigen repeat unit 
by the two distinct serotypes A (B. pseudomallei K96243) and B (B. pseudomallei 576), calls into question 
why and how such a change would evolve in two such closely related serotypes of the same bacterium. 
Generally, the biosynthesis of 6-deoxyhexoses occurs from a nucleotidylated hexose, such as dTDP-glucose 
by dTDP-glucose 4,6-dehydratase (RmlB) from which diverse deoxyhexoses can be generated, including 
dTDP-6-deoxytalose and dTDP-rhamnose (Thibodeaux et al., 2008). The biosynthesis of rhamnose requires 
the actions of glucose-1-phosphate thymidyltransferase (RmlA), dTDP-glucose 4,6-dehydratase (RmlB), 
dTDP-4-hexulose 3,5 epimerase (RmlC) and finally dTDP-6-deoxy-lyxo-4-hexulose reductase / 4-KR (RmlD). 
The biosynthetic gene cluster in B. pseudomallei K96243 and 576 (serotypes A and B) contain the dTDP-
rhamnose biosynthesis genes of rmlABCD (Figure 1.11), however not the 4-KR enzymes appropriate for the 
creation of dTDP-6-deoxytalose from it’s the dTDP-6-deoxy-xylo-4-hexulose. 6-deoxytalose, however is the 
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C4 epimer of rhamnose and it was therefore proposed that an epimerase (WbiB) was responsible for the 
synthesis of dTDP-6-deoxytalose from dTDP-rhamnose (DeShazer et al., 1998). Furthermore, recent studies 
on B. thailandensis demonstrated epimerase activity that interconverted dTDP-rhamnose and dTDP-6-
deoxytalose (Yoo et al., 2011). This suggests an explanation for such a switch in monosaccharide 
incorporation with a possible lack of the wbiB gene present in the B. pseudomallei 576 serotype B 
biosynthesis cassette. This would further be support the B. pseudomallei evolutionary model, whereby both 
gene acquisition and loss occurs in horizontal transfer events, as was previously discussed in Section 1.3.4. 
 
4.3 MS SEQUENCING OF THE B. PSEUDOMALLEI LPS O-ANTIGEN REPEAT 
 
As previously discussed, the size and amphiphilic nature of LPS makes them difficult to analyse intact by 
mass spectrometry. Structure determination is usually attained by independent analyses of the lipid A and 
carbohydrate moieties after their separation by hydrolysis at the Kdo linkage. In favourable cases, MALDI 
data from intact LOS has been possible to be acquired (Silipo et al., 2006). Unfortunately we found that B. 
pseudomallei 576 LPS was refractory to direct MS analysis. Thus when samples were analysed using linear 
MALDI-MS in a sinapinic acid matrix in both the positive and negative ion mode, no molecular ions were 
observed (results not shown). Therefore it was necessary to hydrolyse the polysaccharide into smaller 
pieces prior to MALDI-MS. In this section the various hydrolytic conditions that were tested for optimum 
hydrolysis of the polysaccharides are described together with the resulting MALDI-MS and MS/MS data 
(Section 2.4.7). Furthermore, to understand the efficiency of lipid A removal by each of the methods, we 
analysed the samples with their respective non-hydrolysed samples as standards by FAME analysis and 
compared them with standards for the acyl chains (Section 2.4.8.9). 
 
4.3.1 Mild acid hydrolysis 
 
Mild acid hydrolysis is widely used to liberate the core and O-antigen polysaccharide from the Lipid A by 
selective cleavage of the acid-labile glycosidic linkage between Kdo in the core oligosaccharide and the lipid 
A (Section 2.4.7.1). To examine the suitability of mild acid hydrolysis to release the lipid A from the rest of 
the polysaccharide, the mild acid hydrolysed LPS moieties from B. pseudomallei 576 and B. thailandensis 
were evaluated by fatty acid methyl ester analysis. This allowed for comparison of lipid moieties remaining 
after mild acid hydrolysis and centrifugation to separate the polysaccharide moieties from the lipid A. Whilst 
the O-antigen of various strains of the same species of bacteria can show extreme differences in structures, 
the lipid A and core unit of the LPS are generally quite conserved, suggesting B. thailandensis to be a 
suitable comparison for such analyses with B. pseudomallei 576. 
 
B. pseudomallei 576 and B. thailandensis wild type samples were compared to the same sample post mild 
1% acetic acid hydrolysis. The FAME analysis for B. thailandensis mild acid hydrolysis (Figure 4.15), 
showed the absence of 3-hydroxyl fatty acids present at 20.86mins (C14 3:OH) and 24.11mins (C16 3:OH) 
post 1% acetic acid hydrolysis. The selected ion chromatograms for the ion m/z 103, which is specific for the 
3-hydroxy fatty acids, confirmed the absence of the methyl esters post hydrolysis. In contrast, the FAME 
analysis for B. pseudomallei 576 mild acid hydrolysis (Figure 4.16) showed methyl esters of C14 3:OH and 
C16 3:OH at 20.87mins and 24.10mins respectively, even after hydrolysis with 1% acetic acid. Experiments 
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with B. pseudomallei 576 in comparison with B. pseudomallei K96243 as well as increased concentrations of 
acetic acid used for incubation showed similar results (data not shown). This suggests that mild acid 
hydrolysis and centrifugation does not ensure the loss of the lipid A moiety from the 576 LPS, despite the 
conditions used being effective for cleavage of the other LPS samples examined. 
 
 
Figure 4.15 – FAME analysis chromatograms of B. thailandensis E264. 
The chromatograms presented are of B. thailandensis E264 and post 1% acetic acid hydrolysis. The sample was run alongside 
commercially obtained standards (C15, C14 3:OH and C16 3:OH) on a Perkin Elmer Clarus 500 GC-MS instrument fitted with a 
Stabilwax column. The total ion chromatograms for m/z 103 are specific to the 3-hydroxy fatty acids present in the lipid A. 
Non-FAME impurities present in the chromatogram are labelled x. 
 
 
Figure 4.16 – FAME analysis chromatograms of B. pseudomallei 576. 
The chromatograms presented are of B. pseudomallei 576 and post 1% acetic acid hydrolysis. The sample was run alongside 
commercially obtained standards (C15, C14 3:OH and C16 3:OH) on a Perkin Elmer Clarus 500 GC-MS instrument fitted with a 
Stabilwax column. The total ion chromatograms for m/z 103 are specific to the 3-hydroxy fatty acids present in the lipid A. 
Non-FAME impurities present in the chromatogram are labelled x. 
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4.3.2 Methanolysis 
 
Mild acid hydrolysis is generally understood to be too mild a hydrolysis procedure to fully fragment O-antigen 
polysaccharides into their respective repeating units. However, the procedure can be very useful in cases 
where acid labile linkages are present. In this instance, MALDI-MS showed no data indicative of hydrolysis 
fragments (results not shown). These results suggest that the O-antigen polysaccharides lack acid-sensitive 
glycosidic linkages. Previous investigation into hydrolysis of the O-antigen polysaccharides of the B. 
pseudomallei K96243 (serotype A) by methanolysis showed the heteropolymer repeating units. The same 
hydrolysis conditions, however, achieved no fragmentation for B. pseudomallei 576 (serotype B) by mass 
spectrometry (Section 2.4.7.2). Hydrolysis of the samples investigated by methanolysis at 1M and 0.1M 
MeOH-HCl analysed at 15, 30, 45, 60, 75 and 90min intervals at room temperature provided no additional 
information (results not shown). 
 
Figure 4.17 shows the MALDI spectrum for B. pseudomallei K96243 hydrolysed at 50ºC in 0.25M MeOH-
HCl for 15mins, showing the heteropolymer units made up of glucose and deoxytalose. While hydrolysis 
conditions to achieve effective hydrolysis on B. pseudomallei K96243 and B. thailandensis E264 strains were 
established, it proved far more difficult to break the B. pseudomallei 576 into fragments observable by MS. 
The other samples for B. pseudomallei K96243, the capsule mutant and the B. thailandensis wild type, 
showed similar hydrolysis fragments using the above mentioned conditions (results not shown). The B. 
pseudomallei 576 sample, however, did not show any hydrolysis pattern, despite variations in temperature, 
optimal MeOH-HCl concentrations and reaction times investigated (results not shown). 
 
 
Figure 4.17 – MALDI-MS of B. pseudomallei LPS K96243 post methanolysis. 
The MALDI-MS spectrum above shows the B. pseudomallei K96243 LPS, post hydrolysis with methanolysis in 0.25M MeOH-
HCl for 15mins at 50ºC and permethylation. The data was accumulated on a PerSeptive Biosystems Voyager-DE STR System 
MALDI mass spectrometer. The O-antigen repeat unit of the repeating glucose-deoxytalose polymer is annotated. 
 
4.3.3 Ammonolysis 
 
As previous hydrolysis methods proved ineffective in harvesting suitably sized polysaccharide repeating 
units for analysis by MALDI-MS of the atypical LPS B. pseudomallei 576, ammonolysis was employed 
(Section 2.4.7.3). This is a process used to isolate the polysaccharide while maintaining the fidelity of the 
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repeating structure, in the case of polysaccharides containing certain more susceptible glycosidic linkages. 
The B. pseudomallei 576 strain LPS was hydrolysed using ammonolysis and the MALDI-MS data shown in 
Figure 4.18 and Figure 4.19, which confirmed compositional information and given a greater insight into the 
complexity of the O-antigen. 
 
 
Figure 4.18 – MALDI-MS of B. pseudomallei LPS 576 hydrolysed by ammonolysis (35% ACN). 
The MALDI-MS spectrum above shows the B. pseudomallei 576 LPS, as hydrolysed by ammonolysis in 10M ammonium 
hydroxide for 18hrs at 150°C and permethylated. The spectrum shows the 35% ACN fraction from the Sep-Pak® purification 
process and was analysed on a PerSeptive Biosystems Voyager-DE STR System MALDI mass spectrometer. The 
monosaccharide moieties identified are annotated in the spectrum. 
 
 
Figure 4.19 – MALDI-MS of B. pseudomallei LPS 576 hydrolysed by ammonolysis (100% ACN). 
The MALDI-MS spectrum above shows the B. pseudomallei 576 LPS, as hydrolysed by ammonolysis in 10M ammonium 
hydroxide for 18hrs at 150°C and permethylated. The spectrum shows the 100% ACN fraction from the Sep-Pak® purification 
process and was analysed on a PerSeptive Biosystems Voyager-DE STR System MALDI mass spectrometer. The 
monosaccharide moieties identified are annotated in the spectrum. 
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The figures show a repeated sequence of monosaccharides of the heteropolymer. As suggested by 
compositional analysis these recurring units are made up of xylose, rhamnose and glucose 
monosaccharides. Both figures additionally show the presence of mannoheptose moieties, which are 
assumed to derive from the core (Section 1.1.2.2.1, Section 4.3.4.1 and Figure 4.37). The ammonolysis 
procedure used on B. pseudomallei 576 as presented in these figures, produced fragmentation patterns by 
MALDI-MS, however repetition of the experiments on the samples investigated produced no further 
information on fragmentation of the polysaccharides (results not shown). 
 
4.3.4 SDS hydrolysis 
 
Further investigation into a suitable hydrolysis procedure for the B. pseudomallei 576 LPS led us to follow up 
on the work of Novem and colleagues (Novem et al., 2009), who recently published their findings on the 
structure of the lipid A. The technique used to separate the lipid A from the rest of the polysaccharide using 
sodium dodecyl sulphate (SDS) in sodium acetate was employed and combined with mild acid hydrolysis, 
allowing for MALDI-MS and MS/MS data collection on the core and O-antigen of B. pseudomallei 576 
(Section 2.4.7.4). The samples were further derivatised by deuteropermethylation and reduced or 
deuteroreduced prior to permethylation. MALDI-MS and MALDI-MS/MS data analysis of these samples, 
provided further information on the O-antigen repeat unit. The use of the adjusted SDS hydrolysis procedure 
provided an additional benefit such that different Sep-Pak® purification fractions, contained separate and 
clearly unrelated series of molecular ions. The higher concentrations of ACN purification fractions seemed to 
contain the core domain of the LPS, which was analysed similarly to the O-antigen preparations and 
described in Section 4.3.4.1. 
 
Hydrolysis of B. pseudomallei 576 LPS with this adjusted method of hydrolysis produced MALDI-MS data as 
annotated in the spectrum in Figure 4.20. MALDI-MS data showing a “ladder” of molecular ions (flagged in 
yellow) separated by mass increments consistent with predicted monosaccharides, as visible in the 
annotated spectrum. The spectrum shows mass differences of peaks consistent with xylose, rhamnose and 
hexose monosaccharides, as supported by GC-MS composition data. Each of these molecular ions was 
selected for MS/MS analysis. 
 
 
Figure 4.20 – MALDI-MS spectrum of B. pseudomallei 576 LPS hydrolysed by the adapted SDS method. 
The annotated signal pattern shows the presence of xylose, rhamnose and glucose monosaccharides in the O-antigen repeat. 
The sample was analysed on an Applied Biosystems 4800 MALDI-TOF/TOF mass spectrometer, after hydrolysis with SDS, 
acidified ethanol and acetic acid and derivatisation by permethylation. This spectrum was accumulated from the 50% ACN 
Sep-Pak® purification fraction. 
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In the MALDI-MS spectrum in Figure 4.20, the highlighted molecular ions were further isolated for MS/MS 
analysis. The MALDI-MS/MS spectra of the molecular ions at m/z 781.37, 955.45, 1159.54, 1333.62 and 
1493.68 are shown in Figure 4.21, Figure 4.22, Figure 4.23, Figure 4.24 and Figure 4.25 respectively. 
 
 
Figure 4.21 – MALDI-MS/MS spectrum of the molecular ion at m/z 781.37. 
The molecular ion was obtained from B. pseudomallei 576 LPS preparation analysed on an Applied Biosystems 4800 MALDI-
TOF/TOF mass spectrometer, after hydrolysis with SDS, acidified ethanol and acetic acid and derivatisation by 
permethylation. This spectrum was accumulated from the molecular ion at m/z 781.37 found in the 35% ACN Sep-Pak® 
purification fraction. 
 
 
Figure 4.22 – MALDI-MS/MS spectrum of the molecular ion at m/z 955.45. 
The molecular ion was obtained from B. pseudomallei 576 preparation analysed on an Applied Biosystems 4800 MALDI-
TOF/TOF mass spectrometer, after hydrolysis with SDS, acidified ethanol and acetic acid and derivatisation by 
permethylation. This spectrum was accumulated from the molecular ion at m/z 955.45 found in the 35% ACN Sep-Pak® 
purification fraction. 
 
 
Figure 4.23 – MALDI-MS/MS spectrum of the molecular ion at m/z 1159.54. 
The molecular ion was obtained from B. pseudomallei 576 LPS preparation analysed on an Applied Biosystems 4800 MALDI-
TOF/TOF mass spectrometer, after hydrolysis with SDS, acidified ethanol and acetic acid and derivatisation by 
permethylation. This spectrum was accumulated from the molecular ion at m/z 1159.54 found in the 50% ACN Sep-Pak® 
purification fraction. 
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Figure 4.24 – MALDI-MS/MS spectrum of the molecular ion at m/z 1333.62. 
The molecular ion was obtained from B. pseudomallei 576 LPS preparation analysed on an Applied Biosystems 4800 MALDI-
TOF/TOF mass spectrometer, after hydrolysis with SDS, acidified ethanol and acetic acid and derivatisation by 
permethylation. This spectrum was accumulated from the molecular ion at m/z 1333.62 found in the 50% ACN Sep-Pak® 
purification fraction. 
 
 
Figure 4.25 – MALDI-MS/MS spectrum of the molecular ion at m/z 1493.68. 
The molecular ion was obtained from B. pseudomallei 576 LPS preparation analysed on an Applied Biosystems 4800 MALDI-
TOF/TOF mass spectrometer, after hydrolysis with SDS, acidified ethanol and acetic acid and derivatisation by 
permethylation. This spectrum was accumulated from the molecular ion at m/z 1493.68 found in the 50% ACN Sep-Pak® 
purification fraction. 
 
The observed fragmentation patterns in these figures, as well as other MS/MS spectra of further molecular 
ions (results not shown) and understanding of linkage and composition gained from GC-MS analysis, 
allowed the postulation of various structures of the O-antigen repeat unit. 
 
The molecular ions presented in these figures, specifically the molecular ion at m/z 781.37 and 1493.68 
would suggest a composition of a pentose, a hexose and two deoxyhexoses per O-antigen repeat unit, as is 
presented in Figure 4.26 and Figure 4.27 respectively. It should be noted, however, that this sequence is 
not unambiguous due to the multiple options of fragmentation pattern assignment. However, the proposed 
structures are not the sole fragmentation patterns observed in the MALDI-MS/MS spectra and thus a series 
of possible structures and fragmentation patterns is shown in Figure 4.28. 
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Figure 4.26 – Cartoon representation of a proposed structure of the molecular ion at m/z 781.37. 
This representation of the proposed smallest repeat unit, as hydrolysed and permethylated, suggests a composition of a 
xylose, a glucose and two rhamnose monosaccharides per O-antigen repeat unit. 
 
 
Figure 4.27 – Cartoon representation of a proposed structure of the molecular ion at m/z 1493.68. 
This representation of proposed two repeat units, as hydrolysed and permethylated, is suggested to be composed of two 
xyloses, two glucoses and four rhamnoses. 
 
To help resolve ambiguities, the sample was further prepared with different derivatisation procedures post 
hydrolysis. Once the samples were hydrolysed they were either permethylated, deuteropermethylated, 
reduced or deuteroreduced for comparison (Section 2.4.8.2, Section 2.4.8.3 and Section 2.4.8.4). The 
reduction step was important for differentiating reducing and non-reducing fragment ions. D-labels were 
important for confirming tentative assignements. This, in combination with repetitions to improve and add 
data, allowed for further evidence to support the proposed structure of the O-antigen repeat unit. 
 
All major molecular ions observed in the MS spectra were subjected to MS/MS and data for the molecular 
ion at m/z 1493.68 were chosen for detailed assessment because its composition  is likely to correspond to 
two repeat units of two pentoses, two hexoses and four deoxyhexoses, which based on results from GC-MS 
analysis can be inferred as two xyloses, two glucoses and four rhamnoses (Figure 4.29 and Figure 4.30). 
The fragment ions from the permethylated samples were very useful for partial assignment of the structure of 
the O-antigen repeat unit. Unfortunately, however, the ions could not be unequivocally assigned to a unique 
sequence of the monosaccharides, due to the multiple options of fragmentation pattern assignment. As 
found in Figure 4.25, these include, for example, the rhamnose fragment between m/z 1145.52 and m/z 
971.47, the glucose fragment between m/z 971.47 to m/z 767.37 or the rhamnose fragment between m/z 
433.22 and m/z 259.09. These fragments and many more add uncertainty to the assignment of the 
sequence. Furthermore, any fragment assignment of m/z 174 could suggest the presence of a rhamnose or 
a terminal xylose. 
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Figure 4.28 – Series of cartoon structures possible for the molecular ion at m/z 1493.68. 
The figure shows a series of possibilities accumulated from the MALDI-MS/MS analyses of every molecular ion found in the 
series of MALDI-MS molecular ions corresponding to the O-antigen. 
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Figure 4.29 – MALDI-MS/MS spectrum of B. pseudomallei 576 LPS molecular ion at m/z 1493.50. 
This sample was hydrolysed in SDS, acidified ethanol and acetic acid, permethylated and the molecular ion was present in the 
purified by Sep-Pak® fraction of 50% ACN. The spectrum was accumulated on an Applied Biosystems 4800 MALDI-TOF/TOF 
mass spectrometer. The fragmentation annotated suggests a composition of two xyloses, two glucoses and four rhamnoses. 
This is likely to correspond to two O-antigen repeat units. 
 
 
Figure 4.30 – Proposed structure of two O-antigen repeat units, from MS/MS of m/z 1493.50. 
The schematic also takes into account other MS/MS spectra and compositional and linkage data from GC-MS. This sample 
was prepared by derivatisation by permethylation prior to MS and MS/MS analysis. 
 
The MALDI-MS data for the different derivatisation procedures, produced the same molecular ion distribution 
for fragments as is shown in Figure 4.20, with the exception that masses shifted according to the 
derivatisation procedure performed. In each MALDI-MS spectrum all molecular ions related to the O-antigen 
repeat series were selected for MS/MS analysis. Presented here are the MALDI-MS/MS spectra of the 
molecular ions corresponding to that of m/z 1493.68, in Figure 4.20, which was suggested to represent two 
O-antigen repeat units. These molecular ions were m/z 1554.01, m/z 1509.67 and m/z 1510.63 for the 
deuteropermethylated, reduced and deuteroreduced samples respectively. 
 
The deuteropermethylation distinguished peaks related to the molecular ion in question from those arising 
from non-methylated contaminants, as these were the only ones showing a shift in mass, as shown in Figure 
4.31, with the respective proposed structural assignment in Figure 4.34. Furthermore, reduction or 
deuteroreduction of the oligosaccharides aided in identifying the direction of cleavage thus allowing 
identification of the reducing end of the O-antigen repeat unit. The reduced and deuteroreduced sample 
fragmentations are shown in Figure 4.33 and Figure 4.35 respectively, which allowed for the identification of 
specific reducing end ions, including reducing-end rhamnose, reducing-end xylose-rhamnose and reducing-
end glucose. The most significant peak for the reducing-end ions are m/z 405.19 and m/z 406.21 for the 
reduced and deuteroreduced sample, respectively. This corresponds to a reducing end ion of reducing-end 
xylose-rhamnose. The inferred structural proposals for these reduced and deuteroreduced MALDI-MS/MS 
spectra are shown in Figure 4.34 and Figure 4.36, respectively. 
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Figure 4.31 – MALDI-MS/MS spectrum of B. pseudomallei 576 LPS molecular ion at m/z 1554.01. 
This sample was hydrolysed in SDS, acidified ethanol and acetic acid, deuteropermethylated and the molecular ion was 
present in the purified by Sep-Pak® fraction of 50% ACN. The spectrum was accumulated on an Applied Biosystems 4800 
MALDI-TOF/TOF mass spectrometer. The fragmentation annotated suggests a composition of two xyloses, two glucoses and 
four rhamnoses. The m/z differences corresponding to the monosaccharides are larger, due to the use of deuterium instead of 
hydrogen in the permethylation procedure (see Table 1.4). This spectrum confirms the proposed structure from the 
permethylated sample shown in Figure 4.32. 
 
 
Figure 4.32 – Proposed structure of two O-antigen repeat units from MS/MS of m/z 1554.01. 
The schematic also takes into account other MS/MS spectra and compositional and linkage data from GC-MS. This sample 
was prepared by derivatisation by deuteropermethylation prior to MS and MS/MS analysis. 
 
 
Figure 4.33 – MALDI-MS/MS spectrum of B. pseudomallei 576 LPS molecular ion at m/z 1509.67. 
This sample was hydrolysed in SDS, acidified ethanol and acetic acid and reduced prior to permethylation and the molecular 
ion was present in the purified by Sep-Pak® fraction of 50% ACN. The spectrum was accumulated on an Applied Biosystems 
4800 MALDI-TOF/TOF mass spectrometer. The fragmentation annotated suggests a composition of two xyloses, two glucoses 
and four rhamnoses. The reducing end of the fragments found in the MALDI-MS/MS spectrum will have a slightly larger mass 
(+ m/z 16) in comparison with the non-reducing end monosaccharide signal differences. This spectrum confirms the proposed 
structure from the permethylated sample shown in Figure 4.32. 
 
 
Figure 4.34 – Proposed structure of two O-antigen repeat units, from MS/MS spectrum of m/z 1509.67. 
The schematic also takes into account other MS/MS spectra and compositional and linkage data from GC-MS. This sample 
was reduced before derivatisation by permethylation prior to MS and MS/MS analysis. 
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Figure 4.35 – MALDI-MS/MS spectrum of B. pseudomallei 576 LPS molecular ion at m/z 1510.63. 
This sample was hydrolysed in SDS, acidified ethanol and acetic acid and deuteroreduced prior to permethylation and the 
molecular ion was present in the purified by Sep-Pak® fraction of 50% ACN. The spectrum was accumulated on an Applied 
Biosystems 4800 MALDI-TOF/TOF mass spectrometer. The fragmentation annotated suggests a composition of two xyloses, 
two glucoses and four rhamnoses. The reducing end of the fragments found in the MALDI-MS/MS spectrum will have a slightly 
larger mass (+ m/z 17) in comparison with the non-reducing end monosaccharide signal differences. This spectrum confirms 
the proposed structure from the permethylated sample shown in Figure 4.32. 
 
 
Figure 4.36 – Proposed structure of two O-antigen repeat units, from MS/MS of m/z 1510.63. 
The schematic also takes into account other MS/MS spectra and compositional and linkage data from GC-MS. This sample 
was reduced before derivatisation by permethylation prior to MS and MS/MS analysis. 
 
The proposed structure of the O-Antigen repeat unit in Figure 4.30 is primarily based on information 
deduced from the fragment ions that arose from MS/MS of the molecular ions at m/z 1493.68, m/z 1554.01, 
m/z 1509.67 and m/z 1510.63 for the four derivatisation procedures employed. This was combined with 
information from other MS/MS spectra from different molecular ions as well as, compositional and linkage 
data from GC-MS. These experiments provided confidence that the proposed structures of the hydrolysis 
products are representative of most of the elements of the repeat unit of B. pseudomallei 576 LPS. However 
it is important to bear in mind that labile portions, such as acetyl or methyl group modifications of the repeat 
unit may have been lost or masked during derivatisation or hydrolysis. 
 
4.3.4.1 SDS hydrolysis of the LPS core domain 
 
Upon investigation of the LPS O-antigen through the use of the adjusted SDS hydrolysis procedure 
described in Section 2.4.7.4, some of the Sep-Pak® purification fractions recovered, clearly contained 
molecular ion sequences unrelated to that of the O-antigen. These fractions, mainly higher concentrations of 
ACN, were likely to comprise the core domain of the LPS of B. pseudomallei 576. The MALDI-MS spectra of 
these fractions were therefore assessed and individual molecular ions subjected to MALDI-MS/MS analysis 
as was done for the LPS O-antigen containing fractions. Furthermore, the samples were also 
deuteropermethylated and reduced as well as deuteroreduced prior to permethylation for further data 
accumulation on the core domain of the LPS. 
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The MALDI-MS spectrum presented in Figure 4.37 shows the assumed core domain cluster of molecular 
ions found in fractions of the higher concentrations of ACN post Sep-Pak® purification. The spectrum 
identified in the 75% ACN fraction, was reproduced when deuteropermethylating, as well as reducing and 
deuteroreducing the sample prior to further derivatisation by permethylation (data not shown). The 
monosaccharide moieties presented in the spectrum include 3-deoxy-D-manno-oct-2-ulsonic acid (Kdo) and 
D-glycero-D-talo-octu-2-ulsonic acid (Ko) as well as mannoheptose, hexose and deoxyhexose. The Kdo, 
mannoheptose and hexose moieties are generally expected in the core domains of bacterial LPS, however, 
the finding of Ko led to further understanding of reasons for the inadequate hydrolysis of the LPS with 
standard procedures and the need for further development of such techniques. 
 
 
Figure 4.37 – MALDI-MS spectrum of B. pseudomallei 576 core domain cluster. 
The sample was hydrolysed in SDS, acidified ethanol and acetic acid and permethylated. The molecular ions corresponding to 
the core domain cluster were present in the 75% ACN fraction of the Sep-Pak® purified sample. The spectrum was 
accumulated on an Applied Biosystems 4800 MALDI-TOF/TOF mass spectrometer. The monosaccharide constitution of the 
core domain cluster includes Ko, Kdo, Hep, Hex and dHex moieties. 
 
Albeit accumulating a series of data sets, including MALDI-MS and MALDI-MS/MS data of differentially 
derivatised samples of the core domain of the B. pseudomallei LPS, the focus of this project remained with 
the structural characterisation of the O-antigen of the B. pseudomallei 576 LPS, rather than its core domain. 
Therefore no further work was undertaken at this stage to identify the structure of the core domain. 
 
4.3.5 Summary conclusions and discussion of LPS O-antigen repeat unit elucidation 
 
4.3.5.1 Mild acid hydrolysis for lipid removal 
 
The lipid A in LPS is connected to the core polysaccharide that normally is easily separated by exploiting the 
labile linkage between the Kdo of the core and the lipid A, which can be hydrolysed to separate the two. The 
core structure of the LPS of B. pseudomallei, however, has not been determined yet. It was clear from the 
mild acid hydrolysis techniques employed with B. pseudomallei and B. thailandensis samples, that this 
technique, whilst suitable for B. thailandensis and B. pseudomallei K96243 (serotype A) samples, may not 
be useful for the B. pseudomallei 576 LPS (serotype B). 
 
Preliminary results on B. cepacia showed that the LPS possess the following unusual chemical feature; the 
sugar that interlinks the core and lipid A, which usually is 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) in 
enterobacterial LPS, was not the only moiety involved in the linkage to the lipid A in B. cepacia LPS. In B. 
cepacia 2-keto-octulsonic acid (Ko) has been shown to most commonly replace the second Kdo in linking the 
core directly to lipid A forming a more acid stable ketosidic linkage, where the additional hydroxyl group is 
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thought to play a role in the stability of this linkage (Isshiki et al., 1998, Kawahara et al., 1987, Masoud et al., 
2009). With the SDS hydrolysis procedure adapted for B. pseudomallei 576 degradation, information could 
be gathered on the core domain of the LPS (Section 4.3.4.1), showing that this also seems true for B. 
pseudomallei lipid A-core linkage in B. pseudomallei 576 LPS. These studies on the separated and 
hydrolysed core polysaccharide show the presence of a mass increment consistent with the presence of Ko 
(m/z 306 for permethylated monosaccharides). Furthermore, the linkage between the core and lipid A was 
resistant against mild acid hydrolysis in B. cepacia (Isshiki et al., 1998). In the case of B. pseudomallei, it 
was found that the linkage between the core and the lipid A is susceptible to mild acid hydrolysis only for B. 
pseudomallei K96243 and B. thailandensis LPS (serotype A). In B. pseudomallei 576 (serotype B), this 
linkage seems to be resistant against mild acid hydrolysis and could be due to similar reasons as in B. 
cepacia. Therefore, with the possible presence of such a distinctive core of B. pseudomallei 576, the linkage 
between the lipid A and the core polysaccharide may not be as easily broken, depending on the 
monosaccharide the lipid A is connected to. 
 
Furthermore, it has been shown that the major lipid A species in B. pseudomallei consists of a 
biphosphorylated disaccharide backbone, which is modified with 4-amino-4-deoxy-arabinose (Ara4N) at both 
phosphates and penta-acylated with fatty acids C14:3OH, C16:3OH and either C14:O or C14:2OH (Novem 
et al., 2009). It was abundantly clear that mild acid hydrolysis was not producing easily separable lipid A and 
polysaccharide moieties for further studies, and completely different approaches were then pursued to 
remove the lipid A from the B. pseudomallei 576 LPS, for further structural elucidation. Investigation into a 
different release by acid hydrolysis through sodium dodecyl sulphate in sodium acetate and more aggressive 
methanolysis as employed by Novem and colleagues proved suitable for collection of O-antigen repeat unit 
structural analysis (Novem et al., 2009). 
 
4.3.5.2 O-antigen repeat unit structure and core domains 
 
It was established by MALDI-MS analysis that the LPS, even released from the lipid A, was too large to be 
studied as a whole and therefore a series of hydrolysis methods were carried out to determine the best 
parameters to achieve regular breaking of the polymers to an optimal size for structural determination by 
MALDI-MS. Hydrolysis techniques including various concentrations of methanolic acetylchloride, 
ammonolysis as well as mild acid hydrolysis were employed to find the best hydrolysis parameters to 
observe the polysaccharide units making up the O-antigen. The polysaccharides of different strains seemed 
to behave differently to various hydrolysis techniques, which could be explained by their variations in 
structure, as some bonds might be more unstable than others in distinct arrangements. The preliminary set 
of experiments of the listed hydrolysis procedures employed, generated inconclusive results even though the 
ammonolysis method allowed for some insight by MALDI-MS, but was not reproducible. 
 
Further work into the structural characterisation of the O-antigen repeat unit of B. pseudomallei LPS using 
sodium dodecyl sulphate (SDS) hydrolysis in sodium acetate in combination with different derivatisation 
techniques, provided enough information to propose a theoretical structure and sequence of the O-antigen 
repeat unit by MALDI-MS and MALDI-MS/MS. The proposed structure in Figure 4.30 is based on 
information deduced from the fragment ions that arose from tandem mass spectrometry of various molecular 
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ions as derivatised by different techniques as well as compositional and linkage data from GC-MS (Section 
4.2). These experiments provided confidence that the proposed structures of the hydrolysis products are 
representative of most of the elements of the repeat unit of B. pseudomallei 576 LPS. However it is important 
to bear in mind that labile portions of the repeat unit may have been lost during hydrolysis or derivatisation. It 
should also be noted that earlier linkage analysis experiments showed many peaks with different linkage 
profiles, which could not be fully explained by the tentative sequence, which is further discussed in Section 
4.4.4. 
 
Core domain elucidation of bacterial LPS moieties has been undertaken by various laboratories, however, 
this does not seem a trivial task, as is seen in the structural characterisation of the core domain of the H. 
pylori LPS as described by Altman and colleagues (Altman et al., 2011a, Altman et al., 2011b). The LPS of 
H. pylori has been investigated by various groups for a long time and only the last few years have shown the 
possibility to define the outer core and establish major structural differences from previous conclusions made 
from earlier mass spectrometric data. Furthermore, such characterisation required approximately 60-80mg of 
LPS sample roughly 40x the total sample amounts used for the various experiments described in this thesis. 
This highlights the difficulty of bacterial glycopolymer characterisation, however, data presented in this thesis 
and advances made in this field prove progress in structural characterisation of prokaryotic glycopolymers. 
 
4.4 B. PSEUDOMALLEI LPS ANALYSIS BY NMR 
 
With all the mass spectrometric data culminating in a proposed structure, further work was undertaken to 
confirm the validity of the conclusions that had been arrived at. NMR methods were devised to provide 
information on the linkage and anomeric stereochemistry of the hydrolysates and narrow down the possible 
O-antigen structure. Preliminary NMR analysis was performed on a Bruker Avance III 600 MHz spectrometer 
equipped with a TCI cryoprobe on a sample that had been solubilised by the same SDS hydrolysis technique 
that provided the MALDI-MS and MALDI-MS/MS data. With the understanding that hydrolysed sample 
preparations provided excessive amounts of information due to the heterogeneity of the hydrolysed O-
antigen fragments, further investigations were made into a different method for structural analysis by NMR. A 
method embedding native LPS moieties into mixed-DPC-LPS micelles as adapted from Acquotti and 
Sonnino (Acquotti and Sonnino, 2000) was piloted with a standard LPS and further employed for analysis of 
the intact LPS of B. pseudomallei 576 LPS. 
 
4.4.1 NMR of the hydrolysed B. pseudomallei O-antigen 
 
The sample, previously hydrolysed by SDS hydrolysis in sodium acetate was prepared in bulk for analysis by 
NMR spectroscopy. Multi-dimensional NMR techniques were used to gain further insight into the linkage and 
composition of the O-antigen repeat unit. 
 
The LPS was hydrolysed using the SDS combined method (Section 2.4.7.4) and the separation of the O-
antigen and core fractions of the polysaccharide was achieved by ion-exchange chromatography (Section 
2.4.9.1). The separation was based on the carboxylic acid group of the Kdo and Ko components of the core, 
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where Kdo has a pKa of 2-3. The O-antigen was found in the H2O fraction, whilst the core was found in the 
5% acetic acid and the 0.1M HCl fraction. The fractions were dried down and lyophilised. 
 
In proton NMR spectroscopy, most carbohydrate signals are crowded between 3ppm and 4ppm. The signals 
from the anomeric protons (H-1 bound to C-1 of any monosaccharide residues) are found downfield, allowing 
for interpretation of the anomeric stereochemistry of the monosaccharide residues. In the hydrolysed B. 
pseudomallei sample, it is shown that there are resonances relating to monosaccharides in both α- and β-
form (Figure 4.38). This means that there are multiple α- and β-anomeric residues, as is expected for a 
complex sample. From the 1D proton NMR, we can further tentatively confirm the deoxyhexose moiety 
discovered by GC-MS, MALDI-MS and MALDI-MS/MS, as seen from the signals between 1.1 – 1.3ppm 1H 
chemical shift, which is consistent with the methyl residues found on deoxyhexoses, such as rhamnose. The 
intense signal found at 3.41ppm, could derive from a methoxy substituent of a monosaccharide moiety, 
however this could also arise from residual ethanol moieties from the hydrolysis procedure. 
 
 
Figure 4.38 – 1D 1H NMR spectrum of hydrolysed B. pseudomallei 576 O-antigen. 
The sample was hydrolysed by SDS, acidified ethanol and acetic acid and purified by ion exchange chromatography. The 
spectrum was acquired on a Bruker Avance III 600 MHz spectrometer equipped with a TXI/TCI cryoprobe in 100% D2O. 
Anomeric protons are found in the 4.2-6.0ppm range, whilst non-anomeric protons are found in the 3.0-4.2ppm range. 
 
Homonuclear correlation spectra (COSY, TOCSY) are used to assign the 1H spectrum. TOCSY experiments 
are similar to COSY experiments, where cross peaks of coupled protons are observed. In COSY spectra the 
cross peaks are observed only for nuclei directly coupled, whereas TOCSY spectra show signals for nuclei 
that are connected by a chain of couplings. This allows for signal allocation for a whole spin system, or 
monosaccharide in carbohydrate NMR. This is achieved by a repetitive series of pulses, which cause 
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isotropic mixing; the longer the isotropic mixing time, the further the polarisation can spread throughout the 
spin system, generally allowing cross-peaks for all protons in a monosaccharide. 
 
The 2D homonuclear 1H-1H correlation NMR spectra (TOCSY) of the hydrolysed B. pseudomallei 576 O-
antigen were accumulated at different mixing times, which are used in carbohydrate NMR to build up 
assignments for individual spin systems associated with monosaccharide residues within the O-antigen 
structure (data not shown). These however, did not produce enough data for assignment of the spin systems 
involved in the O-antigen structure, as only fragmentary spin systems could be identified and full spin system 
assignment could therefore not be deduced from the spectra. The weak and fragmentary nature of the 
spectra was attributed to the minimal amounts of sample available and the complexity of the mixture of O-
antigen fragments in the hydrolysate. Sample amounts are a crucial determinant for NMR data accumulation, 
where an increase in sample amount exponentially decreases the time taken to accrue NMR spectra. This 
means that an increase in sample concentration has a greater effect on data quality than extending the 
experiment times. 
 
A ROESY experiment was further conducted, which explores the correlations between nuclei in space and 
could be used to confirm assignments and provide sequence and linkage position information. The sample 
quantity, however, proved too small to accumulate enough data and results are not shown. 
 
A couple of correlation signals were identified in the spectra and used for assignment of the cross-peak 
lattices on the heteronuclear 1H-13C single quantum correlation spectra (HSCQ), which is used to detect 
through-bond correlations between nuclei of two different types, in this case 1H and 13C nuclei. Figure 4.39 
shows the 2D heteronuclear total 1H-13C correlation NMR spectrum of the hydrolysed B. pseudomallei 576 
O-antigen (HSQC-TOCSY), where the 13C chemical shift scale was “folded” and thus minimised to allow for 
more data collection on a small sample amount. Spectral folding, or spectral aliasing is a frequently used 
phenomenon in NMR spectroscopy, if a large spectral width is required for data accumulation, which 
increases the experimental recording times. Folding of the spectral width, allows for signal presentation at 
frequencies, different from their real frequency. Tuning of acquisition parameters are crucial, when applying 
such folding or aliasing, to ensure that folded or aliased peaks do not overlap with other peaks present in the 
spectrum, that cannot easily be distinguished from these folded peaks. Spectral folding allows for an 
increased number of scans, accumulating more data and only slightly reduces the resolution. The coloured 
lattice arrangements assigned on the spectrum show spin systems, where the 1H and 13C correlations within 
a monosaccharide residue are connected. This allows comparison with information on chemical shift 
patterns reported in literature in order to identify monosaccharides. The spectrum shows very poorly resolved 
signals that seem to overlap. This again, could be due to the fact that the O-antigen of the LPS was 
hydrolysed, which allows for solubilisation for NMR, but produces a very heterogeneous sample. 
 
From the 1D proton NMR spectrum it can be concluded that the proposed elements of the O-antigen repeat 
unit show concurring signals in the NMR spectra, confirming the presence of a deoxyhexose as well as 
hexoses. Further to this information, a large methyl signal was observed, which could suggest a methylated 
monosaccharide present in the O-antigen of B. pseudomallei 576, as was previously identified in the wild 
type serotype A of B. pseudomallei K96243. However, due to the hydrolysis method containing solvents with 
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such methyl groups, this signal could arise from residual solvent presence. Additionally, various anomeric 
signals were shown, suggesting multiple α- and β-anomeric residues. A tentative assignment of the 
deoxyhexose as coinciding with literature values for α-rhamnose could be made. Furthermore, partial 
information from both the homo- and heteronuclear spectra are consistent with a β-hexose moiety. 
 
 
Figure 4.39 – 2D HSQC-TOCSY of hydrolysed B. pseudomallei 576 O-antigen. 
The sample was hydrolysed by SDS, acidified ethanol and acetic acid and purified by ion exchange chromatography. The 2D 
heteronuclear 1H-13C total correlation NMR spectrum was acquired on a Bruker Avance III 600 MHz spectrometer equipped with 
a TXI/TCI cryoprobe in 100% D2O. The coloured lattice assignments show partial correlations of some unique spin system. 
 
The O-antigen sample was hydrolysed at different monosaccharide linkages, resulting in a mixture of 
different, yet similar compounds. These fragments will give very similar but not identical signals for each 
monosaccharide in the repeat unit, resulting from the slight change in environment in that specific 
compound. As a result, too much information is presented as a crowded spectrum containing many weak 
signals rather than a minimal number of strong signals, which makes complete assignment impossible. 
 
4.4.2 Pilot study of micelle-LPS 
 
To avoid the above mentioned problems of heterogeneity and solubility of the LPS sample, which are 
exacerbated by the lipid A, a different approach was proposed for obtaining suitable NMR data. In this 
experiment, instead of trying to solubilise the sample into organic solvents, an unhydrolysed sample of B. 
pseudomallei 576 was investigated as mixed micelles with a perdeuterated detergent, such as 
dodecylphosphocholine in aqueous solutions (Section 2.4.10.1) as is discussed by Acquotti and Sonnino 
who describe this method with gangliosides (Acquotti and Sonnino, 2000). This protocol would simplify the 
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spectrum by avoiding hydrolysis of the sample and allowing for NMR analysis on the full sample amount as 
extracted by our collaborators at dstl. Mock experiments using model compounds were therefore developed 
using standardised LPS from E. coli (serotypes O26 and 128) to create micelles with 
dodecylphosphocholine. 
 
The previously characterised LPS O-antigen of the LPS of E. coli O26 was prepared in micelles and 
analysed by NMR to assess this as a technique to elucidate the O-antigen structure of B. pseudomallei LPS. 
With the determination of this technique as viable for the interpretation of non-hydrolysed LPS structures it is 
possible to deduce the O-antigen repeat unit and its modifications as a whole, where the mixed DPC-
micelles of LPS and dodecylphosphocholine mimic the membrane. Furthermore this technique produces 
micelles of almost spherical shape that show rotational mobility, carrying LPS chains that show internal 
mobility, thus allowing for high-resolution NMR spectra and avoiding unnecessary sample loss through 
sample processing. 
 
NMR spectroscopic techniques employed in this series of experiments were aimed at re-producing initial 
result, published on the characterisation of the O-antigen of E.coli LPS O26. The structure of the O-antigen 
of E. coli O26 LPS was published by Manca and colleagues in 1996 at Stockholm University in Sweden 
(Manca et al., 1996). Sugar and methylation analyses as well as 2D NMR spectroscopy were used to 
characterise the O-antigen. 
 
The following structure was proposed by Manca and colleagues (Manca et al., 1996): 
 
→3)-α-L-Rhap-(1→4)-α-L-FucpNAc-(1→3)-β-D-GlcpNAc-(1→ 
 
The chemical shifts (ppm) of the signals produced by the experiments performed by Manca and colleagues 
are shown in Table 4.2. 
 
Sugar residue H/C 
1 2 3 4 5 6 NAc CO 
→4)-α-L-FucNAc-(1→ 5.01 4.17 3.96 3.87 4.43 1.19 1.97  
98.6 [174] 50.6 68.0 82.0 68.0 16.3 23.0 175.1 
→3)-α-L-Rha-(1→ 4.83 (1.9) 4.28 3.90 3.49 4.03 1.22   
102.6 [169] 70.9 81.1 71.7 70.4 17.4   
→3)-β-D-GlcNAc-(1→ 4.68 (8.4) 3.89 3.70 3.55 3.47 3.77;3.89 2.04  
103.5 [163] 56.5 79.6 69.4 76.4 61.5 23.0 175.0 
Table 4.2 – E. coli O26 O-antigen chemical shifts published by Manca and colleagues. 
The table above lists the chemical signals (ppm) observed by Manca and colleagues, including the signals in the 1H and 13C 
NMR spectra of the O-deacetylated E. coli O26 O-antigen polysaccharide (Manca et al., 1996). 
 
The mixed-DPC-LPS micelles of E. coli LPS O26 were run at the Cross Faculty NMR Centre at Imperial 
College London, and the 1D proton NMR spectrum shown in Figure 4.40 was obtained. The anomeric 
residues were annotated with lettered labels A, B and C to denote the anomeric hydrogen residues and the 
respective spin systems of the three monosaccharides. The obtained chemical shifts (ppm) are shown in 
Table 4.3. 
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Sugar residue H 
1 2 3 4 5 6 NAc 
A →4)-α-L-FucNAc-(1→ 
 
5.02 4.12 3.97 ~3.86 4.44 1.20 1.97 
97.6 51.0 67.0 80.9 67.1   
B →3)-α-L-Rha-(1→ 4.82 4.33 ~3.89 3.47 4.06 1.21  
101.5 69.9 80.2 70.8 69.4   
C →3)-β-D-GlcNAc-(1→ ~4.66 ~3.90 3.69 3.55 3.47 3.77; 3.87 2.03 
 55.6 78.2 68.4 75.5 60.5  
Table 4.3 – Chemical shift (ppm) signals of the mixed-DPC-LPS micelles of E. coli LPS O26. 
The values noted here were identified from the 1D proton NMR spectrum shown in Figure 4.40 and Figure 4.41. The values are 
to two decimal places but can vary by a decimal place within the spectra due to the difficulty of calibration at low resolution. 
 
 
Figure 4.40 – 1D 1H NMR spectrum of the E. coli O26 LPS embedded in mixed DPC-LPS-micelles. 
The spectrum was acquired on a Bruker Avance III 600 MHz spectrometer equipped with a TXI/TCI cryoprobe in 100% D2O. 
Anomeric residues of each monosaccharide spin system are labelled with letters in colour. Contaminants and micelle signals 
are labelled with x. 
 
The signal at 2.15 ppm in Figure 4.40 is discussed to disappear on alkaline treatment by Manca and 
colleagues. The O-acetylation of the O-antigen is partial, as was deducible from the peak intensity, which is 
relatively less intense than other signals in the spectrum. This would also suggest that there are two different 
versions of the O-antigen, which could also be the case for the B. pseudomallei 576 LPS, where it is 
common for bacterial polysaccharides to be modified further by acetylation, methylation or phosphorylation. 
The H-1 of the GlcNAc monosaccharide is buried beneath the D2O peak and therefore obscured from 
precise assignment. 
 
The 2D TOCSY NMR spectrum shown in Figure 4.41 allowed for partial spin system assignments, which 
could be interpreted for each monosaccharide in the O-antigen repeat unit. The coloured spin system 
assignments for each monosaccharide present is carried forward from the assignemnts of the anomeric 
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hydrogen signals found in the 1D spectrum. A heteronuclear HSQC was run for the mixed DPC-LPS-micelles 
(results not shown) and cross peaks from each monosaccharide could be annotated. 
 
Although a lot of information could be deduced from the spectra, the signals were still faint and the spectral 
accumulation needed to be run for longer times and particularly with more sample. 
 
 
Figure 4.41 – 2D TOCSY of the E. coli O26 LPS embedded in mixed-DPC-micelles. 
The 2D 1H-1H total correlation NMR spectrum shows the LPS of E. coli O26 LPS embedded in mixed DPC-LPS-micelles. The 
spectrum was acquired on a Bruker Avance III 600 MHz spectrometer equipped with a TXI/TCI cryoprobe in 100% D2O. Spin 
systems of respective monosaccharide residues are shown in colour. 
 
4.4.3 NMR analysis of B. pseudomallei LPS embedded in micelles 
 
Investigation into the method using micelles to embed LPS moieties for assessment of the repeat unit 
structure of their O-antigens proved effective, where heterogeneity and solubility issues of the samples were 
overcome. The O-antigen repeat unit of E. coli serotype O26 was successfully assigned using both 1D and 
2D NMR spectroscopy. Therefore further B. pseudomallei 576 LPS sample was prepared in the same way 
for analysis of the O-antigen repeat unit (Section 2.4.10.2). Since the literature on structural elucidation by 
NMR of LPS embedded in micelles is rather short and to overcome the problem of signals belonging to the 
micelle creating moieties such as DPC, NMR spectra of micelle-DPC only samples were accumulated to 
allow for exclusion of the respective signals. All spectra were calibrated to acetone supplemented in one of 
the samples and collectively aligned. 
 
178 
 
Chapter 4  B. pseudomallei 576 LPS analysis 
The 1D proton NMR spectrum of B. pseudomallei 576 LPS embedded in DPC-mixed micelles is shown in 
Figure 4.42. Anomeric hydrogen resonances were annotated with letters to denote specific spin systems 
that could be present in the O-antigen repeat unit. These are labelled with different colours to carry over 
assignments into spin lattice arrangements on 2D NMR spectra. Eight anomeric residues were denoted, 
evidently far too many to be consistent with the mass spectrometry derived proposed O-antigen repeat unit 
of four monosaccharides per repeat unit and these anomeric signals were further investigated in 2D TOCSY 
experiments. The 1D NMR spectrum of the micelle-embedded moieties of LPS from B. pseudomallei in 
comparison to that of the hydrolysed sample shows similarities in both the presence of the glucose moiety as 
well as the methyl cluster and partial O-acetylation signals previously identified. 
 
Furthermore there is an overall pattern especially visible in the α and β anomeric region. With the objective of 
full characterisation of any O-antigen repeat unit or polysaccharide by NMR, the anomeric signals of the H-1 
carbons (α and β anomers) were initially assessed to accumulate information on the global organisation of 
the O-antigen repeat unit. The number of signals found in the anomeric region provides an indication of the 
number of monosaccharide spin systems and hence the number of monosaccharide residues present in the 
O-antigen repeat unit, due to the repetitive environment encountered by each monosaccharide in a repeat 
unit. The proton signals corresponding to the monosaccharides spin systems could be traced from each 
anomeric proton signal. With the information collected by compositional and linkage analysis, as well as 
MALDI-MS and MALDI-MS/MS data in combination with literature values, the structure of the O-antigen in 
question could be projected. 
 
A 2D TOCSY NMR spectrum was accumulated as shown in Figure 4.43. This allowed for partial spin system 
assignemnt, which could be interpreted to suggest specific monosaccharides in the O-antigen repeat unit of 
B. pseudomallei 576 LPS, by corroboration with literature values. The coloured spin system assignment for 
each monosaccharide present is carried forward from the assignment of the anomeric proton signals found 
in the 1D spectrum. 
 
Analysis of the 2D TOCSY NMR spectrum of the B. pseudomallei 576 LPS embedded in micelles as 
prepared from a newly provided sample for NMR analysis, showed that the NMR spectra contained signals 
far outside the predicted chemical shifts for normal sugars (Figure 4.44). Upon investigation of the nature of 
such signals as are found between 5.5ppm and 8.0ppm, it became clear that signals representative of RNA 
and DNA nucleotides were present in the spectrum. Furthermore, these signals showed cross-peaks to the 
region investigated for the O-antigen repeat unit monosaccharide hydrogen signals, and thus created an 
overcrowded envelope region, that was too complex to investigate. To overcome such signal crowding and 
for purification of the LPS embedded in the micelles, the sample had to be further treated with Benzonase® 
endonuclease , which was then digested with pronase enzyme (Section 2.4.10.2). Analysis of the dialysed 
and re-exchanged sample allowed for a much cleaner spectrum Figure 4.45. This allowed for a much purer 
sample preparation for analysis by NMR and a 2D TOCSY NMR spectrum of the B. pseudomallei 576 LPS is 
shown in Figure 4.46, post sample purification and clean up. 
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Figure 4.42 – 1D 1H NMR spectrum of the B. pseudomallei 576 LPS in micelles. 
The spectrum was acquired on a Bruker Avance III 600 MHz spectrometer equipped with a TXI/TCI cryoprobe in 100% D2O. 
Proposed anomeric residues of possible monosaccharide spin system are labelled with letters in colour. Contaminants and 
micelle signals are labelled with x. 
 
 
Figure 4.43 – 2D TOCSY spectrum of the B. pseudomallei 576 LPS in micelles. 
The spectrum was acquired on a Bruker Avance III 600 MHz spectrometer equipped with a TXI/TCI cryoprobe in 100% D2O. 
Proposed spin system assignments of respective monosaccharide residues are labelled with letters and highlighted in colour. 
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Figure 4.44 – 2D TOCSY spectrum of the B. pseudomallei 576 LPS (contamination). 
The sample was embedded in mixed DPC-LPS-micelles. The 1H-1H total correlation NMR spectrum was acquired on a Bruker 
Avance III 600 MHz spectrometer equipped with a TXI/TCI cryoprobe in 100% D2O. The coloured areas show contamination 
signals arising from the sample preparation, which contained nucleotide (RNA and DNA) signals. 
 
 
Figure 4.45 – 2D TOCSY spectrum of the B. pseudomallei 576 LPS (clean). 
The sample was embedded in mixed DPC-LPS-micelles. The 1H-1H total correlation NMR spectrum was acquired on a Bruker 
Avance III 600 MHz spectrometer equipped with a TXI/TCI cryoprobe in 100% D2O. The coloured areas previously showed 
contamination signals arising from the sample preparation which contained nucleotide (RNA and DNA) signals, which were 
removed by treatment with benzonase, pronase and dialysis. 
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Figure 4.46 – 2D TOCSY spectrum of the B. pseudomallei 576 LPS in micelles (clean). 
The spectrum was acquired on a Bruker Avance III 600 MHz spectrometer equipped with a TXI/TCI cryoprobe in 100% D2O. 
Proposed spin system assignments of respective monosaccharide residues are labelled with letters and highlighted in colour. 
Contamination signals arising from the sample preparation which contained nucleotide (RNA and DNA) signals were removed 
by treatment with benzonase, pronase and dialysis. 
 
The assessment and annotation of the two 2D TOCSY NMR spectra of B. pseudomallei 576 LPS embedded 
in micelles allowed for the identification of spin systems associated with the anomeric signals found in the 1D 
NMR spectrum. The anomeric signals labelled A and B in Figure 4.42 were initially understood to be 
monosaccharide spin systems from interpretation of the TOCSY spectrum. Anomeric carbon chemical shifts 
are generally found between 90-110ppm in pyranose or slightly above 110ppm for furanose sugars. 
However upon assessment of the HSQC-TOCSY carbon chemical shifts respective to the H-1 anomeric 
chemical shifts, the signals associated with the anomeric carbons, were not in this region. In bacterial 
polysacharides it is not unprecedented that non-monosaccharide components can be associated with the O-
antigen moiety of an LPS, however no mass spectrometric data suggested the presence of such non-
carbohydrate moieties to be included in the O-antigen repeat unit and thus the signals corresponding to spin 
systems A and B were determined not to be part of the O-antigen and thus disregarded at the present time. 
The rest of the spin systems annotated in the 1D and the 2D TOCSY NMR spectra of the B. pseudomallei 
576 LPS O-antigen were analysed and combined as is shown in Table 4.4. 
 
It is clear from the 1D proton NMR spectrum of the B. pseudomallei 576 LPS embedded micelles, that the 
creation of micelles allowed for suitable solubilisation of the LPS, however due to the now much larger 
nature of this new macromolecular complex, the multiplicity (fine structure) of the LPS O-antigen repeat unit 
is lost from the NMR spectrum. This was additionally worsened by the necessity to further purify the sample 
provided, where sample loss could have occurred during dialysis for removal of the contaminants, whilst 
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repeated D2O exchanges might have allowed the micelles to coalesce resulting in larger micelles being 
formed, thus decreasing resolution of signals due to the size of the macromolecular complex. 
 
Residue assignment 1H chemical shift (ppm) 
C 5.16, 4.18, 4.12, 4.00, 3.69, 1.2-1.4 
D 5.09, 4.22, 3.99, 3.94 
E 5.00, 4.20, 3.76, 3.57, 3.43, 1.2-1.4 
F 4.94, 4.10, 4.01, 3.53 
G 4.52, 3.93, 3.63, 3.47, 3.30, 3.21 
H 4.43, 3.64, 3.44, 3.31 
Table 4.4 – Chemical shift signals of proton spin systems of B. pseudomallei 576 LPS. 
The proton spin system signals of the B. pseudomallei 576 LPS sample, as embedded in mixed DPC-LPS-micelles, were 
identified from the 1D proton NMR spectrum (Figure 4.42) as well as 2D TOCSY NMR spectra (Figure 4.43 and Figure 4.46). The 
values are to two decimal places but can vary by a decimal place within the spectra due to the difficulty of calibration at low 
resolution. 
 
In Table 4.4, six spin systems are identified, however, mass spectrometric analysis allowed for the 
proposition of an O-antigen repeat unit for B. pseudomallei 576 LPS of a repeat unit containing four 
monosaccharides (one pentose, two deoxyhexoses and one hexose, denoted as a xylose, two rhamnoses 
and a glucose moiety). Due to the novelty of the method employed in creating mixed micelles with LPS for 
analys by NMR and with the time constraints on thesis submission, the method could not be optimised 
further. From the data obtained by NMR in the limited time permitted, the proposed O-antigen repeat unit 
structure cannot be verified and further analysis will be necessary to corroborate the postulated structure. 
There is unfortunately not enough data from the TOCSY data to allow for full spin system assignment of 
each monosaccharide. However, some of the anomeric signals could be ruled out as signals deriving from 
monosaccharides and possible assignments can be made with the support of literature values for 1H 
chemical shifts. This will by no means validate the structure of the O-antigen unit investigated, but is 
presented here as a possibility that is in line with the data and structural proposition derived from mass 
spectrometric data. 
 
The spin systems derived from analysis of the 1D and 2D TOCSY NMR spectra in comparison with literature 
values, allowed for a tentative proposition of monosaccharide identities that support previous findings by 
MALDI-MS, MALDI-MS/MS and GC-MS suggesting a proposed O-antigen repeat unit of a four 
monosaccharide repeat unit branched at a deoxyhexose (rhamnose) moiety, containing a xylose, two 
rhamnoses and a glucose monosaccharide moiety. Using the data available, the provisional assignments of 
the monosaccharide identities shown in Table 4.5 offer the best possible interpretations that can be made at 
the time of thesis submission. 
 
The unannotated spin systems shown in Table 4.5 did not allow for identification of any monosaccharides 
and further information is required for complete description, however variations in environments can be 
expected in different parts of the O-antigen repeat unit, allowing for the occurrence of further spin systems. 
Furthermore, it is widely understood that bacterial LPS moieties can be extensively modified, such as is seen 
by acetylation and methylation, which will undoubtedly allow for such differences. The 1D proton NMR 
spectrum describes such modification, if only partial, to be present in this O-antigen repeat unit, providing a 
possible explanation for the chemical shift systems denoted by D and F. 
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Residue 1H chemical shift (ppm) Tentative assignment Reference 
C 5.16, 4.18, 4.12, 4.00, 3.69, 1.2-1.4 α-rhamnose (2,3-linked) (Czerwicka et al., 2011) 
5.18, 4.19, 3.96, 3.71, 3.51, 1.27 
D 5.09, 4.22, 3.99, 3.94   
E 5.00, 4.20, 3.76, 3.57, 3.43, 1.2-1.4 α-rhamnose (2-linked) (Mattos et al., 2005) 
4.97, 4.19, 3.89, 3.84, 3.57, 1.31 
F 4.94, 4.10, 4.01, 3.53   
G 4.52, 3.93, 3.63, 3.47, 3.30, 3.21 β-glucose (3-linked) (Perry et al., 1995) 
4.62, 3.62, 3.49, 3.47, 3.45, 3.75/3.86  
H 4.43, 3.64, 3.44, 3.31 β-xylose (terminal) (Molinaro et al., 2003) 
4.55, 3.69, 3.45, 3.33, 3.37/3.91 
Table 4.5 – Tentative assignments of systems in B. pseudomallei 576 LPS O-antigen. 
The table shows the proposed monosaccharide residue assignments for the O-antigen of the B. pseudomallei 576 LPS and the 
associated reference signals from published data (italics). The signals were identified from the 1D proton NMR spectrum as 
well as the 2D TOCSY NMR spectra shown in Figure 4.42, Figure 4.43 and Figure 4.46, respectively. The values are to two 
decimal places but can vary by a decimal place within the spectra due to the difficulty of calibration at low resolution. 
 
Inspection of the 2D homonuclear NOESY NMR spectrum of B. pseudomallei 576 LPS as embedded in 
micelles also showed the previously annotated spin system arrangements as derived from the 2D TOCSY 
experiments. This is shown in Figure 4.47. The spin systems of the previously annotated monosaccharide 
residues are shown in colour, whilst new chemical shifts, not previously seen in the 2D TOCSY experiments 
are highlighted in green. The highlighted crosspeaks generally suggest possible correlation to a different spin 
system/monosaccharide. Due to the partial nature of the assignment owing to the inadequate data collection, 
such sequence information could not definitively be deduced at the present time. 
 
 
Figure 4.47 – 2D NOESY spectrum of B. pseudomallei 576 LPS in micelles. 
The 2D homonuclear 1H-1H correlation NMR spectrum was acquired on a Bruker Avance III 600 MHz spectrometer equipped 
with a TXI/TCI cryoprobe in 100% D2O. Spin systems of respective monosaccharide residues are shown in colour, whilst new 
chemical shifts, not previously seen in the 2D TOCSY experiments are highlighted in green, suggesting possible correlation to 
a different spin system/monosaccharide. 
 
184 
 
Chapter 4  B. pseudomallei 576 LPS analysis 
A 2D heteronuclear HSQC-TOCSY was run for the mixed DPC-LPS-micelles of B. pseudomallei 576. Again, 
it is important to note that the data collected up to the time of submission of this thesis, does not allow for full 
assignment of spin systems or characterisation of the O-antigen repeat unit, however, an attempt was made 
to propose a possibility that sustains the proposed O-antigen repeat structure from mass spectrometric 
analyses. The heteronuclear HSQC-TOCSY run for the mixed DPC-LPS-micelles of B. pseudomallei 576 is 
shown in Figure 4.48. The coloured lattice assignment is presented to show the partially annotated total 
correlation lattice of the proposed tentative β-glucose moiety. 
 
 
Figure 4.48 – 2D HSQC-TOCSY spectrum of B. pseudomallei 576 LPS in micelles. 
The 2D heteronuclear 1H-13C total correlation NMR spectrum was acquired on a Bruker Avance III 600 MHz spectrometer 
equipped with a TXI/TCI cryoprobe in 100% D2O. The coloured lattice assignment (blue) shows the partial correlations of the 
proposed β-glucose spin system. 
 
Assessment of the 2D heteronuclear HSQC-TOCSY NMR spectrum shown in Figure 4.48, presented the 
opportunity to allocate carbon chemical shifts to the proposed monosaccharides that were identified in the 
TOCSY spectra, to further assign the proposed possible O-antigen repeat unit structure, as is presented in 
Figure 4.36. The information collected in Table 4.6 is only one of a few possibilities of structural 
assignments that can be deduced from the present data, and should not be construed as definite. Further 
data collection and experiments are required to support any claims to this proposed structure. 
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Sugar residue H/C Reference 
 
C →2,3)-α-Rha-(1→ 
5.16 4.18 4.12 4.00 3.69 1.2-1.4  
(Czerwicka et al., 2011) 5.18 4.19 3.96 3.71 3.51 1.27 
99.1  69.8 67.5 72.1  
101.4 78.0 75.9 70.2 72.8 17.1 
 
E →2)-α-Rha-(1→ 
 
5.00 4.20 3.76 3.57 3.43 1.2-1.4  
(Gaur et al., 1998) 4.97 4.19 3.89 3.84 3.57 1.31 
102.5 70.0 76.3 72.1 69.6  
102.4 70.3  78.3   
 
G →3)-β-Glc-(1→ 
4.52 3.93 3.63 3.47 3.30 3.21  
(Perry et al., 1995) 4.62 3.62 3.49 3.47 3.45 3.75/3.86 
103.3 73.8 75.6 75.5 72.7 73.8 
102.4 82.7 68.7 74.8 76.6 61.5 
 
B →t)-β-Xyl-(1→ 
4.43 3.64 3.44 3.31    
(Molinaro et al., 2003) 4.55 3.69 3.45 3.33 3.37/3.91  
103.3 75.6 72.7 75.6   
105.5 71.5 77.8 75.6 65.5  
Table 4.6 – Full tentative assignment of the chemical shifts of the B. pseudomallei 576 LPS O-antigen. 
The table shows the proposed H/C and monosaccharide residue assignments for the O-antigen of the B. pseudomallei 576 
LPS and the associated reference signals from published data (italics). The signals were identified from the 1D proton NMR 
spectrum, the 2D TOCSY NMR spectra as well as the 2D HSQC-TOCSY NMR spectrum shown in Figure 4.42, Figure 4.43, 
Figure 4.46 and Figure 4.48, respectively. The values are to two decimal places but can vary by a decimal place within the 
spectra due to the difficulty of calibration at low resolution. 
 
4.4.4 Summary and discussion of NMR analysis of LPS 
 
The NMR data presented in this section, albeit not conclusive, provided further steps in the full structural 
elucidation of the O-antigen repeat unit of the B. pseudomallei 576 LPS. The NMR spectra obtained from 
hydrolysed and purified O-antigen repeat units as prepared for mass spectrometric analysis, proved difficult 
for de novo interpretation of the data as the signals were too complex owing to the heterogeneous nature of 
the hydrolysed sample. This brought about the search for further methods to analyse the LPS in its natural 
environment and research conducted, culminated in the development of a method embedding the LPS 
moieties into mixed-DPC-LPS micelles for analysis on soluble LPS. This technique was initially tested in a 
pilot study revealing concurrent results for an industrially acquired LPS of E. coli serotype O26, allowing for 
the structural determination of the LPS O-antigen. 
 
The B. pseudomallei LPS embedded in micelles was further analysed by NMR using various 1D and 2D 
experiments. The NMR study fell short of definitive structural characterisation, as only partial information 
could be deduced from the sample. Problems underlying complete data collection were reflected by micelle 
amalgamation during repeat purification and deuterium exchange of samples. Furthermore, the resultant size 
of these macromolecular complexes diminished resolution and multiplicity as required for identification of the 
fine structure of any polysaccharide. No sequence information could be deduced from the interpreted data. 
The data accumulated in this series of experiments can be returned to for interpretation, once the micelle 
method has been further optimised with appropriate planning and more information is gathered about the 
structure of the O-antigen repeat unit. 
 
However, certain proposals on the O-antigen repeat unit structure as suggested by mass spectrometric data 
(Section 4.2 and Section 4.3) could be emphasized and supported, such as the presence of glucose in the 
repeat unit structure, which is reminiscent of the hexose present in the B. pseudomallei K96243 LPS, 
whereas the replacement of deoxytalose with rhamnose is explained in Section 4.2.5. 
186 
 
Chapter 4  B. pseudomallei 576 LPS analysis 
Anomeric resonances identified by 1D proton NMR along with assignment of their respective spin systems 
using TOCSY experiments and further investigation of their NOESY and HSQC-TOCSY spectra proposed 
partial insight into the monosaccharides comprised in the O-antigen repeat unit of B. pseudomallei 576. In an 
attempt to extract as much information of current data as possible a plausible presentation of the O-antigen 
repeat unit is proposed in Figure 4.49. This provides a likely organisation of the O-antigen repeat unit in B. 
pseudomallei 576, as was previously suggested to be a possibility from mass spectrometric MALDI-MS/MS 
data. 
 
 
Figure 4.49 – Proposed structural repeat unit of the O-antigen of B. pseudomallei 576 LPS. 
 
When considering the suggested linkages inferred from the NMR data presented in this section, the complex 
chromatogram of the initial linkage analysis needs to be considered (Section 4.2.3). The proposed structure 
reflects selected linkage data consistent with the GC-MS data; however some linkage chromatogram peaks 
were discounted for a variety of reasons, including the presence of signals arising from core domain linkages 
as well as the possibility of partial O-acetylation as is commonly observed in O-antigen and core 
polysaccharides of bacteria. The core polysaccharide was found to contain a series of monosaccharides 
including rhamnose, hexose, mannoheptose as well as Kdo and Ko. The presence of rhamnose and hexose 
in the core domain allows for some allocation of less prominent linkage peaks to such core domain linkages, 
including 4-linked, 3-linked and terminal deoxyhexose peaks, along with 6-linked, terminal and 2,6-linked 
hexose peaks in Figure 4.10. Furthermore, the unassigned anomeric signals and their spin systems 
corresponding to spin systems D and F in Table 4.4 and Table 4.5, contain H-2 signals with relatively high 
values above 4ppm, characteristic of rhamnose residues. The identification of these further signals as arising 
from rhamnose systems, presents additional explanation for the complexity of the linkage chromatogram and 
the presence of uninterpreted signals. This further highlights the tentative nature of the O-antigen repeat unit 
proposal, for which the most convincing data was chosen. Moreover, it is clear from NMR data that the O-
antigen repeat unit is further modified by partial O-acetylation, which presents another reason for the 
complexity of the linkage data in Section 4.2.3. Natural acetylation of any monosaccharide residue would 
affect its linkage mass fingerprint, such that more linkages than are present could be induced. 
 
The four-monosaccharide repeat unit structure of B. pseudomallei 576 would be double the two-
monosaccharide (glucose-deoxytalose) repeat unit structure of the O-antigen found in B. pseudomallei 
K96243. This seems consistent with the silver stain ladder profiles of the two serotypes, where B. 
pseudomallei 576 (serotype B) shows larger distance between the rungs in comparison with the B. 
pseudomallei K96243 (serotype A) profile as shown on in Figure 1.10. 
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The technique devised for NMR analysis of intact soluble LPS molecules as embedded in micelles, is not 
deemed to be at fault for the incomplete data analysis if starting samples of utmost purity are investigated. 
As far as is known, the method developed here has not previously been used for structural analysis of LPS 
by NMR and thus needs further optimisation, which was not possible to the desired extent for the work 
presented in this thesis. Fine-tuning of the method, however, would assess the mixed micelle sizes as 
related to tumbling in solution and resolution, as well as DPC-LPS-micelle ratios. LPS molecules will form 
micelles in vivo in respective solvents, which would be another avenue to be explored in the complete 
elucidation of the LPS O-antigen of B. pseudomallei 576. 
 
4.5 CURRENT APPROACHES TO GLYCOCONJUGATE VACCINE CREATION 
 
Genome sequencing has provided the springboard for new insights into the relatedness of B. pseudomallei, 
B. thailandensis and B. mallei, as well as their potential virulence factors and vaccine candidates, but 
vaccine creation requires a clearer understanding of the complexity of the lifestyle of the bacteria, their 
survival in the host and environment as well as the history of infection and disease (Bondi and Goldberg, 
2008). 
 
The nature of the bacteria, capable of residing in the vacuoles of eukaryotic cells, complicates antibiotic 
treatment and highlights the need to generate cell-mediated immunity to combat the infection (Stevens et al., 
2005). The eradication of B. pseudomallei was proposed to be dependent on the induction of a Th1 type 
immune response at the onset of melioidosis, because even in the presence of protective humoral 
antibodies, B. pseudomallei was found to still be able to invade epithelial or phagocytic cells, which resulted 
in a long term intracellular latent infection before relapse occurred many years later (Healey et al., 2005, 
Jones et al., 1996, Bondi and Goldberg, 2008). Sterile immunity has rarely been reported other than at very 
low challenge doses and bacteria were isolated from mice that were alive at the end of these studies, 
suggesting that antibodies, though able to delay the onset of disease, were not able to completely eradicate 
the infection (Sarkar-Tyson et al., 2009). 
 
Various vaccination strategies are being investigated with regards to B. pseudomallei induced melioidosis. 
Significant protection could be demonstrated in animal models, following vaccination with attenuated strains 
of B. pseudomallei (Haque et al., 2006a). The use of dendritic cells as a delivery vector was investigated by 
Healey and colleagues, whilst Chen and co-workers explored the use of a DNA vaccine against the fliC 
flagellin structural gene and the use of conjugate vaccines with CPS and LPS has been under investigation 
by Brett and Nelson and their teams (Nelson et al., 2004, Brett and Woods, 1996). 
 
4.5.1.1 Whole-cell vaccines for B. pseudomallei 
 
The creation of non-viable, whole-cell bacterial preparations have traditionally represented a starting point in 
the development of vaccines and have been shown to be effective in the prevention of cholera, typhoid fever, 
whooping cough, anthrax and plague (Bondi and Goldberg, 2008). This technique was employed against B. 
mallei in BALB/c mice and showed immune responses with cytokines (IFN-γ, IL-4 and IL-10), however the 
mice seemed to be unable to generate a directed Th1 or Th2-like response (Amemiya et al., 2002). Heat-
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inactivated B. pseudomallei immunogens have also been found to provide some protection in the mouse 
model of infection (Barnes and Ketheesan, 2007, Sarkar-Tyson et al., 2009). Immunisation with killed whole 
cell vaccines provided protection against subsequent challenge with B. pseudomallei in mice, however, 
similar to the B. mallei model, sterile immunity was difficult to achieve. One approach to overcome this 
problem and to enhance the protective response induced by inactivated preparations, was to combine them 
with immune adjuvants that promote the production of Th1 and proinflammatory cytokines as well as the 
maturation and activation of professional antigen-presenting cells (Elvin et al., 2006). 
 
4.5.1.2 Live-attenuated vaccines for B. pseudomallei 
 
Various vaccination strategies that have been investigated have demonstrated the necessity of a cell-
mediated immune response in conjunction with a humoral response to successfully clear infection by B. 
pseudomallei. This mechanism of immunity was explored by Haque and colleagues where IFN-γ was found 
to be important for protection against acute sepsis in mice. Immunisation with live immunogens was reported 
to activate antigen-specific CD4+ T cells which produced high levels of IFN-γ, placing high importance on 
IFN-γ (Haque et al., 2006a, Haque et al., 2006b, Santanirand et al., 1999). To determine the roles of specific 
T cells in protection, immunised mice were depleted of CD4+ and CD8+ T cells before and after B. 
pseudomallei challenge. CD4+ T cell depleted mice were substantially more susceptible to infection 
compared to controls, whereas CD8+ T cell depletion had no effect on the vaccine mediated protection, 
suggesting that protection generated by this vaccine is mediated by CD4+ T cells only (Atkins et al., 2002, 
Easton et al., 2007, Haque et al., 2006a). The vaccinated mice, however, were unable to completely clear 
challenge infection, even in the presence of both CD4+ and CD8+ cells, further suggesting the necessity of 
cytotoxic T lymphocytes to clear the host cells (Haque et al., 2006b). 
 
Bacterial polysaccharides have been found to be potent stimulators of the host immune system and 
response, thus have previously represented a critical component of subunit and conjugate vaccines for 
clinically relevant diseases including Haemophilus influenza type b, Pneumococcal and Meningococcal 
infections (Bondi and Goldberg, 2008). 
 
LPS have been shown to be an immunodominant antigen, as recognised in patients infected with B. 
pseudomallei, where  anti-LPS antibodies were found at higher levels in surviving patients and those with 
nonsepticaemic melioidosis as compared to those with septicaemic melioidosis and those that died 
(Wiersinga et al., 2006). This suggests that antibodies raised against this antigen, may protect the host from 
death, prompting a more efficient host immune response including cell-mediated killing, thus making this a 
noteworthy potential approach to vaccine development. The capsular polysaccharide of B. pseudomallei was 
also shown to be an important virulence determinant in Syrian golden hamsters and BALB/c mice (Perry et 
al., 1995, Reckseidler et al., 2001). Both LPS and CPS were evaluated as subunit vaccine candidates 
against B. pseudomallei by Nelson and colleagues; however protection by this procedure was not complete 
(Nelson et al., 2004). 
It was suggested that the antibodies were most likely directed against these cell-surface polysaccharide of B. 
pseudomallei, as the passive transfer of polyclonal sera against the antigens into naive mice was found to 
double their survival time after subsequent challenge. Nelson and co-workers used LPS and CPS to 
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immunise BALB/c mice, where the polysaccharide antigens induced varying antibody responses. LPS 
vaccinated mice mostly developed IgM and IgG3 responses, whilst CPS vaccinated mice developed mainly 
IgG2b responses. When challenged by intraperitoneal injection, mice exhibited the highest level of protection 
upon immunisation with LPS, where 50% survival was seen at the last day of monitoring (day 35), with a 
mean time to death (MTTD) of 17.6 days. Mice immunised with CPS also showed increased MTTD, however 
exhibited 100% mortality by day 28. 
 
The use of polysaccharides to achieve active immunity was shown to provide some, but not comprehensive 
protection against experimental murine melioidosis via the intraperitoneal route and the polysaccharide 
moiety would have to be complemented with a protein subunit to stimulate the protective cell-mediated 
immune response, thus increasing the efficiency of the subunit vaccine (Nelson et al., 2004). It was further 
suggested that the natural exposure to B. thailandensis in melioidosis endemic areas and the subsequent 
development of an antibody response without overt infection, may also provide protection against melioidosis 
(Nelson et al., 2004). 
 
Studies presented in this thesis with our collaborators at the Defence Science and Technology Laboratory 
(dstl), showed that LPS from B. thailandensis provided protection against a lethal challenge of B. 
pseudomallei in a mouse model of melioidosis (Section 4.2). Sugar analysis of the LPS from B. 
thailandensis E264 confirmed similar composition and structures of the O-antigen (Figure 4.12, Figure 4.13 
and Figure 4.14). This was also suggested by the ladder profile on a silver stained LPS (Figure 1.10), 
showing the O-antigen polysaccharide had a similar structure to that of the LPS of B. pseudomallei K96243, 
bar the capsule and O-methylation discussed previously (Section 1.3.4.2). This addresses the importance of 
understanding the structure of the various O-antigens present in the B. pseudomallei strains for a 
comprehensive subunit based vaccine creation. Immunisation of BALB/c mice with both B. thailandensis and 
B. pseudomallei LPS provided similar levels of protection upon a challenge with a lethal dose of B. 
pseudomallei K96243, suggesting the use of B. thailandensis LPS as a potential candidate to make up a 
subunit vaccine against pathogenic B. pseudomallei. Mice immunised with the LPS from B. thailandensis 
showed 50% survival, compared to 66% survival of the mice immunised with B. pseudomallei LPS. The 
mean time to death (MTTD) of naive mice was 2.2 days, whilst the MTTD of mice immunised with B. 
thailandensis and B. pseudomallei LPS was 32.8 and 31.5 days respectively. The production of B. 
thailandensis is associated with reduced costs and hazards and thus was suggested to present a very 
suitable molecule to be studied regarding the development of a vaccine against melioidosis infection (Ngugi 
et al., 2010). 
 
This phenomenon is reflected in geographical epidemiology studies, that found that the rate of the closely 
related but less virulent B. thailandensis, may account for the variation in disease throughout Southeast Asia 
and may also account for the much higher rates of seropositivity seen in Thailand compared to the areas of 
endemicity of northern Australia (Trakulsomboon et al., 1999). This is further supported by the high 
prevalence of melioidosis in the Issan region of north-eastern Thailand, which contrasts with low prevalence 
in Laos to the east of the Mekong River and in Cambodia further south (Phetsouvanh et al., 2001). Despite 
the recovery of B. pseudomallei from soil isolates in the Vientiane region, only a handful of cases are 
registered in Laos (Wuthiekanun et al., 2005). This paradox could be explained by the uncertainty associated 
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with the seropositivity rates in Southeast Asia, which may represent exposure to the less pathogenic B. 
thailandensis (White, 2003). 
 
The effectiveness of live attenuated vaccines depends both on the number of different antigens presented 
and on the ability to stimulate both the antibody and cell-mediated arms of the immune system. The 
likelihood of an effective live attenuated vaccine against B. pseudomallei being developed may be limited by 
the bacterium’s potential to establish a persistent infection. Successful development of such vaccines may 
depend on gaining a fuller understanding of the genetic basis underlying latency and how this can be 
effectively disabled (Sarkar-Tyson and Titball, 2010). LPS and CPS of B. pseudomallei have been suggested 
to be protective antigens and important determinants of virulence, however, even though CPS and LPS 
show promise as vaccine candidates, immunisation with these antigens alone does not appear to provide 
complete protection against disease or sterile immunity (Sarkar-Tyson et al., 2007). 
 
4.5.1.3 Vaccines aimed at other B. pseudomallei antigens 
 
Patients recovering from melioidosis presented antibodies that reacted with B. pseudomallei proteins, 
including the lipoprotein-releasing system transmembrane protein (LolC), an adenosine triphosphate-binding 
cassette transporter protein and two outer membrane proteins (OmpAs) of B. pseudomallei that reacted with 
melioidosis (Hara et al., 2009, Harland et al., 2007). The potential of inducing protective immunity after 
immunisation with individual B. pseudomallei antigens is there, but it has become clear that single 
component vaccines, at least delivered as a purified polysaccharide or protein, will not provide complete 
protection against disease and polysaccharide conjugate vaccines as well as DNA vaccines are being 
investigated. 
 
Flagella have been implicated in cell invasion of phagocytic and nonphagocytic cells (Chuaygud et al., 2008) 
and electron microscopy studies have demonstrated the presence of flagella and the variable expression of 
pili on B. pseudomallei (Vorachit et al., 1995). Mutagenesis screens for genes involved in motility of the 
bacterium identified 19 unique genetic loci (DeShazer et al., 1997), whilst bioinformatic analysis of the 
K96243 genome of B. pseudomallei identified 13 gene clusters predicted to be involved in the synthesis of 
type I fimbria, type IV pili and Tad-like pili (Holden et al., 2004). The flagella of clinical and environmental B. 
pseudomallei isolates are antigenically conserved and polyclonal rabbit antisera raised against flagellin or a 
flagellin polysaccharide antigen conjugate passively protected infant diabetic rats from challenge with B. 
pseudomallei (DeShazer et al., 1997). The flagella of a range of different bacterial species have been shown 
to have a role in virulence, through either motility directly or adherence. DNA vaccines are potent stimulators 
of both humoral and cell-mediated immunity. Candidate DNA vaccines against melioidosis have been 
investigated based on the ability to promote cell-mediated immunity. Studies on the B. pseudomallei flagellar 
subunit gene fliC have shown that the FliC naked DNA resulted in the induction of both antibody and cell-
mediated responses, and reduced the number of bacteria found in the liver and spleen of challenged mice as 
compared to the control mice (Chen et al., 2006). The potency of this naked DNA construct was further 
improved by incorporating CpG oligodeoxynucleotide motifs into the DNA plasmid/fliC construct. 
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On the basis of investigating the genes encoding the known immunogenic outer membrane proteins of B. 
pseudomallei, outer membrane protein A (OmpA) was assessed as a potential candidate for vaccine targets 
using a bioinformatics based approach. OmpA’s are known to be virulence factors in bacterial pathogenesis 
and are capable of inducing both humoral and cytotoxic responses (Kim et al., 2000). Out of the 12 ORFs 
assessed, two OmpAs (Omp3 and Omp7) were successfully cloned, expressed as soluble proteins and 
purified. They were found to induce 50% protection upon immunisation with the respective OmpA via the 
intraperitoneal route, examined over 21 days post-challenge (Hara et al., 2009). 
 
The immunogenicity of bacterial polysaccharides can be improved by covalently linking them to protein 
carriers to form a conjugate. Polysaccharide-protein glycoconjugates work by promoting T-cell-dependent 
immune responses, thus enhancing immunologic memory (Jones, 2005, Wuorimaa et al., 2001). Glycomic 
research is now opening doors for carbohydrate vaccine researchers to better tackle the challenges inherent 
to carbohydrate vaccine development and to expand the field to encompass a broader spectrum of diseases 
(Astronomo and Burton, 2010). 
 
4.6 FUTURE DIRECTIONS 
 
Efforts made into the structural elucidation of the B. pseudomallei 576 LPS, although incomplete, have 
nevertheless provided a plausible identification of the structural repeat unit of the O-antigen. Mass 
spectrometric data allowed for determination of the monosaccharides comprised in the O-antigen repeat unit, 
as well as provided structural information on the constitution of the O-antigen repeat unit resulting in the 
proposal of a series of possibilities. The complementing NMR analyses conducted have not yet produced 
evidence of the explicit configuration of said O-antigen repeat unit, but have provided valuable insight into 
the methods employable and the analytical strategies to finalise such a goal. 
 
Further experimentation on the side of the mass spectrometric approach in such complete structural 
characterisation will focus on the further modifications decorating most bacterial O-antigen and that have 
been evident throughout the strategies employed in this research. Bacterial core and O-antigen 
polysaccharides are commonly further modified by acetyl, methyl or phosphate groups. The presence of 
phosphates on the core or O-antigen polysaccharides can be investigated by dephosphorylation with 
hydrofluoric acid (HF), which has been shown to selectively remove phosphate and phosphate linked 
moieties that are then lost during purification upon derivatisation of the samples (Prehm et al., 1975). 
Comparison of samples treated or untreated with such dephosphorylation techniques will provide insight into 
this modification. Comparisons of de-O-acylated and untreated samples can also further give insight into the 
presence of acetylation on specific monosaccharides. 
 
Although mass spectrometry is an invaluable tool for structural characterisation, limitations to the complete 
elucidation of LPS include the anomeric configuration of individual sugars and the location within a molecule 
of sugar epimers. Generally such determination is investigated using NMR, but the possibility of the 
determination of the anomeric configuration exist in the form of commercially available enzymes, which are, 
on the other hand, largely unavailable for the vast array of bacterial sugars. The determination of absolute 
configuration of the monosaccharides (D- and L-) can be achieved in an adjusted method, where hydrolysis 
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occurs in the presence of butanolic-HCl prior to TMS derivatisation and GC-MS analysis in the presence of 
standards. 
 
The method devised for LPS analysis by NMR in creating mixed-DPC-LPS micelles is still in its infancy and 
will further need to be fine-tuned with regards to avoid tumbling and resolution problems faced in the series 
of experiments described in this thesis, due to micelle coagulation and the creation of macromolecular 
complexes that prevent the accumulation of information on the multiplicity of the polysaccharide investigated. 
Further experiments not attempted at the present time will include heteronuclear multiple-bond spectroscopy 
(HBMC), which allows for correlation of 1H and 13C atoms separated by several chemical bonds, thus 
allowing for sequence information over the glycosidic linkages and allowing for unequivocal determination of 
linkage positions of the B. pseudomallei 576 LPS. 
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5 OVERVIEW AND CONCLUDING REMARKS 
 
This thesis documents two related projects, where high sensitivity methodologies including mass 
spectrometry and nuclear magnetic resonance were employed and developed with the aim of characterising 
bacterial and archaeal glycopolymers. Appropriate structural analysis methods were exploited for the 
evaluation of prokaryotic problems with the focus on the LPS O-antigen of B. pseudomallei 576 and the S-
layer glycoprotein of the halophilic archaeon H. volcanii. The projects documented in this thesis demonstrate 
sample and goal specific strategies employed in order to gain further understanding of glycosylation in 
prokaryotic organisms. 
 
The first project, discussed in Chapter 3, used a series of complementary high sensitivity mass 
spectrometric methods to unambiguously demonstrate the sequence fidelity as well as site-specific N-
glycosylation pattern of the S-layer glycoprotein of H. volcanii. Glycosylation composition, location as well as 
insight into a further putative post-translational modification of the protein were also investigated. Such 
methods coupled with biological experiments in genomics and proteomics, further allowed for functional 
characterisation of several agl genes in the agl gene cluster of H. volcanii providing more insight into the N-
glycan biosynthetic pathway in archaea. These investigations demonstrated the diversity of mass 
spectrometry as a technology that can be exploited to achieve a variety of different goals addressing 
biological and structural problems. 
 
Investigations using GC-MS and MALDI-MS/MS led to evidence for the composition of the glycan moieties 
present on the S-layer glycoprotein as well as the confirmation of the O-glycan present, highlighting the 
necessity for enzymatic and chemical methods appropriate for each glycosylation type in prokaryotes. 
Functional characterisation by MALDI-MS of the pentasaccharide N-glycan decorating the first glycosylation 
site, provided insight into three further agl genes from the agl gene cluster, responsible for such N-
glycosylation, demonstrated the importance of the rapport between genomic experimentation and mass 
spectrometric mapping, in order to get an overview of the N-glycosylation biosynthesis process in archea. 
This work sparked further interest in the overall site-specific occupation of this N-glycan throughout the S-
layer glycoprotein. A host of different protein degradation, separation and mass spectrometric ionisation 
techniques, including MALDI-MS/MS, ESI-MS/MS and MSE, were employed to create a comprehensive map 
of the S-layer glycoprotein, with the exception of the C-terminal domain. Six out of seven predicted N-
glycosylation consensus sites were mapped and found to be occupied with the same pentasaccharide N-
glycan together with its biosynthetic precursors. The use of various analysis techniques specifically matched 
to the differences in biologically and chemically prepared samples, exhibits the multifaceted applications of 
mass spectrometry. 
 
The problems encountered in the profiling of the C-terminal region, which includes the final N-glycosylation 
site, a threonine-rich region with expected O-glycosylation as well as a putative membrane spanning domain, 
pushed investigations into the direction of characterising a potential lipid modification of the S-layer 
glycoprotein. With the objective geared towards providing definitive proof of previously proposed covalent 
lipid modification, mass spectrometric techniques were fine-tuned and a structural, high sensitivity approach 
was employed, different from the biological experiments that gave rise to such suggestions. No such 
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validations could be made on the current sample preparations, opening the debate on possibilities of such 
lipid association or the mechanisms by which these could occur. Other than accumulating information on 
protein glycosylation in the H. volcanii S-layer and thus providing further understanding of this process in 
archaea, these studies raised further intriguing questions specific to archaeal mechanisms of glycoprotein 
modification, lipid anchoring of the protein in the lipid bilayer, as well as creating a basis for investigation of 
glycosylation in halophiles as a mechanism for adaption to variations in environments. 
 
The second project sought to characterise the structure of the O-antigen repeat unit of the serotype B LPS of 
an atypical strain of B. pseudomallei, a pathogen that is the causative agent of melioidosis. Chapter 4 
describes the O-antigen structural information that emerged from several chemical and derivatisation 
techniques teamed with high sensitivity mass spectrometric techniques as well as a novel approach to 
nuclear magnetic resonance for LPS analysis. Various sample handling methods were employed and 
devised, including new hydrolysis techniques for investigation of the O-antigen repeat unit for analysis by 
mass spectrometry, as well as creating a new approach for LPS analysis by NMR, which involved 
embedding the LPS into micelles. Mass spectrometry and nuclear magnetic resonance techniques are 
complementary approaches allowing for the accumulation of different information on the investigated sample 
for structural characterisation. 
 
The results of this work are aiding the development of a comprehensive glycoconjugate vaccine. In the 
structural characterisation of LPS, no specific approach is commonly employed and methods have to be 
improved, modified and adapted to the unknown LPS under investigation, as only little is known on the 
structural biosynthesis of O-antigen units of the LPS in different bacteria. This is further complicated by the 
many variations in further modifications that monosaccharide repeat units can undergo. However, the 
importance of correct structural assignment of O-antigens, inclusive of further modifications by methylation, 
phosphorylation or acetylation is not to be underestimated when the final aim of such structural 
characterisation lies with the creation of an all-encompassing glycoconjugate vaccine. This warranted a 
multi-faceted approach exploring several avenues for investigation, resulting in a range of techniques 
explored throughout this project with the purpose of producing suitable sample preparations analysable by 
mass spectrometry. 
 
The development of a procedure circumventing such difficulties in hydrolysis techniques tailored to the 
structure of the LPS, was proposed in Section 4.4, when the LPS was embedded in micelles for analysis by 
multi-dimensional NMR. This technique permits LPS analysis without degradation allowing assessment of all 
further glycan modifications and avoiding the limitations encountered with other techniques, where 
degradation could lead to the loss of glycan modifications during sample preparation. This technique, albeit 
in its infancy, when further fine-tuned can be applied to any phenol extracted LPS moiety, due to the relative 
similarity of lipid A properties across the board and thus presents enormous potential. 
 
Substantial progress has been made in each of the above projects. Nevertheless the findings presented in 
this thesis are not complete, but further directions in each project are discussed in Section 3.8 and Section 
4.6, which describe current issues to be addressed in future work in order to round off these investigations. 
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Researchers are only now beginning to appreciate the variety of prokaryotes capable of protein glycosylation 
and the wider range of monosaccharides found in the glycan moieties of prokaryotic glycoproteins. Studying 
glycosylation in relatively less-complicated prokaryotic systems provides the opportunity to elucidate and 
exploit glycoprotein and lipopolysaccharide biosynthetic pathways. A review of the genetic organisation, 
glycan structures and function of glycosylation systems in prokaryotes may help us to understand 
glycosylation processes in more complex eukaryotic systems and how these can be used for 
glycoengineering. Continued investigation into the bacterial N-glycosylation and O-glycosylation process will 
advance glycoengineering efforts as well as have therapeutic value in the development of new antibacterial 
agents. A more comprehensive understanding of N-glycosylation and O-glycosylation in archaea also carries 
enormous applied potential, given the possible links between glycosylation of archaeal proteins and their 
ability to withstand diverse physical challenges. Furthermore, such studies give insight into this post-
translational modification across evolution as well as protein processing under extreme conditions. 
 
The field of glycomics in the prokaryotic domain has slightly lagged behind its eukaryotic counterpart, in part, 
due to the unexplored processes underlying glycosylation in archaea and bacteria as compared to the 
established pathways described in eukaryotic cells. The simpler glycosylation systems encountered in 
prokaryotes, however, produce glycopolymers and glycoconjugates of an extremely high complexity in 
composition and structure in relation to those found in eukaryotes. With the advances of molecular biology 
and with improved analytical techniques to some extent described in this thesis, a significant change of 
perception has taken place regarding prokaryotic polysaccharides and glycoproteins. Glycosylation in 
prokaryotes is no longer considered a specific feature of certain organisms but has been demonstrated for 
many archaea and bacteria. 
 
The work described in this thesis has brought together many established techniques and described the 
development of new methods in the field of protein, glycan and lipid characterisation. It is hoped that this 
research, not only allows for the creation of a fully comprehensive glycoconjugate vaccine against B. 
pseudomallei and related melioidosis-causing bacteria, but also provides further insight into glycosylation of 
important archaeal proteins. 
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